<!DOCTYPE html> <html class="js webfonts-loaded" style lang=en><!--
 Page saved with SingleFile 
 url: https://cardiab.biomedcentral.com/articles/10.1186/s12933-018-0746-4 
 saved date: Sun Nov 27 2022 00:13:23 GMT-0500 (Eastern Standard Time)
--><meta charset=utf-8>
<meta http-equiv=X-UA-Compatible content="IE=edge">
<meta name=applicable-device content=pc,mobile>
<meta name=viewport content="width=device-width, initial-scale=1">
<title>Risk of heart failure hospitalization among users of dipeptidyl peptidase-4 inhibitors compared to glucagon-like peptide-1 receptor agonists | Cardiovascular Diabetology | Full Text</title>
<meta name=citation_abstract content="Incretin-based therapies including dipeptidyl peptidase-4 (DPP-4) inhibitors and glucagon like peptide-1 (GLP-1) receptor agonists are novel medications for type 2 diabetes management. Several studies have&nbsp;found cardioprotective effects of incretin-based therapies; however, it remains unclear whether there is any difference in heart failure (HF) risk between the two incretin-based therapies (DPP-4 inhibitors and GLP-1 receptor agonists). We aimed&nbsp;to assess the risk of hospitalization due to HF with the use of DPP-4 inhibitors compared to GLP-1 receptor agonists. Using Truven Health Marketscan data, we conducted a retrospective cohort study of patients with type 2 diabetes, who were newly initiated on DPP-4 inhibitors or GLP-1 agonists. Follow-up continued from drug initiation until the first occurrence of: HF hospitalization (primary outcome),&nbsp;discontinuation of therapy (i.e. no fill for 7 days), switch to the comparator, end of enrollment, or end of study (December 2013). Cox proportional hazards models with propensity-score-matching were used to compare the risk of HF hospitalization between DPP-4 inhibitors and GLP-1 agonists. A total of 321,606 propensity score-matched patients were included in the analysis (n = 160,803 for DPP-4 inhibitors; n = 160,803 for GLP-1 agonists). After adjusting for baseline characteristics and disease risk factors, the use of DPP-4 inhibitors was associated with a 14% decreased risk of HF hospitalization compared to GLP-1 agonists use [hazard ratio (HR), 0.86; 95% confidence interval (CI) 0.83, 0.90]. The results were consistent in patients without baseline HF (HR, 0.85; 95% CI 0.82, 0.89), but the association was not statistically significant for patients with baseline HF (HR, 0.90; 95% CI 0.74, 1.07). In this retrospective matched cohort of patients with type 2 diabetes, the use of DPP-4 inhibitors was associated with a reduced risk of HF hospitalization compared to GLP-1 agonists. However, the association was not statistically significant in patients who had HF prior to the use of DPP-4 inhibitors.">
<meta name=journal_id content=12933>
<meta name=dc.title content="Risk of heart failure hospitalization among users of dipeptidyl peptidase-4 inhibitors compared to glucagon-like peptide-1 receptor agonists">
<meta name=dc.source content="Cardiovascular Diabetology 2018 17:1">
<meta name=dc.format content=text/html>
<meta name=dc.publisher content="BioMed Central">
<meta name=dc.date content=2018-07-17>
<meta name=dc.type content=OriginalPaper>
<meta name=dc.language content=En>
<meta name=dc.copyright content="2018 The Author(s)">
<meta name=dc.rights content="2018 The Author(s)">
<meta name=dc.rightsAgent content=reprints@biomedcentral.com>
<meta name=dc.description content="Incretin-based therapies including dipeptidyl peptidase-4 (DPP-4) inhibitors and glucagon like peptide-1 (GLP-1) receptor agonists are novel medications for type 2 diabetes management. Several studies have&amp;nbsp;found cardioprotective effects of incretin-based therapies; however, it remains unclear whether there is any difference in heart failure (HF) risk between the two incretin-based therapies (DPP-4 inhibitors and GLP-1 receptor agonists). We aimed&amp;nbsp;to assess the risk of hospitalization due to HF with the use of DPP-4 inhibitors compared to GLP-1 receptor agonists. Using Truven Health Marketscan data, we conducted a retrospective cohort study of patients with type 2 diabetes, who were newly initiated on DPP-4 inhibitors or GLP-1 agonists. Follow-up continued from drug initiation until the first occurrence of: HF hospitalization (primary outcome),&amp;nbsp;discontinuation of therapy (i.e. no fill for 7 days), switch to the comparator, end of enrollment, or end of study (December 2013). Cox proportional hazards models with propensity-score-matching were used to compare the risk of HF hospitalization between DPP-4 inhibitors and GLP-1 agonists. A total of 321,606 propensity score-matched patients were included in the analysis (n = 160,803 for DPP-4 inhibitors; n = 160,803 for GLP-1 agonists). After adjusting for baseline characteristics and disease risk factors, the use of DPP-4 inhibitors was associated with a 14% decreased risk of HF hospitalization compared to GLP-1 agonists use [hazard ratio (HR), 0.86; 95% confidence interval (CI) 0.83, 0.90]. The results were consistent in patients without baseline HF (HR, 0.85; 95% CI 0.82, 0.89), but the association was not statistically significant for patients with baseline HF (HR, 0.90; 95% CI 0.74, 1.07). In this retrospective matched cohort of patients with type 2 diabetes, the use of DPP-4 inhibitors was associated with a reduced risk of HF hospitalization compared to GLP-1 agonists. However, the association was not statistically significant in patients who had HF prior to the use of DPP-4 inhibitors.">
<meta name=prism.issn content=1475-2840>
<meta name=prism.publicationName content="Cardiovascular Diabetology">
<meta name=prism.publicationDate content=2018-07-17>
<meta name=prism.volume content=17>
<meta name=prism.number content=1>
<meta name=prism.section content=OriginalPaper>
<meta name=prism.startingPage content=1>
<meta name=prism.endingPage content=9>
<meta name=prism.copyright content="2018 The Author(s)">
<meta name=prism.rightsAgent content=reprints@biomedcentral.com>
<meta name=prism.url content=https://cardiab.biomedcentral.com/articles/10.1186/s12933-018-0746-4>
<meta name=prism.doi content=doi:10.1186/s12933-018-0746-4>
<meta name=citation_pdf_url content=https://cardiab.biomedcentral.com/counter/pdf/10.1186/s12933-018-0746-4>
<meta name=citation_fulltext_html_url content=https://cardiab.biomedcentral.com/articles/10.1186/s12933-018-0746-4>
<meta name=citation_journal_title content="Cardiovascular Diabetology">
<meta name=citation_journal_abbrev content="Cardiovasc Diabetol">
<meta name=citation_publisher content="BioMed Central">
<meta name=citation_issn content=1475-2840>
<meta name=citation_title content="Risk of heart failure hospitalization among users of dipeptidyl peptidase-4 inhibitors compared to glucagon-like peptide-1 receptor agonists">
<meta name=citation_volume content=17>
<meta name=citation_issue content=1>
<meta name=citation_publication_date content=2018/12>
<meta name=citation_online_date content=2018/07/17>
<meta name=citation_firstpage content=1>
<meta name=citation_lastpage content=9>
<meta name=citation_article_type content="Original investigation">
<meta name=citation_fulltext_world_readable content>
<meta name=citation_language content=en>
<meta name=dc.identifier content=doi:10.1186/s12933-018-0746-4>
<meta name=DOI content=10.1186/s12933-018-0746-4>
<meta name=size content=201101>
<meta name=citation_doi content=10.1186/s12933-018-0746-4>
<meta name=citation_springer_api_url content="http://api.springer.com/xmldata/jats?q=doi:10.1186/s12933-018-0746-4&amp;api_key=">
<meta name=description content="Incretin-based therapies including dipeptidyl peptidase-4 (DPP-4) inhibitors and glucagon like peptide-1 (GLP-1) receptor agonists are novel medications for type 2 diabetes management. Several studies have&amp;nbsp;found cardioprotective effects of incretin-based therapies; however, it remains unclear whether there is any difference in heart failure (HF) risk between the two incretin-based therapies (DPP-4 inhibitors and GLP-1 receptor agonists). We aimed&amp;nbsp;to assess the risk of hospitalization due to HF with the use of DPP-4 inhibitors compared to GLP-1 receptor agonists. Using Truven Health Marketscan data, we conducted a retrospective cohort study of patients with type 2 diabetes, who were newly initiated on DPP-4 inhibitors or GLP-1 agonists. Follow-up continued from drug initiation until the first occurrence of: HF hospitalization (primary outcome),&amp;nbsp;discontinuation of therapy (i.e. no fill for 7 days), switch to the comparator, end of enrollment, or end of study (December 2013). Cox proportional hazards models with propensity-score-matching were used to compare the risk of HF hospitalization between DPP-4 inhibitors and GLP-1 agonists. A total of 321,606 propensity score-matched patients were included in the analysis (n = 160,803 for DPP-4 inhibitors; n = 160,803 for GLP-1 agonists). After adjusting for baseline characteristics and disease risk factors, the use of DPP-4 inhibitors was associated with a 14% decreased risk of HF hospitalization compared to GLP-1 agonists use [hazard ratio (HR), 0.86; 95% confidence interval (CI) 0.83, 0.90]. The results were consistent in patients without baseline HF (HR, 0.85; 95% CI 0.82, 0.89), but the association was not statistically significant for patients with baseline HF (HR, 0.90; 95% CI 0.74, 1.07). In this retrospective matched cohort of patients with type 2 diabetes, the use of DPP-4 inhibitors was associated with a reduced risk of HF hospitalization compared to GLP-1 agonists. However, the association was not statistically significant in patients who had HF prior to the use of DPP-4 inhibitors.">
<meta name=dc.creator content="Dawwas, Ghadeer K.">
<meta name=dc.creator content="Smith, Steven M.">
<meta name=dc.creator content="Park, Haesuk">
<meta name=dc.subject content=Diabetes>
<meta name=dc.subject content=Angiology>
<meta name=dc.subject content=Cardiology>
<meta name=citation_reference content="citation_journal_title=Diabetes Care; citation_title=DPP-4 inhibitors and heart failure: some reassurance, some uncertainty; citation_author=KB Filion, S Suissa; citation_volume=39; citation_issue=5; citation_publication_date=2016; citation_pages=735-737; citation_doi=10.2337/dci15-0036; citation_id=CR1">
<meta name=citation_reference content="citation_journal_title=Ann Intern Med; citation_title=Risk for hospitalized heart failure among new users of saxagliptin, sitagliptin, and other antihyperglycemic drugs: a retrospective cohort study; citation_author=S Toh, C Hampp, ME Reichman; citation_volume=164; citation_issue=11; citation_publication_date=2016; citation_pages=705-714; citation_doi=10.7326/M15-2568; citation_id=CR2">
<meta name=citation_reference content="citation_journal_title=J Clin Endocrinol Metab; citation_title=Mechanism of action of DPP-4 inhibitors–new insights; citation_author=A Vella; citation_volume=97; citation_issue=8; citation_publication_date=2012; citation_pages=2626-2628; citation_doi=10.1210/jc.2012-2396; citation_id=CR3">
<meta name=citation_reference content="citation_journal_title=BMJ; citation_title=Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: Systematic review and meta-analysis of randomised and observational studies; citation_author=L Li, S Li, K Deng; citation_volume=352; citation_publication_date=2016; citation_pages=i610; citation_doi=10.1136/bmj.i610; citation_id=CR4">
<meta name=citation_reference content="citation_journal_title=Ther Adv Drug Saf; citation_title=Safety of dipeptidyl peptidase 4 inhibitors: a perspective review; citation_author=T Karagiannis, P Boura, A Tsapas; citation_volume=5; citation_issue=3; citation_publication_date=2014; citation_pages=138-146; citation_doi=10.1177/2042098614523031; citation_id=CR5">
<meta name=citation_reference content="citation_journal_title=N Engl J Med; citation_title=Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus; citation_author=BM Scirica, DL Bhatt, E Braunwald; citation_volume=369; citation_issue=14; citation_publication_date=2013; citation_pages=1317-1326; citation_doi=10.1056/NEJMoa1307684; citation_id=CR6">
<meta name=citation_reference content="citation_journal_title=Eur Heart J Cardiovasc Pharmacother; citation_title=Assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversion; citation_author=F Zannad, WG Stough, RJ Lipicky; citation_volume=2; citation_issue=3; citation_publication_date=2016; citation_pages=200-205; citation_doi=10.1093/ehjcvp/pvw007; citation_id=CR7">
<meta name=citation_reference content="citation_journal_title=N Engl J Med; citation_title=Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes; citation_author=JB Green, MA Bethel, PW Armstrong; citation_volume=373; citation_issue=3; citation_publication_date=2015; citation_pages=232-242; citation_doi=10.1056/NEJMoa1501352; citation_id=CR8">
<meta name=citation_reference content="Food and Drug Administration. FDA drug safety communication: FDA adds warnings about heart failure risk to labels of type 2 diabetes medicines containing saxagliptin and alogliptin. US Food and Drug Administration Web site. 
                    https://www.fda.gov/Drugs/DrugSafety/ucm486096.htm
                    
                  . Updated 2016. Accessed 04 Apr 2018.">
<meta name=citation_reference content="citation_journal_title=Diabetes Care; citation_title=Association between hospitalization for heart failure and dipeptidyl peptidase 4 inhibitors in patients with type 2 diabetes: an observational study; citation_author=AZ Fu, SS Johnston, A Ghannam; citation_volume=39; citation_issue=5; citation_publication_date=2016; citation_pages=726-734; citation_doi=10.2337/dc15-0764; citation_id=CR10">
<meta name=citation_reference content="citation_journal_title=Diabetes Care; citation_title=8. pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2018; citation_author=; citation_volume=41; citation_issue=Suppl 1; citation_publication_date=2018; citation_pages=S73-S85; citation_doi=10.2337/dc18-S008; citation_id=CR11">
<meta name=citation_reference content="citation_journal_title=Int J Clin Pract; citation_title=GLP-1 receptor agonists vs. DPP-4 inhibitors for type 2 diabetes: Is one approach more successful or preferable than the other?; citation_author=S Brunton; citation_volume=68; citation_issue=5; citation_publication_date=2014; citation_pages=557-567; citation_doi=10.1111/ijcp.12361; citation_id=CR12">
<meta name=citation_reference content="citation_journal_title=JAMA; citation_title=Association between use of sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide 1 agonists, and dipeptidyl peptidase 4 inhibitors with all-cause mortality in patients with type 2 diabetes: a systematic review and meta-analysis; citation_author=SL Zheng, AJ Roddick, R Aghar-Jaffar; citation_volume=319; citation_issue=15; citation_publication_date=2018; citation_pages=1580-1591; citation_doi=10.1001/jama.2018.3024; citation_id=CR13">
<meta name=citation_reference content="citation_journal_title=Pharmacoepidemiol Drug Saf; citation_title=A systematic review of validated methods for identifying heart failure using administrative data; citation_author=JS Saczynski, SE Andrade, LR Harrold; citation_volume=21; citation_issue=Suppl 1; citation_publication_date=2012; citation_pages=129-140; citation_doi=10.1002/pds.2313; citation_id=CR14">
<meta name=citation_reference content="citation_journal_title=Pharmacoepidemiol Drug Saf; citation_title=A protocol for active surveillance of acute myocardial infarction in association with the use of a new antidiabetic pharmaceutical agent; citation_author=B Fireman, S Toh, MG Butler; citation_volume=21; citation_issue=Suppl 1; citation_publication_date=2012; citation_pages=282-290; citation_doi=10.1002/pds.2337; citation_id=CR15">
<meta name=citation_reference content="citation_journal_title=SAS Global Forum; citation_title=A unified approach to measuring the effect size between two groups using SAS®; citation_author=D Yang, J Dalton; citation_volume=35; citation_publication_date=2012; citation_pages=1-6; citation_id=CR16">
<meta name=citation_reference content="citation_journal_title=Stat Med; citation_title=Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group; citation_author=RB D’Agostino; citation_volume=17; citation_issue=19; citation_publication_date=1998; citation_pages=2265-2281; citation_doi=10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; citation_id=CR17">
<meta name=citation_reference content="citation_journal_title=Circ Heart Fail; citation_title=Dipeptidyl peptidase-4 inhibitors and risk of heart failure in patients with type 2 diabetes mellitus: a population-based cohort study; citation_author=YG Kim, D Yoon, S Park; citation_volume=10; citation_issue=9; citation_publication_date=2017; citation_pages=e003957; citation_doi=10.1161/CIRCHEARTFAILURE.117.003957; citation_id=CR18">
<meta name=citation_reference content="citation_journal_title=Diabetes Care; citation_title=Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American heart association and American diabetes association; citation_author=RW Nesto, D Bell, RO Bonow; citation_volume=27; citation_issue=1; citation_publication_date=2004; citation_pages=256-263; citation_doi=10.2337/diacare.27.1.256; citation_id=CR19">
<meta name=citation_reference content="citation_journal_title=Cardiovasc Diabetol; citation_title=DPP-4 inhibition has no acute effect on BNP and its N-terminal pro-hormone measured by commercial immune-assays. A randomized cross-over trial in patients with type 2 diabetes; citation_author=GP Fadini, BM Bonora, M Albiero, M Zaninotto, M Plebani, A Avogaro; citation_volume=16; citation_issue=1; citation_publication_date=2017; citation_pages=22; citation_doi=10.1186/s12933-017-0507-9; citation_id=CR20">
<meta name=citation_reference content="citation_journal_title=Endocr Rev; citation_title=Cardiovascular biology of the incretin system; citation_author=JR Ussher, DJ Drucker; citation_volume=33; citation_issue=2; citation_publication_date=2012; citation_pages=187-215; citation_doi=10.1210/er.2011-1052; citation_id=CR21">
<meta name=citation_reference content="citation_journal_title=Cardiovasc Diabetol; citation_title=Effect of vildagliptin, a dipeptidyl peptidase 4 inhibitor, on cardiac hypertrophy induced by chronic beta-adrenergic stimulation in rats; citation_author=T Miyoshi, K Nakamura, M Yoshida; citation_volume=13; citation_publication_date=2014; citation_pages=43; citation_doi=10.1186/1475-2840-13-43; citation_id=CR22">
<meta name=citation_reference content="citation_journal_title=Medicine (Baltimore); citation_title=Comparative safety for cardiovascular outcomes of DPP-4 inhibitors versus glimepiride in patients with type 2 diabetes: a retrospective cohort study; citation_author=HJ Chin, JH Nam, EK Lee, JY Shin; citation_volume=96; citation_issue=25; citation_publication_date=2017; citation_pages=e7213; citation_doi=10.1097/MD.0000000000007213; citation_id=CR23">
<meta name=citation_reference content="citation_journal_title=Heart Vessels; citation_title=Teneligliptin improves left ventricular diastolic function and endothelial function in patients with diabetes; citation_author=T Hashikata, M Yamaoka-Tojo, R Kakizaki; citation_volume=31; citation_issue=8; citation_publication_date=2016; citation_pages=1303-1310; citation_doi=10.1007/s00380-015-0724-7; citation_id=CR24">
<meta name=citation_reference content="citation_journal_title=Cardiovasc Diabetol; citation_title=Heart failure hospitalization risk associated with use of two classes of oral antidiabetic medications: an observational, real-world analysis; citation_author=S Gautam, A Agiro, J Barron, T Power, H Weisman, J White; citation_volume=16; citation_issue=1; citation_publication_date=2017; citation_pages=93; citation_doi=10.1186/s12933-017-0575-x; citation_id=CR25">
<meta name=citation_reference content="citation_journal_title=BMC Cardiovasc Disord; citation_title=Glucagon-like peptide-1 receptor agonists and heart failure in type 2 diabetes: systematic review and meta-analysis of randomized and observational studies; citation_author=L Li, S Li, J Liu; citation_volume=16; citation_publication_date=2016; citation_pages=91; citation_doi=10.1186/s12872-016-0260-0; citation_id=CR26">
<meta name=citation_reference content="citation_journal_title=Nutr Metab Cardiovasc Dis; citation_title=Efficacy and safety of glucagon-like peptide-1 agonists on macrovascular and microvascular events in type 2 diabetes mellitus: A meta-analysis; citation_author=P Gargiulo, G Savarese, C D’Amore; citation_volume=27; citation_issue=12; citation_publication_date=2017; citation_pages=1081-1088; citation_doi=10.1016/j.numecd.2017.09.006; citation_id=CR27">
<meta name=citation_reference content="citation_journal_title=Diabetes Metab; citation_title=GLP-1 receptor agonists and heart failure in diabetes; citation_author=AJ Scheen; citation_volume=43; citation_issue=Suppl 1; citation_publication_date=2017; citation_pages=2S13-2S19; citation_doi=10.1016/S1262-3636(17)30068-X; citation_id=CR28">
<meta name=citation_author content="Dawwas, Ghadeer K.">
<meta name=citation_author_institution content="Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, USA">
<meta name=citation_author content="Smith, Steven M.">
<meta name=citation_author_institution content="Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, USA">
<meta name=citation_author_institution content="Department of Community Health and Family Medicine, College of Medicine, University of Florida, Gainesville, USA">
<meta name=citation_author content="Park, Haesuk">
<meta name=citation_author_institution content="Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, USA">
<meta name=format-detection content="telephone=no">
<meta name=msapplication-config content=/static/app-bmc/browserconfig-ecd9aa8205.xml>
<meta name=msapplication-TileColor content=#1b3051>
<meta name=msapplication-TileImage content=/static/img/favicons/bmc/app-icon-144x144.png>
<meta name=theme-color content=#1b3051>
<style media=screen>.u-h3{font-weight:700}.u-h3{font-size:1.25rem}html{font-family:sans-serif;line-height:1.15;-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%}body{margin:0}article,aside,figcaption,figure,footer,header,main,nav,section{display:block}h1{font-size:2em;margin:.67em 0}figure{margin:1em 40px}a{background-color:transparent;-webkit-text-decoration-skip:objects}a:active,a:hover{outline-width:0}abbr[title]{border-bottom:none;-webkit-text-decoration:underline dotted;text-decoration:underline dotted}b,strong{font-weight:bolder}dfn{font-style:italic}sup{font-size:75%;line-height:0;position:relative;vertical-align:baseline}sup{top:-.5em}img{border-style:none}svg:not(:root){overflow:hidden}button{font-family:sans-serif;font-size:100%;line-height:1.15;margin:0}button{overflow:visible}button{text-transform:none}button,html [type=button]{-webkit-appearance:button}[type=button]::-moz-focus-inner,[type=reset]::-moz-focus-inner,[type=submit]::-moz-focus-inner,button::-moz-focus-inner{border-style:none;padding:0}[type=button]:-moz-focusring,[type=reset]:-moz-focusring,[type=submit]:-moz-focusring,button:-moz-focusring{outline:1px dotted ButtonText}::-webkit-file-upload-button{-webkit-appearance:button;font:inherit}.c-article-author-affiliation__list,.c-article-references{list-style:none;padding:0}.u-hide{display:none;visibility:hidden}.u-show{display:block;visibility:visible}.u-visually-hidden{border:0;clip:rect(0,0,0,0);height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}.u-float-left{float:left}.u-list-reset{list-style:none;margin:0;padding:0}.u-text-right{text-align:right}.u-text-normal{font-weight:400}.u-text-bold{font-weight:700}html{font-family:sans-serif;line-height:1.15;-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%}body{margin:0;font-size:.813rem;line-height:1.5}article,aside,figcaption,figure,footer,header,main,nav,section{display:block}h1{margin:.67em 0;font-size:1.875rem}figure{margin:1em 40px}a{background-color:transparent;-webkit-text-decoration-skip:objects;color:#069}a:active,a:hover{outline-width:0}abbr[title]{border-bottom:none;-webkit-text-decoration:underline dotted;text-decoration:underline dotted}b,strong{font-weight:bolder}dfn{font-style:italic}sup{font-size:75%;line-height:0;position:relative;vertical-align:baseline}sup{top:-.5em}img{border:0;max-width:100%;height:auto;vertical-align:middle}svg:not(:root){overflow:hidden}button{font-size:100%;line-height:1.15;margin:0}button{overflow:visible}button{text-transform:none}button,html [type=button]{-webkit-appearance:button}[type=button]::-moz-focus-inner,[type=reset]::-moz-focus-inner,[type=submit]::-moz-focus-inner,button::-moz-focus-inner{border-style:none;padding:0}[type=button]:-moz-focusring,[type=reset]:-moz-focusring,[type=submit]:-moz-focusring,button:-moz-focusring{outline:1px dotted ButtonText}::-webkit-file-upload-button{-webkit-appearance:button;font:inherit}h2{font-size:1.5rem}h3{font-size:1.0625rem}h4{font-size:.875rem}button{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;border-radius:0}b:focus,dd:focus,div:focus,dl:focus,dt:focus,em:focus,h1:focus,h2:focus,h3:focus,h4:focus,h5:focus,i:focus,li:focus,ol:focus,p:focus,span:focus,strong:focus,ul:focus{outline:0}</style>
<style>@media only print,only all and (prefers-color-scheme:no-preference),only all and (prefers-color-scheme:light),only all and (prefers-color-scheme:dark){button{line-height:inherit}html{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}html{-webkit-font-smoothing:subpixel-antialiased;box-sizing:border-box;color:#333;font-size:100%;height:100%;line-height:1.61803;overflow-y:scroll}*{box-sizing:inherit}body{background:#fff;margin:0;max-width:100%;min-height:100%}button,div{margin:0;padding:0}body,p{padding:0}a{color:#004b83;text-decoration:underline;text-decoration-skip-ink:auto}a>img{vertical-align:middle}h1,h2,h3{margin-top:0}h1{font-size:28px;font-weight:700}html.webfonts-loaded h1,html.webfonts-loaded h2,html.webfonts-loaded h3{font-family:Europa,Trebuchet MS}h1,h2,h3{color:#1b3051;font-style:normal;line-height:1.4}h2{font-size:26px;font-weight:700;margin-bottom:.5em}h3{font-size:18px;margin-bottom:.7em}p{margin:0}ul{margin-top:0}p{margin-bottom:1.5em}p:last-child{margin-bottom:0}p:empty{display:none}.c-ad{text-align:center}@media only screen and (min-width:320px){.c-ad{padding:8px}}.c-ad--728x90{background-color:#ccc;display:none}.c-ad--728x90 .c-ad__inner{min-height:calc(1.5em + 94px)}@media only screen and (min-width:768px){.js .u-show-following-ad+.c-ad--728x90{display:block}}.c-ad--300x250{background-color:#f2f2f2;display:none;padding:8px}.c-ad--300x250 .c-ad__inner{min-height:calc(1.5em + 254px)}@media only screen and (min-width:320px){.js .c-ad--300x250{display:block}}.c-ad__label{color:#333;font-weight:400;line-height:1.5;margin-bottom:4px}.c-ad__label,.c-skip-link{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:.875rem}.c-skip-link{background:#dceaf6;bottom:auto;color:#004b83;padding:8px;position:absolute;text-align:center;transform:translateY(-100%);z-index:9999}@media (prefers-reduced-motion:reduce){.c-skip-link{transition:top .3s ease-in-out 0s}}.c-skip-link:link{color:#004b83}.c-header{background-color:#1b3051;border-bottom:4px solid #1b3051;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:14px;padding:16px 0}.c-header__container,.c-header__menu{align-items:center;display:flex;flex-wrap:wrap}@supports (gap:2em){.c-header__container,.c-header__menu{gap:2em 2em}}.c-header__menu{list-style:none;margin:0;padding:0}.c-header__item{color:#fff}@supports not (gap:2em){.c-header__item{margin-left:24px}}.c-header__container{justify-content:space-between;margin:0 auto;max-width:1280px;padding:0 16px}@supports not (gap:2em){.c-header__brand{margin-right:48px}}.c-header__brand a{text-decoration:none}.c-header__link{color:#fff}.c-header__link{text-decoration:none}html.webfonts-loaded .c-journal-title{font-family:Europa,Trebuchet MS}.c-logo img{display:block}.c-journal-header{overflow:hidden}.c-journal-header__inner{padding-bottom:8px;padding-top:8px}@media only screen and (min-width:540px){.c-journal-header__inner{display:flex;justify-content:space-between}}.c-journal-header__identity{background-size:auto 80px;min-height:16px;padding:6px 0}@media only screen and (min-width:540px){.c-journal-header__identity{background-position:0}}.c-journal-title{color:#1b3051;display:flex;font-size:26px;font-style:normal;font-weight:700;line-height:1.4;margin-bottom:0}.c-journal-title>a{color:#1b3051;display:flex;text-decoration:none}.c-journal-title__text{align-self:center;display:block;flex:0 1 auto}.c-logo,.c-logo>a{align-items:baseline;display:flex}.c-logo__strapline{display:none}@media only screen and (min-width:540px){.c-logo__strapline{display:block;margin:0 0 0 16px;transform:translateY(1px)}}.c-navbar{background:#f2f2f2;border-bottom:1px solid #d9d9d9;border-top:1px solid #d9d9d9;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:14px;line-height:1.42857;padding:16px 0}.c-navbar__container{align-items:center;display:flex;flex-wrap:wrap;justify-content:space-between;margin:0 auto;max-width:1280px;padding:0 16px}.c-navbar__content{align-items:center;display:flex;flex:0 1 auto}@media only screen and (min-width:1024px){.c-navbar__content{display:flex!important}}.c-navbar__nav{display:flex;list-style:none;margin:0;padding:0}@media only screen and (min-width:1024px){.c-navbar__nav{transform:translateY(1px)}}.c-navbar__item{flex:1 0 auto}@media only screen and (max-width:539px){.c-navbar__item{font-size:.75rem}}.c-navbar__item:not(:first-child){margin-left:16px}.c-navbar__link{background:0 0;border:0;color:currentcolor;display:block;text-decoration:none;text-transform:capitalize}.c-navbar__link--is-shown{text-decoration:underline}.c-logo{display:block}html.webfonts-loaded .u-h3{font-family:Europa,Trebuchet MS}.u-button{align-items:center;background-color:#f2f2f2;background-image:linear-gradient(#fff,#f2f2f2);border:1px solid #ccc;border-radius:2px;cursor:pointer;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1rem;line-height:1.3;margin:0;padding:8px;position:relative;text-decoration:none;transition:all .25s ease 0s,color .25s ease 0s,border-color .25s ease 0s}.u-button svg{fill:currentcolor}.u-button{color:#004b83}.u-button--primary{background-color:#33629d;background-image:linear-gradient(#4d76a9,#33629d);border:1px solid rgba(0,59,132,.5);color:#fff}.u-button--full-width{display:flex;width:100%}.u-clearfix:after,.u-clearfix:before{content:"";display:table}.u-clearfix:after{clear:both}.u-container{margin:0 auto;max-width:1280px;padding:0 16px}.u-display-flex{display:flex;width:100%}.u-align-items-center{align-items:center}.u-justify-content-space-between{justify-content:space-between}.u-flex-static{flex:0 0 auto}.u-show{display:block;visibility:visible}.u-icon{fill:currentcolor;display:inline-block;height:1em;transform:translate(0);vertical-align:text-top;width:1em}.u-list-reset{list-style:none;margin:0;padding:0}.u-position-relative{position:relative}.u-mt-16{margin-top:16px}.u-mt-32{margin-top:32px}.u-mr-24{margin-right:24px}.u-mr-48{margin-right:48px}.u-mb-32{margin-bottom:32px}.u-ml-8{margin-left:8px}.u-button-reset{background-color:transparent;border:0;padding:0}.u-text-sm{font-size:14px}.u-h3{color:#1b3051;font-size:18px;font-style:normal;line-height:1.4;margin-bottom:.7em}.u-vh-full{min-height:100vh}.u-hide{display:none;visibility:hidden}@media only screen and (max-width:1023px){.u-hide-at-lt-lg{display:none;visibility:hidden}}.u-visually-hidden{clip:rect(0,0,0,0);border:0;height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}body{font-size:1.125rem}.c-header__navigation{display:flex;gap:.5rem .5rem}}@media only print,only all and (prefers-color-scheme:no-preference),only all and (prefers-color-scheme:light),only all and (prefers-color-scheme:dark){.u-h3{font-style:normal;line-height:1.4}.u-h3{margin-bottom:1em}button{line-height:inherit}html{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}html{-webkit-font-smoothing:subpixel-antialiased;box-sizing:border-box;color:#333;font-size:100%;height:100%;line-height:1.61803;overflow-y:scroll}*{box-sizing:inherit}body{background:#fff;margin:0;max-width:100%;min-height:100%}button,div{margin:0;padding:0}body,p{padding:0}a{color:#004b83;overflow-wrap:break-word;text-decoration:underline;text-decoration-skip-ink:auto;word-break:break-word}a>img{vertical-align:middle}h1,h2,h3{margin-top:0}h1{font-weight:700}html.webfonts-loaded h1,html.webfonts-loaded h2,html.webfonts-loaded h3{font-family:Europa,Trebuchet MS}h1,h2,h3{color:#1b3051;font-style:normal;line-height:1.4}h2{font-weight:700;margin-bottom:.5em}h3{font-size:18px;margin-bottom:.7em}p{margin:0}ul{margin-top:0}p{margin-bottom:1.5em;overflow-wrap:break-word;word-break:break-word}p:last-child{margin-bottom:0}p:empty{display:none}.u-h3{font-size:1.5rem}.u-h3{font-weight:700}body{font-size:1.125rem}.c-article-header{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;margin-bottom:40px}.c-article-identifiers{color:#6f6f6f;display:flex;flex-wrap:wrap;font-size:1rem;line-height:1.3;list-style:none;margin:0 0 8px;padding:0}.c-article-identifiers__item{border-right:1px solid #6f6f6f;list-style:none;margin-right:8px;padding-right:8px}.c-article-identifiers__item:last-child{border-right:0;margin-right:0;padding-right:0}.c-article-identifiers__open{color:#cc4b14}.c-article-title{font-size:1.5rem;line-height:1.25;margin-bottom:16px}@media only screen and (min-width:768px){.c-article-title{font-size:1.875rem;line-height:1.2}}.c-article-author-list{display:inline;font-size:1rem;list-style:none;margin:0 8px 0 0;padding:0;width:100%}.c-article-author-list__item{display:inline;padding-right:0}.c-article-author-list svg{margin-left:4px}.c-article-info-details{font-size:1rem;margin-bottom:8px;margin-top:16px}.c-article-info-details__cite-as{border-left:1px solid #6f6f6f;margin-left:8px;padding-left:8px}.c-article-metrics-bar{display:flex;flex-wrap:wrap;font-size:1rem;line-height:1.3}.c-article-metrics-bar__wrapper{margin:0 0 16px}.c-article-metrics-bar__item{align-items:baseline;border-right:1px solid #6f6f6f;margin-right:8px}.c-article-metrics-bar__item:last-child{border-right:0}.c-article-metrics-bar__count{font-weight:700;margin:0}.c-article-metrics-bar__label{color:#626262;font-style:normal;font-weight:400;margin:0 10px 0 5px}.c-article-metrics-bar__details{margin:0}.c-article-main-column{font-family:Georgia,Palatino,serif;margin-right:8.6%;width:60.2%}@media only screen and (max-width:1023px){.c-article-main-column{margin-right:0;width:100%}}.c-article-extras{float:left;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;width:31.2%}@media only screen and (max-width:1023px){.c-article-extras{display:none}}.c-article-section__title{border-bottom:2px solid #d5d5d5;font-size:1.25rem;margin:0;padding-bottom:8px}@media only screen and (min-width:768px){.c-article-section__title{font-size:1.5rem;line-height:1.24}}.c-article-section{clear:both}.c-article-section__content{margin-bottom:40px;padding-top:8px}@media only screen and (max-width:1023px){.c-article-section__content{padding-left:0}}.c-article__sub-heading{color:#222;font-size:1.125rem;font-style:normal;font-weight:400;line-height:1.3;margin:0 0 8px}@media only screen and (min-width:768px){.c-article__sub-heading{font-size:1.5rem;line-height:1.24}}.c-reading-companion{clear:both;min-height:389px}.c-reading-companion .u-lazy-ad-wrapper{background-color:transparent!important;min-height:250px}.c-reading-companion__sticky{max-width:389px}.c-reading-companion__scroll-pane{margin:0;min-height:200px;overflow:hidden auto}.c-reading-companion__tabs{display:flex;flex-flow:row nowrap;font-size:1rem;list-style:none;margin:0 0 8px;padding:0}.c-reading-companion__tabs>li{flex-grow:1}.c-reading-companion__tab{background-color:#eee;border:1px solid #d5d5d5;border-image:initial;border-left-width:0;color:#0067c5;font-size:1rem;padding:8px 8px 8px 15px;text-align:left;width:100%}.c-reading-companion__tabs li:first-child .c-reading-companion__tab{border-left-width:1px}.c-reading-companion__tab--active{background-color:#fff;border-bottom:1px solid #fff;color:#222;font-weight:700}.c-reading-companion__sections-list{list-style:none;padding:0}.c-reading-companion__sections-list{margin:0 0 8px;min-height:50px}.c-reading-companion__section-item{font-size:1rem;padding:0}.c-reading-companion__section-item a{display:block;line-height:1.5;overflow:hidden;padding:8px 0 8px 16px;text-overflow:ellipsis;white-space:nowrap}.c-reading-companion__panel{border-top:none;margin-top:0;padding-top:0}.c-reading-companion__panel--active{display:block}.c-pdf-download__link .u-icon{padding-top:2px}.c-pdf-download{display:flex;margin-bottom:16px;max-height:48px}@media only screen and (min-width:540px){.c-pdf-download{max-height:none}}@media only screen and (min-width:1024px){.c-pdf-download{max-height:48px}}.c-pdf-download__link{display:flex;flex:1 1 0%;padding:13px 24px!important}.c-pdf-download__text{padding-right:4px}@media only screen and (max-width:539px){.c-pdf-download__text{text-transform:capitalize}}@media only screen and (min-width:540px){.c-pdf-download__text{padding-right:8px}}.u-show{display:block;visibility:visible}.u-visually-hidden{clip:rect(0,0,0,0);border:0;height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}.u-icon{fill:currentcolor;display:inline-block;height:1em;transform:translate(0);vertical-align:text-top;width:1em}.u-list-reset{list-style:none;margin:0;padding:0}.hide{display:none;visibility:hidden}.webfonts-loaded .c-article__sub-heading{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}}</style>
<style media="only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark)">@-webkit-keyframes slide-from-bottom{0%{max-height:0}to{max-height:200px}}@keyframes slide-from-bottom{0%{max-height:0}to{max-height:200px}}button{line-height:inherit}[contenteditable]:focus,[tabindex="0"]:focus,button:focus,input:focus,select:focus,textarea:focus{outline:4px solid #fc0}button:disabled:focus,input:disabled:focus,select:disabled:focus,textarea:disabled:focus{outline:0}html{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif}html{height:100%;overflow-y:scroll;font-size:100%;box-sizing:border-box;color:#333;line-height:1.6180339888;-moz-osx-font-smoothing:auto;-webkit-font-smoothing:subpixel-antialiased}*,:after,:before{box-sizing:inherit}body{max-width:100%;min-height:100%;background:#fff}body,figure{margin:0}button,div,dt{margin:0;padding:0}body,dd,dl,p{padding:0}abbr[title]{text-decoration:none}a{color:#004b83;text-decoration:underline;-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto}a.visited,a:visited{color:#8e2555}a.hover,a:hover{color:#0097ef}a.active,a:active{color:#25426f;text-decoration:none}a.focus,a:focus{outline:4px solid #fc0}a>img{vertical-align:middle}h1,h2,h3,h4{margin-top:0}h1{font-size:28px;font-weight:700}html.webfonts-loaded h1,html.webfonts-loaded h2,html.webfonts-loaded h3,html.webfonts-loaded h4{font-family:"Europa","Trebuchet MS"}h1,h2,h3,h4{color:#1b3051;font-style:normal;line-height:1.4}h2{font-size:26px;font-weight:700;margin-bottom:.5em}h3,h4{font-size:18px;margin-bottom:.7em}h3 a:hover{color:#004b83}h3 a:visited{color:#8e2555}h3 a:hover{text-decoration:underline}h3 a:active{color:#0097ef;text-decoration:none}h4{font-weight:700}ol,ul{margin-top:0}dl,p{margin:0}ol:not([class]),ul:not([class]){padding-left:.9em}dd{margin:0}p{margin-bottom:1.5em}p:last-child{margin-bottom:0}p:empty{display:none}@font-face{font-family:"Europa";font-style:normal;font-weight:400;src:local("Europa-Regular"),url(data:application/font-woff2;base64,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)format("woff2")}@font-face{font-family:"Europa";font-style:normal;font-weight:700;src:local("Europa-Bold"),url(data:application/font-woff2;base64,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)format("woff2")}.c-ad{text-align:center}@media only screen and (min-width:320px){.c-ad{padding:8px}}.c-ad--728x90{display:none;background-color:#ccc}.c-ad--728x90 .c-ad__inner{min-height:calc(1.5em + 4px + 90px)}@media only screen and (min-width:768px){.js .u-show-following-ad+.c-ad--728x90{display:block}}.c-ad--300x250{display:none;background-color:#f2f2f2;padding:8px}.c-ad--300x250 .c-ad__inner{min-height:calc(1.5em + 4px + 250px)}@media only screen and (min-width:320px){.js .c-ad--300x250{display:block}}.c-ad__label,.c-banner{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif}.c-ad__label{font-size:.875rem;font-weight:400;margin-bottom:4px;color:#333;line-height:1.5}.c-banner{border-bottom:1px solid #25426f;background-color:#dceaf6;padding:16px 12px;font-size:1rem;margin:0 auto;position:relative;text-align:center}.c-corporate-footer{background-color:#f2f2f2;border-top:1px solid #ccc;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;padding-top:16px;padding-bottom:24px}.c-corporate-footer__legal{color:#666;font-size:1rem;margin-bottom:0;padding-top:4px}.c-corporate-footer__link,.c-corporate-footer__link:hover,.c-corporate-footer__link:visited{color:inherit}.c-list-group{list-style:none;margin:0;padding:0;line-height:1.4}.c-list-group__item>a.active,.c-list-group__item>a.hover,.c-list-group__item>a:active,.c-list-group__item>a:hover{text-decoration:underline;-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto}.c-list-group--sm .c-list-group__item{padding:8px 0}.c-skip-link{background:#dceaf6;color:#004b83;font-size:.875rem;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;text-align:center;padding:8px;position:absolute;inset:0;bottom:auto;z-index:9999;transform:translateY(-100%)}@media (prefers-reduced-motion:reduce){.c-skip-link{transition:top .3s ease-in-out}}.c-skip-link:active,.c-skip-link:hover,.c-skip-link:link,.c-skip-link:visited{color:#004b83}.c-skip-link:focus{transform:translateY(0)}@supports (gap:1em){.c-listing__view-options{gap:.5em}}@supports not (gap:1em){.c-listing__view-options li{margin:.25em}}.c-header{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;font-size:14px;background-color:#1b3051;padding:16px 0;border-bottom:4px solid #1b3051}.c-header__container,.c-header__menu{display:flex;align-items:center;flex-wrap:wrap}@supports (gap:2em){.c-header__container,.c-header__menu,.c-header__nav-menu{gap:2em}}.c-header__menu{list-style:none;margin:0;padding:0}.c-header__item{color:#fff}@supports not (gap:2em){.c-header__item{margin-left:24px}}@supports not (gap:2em){.c-header__nav .c-header__item{margin-left:0;margin-right:24px}}.c-header__container{margin:0 auto;max-width:1280px;padding:0 16px;justify-content:space-between}@supports not (gap:2em){.c-header__brand{margin-right:48px}}.c-header__brand a{text-decoration:none}.c-header__link.active,.c-header__link.hover,.c-header__link:active,.c-header__link:hover{text-decoration:underline;-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto}.c-header__link,.c-header__link:hover,.c-header__link:visited{color:#fff}html.webfonts-loaded .c-journal-title{font-family:"Europa","Trebuchet MS"}.c-publisher-footer{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;font-size:14px;background:0 0;padding:16px;border-top:1px solid #ccc}.c-logo img{display:block}.c-journal-header{overflow:hidden}.c-journal-header__inner{padding-top:8px;padding-bottom:8px}@media only screen and (min-width:540px){.c-journal-header__inner{display:flex;justify-content:space-between}}.c-journal-header__identity{background-size:auto 80px;min-height:16px;padding:6px 0}@media only screen and (min-width:540px){.c-journal-header__identity{background-position:left center}}.c-journal-header__identity--wine-red{background-color:#840029}.c-journal-header__identity--wine-red{background-image:url(data:image/svg+xml;base64,<svg xmlns="http://www.w3.org/2000/svg" viewBox="352 376.9 1300 89" enable-background="new 352 376.9 1300 89"><filter width="155.5%" height="156.6%" id="d" filterUnits="objectBoundingBox" y="-39.6%" x="-35.2%"><feOffset result="shadowOffsetOuter1" in="SourceAlpha" dx="-2" dy="-3"/><feGaussianBlur stdDeviation="2" result="shadowBlurOuter1" in="shadowOffsetOuter1"/><feComposite result="shadowBlurOuter1" in="shadowBlurOuter1" operator="out" in2="SourceAlpha"/><feColorMatrix in="shadowBlurOuter1" values="0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.191887455 0"/></filter><filter width="125.4%" height="125%" id="c" filterUnits="objectBoundingBox" y="-17.5%" x="-16.1%"><feOffset result="shadowOffsetOuter1" in="SourceAlpha" dx="-2" dy="-3"/><feGaussianBlur stdDeviation="2" result="shadowBlurOuter1" in="shadowOffsetOuter1"/><feComposite result="shadowBlurOuter1" in="shadowBlurOuter1" operator="out" in2="SourceAlpha"/><feColorMatrix in="shadowBlurOuter1" values="0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.191887455 0"/></filter><filter width="125.4%" height="125%" id="b" filterUnits="objectBoundingBox" y="-17.5%" x="-16.1%"><feOffset result="shadowOffsetOuter1" in="SourceAlpha" dx="-2" dy="-3"/><feGaussianBlur stdDeviation="2" result="shadowBlurOuter1" in="shadowOffsetOuter1"/><feComposite result="shadowBlurOuter1" in="shadowBlurOuter1" operator="out" in2="SourceAlpha"/><feColorMatrix in="shadowBlurOuter1" values="0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.191887455 0"/></filter><filter width="132.6%" height="132%" id="o" filterUnits="objectBoundingBox" y="-22.4%" x="-20.6%"><feOffset result="shadowOffsetOuter1" in="SourceAlpha" dx="-2" dy="-3"/><feGaussianBlur stdDeviation="2" result="shadowBlurOuter1" in="shadowOffsetOuter1"/><feComposite result="shadowBlurOuter1" in="shadowBlurOuter1" operator="out" in2="SourceAlpha"/><feColorMatrix in="shadowBlurOuter1" values="0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.191887455 0"/></filter><filter width="125.4%" height="125%" id="n" filterUnits="objectBoundingBox" y="-17.5%" x="-16.1%"><feOffset result="shadowOffsetOuter1" in="SourceAlpha" dx="-2" dy="-3"/><feGaussianBlur stdDeviation="2" result="shadowBlurOuter1" in="shadowOffsetOuter1"/><feComposite result="shadowBlurOuter1" in="shadowBlurOuter1" operator="out" in2="SourceAlpha"/><feColorMatrix in="shadowBlurOuter1" values="0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.191887455 0"/></filter><filter width="170%" height="171.1%" id="m" filterUnits="objectBoundingBox" y="-49.8%" x="-44.3%"><feOffset result="shadowOffsetOuter1" in="SourceAlpha" dx="-2" dy="-3"/><feGaussianBlur stdDeviation="2" result="shadowBlurOuter1" in="shadowOffsetOuter1"/><feComposite result="shadowBlurOuter1" in="shadowBlurOuter1" operator="out" in2="SourceAlpha"/><feColorMatrix in="shadowBlurOuter1" values="0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0"/></filter><filter width="149.5%" height="150.3%" id="l" filterUnits="objectBoundingBox" y="-35.2%" x="-31.4%"><feOffset result="shadowOffsetOuter1" in="SourceAlpha" dx="-2" dy="-3"/><feGaussianBlur stdDeviation="2" result="shadowBlurOuter1" in="shadowOffsetOuter1"/><feComposite result="shadowBlurOuter1" in="shadowBlurOuter1" operator="out" in2="SourceAlpha"/><feColorMatrix in="shadowBlurOuter1" values="0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.191887455 0"/></filter><filter width="178.9%" height="175%" id="k" filterUnits="objectBoundingBox" y="-52.5%" x="-50%"><feOffset result="shadowOffsetOuter1" in="SourceAlpha" dx="-2" dy="-3"/><feGaussianBlur stdDeviation="2" result="shadowBlurOuter1" in="shadowOffsetOuter1"/><feComposite result="shadowBlurOuter1" in="shadowBlurOuter1" operator="out" in2="SourceAlpha"/><feColorMatrix in="shadowBlurOuter1" values="0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0"/></filter><filter width="153.6%" height="153.6%" id="j" filterUnits="objectBoundingBox" y="-37.5%" x="-33.9%"><feOffset result="shadowOffsetOuter1" in="SourceAlpha" dx="-2" dy="-3"/><feGaussianBlur stdDeviation="2" result="shadowBlurOuter1" in="shadowOffsetOuter1"/><feComposite result="shadowBlurOuter1" in="shadowBlurOuter1" operator="out" in2="SourceAlpha"/><feColorMatrix in="shadowBlurOuter1" values="0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.191887455 0"/></filter><filter width="135.2%" height="134.9%" id="a" filterUnits="objectBoundingBox" y="-24.4%" x="-22.3%"><feOffset result="shadowOffsetOuter1" in="SourceAlpha" dx="-2" dy="-3"/><feGaussianBlur stdDeviation="2" result="shadowBlurOuter1" in="shadowOffsetOuter1"/><feComposite result="shadowBlurOuter1" in="shadowBlurOuter1" operator="out" in2="SourceAlpha"/><feColorMatrix in="shadowBlurOuter1" values="0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.191887455 0"/></filter><filter width="175%" height="175%" id="i" filterUnits="objectBoundingBox" y="-52.5%" x="-47.5%"><feOffset result="shadowOffsetOuter1" in="SourceAlpha" dx="-2" dy="-3"/><feGaussianBlur stdDeviation="2" result="shadowBlurOuter1" in="shadowOffsetOuter1"/><feComposite result="shadowBlurOuter1" in="shadowBlurOuter1" operator="out" in2="SourceAlpha"/><feColorMatrix in="shadowBlurOuter1" values="0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0"/></filter><filter width="153.6%" height="153.6%" id="h" filterUnits="objectBoundingBox" y="-37.5%" x="-33.9%"><feOffset result="shadowOffsetOuter1" in="SourceAlpha" dx="-2" dy="-3"/><feGaussianBlur stdDeviation="2" result="shadowBlurOuter1" in="shadowOffsetOuter1"/><feComposite result="shadowBlurOuter1" in="shadowBlurOuter1" operator="out" in2="SourceAlpha"/><feColorMatrix in="shadowBlurOuter1" values="0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.191887455 0"/></filter><filter width="171.3%" height="173.7%" id="g" filterUnits="objectBoundingBox" y="-51.6%" x="-45.1%"><feOffset result="shadowOffsetOuter1" in="SourceAlpha" dx="-2" dy="-3"/><feGaussianBlur stdDeviation="2" result="shadowBlurOuter1" in="shadowOffsetOuter1"/><feComposite result="shadowBlurOuter1" in="shadowBlurOuter1" operator="out" in2="SourceAlpha"/><feColorMatrix in="shadowBlurOuter1" values="0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0"/></filter><filter width="150.5%" height="151.4%" id="f" filterUnits="objectBoundingBox" y="-36%" x="-32%"><feOffset result="shadowOffsetOuter1" in="SourceAlpha" dx="-2" dy="-3"/><feGaussianBlur stdDeviation="2" result="shadowBlurOuter1" in="shadowOffsetOuter1"/><feComposite result="shadowBlurOuter1" in="shadowBlurOuter1" operator="out" in2="SourceAlpha"/><feColorMatrix in="shadowBlurOuter1" values="0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.191887455 0"/></filter><filter width="178.5%" height="180%" id="e" filterUnits="objectBoundingBox" y="-56%" x="-49.7%"><feOffset result="shadowOffsetOuter1" in="SourceAlpha" dx="-2" dy="-3"/><feGaussianBlur stdDeviation="2" result="shadowBlurOuter1" in="shadowOffsetOuter1"/><feComposite result="shadowBlurOuter1" in="shadowBlurOuter1" operator="out" in2="SourceAlpha"/><feColorMatrix in="shadowBlurOuter1" values="0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0"/></filter><title>identity BMC series</title><g opacity=".756"><path d="M416.6-308.9l42.5 43h-42.6" filter="url(#a)" transform="rotate(180 772.3 55.5)"/><path fill="#FFF" fill-opacity=".107" d="M1128 419.9l-42.5-43h42.6"/></g><path d="M273.8-280.8l59.1 59.9h-59.1" filter="url(#b)" transform="rotate(180 637.825 92.033)"/><path fill="#FFF" fill-opacity=".107" d="M1001.85 464.866l-59.1-59.9h59.1"/><path opacity=".266" fill="#FFF" fill-opacity=".707" enable-background="new" d="M943 405.3l59.4.1-29.6 29.8"/><path d="M-213.5-308.4l59.1 60h-59.1" filter="url(#c)" transform="rotate(180 150.533 64.5)"/><path fill="#FFF" fill-opacity=".09" d="M514.566 437.4l-59.1-60h59.1"/><path opacity=".242" fill="#FFF" fill-opacity=".707" enable-background="new" d="M1085.5 377.3h42.5l-21.2 21.3"/><path fill="#e4002b" d="M1085.6 377.3l42.3 42.8h-42.3"/><path fill="#e4002b" d="M1127.7 419.9l20 20h-20"/><path d="M-154.1-248.5l27 26.5h-27" filter="url(#d)" transform="rotate(180 193.907 107.683)"/><path fill="#FFF" fill-opacity=".253" d="M541.914 463.866l-27-26.5h27"/><g opacity=".313"><path d="M178.4 564l19.1 18.8h-19.1" filter="url(#e)" transform="rotate(-45 193.913 94.39)"/><path fill="#FFF" fill-opacity=".53" d="M515.008 437.424l26.8-.212-13.506 13.505"/></g><path opacity=".16" fill="#FFF" enable-background="new" d="M455.6 377.6l59.4.1-29.6 29.8"/><path d="M137.5-281.1l29.7 29.2h-29.7" filter="url(#f)" transform="rotate(180 486.862 76.365)"/><path fill="#FFF" fill-opacity=".073" d="M836.224 433.83l-29.7-29.2h29.7"/><g opacity=".359"><path d="M470.4 530.6l21 20.3h-21" filter="url(#g)" transform="rotate(-45 486.862 61.764)"/><path fill="#FFF" fill-opacity=".53" d="M806.74 404.922l29.202-.495-14.85 14.85"/></g><path fill="#E4002B" d="M-333.5-327.9l28 28h-28" filter="url(#h)" transform="rotate(180 193.5 38.5)"/><path fill="#FFF" fill-opacity=".276" d="M720.5 404.9l-28-28h28"/><g opacity=".488"><path d="M-.9 484l20 20h-20" filter="url(#i)" transform="rotate(-45 216.435 -406.437)"/><path fill="#FFF" fill-opacity=".43" d="M692.39 376.876h28.284l-14.142 14.142"/></g><path d="M-305.5-298.9l28 28h-28" filter="url(#j)" transform="rotate(180 221.5 67.5)"/><path fill="#FFF" fill-opacity=".073" d="M748.5 433.9l-28-28h28"/><g opacity=".548"><path d="M27.1 513l19 20h-19" filter="url(#k)" transform="rotate(-45 243.935 -377.437)"/><path fill="#FFF" fill-opacity=".43" d="M720.244 405.523l27.577.707-13.434 13.435"/></g><path fill="#e4002b" d="M692.5 376.9l29 29h-29"/><g><path d="M167.8-249.7l30.3 29.8h-30.3" filter="url(#l)" transform="rotate(180 517.48 108.09)"/><path fill="#FFF" fill-opacity=".073" d="M867.16 465.88l-30.3-29.8h30.3"/></g><g opacity=".453"><path d="M500.8 561.5l21.5 21.1h-21.5" filter="url(#m)" transform="rotate(-45 517.492 93.077)"/><path fill="#FFF" fill-opacity=".43" d="M836.914 436.105l30.123-.283-15.203 15.203"/></g><g><path d="M-153.6-308.4l59.1 60h-59.1" filter="url(#n)" transform="rotate(180 210.467 64.5)"/><path fill="#FFF" fill-opacity=".107" d="M574.534 437.4l-59.1-60h59.1"/></g><path opacity=".266" fill="#FFF" fill-opacity=".707" enable-background="new" d="M514.6 377.8l59.5.1-29.7 29.8"/><g><path d="M612.6-285.8l46 46.9h-46" filter="url(#o)" transform="rotate(180 970.07 80.547)"/><path fill="#FFF" fill-opacity=".107" d="M1327.54 446.894l-46-46.9h46"/></g><path opacity=".137" fill="#FFF" fill-opacity=".707" enable-background="new" d="M1280.7 400.1l47.1.1-23.5 23.6"/><path fill="#e4002b" d="M942.8 405l59.1 59.9h-59.1M514.6 377.4l59 60h-59"/></svg>)}.c-journal-header__identity--gold-dark-blue .c-journal-header__submit-button:visited,.c-journal-header__identity--gold-grey .c-journal-header__submit-button:visited,.c-journal-header__identity--grape-dark-blue .c-journal-header__submit-button:visited,.c-journal-header__identity--grape-light-grey .c-journal-header__submit-button:visited,.c-journal-header__identity--jungle-light-blue .c-journal-header__submit-button:visited,.c-journal-header__identity--jungle-light-green .c-journal-header__submit-button:visited,.c-journal-header__identity--jungle-yellow .c-journal-header__submit-button:visited,.c-journal-header__identity--midnight-light-grey .c-journal-header__submit-button:visited,.c-journal-header__identity--midnight-purple .c-journal-header__submit-button:visited,.c-journal-header__identity--midnight-yellow .c-journal-header__submit-button:visited,.c-journal-header__identity--ocean-light-blue .c-journal-header__submit-button:visited,.c-journal-header__identity--ruby-dark-blue .c-journal-header__submit-button:visited,.c-journal-header__identity--ruby-dark-red .c-journal-header__submit-button:visited,.c-journal-header__identity--sky-blue .c-journal-header__submit-button:visited,.c-journal-header__identity--sky-dark-blue .c-journal-header__submit-button:visited,.c-journal-header__identity--wine-purple .c-journal-header__submit-button:visited,.c-journal-header__identity--wine-red .c-journal-header__submit-button:visited,.c-journal-title a:hover{color:#004b83}.c-journal-title{font-size:26px;font-weight:700;color:#1b3051;line-height:1.4;display:flex;font-style:normal;margin-bottom:0}.c-journal-title a:visited{color:#8e2555}.c-journal-title a:hover{text-decoration:underline}.c-journal-title a:active,.c-journal-title>a{color:#0097ef;text-decoration:none}.c-journal-title>a{color:#1b3051;display:flex}.c-journal-title>a:active,.c-journal-title>a:hover,.c-journal-title>a:visited{color:#1b3051}.c-journal-title--footer{font-size:24px;margin-bottom:8px}.c-journal-title--footer .c-journal-title__logo{margin-right:0;transform:scale(.75);transform-origin:left}.c-journal-title__logo{display:block;margin-right:16px;max-height:40px}.c-journal-title__text{display:block;flex:0 1 auto;align-self:center}.c-logo,.c-logo>a{display:flex;align-items:baseline}.c-logo>a:active,.c-logo>a:focus,.c-logo>a:hover,.c-logo>a:visited{text-decoration:none}.c-logo__strapline{display:none}@media only screen and (min-width:540px){.c-logo__strapline{display:block;margin:0 0 0 16px;transform:translateY(1px)}}.c-navbar{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;font-size:14px;background:#f2f2f2;border-top:1px solid #d9d9d9;border-bottom:1px solid #d9d9d9;line-height:1.4285714286;padding:16px 0}.c-navbar__container{margin:0 auto;max-width:1280px;padding:0 16px;display:flex;align-items:center;justify-content:space-between;flex-wrap:wrap}.c-navbar__content{flex:0 1 auto;display:flex;align-items:center}@media only screen and (min-width:1024px){.c-navbar__content{display:flex!important}}.c-navbar__nav{list-style:none;margin:0;padding:0;display:flex}@media only screen and (min-width:1024px){.c-navbar__nav{transform:translateY(1px)}}.c-navbar__item{flex:1 0 auto}@media only screen and (max-width:539px){.c-navbar__item{font-size:.75rem}}.c-navbar__item:not(:first-child){margin-left:16px}.c-navbar__link{display:block;text-decoration:none;background:0 0;border:0;text-transform:capitalize}.c-navbar__link,.c-navbar__link:active,.c-navbar__link:hover,.c-navbar__link:visited{color:currentColor}.c-navbar__link--is-shown,.c-navbar__link:hover{text-decoration:underline}.c-navbar__link:active{outline:0}.c-journal-footer{font-size:18px;border-top:1px solid #ccc;padding-top:16px;padding-bottom:16px}.c-journal-footer__inner{margin:0 auto;max-width:1280px;padding:0 16px}@media only screen and (min-width:768px){.c-journal-footer__inner{display:flex;justify-content:space-between}}.c-journal-footer__summary{margin-bottom:16px}@media only screen and (min-width:768px){.c-journal-footer__summary{display:flex;flex-direction:column;justify-content:space-between;margin-bottom:0}}.c-journal-footer__issn{color:#1b3051;margin-bottom:0}.c-journal-footer__contact-title{font-size:18px;font-style:normal}@media only screen and (min-width:768px){.c-journal-footer__contact-title{margin-bottom:16px}}.c-journal-footer__contact-title--adjust-for-logo{margin-top:18px}.c-journal-footer__contact-list{list-style:none;margin:0;padding:0;color:#1b3051}.c-logo{display:block}html.webfonts-loaded .u-h3{font-family:"Europa","Trebuchet MS"}.u-button{align-items:center;cursor:pointer;margin:0;position:relative;text-decoration:none;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;font-size:1rem;line-height:1.3;padding:8px;transition:.25s ease,color .25s ease,border-color .25s ease;border-radius:2px;background-color:#f2f2f2;background-image:linear-gradient(to bottom,#fff,#f2f2f2);border:1px solid #ccc}.u-button svg{fill:currentColor}.u-button,.u-button:visited{color:#004b83}.u-button:hover{border:1px solid #666;text-decoration:none}.u-button:focus{border:1px solid #666;text-decoration:none}.u-button:focus,.u-button:hover{color:#fff;background-color:#666;background-image:none}.u-button--primary{color:#fff;background-color:#33629d;background-image:linear-gradient(to bottom,#4d76a9,#33629d);border:1px solid rgba(0,59,132,.5)}.u-button--primary:visited{color:#fff}.u-button--primary:hover{border:1px solid #0061a9}.u-button--primary:focus{border:1px solid #0061a9}.u-button--primary:focus,.u-button--primary:hover{color:#fff;background-color:#0061a9;background-image:none}.u-button--disabled,.u-button:disabled{color:#333;background-color:transparent;background-image:none;border:1px solid #ccc;opacity:.67;cursor:default}.u-button--disabled svg,.u-button:disabled svg{fill:currentColor}.u-button--disabled:visited,.u-button:disabled:visited{color:#333}.u-button--disabled:hover,.u-button:disabled:hover{border:1px solid #ccc;text-decoration:none}.u-button--disabled:focus,.u-button:disabled:focus{border:1px solid #ccc;text-decoration:none}.u-button--disabled:focus,.u-button--disabled:hover,.u-button:disabled:focus,.u-button:disabled:hover{color:#333;background-color:transparent;background-image:none}.u-button--full-width{display:flex;width:100%}.u-clearfix::after,.u-clearfix::before{content:"";display:table}.u-clearfix::after{clear:both}.u-container{margin:0 auto;max-width:1280px;padding:0 16px}.u-display-block{display:block}.u-display-flex{display:flex;width:100%}.u-flex-wrap{flex-wrap:wrap}.u-align-items-center{align-items:center}.u-justify-content-space-between{justify-content:space-between}.u-flex-static{flex:0 0 auto}.u-show{display:block;visibility:visible}.u-icon{fill:currentColor;transform:translate(0,0);display:inline-block;vertical-align:text-top;width:1em;height:1em}.u-list-reset{list-style:none;margin:0;padding:0}.u-position-relative{position:relative}.u-mt-8{margin-top:8px}.u-mt-16{margin-top:16px}.u-mt-32{margin-top:32px}.u-mr-8{margin-right:8px}.u-mr-24{margin-right:24px}.u-mr-48{margin-right:48px}.u-mb-16{margin-bottom:16px}.u-mb-24{margin-bottom:24px}.u-mb-32{margin-bottom:32px}.u-ml-8{margin-left:8px}.u-pr-16{padding-right:16px}.u-button-reset{background-color:transparent;border:0;padding:0}.u-text-normal{font-weight:400}.u-text-bold{font-weight:700}.u-h3 a{text-decoration:none}.u-text-sm{font-size:14px}.u-text-lg{font-size:24px}.u-text-right{text-align:right}.u-h3{color:#1b3051;font-style:normal;line-height:1.4}.u-h3{font-size:18px;margin-bottom:.7em}.u-h3 a:hover{color:#004b83}.u-h3 a:visited{color:#8e2555}.u-h3 a:hover{text-decoration:underline}.u-h3 a:active{color:#0097ef;text-decoration:none}.u-vh-full{min-height:100vh}.u-hide{display:none;visibility:hidden}@media only screen and (max-width:1023px){.u-hide-at-lt-lg{display:none;visibility:hidden}}.u-visually-hidden{border:0;clip:rect(0,0,0,0);height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}.u-gray-link,.u-gray-link:hover,.u-gray-link:visited{color:#666}body{font-size:1.125rem}.c-header__navigation{display:flex;gap:.5rem}@-webkit-keyframes transparent-to-yellow{0%,to{background:0 0}25%,75%{background:#ff9}}@keyframes transparent-to-yellow{0%,to{background:0 0}25%,75%{background:#ff9}}@-webkit-keyframes highlight{0%,60%{background-color:#ff9}to{background-color:#fff}}@keyframes highlight{0%,60%{background-color:#ff9}to{background-color:#fff}}.c-article-editorial-summary__container .c-article-editorial-summary__article-title a.active,.c-article-editorial-summary__container .c-article-editorial-summary__article-title a.hover,.c-article-editorial-summary__container .c-article-editorial-summary__article-title a:active,.c-article-editorial-summary__container .c-article-editorial-summary__article-title a:hover,.c-card--major .c-card__title a.active,.c-card--major .c-card__title a.hover,.c-card--major .c-card__title a:active,.c-card--major .c-card__title a:hover,.c-card__title a.active,.c-card__title a.hover,.c-card__title a:active,.c-card__title a:hover,.c-reading-companion__figure-title a.active,.c-reading-companion__figure-title a.hover,.c-reading-companion__figure-title a:active,.c-reading-companion__figure-title a:hover,.u-h1 a.active,.u-h1 a.hover,.u-h1 a:active,.u-h1 a:hover,.u-h2 a.active,.u-h2 a.hover,.u-h2 a:active,.u-h2 a:hover,.u-h3 a.active,.u-h3 a.hover,.u-h3 a:active,.u-h3 a:hover,.u-h4 a.active,.u-h4 a.hover,.u-h4 a:active,.u-h4 a:hover,h5 a.active,h5 a.hover,h5 a:active,h5 a:hover,h6 a.active,h6 a.hover,h6 a:active,h6 a:hover{text-decoration:underline;-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto}.u-h3{font-style:normal;margin-bottom:1em}button{line-height:inherit}[contenteditable]:focus,[tabindex="0"]:focus,button:focus,input:focus,select:focus,textarea:focus{outline:4px solid #fc0}button:disabled:focus,input:disabled:focus,select:disabled:focus,textarea:disabled:focus{outline:0}html{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif}html{height:100%;overflow-y:scroll;box-sizing:border-box;color:#333;line-height:1.6180339888;-moz-osx-font-smoothing:auto;-webkit-font-smoothing:subpixel-antialiased;font-size:100%}*,:after,:before{box-sizing:inherit}body{max-width:100%;min-height:100%;background:#fff}body,figure{margin:0}button,div,dt{margin:0;padding:0}body,dd,dl,p{padding:0}abbr[title],h3 a{text-decoration:none}a{color:#004b83;-webkit-text-decoration-skip:ink;text-decoration-skip-ink:auto;word-wrap:break-word;overflow-wrap:break-word;word-break:break-word;text-decoration:underline;text-decoration-thickness:.0625rem;text-underline-offset:.08em}a.visited,a:visited{color:#8e2555}a.hover,a:hover{color:#0097ef}a.active,a:active{color:#25426f;text-decoration:none}a.focus,a:focus{outline:4px solid #fc0}a>img{vertical-align:middle}h1,h2,h3,h4{margin-top:0}h1{font-weight:700}html.webfonts-loaded h1,html.webfonts-loaded h2,html.webfonts-loaded h3,html.webfonts-loaded h4{font-family:"Europa","Trebuchet MS"}h1,h2,h3,h4{color:#1b3051;font-style:normal;line-height:1.4}h2{font-weight:700;margin-bottom:.5em}h3,h4{font-size:18px;margin-bottom:.7em}h3 a:hover{color:#004b83}h3 a:visited{color:#8e2555}h3 a:hover{text-decoration:underline}h3 a:active{color:#0097ef;text-decoration:none}h4{font-style:italic;font-weight:700}dl,p{margin:0}ol,ul{margin-top:0}ol:not([class]),ul:not([class]){padding-left:.9em}dd{margin:0}p{margin-bottom:1.5em;word-wrap:break-word;overflow-wrap:break-word;word-break:break-word}.c-article-editorial-summary__container .c-article-editorial-summary__content p:last-child,p:last-child{margin-bottom:0}p:empty{display:none}@font-face{font-family:"Europa";font-style:normal;font-weight:400;src:local("Europa-Regular"),url(data:application/font-woff2;base64,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)format("woff2")}@font-face{font-family:"Europa";font-style:normal;font-weight:700;src:local("Europa-Bold"),url(data:application/font-woff2;base64,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)format("woff2")}a:hover{text-decoration:underline;text-decoration-thickness:.25rem;text-underline-offset:.08em}.u-h3{font-size:1.5rem;font-weight:700}body{font-size:1.125rem}.c-article-header{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;margin-bottom:40px}.c-article-identifiers{list-style:none;font-size:1rem;line-height:1.3;display:flex;flex-wrap:wrap;color:#6f6f6f;padding:0;margin:0 0 8px}.c-article-identifiers__item{border-right:1px solid #6f6f6f;margin-right:8px;padding-right:8px;list-style:none}.c-article-identifiers__item:last-child{margin-right:0;padding-right:0;border-right:0}.c-article-identifiers__open{color:#cc4b14}.c-article-title{font-size:1.5rem;line-height:1.25;margin-bottom:16px}@media only screen and (min-width:768px){.c-article-title{font-size:1.875rem;line-height:1.2}}.c-article-author-list{width:100%;margin:0 8px 0 0;padding:0;display:inline;list-style:none;font-size:1rem}.c-article-author-list__item{display:inline;padding-right:0}.c-article-author-list svg{margin-left:4px}.c-article-info-details{font-size:1rem;margin-bottom:8px;margin-top:16px}.c-article-info-details__cite-as{border-left:1px solid #6f6f6f;margin-left:8px;padding-left:8px}.c-article-metrics-bar{display:flex;flex-wrap:wrap;line-height:1.3;font-size:1rem}.c-article-metrics-bar__wrapper{margin:0 0 16px}.c-article-metrics-bar__item{align-items:baseline;border-right:1px solid #6f6f6f;margin-right:8px}.c-article-metrics-bar__item:last-child{border-right:0}.c-article-metrics-bar__count{font-weight:700;margin:0}.c-article-metrics-bar__label{color:#626262;font-weight:400;font-style:normal;margin:0 10px 0 5px}.c-article-metrics-bar__details{margin:0}.c-article-main-column{font-family:Georgia,Palatino,serif;margin-right:8.6%;width:60.2%}@media only screen and (max-width:1023px){.c-article-main-column{margin-right:0;width:100%}}.c-article-extras{float:left;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;width:31.2%}@media only screen and (max-width:1023px){.c-article-extras{display:none}}.c-article-author-affiliation__list,.c-article-references{list-style:none;padding:0}.c-article-section__title{border-bottom:2px solid #d5d5d5;font-size:1.25rem;padding-bottom:8px;margin:0}@media only screen and (min-width:768px){.c-article-section__title{font-size:1.5rem;line-height:1.24}}.c-article-section{clear:both}.c-article-section__content{padding-top:8px;margin-bottom:40px}@media only screen and (max-width:1023px){.c-article-section__content{padding-left:0}}.c-article__pill-button{padding:8px 16px 8px 20px;background-color:#fff;border:4px solid #bcd2dc;border-radius:20px;font-size:.875rem;line-height:1.4;font-weight:700;margin-bottom:10px;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;text-decoration:none;display:inline-flex;align-items:center}.c-article__pill-button:hover{background-color:#0067c5;color:#fff;text-decoration:none}.c-article__pill-button:focus{outline:0;box-shadow:0 0 0 3px #fece3e;text-decoration:none}.c-article__pill-button:active,.c-article__pill-button:hover{box-shadow:0 0 0 0}.c-article__pill-button svg{height:.8em;margin-left:2px}.c-article__sub-heading{font-size:1.125rem;font-weight:400;font-style:normal;line-height:1.3;color:#222;margin:0 0 8px}@media only screen and (min-width:768px){.c-article__sub-heading{font-size:1.5rem;line-height:1.24}}.c-article-references__item{display:flex;flex-wrap:wrap;border-bottom:1px solid #d5d5d5;padding-bottom:16px;margin-bottom:16px}.c-article-references__item::before{content:attr(data-counter);font-size:1.5rem;line-height:1.4;text-align:right}@media only screen and (max-width:1023px){.c-article-references__item::before{font-size:1.125rem;line-height:inherit}}.c-article-references__item>p.c-article-references__text{flex:1;padding-left:8px}.c-article-references__text{margin-bottom:8px}.c-article-references__links{display:flex;flex-basis:100%;justify-content:flex-end;flex-wrap:wrap;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;font-size:1rem;font-weight:700;margin:0;padding:0;list-style:none}.c-article-references__links a{padding-left:8px}.c-article-references__links a:first-child{padding-left:0}.c-article-references__download{text-align:right}.c-article-references__download>a{font-size:1rem;font-weight:700;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif}.c-article-references__download svg,.c-bibliographic-information__download-citation svg{margin-left:4px}.c-article-author-affiliation__list>li{margin-bottom:16px}.c-article-author-affiliation__address{color:inherit;font-weight:700;margin:0}.c-article-author-affiliation__authors-list{list-style:none;padding:0;margin:0}.c-article-supplementary__item{margin-bottom:24px;position:relative}.c-article-supplementary__description>*{margin-bottom:0}.c-article-supplementary__title{margin:0 0 8px;line-height:1.5}.c-article-subject-list{font-size:1rem;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;list-style:none;display:flex;flex-wrap:wrap;padding:0;margin:0 0 24px}.c-article-subject-list__subject{background-color:#e1e1e1;border-radius:20px;padding:4px 10px;font-weight:700;margin-right:15px;margin-bottom:16px;flex:0 1 auto}.c-bibliographic-information{display:flex;padding-top:8px}@media only screen and (max-width:1023px){.c-bibliographic-information{padding-top:0;display:block}}.c-bibliographic-information__value{font-size:1rem;display:block}.c-bibliographic-information__column:first-child{width:81px;flex:0 0 81px}@media only screen and (max-width:1023px){.c-bibliographic-information__column:first-child{width:100%}}.c-bibliographic-information__column:last-child{flex:1}.c-bibliographic-information__column--border{border-right:1px solid #d5d5d5;margin-right:24px}@media only screen and (max-width:1023px){.c-bibliographic-information__column--border{border-bottom:1px solid #d5d5d5;padding-bottom:8px;margin-bottom:8px;border-right:0;margin-right:0}}.c-bibliographic-information__list{list-style:none;margin:0;padding:0;display:flex;justify-content:flex-start;flex-wrap:wrap}.c-bibliographic-information__list-item{flex:0 0 33%;box-sizing:border-box;padding-right:8px;margin-bottom:16px;font-size:1rem;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif}@media only screen and (max-width:1023px){.c-bibliographic-information__list-item{flex:0 0 100%}}.c-bibliographic-information__list-item p{margin-bottom:0}.c-bibliographic-information__list-item:last-child{padding-right:0}.c-bibliographic-information__list-item--doi{flex:0 0 100%}.c-bibliographic-information__citation,.c-bibliographic-information__download-citation{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;font-size:1rem;margin-bottom:8px}.c-bibliographic-information__download-citation{margin-bottom:24px}.c-article-share-box{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif;margin-bottom:24px}.c-article-share-box__description{font-size:1rem;margin-bottom:8px}.c-article-share-box__additional-info{color:#626262;font-size:.813rem}.c-article-share-box__button{background:#fff;border:1px solid #0067c5;box-sizing:content-box;color:#0067c5;font-size:1rem;line-height:1.5;margin-bottom:8px;padding:8px 20px;text-align:center}@supports ((-webkit-backdrop-filter:blur(10px)) or (backdrop-filter:blur(10px))){.c-context-bar--sticky:after{background:linear-gradient(to top,rgba(255,255,255,.75) 50%,#fff);-webkit-backdrop-filter:blur(10px);backdrop-filter:blur(10px)}}img[src*="delivery.pbgrd.com/network/logger"]{position:absolute;height:0;width:0}.c-reading-companion{clear:both;min-height:389px}.c-reading-companion .u-lazy-ad-wrapper{background-color:transparent!important;min-height:250px}.c-reading-companion__sticky{max-width:389px}.c-reading-companion__scroll-pane{overflow-x:hidden;overflow-y:auto;margin:0;min-height:200px}.c-reading-companion__tabs{font-size:1rem;list-style:none;display:flex;flex-direction:row;flex-wrap:nowrap;margin:0 0 8px;padding:0}.c-reading-companion__tabs>li{flex-grow:1}.c-reading-companion__tab{color:#0067c5;border:solid #d5d5d5;border-width:1px 1px 1px 0;background-color:#eee;padding:8px 8px 8px 15px;text-align:left;font-size:1rem;width:100%}.c-reading-companion__tab:focus{text-decoration:none;outline-offset:-4px}.c-reading-companion__tabs li:first-child .c-reading-companion__tab{border-left-width:1px}.c-reading-companion__tab--active{color:#222;background-color:#fff;border-bottom:1px solid #fff;font-weight:700}.c-reading-companion__sections-list{list-style:none;padding:0}.c-reading-companion__sections-list{margin:0 0 8px;min-height:50px}.c-reading-companion__section-item{font-size:1rem;padding:0}.c-reading-companion__section-item a{display:block;padding:8px 0 8px 16px;line-height:1.5;overflow:hidden;white-space:nowrap;text-overflow:ellipsis}.c-reading-companion__section-item--active a{white-space:normal;border-left:4px solid #d5d5d5;padding-left:12px;color:#222}.c-reading-companion__panel{border-top:none;margin-top:0;padding-top:0}.c-reading-companion__panel--active{display:block}.c-article-section__figure{border:2px solid #d5d5d5;padding:20px 10px;max-width:100%;margin-bottom:24px;clear:both}.c-article-section__figure-caption{margin-bottom:8px;display:block;word-break:break-word}.c-article-section__figure-content{margin-bottom:16px}.c-article-section__figure-item{max-width:100%}.c-article-section__figure-link{max-width:100%;display:block;margin:0 0 16px;padding:0}.c-article-section__figure-item img{display:block;margin:0 auto}.c-article-section__figure-description{font-size:1rem}.c-article-section__figure-description>*{margin-bottom:0}.c-article-table{border:2px solid #d5d5d5;clear:both;padding:20px 10px;margin-bottom:24px}.c-article-table__figcaption{line-height:1.4;margin-bottom:16px;word-break:break-word}.c-pdf-download__link .u-icon{padding-top:2px}.c-pdf-download{display:flex;margin-bottom:16px;max-height:48px}@media only screen and (min-width:540px){.c-pdf-download{max-height:none}}@media only screen and (min-width:1024px){.c-pdf-download{max-height:48px}}.c-pdf-download__link{display:flex;flex:1;padding:13px 24px!important}.c-pdf-download__link:hover{text-decoration:none}.c-pdf-download__text{padding-right:4px}@media only screen and (max-width:539px){.c-pdf-download__text{text-transform:capitalize}}@media only screen and (min-width:540px){.c-pdf-download__text{padding-right:8px}}@supports (display:grid) and (grid-auto-rows:auto){.c-article-metrics__legend ul{display:grid;grid-column-gap:8px;grid-auto-rows:auto;grid-template-columns:repeat(auto-fill,minmax(120px,1fr))}@media only screen and (min-width:540px){.c-article-metrics__legend ul{padding-left:16px;grid-template-columns:repeat(2,50%)}}@media only screen and (min-width:1024px){.c-article-metrics__legend ul{grid-template-columns:repeat(3,33%)}}.c-article-metrics__legend ul li{font-size:.875rem}}@supports (aspect-ratio:1/1){.c-card__image{padding-bottom:0;aspect-ratio:var(--card--image-aspect-ratio,16/9)}}@supports ((-o-object-fit:cover) or (object-fit:cover)){.c-card__image img{width:100%;height:100%;-o-object-fit:cover;object-fit:cover}}.u-show{display:block;visibility:visible}.u-visually-hidden{border:0;clip:rect(0,0,0,0);height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}.u-icon{fill:currentColor;transform:translate(0,0);display:inline-block;vertical-align:text-top;width:1em;height:1em}.u-list-reset{list-style:none;margin:0;padding:0}.u-text-right{text-align:right}.u-text-normal{font-weight:400}.u-text-bold{font-weight:700}.hide{display:none;visibility:hidden}.c-article-section__figure-description{font-family:Georgia,Palatino,serif}.u-reset-margin a:hover{text-decoration:inherit}.c-banner{margin-top:-13px}.c-article-figshare-container{min-height:1px}.c-article-figshare-container:not(:empty){cursor:default;margin-bottom:16px;margin-top:8px}.webfonts-loaded .c-article__sub-heading{font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Oxygen-Sans,Ubuntu,Cantarell,"Helvetica Neue",sans-serif}</style>
<link rel=canonical href=https://cardiab.biomedcentral.com/articles/10.1186/s12933-018-0746-4>
<meta property=og:url content=https://cardiab.biomedcentral.com/articles/10.1186/s12933-018-0746-4>
<meta property=og:type content=article>
<meta property=og:site_name content="BioMed Central">
<meta property=og:title content="Risk of heart failure hospitalization among users of dipeptidyl peptidase-4 inhibitors compared to glucagon-like peptide-1 receptor agonists - Cardiovascular Diabetology">
<meta property=og:description content="Background Incretin-based therapies including dipeptidyl peptidase-4 (DPP-4) inhibitors and glucagon like peptide-1 (GLP-1) receptor agonists are novel medications for type 2 diabetes management. Several studies have found cardioprotective effects of incretin-based therapies; however, it remains unclear whether there is any difference in heart failure (HF) risk between the two incretin-based therapies (DPP-4 inhibitors and GLP-1 receptor agonists). We aimed to assess the risk of hospitalization due to HF with the use of DPP-4 inhibitors compared to GLP-1 receptor agonists. Methods Using Truven Health Marketscan data, we conducted a retrospective cohort study of patients with type 2 diabetes, who were newly initiated on DPP-4 inhibitors or GLP-1 agonists. Follow-up continued from drug initiation until the first occurrence of: HF hospitalization (primary outcome), discontinuation of therapy (i.e. no fill for 7 days), switch to the comparator, end of enrollment, or end of study (December 2013). Cox proportional hazards models with propensity-score-matching were used to compare the risk of HF hospitalization between DPP-4 inhibitors and GLP-1 agonists. Results A total of 321,606 propensity score-matched patients were included in the analysis (n = 160,803 for DPP-4 inhibitors; n = 160,803 for GLP-1 agonists). After adjusting for baseline characteristics and disease risk factors, the use of DPP-4 inhibitors was associated with a 14% decreased risk of HF hospitalization compared to GLP-1 agonists use [hazard ratio (HR), 0.86; 95% confidence interval (CI) 0.83, 0.90]. The results were consistent in patients without baseline HF (HR, 0.85; 95% CI 0.82, 0.89), but the association was not statistically significant for patients with baseline HF (HR, 0.90; 95% CI 0.74, 1.07). Conclusion In this retrospective matched cohort of patients with type 2 diabetes, the use of DPP-4 inhibitors was associated with a reduced risk of HF hospitalization compared to GLP-1 agonists. However, the association was not statistically significant in patients who had HF prior to the use of DPP-4 inhibitors.">
<meta property=og:image content=https://media.springernature.com/w200/springer-static/cover/journal/12933.jpg>
<script type=application/ld+json>{"mainEntity":{"headline":"Risk of heart failure hospitalization among users of dipeptidyl peptidase-4 inhibitors compared to glucagon-like peptide-1 receptor agonists","description":"Incretin-based therapies including dipeptidyl peptidase-4 (DPP-4) inhibitors and glucagon like peptide-1 (GLP-1) receptor agonists are novel medications for type 2 diabetes management. Several studies have found cardioprotective effects of incretin-based therapies; however, it remains unclear whether there is any difference in heart failure (HF) risk between the two incretin-based therapies (DPP-4 inhibitors and GLP-1 receptor agonists). We aimed to assess the risk of hospitalization due to HF with the use of DPP-4 inhibitors compared to GLP-1 receptor agonists. Using Truven Health Marketscan data, we conducted a retrospective cohort study of patients with type 2 diabetes, who were newly initiated on DPP-4 inhibitors or GLP-1 agonists. Follow-up continued from drug initiation until the first occurrence of: HF hospitalization (primary outcome), discontinuation of therapy (i.e. no fill for 7 days), switch to the comparator, end of enrollment, or end of study (December 2013). Cox proportional hazards models with propensity-score-matching were used to compare the risk of HF hospitalization between DPP-4 inhibitors and GLP-1 agonists. A total of 321,606 propensity score-matched patients were included in the analysis (n = 160,803 for DPP-4 inhibitors; n = 160,803 for GLP-1 agonists). After adjusting for baseline characteristics and disease risk factors, the use of DPP-4 inhibitors was associated with a 14% decreased risk of HF hospitalization compared to GLP-1 agonists use [hazard ratio (HR), 0.86; 95% confidence interval (CI) 0.83, 0.90]. The results were consistent in patients without baseline HF (HR, 0.85; 95% CI 0.82, 0.89), but the association was not statistically significant for patients with baseline HF (HR, 0.90; 95% CI 0.74, 1.07). In this retrospective matched cohort of patients with type 2 diabetes, the use of DPP-4 inhibitors was associated with a reduced risk of HF hospitalization compared to GLP-1 agonists. However, the association was not statistically significant in patients who had HF prior to the use of DPP-4 inhibitors.","datePublished":"2018-07-17","dateModified":"2018-07-17","pageStart":"1","pageEnd":"9","license":"http://creativecommons.org/publicdomain/zero/1.0/","sameAs":"https://doi.org/10.1186/s12933-018-0746-4","keywords":"Diabetes,Angiology,Cardiology","image":"https://static-content.springer.com/image/art%3A10.1186%2Fs12933-018-0746-4/MediaObjects/12933_2018_746_Fig1_HTML.png","isPartOf":{"name":"Cardiovascular Diabetology","issn":["1475-2840"],"volumeNumber":"17","@type":["Periodical","PublicationVolume"]},"publisher":{"name":"BioMed Central","logo":{"url":"https://www.springernature.com/app-sn/public/images/logo-springernature.png","@type":"ImageObject"},"@type":"Organization"},"author":[{"name":"Dawwas, Ghadeer K.","affiliation":[{"name":"University of Florida","address":{"name":"Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, USA","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Smith, Steven M.","affiliation":[{"name":"University of Florida","address":{"name":"Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, USA","@type":"PostalAddress"},"@type":"Organization"},{"name":"University of Florida","address":{"name":"Department of Community Health and Family Medicine, College of Medicine, University of Florida, Gainesville, USA","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Park, Haesuk","url":"http://orcid.org/0000-0003-3299-8111","affiliation":[{"name":"University of Florida","address":{"name":"Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, USA","@type":"PostalAddress"},"@type":"Organization"}],"email":"hpark@cop.ufl.edu","@type":"Person"}],"isAccessibleForFree":true,"@type":"ScholarlyArticle"},"@context":"https://schema.org","@type":"WebPage"}</script>
<style>#MathJax_Message{position:fixed;left:1px;bottom:2px;background-color:#E6E6E6;border:1px solid #959595;margin:0px;padding:2px 8px;z-index:102;color:black;font-size:80%;width:auto;white-space:nowrap}</style><meta http-equiv=origin-trial content="Az6AfRvI8mo7yiW5fLfj04W21t0ig6aMsGYpIqMTaX60H+b0DkO1uDr+7BrzMcimWzv/X7SXR8jI+uvbV0IJlwYAAACFeyJvcmlnaW4iOiJodHRwczovL2RvdWJsZWNsaWNrLm5ldDo0NDMiLCJmZWF0dXJlIjoiUHJpdmFjeVNhbmRib3hBZHNBUElzIiwiZXhwaXJ5IjoxNjgwNjUyNzk5LCJpc1N1YmRvbWFpbiI6dHJ1ZSwiaXNUaGlyZFBhcnR5Ijp0cnVlfQ=="><meta http-equiv=origin-trial content="A+USTya+tNvDPaxUgJooz+LaVk5hPoAxpLvSxjogX4Mk8awCTQ9iop6zJ9d5ldgU7WmHqBlnQB41LHHRFxoaBwoAAACLeyJvcmlnaW4iOiJodHRwczovL2dvb2dsZXN5bmRpY2F0aW9uLmNvbTo0NDMiLCJmZWF0dXJlIjoiUHJpdmFjeVNhbmRib3hBZHNBUElzIiwiZXhwaXJ5IjoxNjgwNjUyNzk5LCJpc1N1YmRvbWFpbiI6dHJ1ZSwiaXNUaGlyZFBhcnR5Ijp0cnVlfQ=="><meta http-equiv=origin-trial content="A7FovoGr67TUBYbnY+Z0IKoJbbmRmB8fCyirUGHavNDtD91CiGyHHSA2hDG9r9T3NjUKFi6egL3RbgTwhhcVDwUAAACLeyJvcmlnaW4iOiJodHRwczovL2dvb2dsZXRhZ3NlcnZpY2VzLmNvbTo0NDMiLCJmZWF0dXJlIjoiUHJpdmFjeVNhbmRib3hBZHNBUElzIiwiZXhwaXJ5IjoxNjgwNjUyNzk5LCJpc1N1YmRvbWFpbiI6dHJ1ZSwiaXNUaGlyZFBhcnR5Ijp0cnVlfQ=="><style>.frontend-filesViewer-components-fileDescription-module__descriptionContainer--5IiG5{line-height:21px}.frontend-filesViewer-components-fileDescription-module__title--Zri4r{margin-bottom:7px;font-weight:bold}.frontend-filesViewer-components-fileDescription-module__description--rwuvv{margin-bottom:7px}.frontend-filesViewer-components-skipButton-index-module__button--wpP\+-{display:inline-block;line-height:24px;border-radius:3px;padding:0 6px;text-decoration:none}.frontend-filesViewer-components-skipButton-index-module__fsButton--lRWNp:focus,.frontend-filesViewer-components-skipButton-index-module__button--wpP\+-:focus{box-shadow:0 0 3px 0px #ffa500 inset,0 0 3px 3px #ffa500}.frontend-filesViewer-components-skipButton-index-module__fsButton--lRWNp::before,.frontend-filesViewer-components-skipButton-index-module__fsButton--lRWNp::after,.frontend-filesViewer-components-skipButton-index-module__button--wpP\+-::before,.frontend-filesViewer-components-skipButton-index-module__button--wpP\+-::after{display:inline;font-size:10px}.frontend-filesViewer-components-skipButton-index-module__button--wpP\+-.frontend-filesViewer-components-skipButton-index-module__hidden--TAOdS{position:absolute;left:-10000px;top:auto;width:1px;height:1px;overflow:hidden}.frontend-filesViewer-components-skipButton-index-module__button--wpP\+-.frontend-filesViewer-components-skipButton-index-module__hidden--TAOdS:focus{width:auto;height:auto}.frontend-filesViewer-inlineMode-footer-figshareButton-module__fs-icon-base--qOzXx,.frontend-filesViewer-inlineMode-footer-figshareButton-module__figshareButton--jh7bg::after{font-family:"figIcon";speak:none;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;line-height:1;letter-spacing:0;-ms-font-feature-settings:"liga"1;-o-font-feature-settings:"liga";font-feature-settings:"liga",normal;-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale}.frontend-filesViewer-inlineMode-footer-figshareButton-module__figshareButton--jh7bg{height:32px;color:#556471;text-decoration:none;display:flex;align-items:center}.frontend-filesViewer-inlineMode-footer-figshareButton-module__figshareButton--jh7bg .figshare-logo{width:32px;height:32px}.frontend-filesViewer-inlineMode-footer-figshareButton-module__figshareButton--jh7bg .figshare-logo .style0{fill:#58585a}.frontend-filesViewer-inlineMode-footer-figshareButton-module__figshareButton--jh7bg .figshare-logo .style1{fill:#d1d2d4}.frontend-filesViewer-inlineMode-footer-figshareButton-module__figshareButton--jh7bg .figshare-logo .style2{fill:#818286}.frontend-filesViewer-inlineMode-footer-figshareButton-module__figshareButton--jh7bg .figshare-logo .style3{fill:#a8a9ad}.frontend-filesViewer-inlineMode-footer-figshareButton-module__figshareButton--jh7bg::after{content:"";font-size:10px;line-height:32px;color:transparent;margin-left:3px}.frontend-filesViewer-inlineMode-footer-figshareButton-module__figshareButton--jh7bg:focus{box-shadow:0 0 3px 0px #ffa500 inset,0 0 3px 3px #ffa500}.frontend-filesViewer-inlineMode-footer-figshareButton-module__figshareButton--jh7bg:focus::after,.frontend-filesViewer-inlineMode-footer-figshareButton-module__figshareButton--jh7bg:hover::after{color:#556471}.frontend-filesViewer-inlineMode-footer-figshareButton-module__figshareButton--jh7bg:focus .figshare-logo .style0,.frontend-filesViewer-inlineMode-footer-figshareButton-module__figshareButton--jh7bg:hover .figshare-logo .style0{fill:#566471}.frontend-filesViewer-inlineMode-footer-figshareButton-module__figshareButton--jh7bg:focus .figshare-logo .style1,.frontend-filesViewer-inlineMode-footer-figshareButton-module__figshareButton--jh7bg:hover .figshare-logo .style1{fill:#A2CD3C}.frontend-filesViewer-inlineMode-footer-figshareButton-module__figshareButton--jh7bg:focus .figshare-logo .style2,.frontend-filesViewer-inlineMode-footer-figshareButton-module__figshareButton--jh7bg:hover .figshare-logo .style2{fill:#C54C59}.frontend-filesViewer-inlineMode-footer-figshareButton-module__figshareButton--jh7bg:focus .figshare-logo .style3,.frontend-filesViewer-inlineMode-footer-figshareButton-module__figshareButton--jh7bg:hover .figshare-logo .style3{fill:#5BC4BD}.frontend-filesViewer-inlineMode-footer-figshareButton-module__figshareText--yx0hv{font-size:13px;margin-left:7px;line-height:32px}.frontend-filesViewer-inlineMode-downloadMenu-trigger-module__fs-icon-base--OwY4q,.frontend-filesViewer-inlineMode-downloadMenu-trigger-module__downloadButton--UsBvq::before,.frontend-filesViewer-inlineMode-downloadMenu-trigger-module__mobileMode--J5z8\+::after{font-family:"figIcon";speak:none;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;line-height:1;letter-spacing:0;-ms-font-feature-settings:"liga"1;-o-font-feature-settings:"liga";font-feature-settings:"liga",normal;-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale}.frontend-filesViewer-inlineMode-downloadMenu-trigger-module__downloadButton--UsBvq{height:24px;line-height:24px;border-radius:3px;padding:0 6px;text-decoration:none}.frontend-filesViewer-inlineMode-downloadMenu-trigger-module__fsButton--Ih8rm:focus,.frontend-filesViewer-inlineMode-downloadMenu-trigger-module__downloadButton--UsBvq:focus{box-shadow:0 0 3px 0px #ffa500 inset,0 0 3px 3px #ffa500}.frontend-filesViewer-inlineMode-downloadMenu-trigger-module__fsButton--Ih8rm::before,.frontend-filesViewer-inlineMode-downloadMenu-trigger-module__fsButton--Ih8rm::after,.frontend-filesViewer-inlineMode-downloadMenu-trigger-module__downloadButton--UsBvq::before,.frontend-filesViewer-inlineMode-downloadMenu-trigger-module__downloadButton--UsBvq::after{display:inline;font-size:10px}.frontend-filesViewer-inlineMode-downloadMenu-trigger-module__downloadButton--UsBvq{margin-left:7px;display:flex;white-space:nowrap;align-items:center}.frontend-filesViewer-inlineMode-downloadMenu-trigger-module__downloadButton--UsBvq::before{content:"";margin-right:6px}.frontend-filesViewer-inlineMode-downloadMenu-trigger-module__buttonText--GEnvG{display:inherit;font-size:13px}.frontend-filesViewer-inlineMode-footer-genericControls-module__fs-icon-base--a-WBW,.frontend-filesViewer-inlineMode-footer-genericControls-module__enlargeButton--qJnBC::after,.frontend-filesViewer-inlineMode-footer-genericControls-module__shareButton--RoEPD::before,.frontend-filesViewer-inlineMode-footer-genericControls-module__mobileMode--cGFEe .frontend-filesViewer-inlineMode-footer-genericControls-module__shareButton--RoEPD::after{font-family:"figIcon";speak:none;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;line-height:1;letter-spacing:0;-ms-font-feature-settings:"liga"1;-o-font-feature-settings:"liga";font-feature-settings:"liga",normal;-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale}.frontend-filesViewer-inlineMode-footer-genericControls-module__enlargeButton--qJnBC{display:inline-block;height:24px;line-height:24px;border-radius:3px;text-decoration:none}.frontend-filesViewer-inlineMode-footer-genericControls-module__fsButton--IvGIW:focus,.frontend-filesViewer-inlineMode-footer-genericControls-module__enlargeButton--qJnBC:focus,.frontend-filesViewer-inlineMode-footer-genericControls-module__shareButton--RoEPD:focus{box-shadow:0 0 3px 0px #ffa500 inset,0 0 3px 3px #ffa500}.frontend-filesViewer-inlineMode-footer-genericControls-module__fsButton--IvGIW::before,.frontend-filesViewer-inlineMode-footer-genericControls-module__fsButton--IvGIW::after,.frontend-filesViewer-inlineMode-footer-genericControls-module__enlargeButton--qJnBC::before,.frontend-filesViewer-inlineMode-footer-genericControls-module__enlargeButton--qJnBC::after,.frontend-filesViewer-inlineMode-footer-genericControls-module__shareButton--RoEPD::before,.frontend-filesViewer-inlineMode-footer-genericControls-module__shareButton--RoEPD::after{display:inline;font-size:10px}.frontend-filesViewer-inlineMode-footer-genericControls-module__container--Ok8Uj{display:flex;align-items:center}.frontend-filesViewer-inlineMode-footer-genericControls-module__enlargeButton--qJnBC::after{content:"";display:inline-block;width:24px;line-height:24px;text-align:center}.frontend-filesViewer-inlineMode-footer-index-module__footer--9uUmL{padding:14px;box-sizing:border-box;background:#f5f5f5;border-top:1px solid #ddd}.frontend-filesViewer-inlineMode-footer-index-module__navigation--\+GhAf{display:flex;align-items:center;justify-content:space-between;width:100%}.frontend-filesViewer-inlineMode-footer-index-module__figshareButton--nJvGg{order:0}.frontend-filesViewer-inlineMode-footer-index-module__genericControls--q\+AJj{order:2}.frontend-filesViewer-inlineMode-header-module__header--L5zPq{display:flex;max-width:100%;flex-direction:row;flex-wrap:nowrap;border-bottom:1px solid #ddd;overflow:hidden;background:#f5f5f5}.frontend-filesViewer-inlineMode-header-module__titleSection--cXZcY{flex-grow:1;width:50%;padding:14px}.frontend-filesViewer-inlineMode-header-module__title--WcAab{margin:0;font-size:18px;line-height:25px;font-weight:bold;color:#464646}.frontend-filesViewer-inlineMode-mainSection-module__mainSection--xdIHv{position:relative}.frontend-filesViewer-inlineMode-mainSection-module__viewerContainer--HLGmA{position:relative;overflow:hidden;border-left:1px solid #ddd;border-right:1px solid #ddd;box-sizing:border-box;background:#fff}.frontend-filesViewer-inlineMode-mainSection-module__viewerContainer--HLGmA .click-outside-wrapper{display:inline}.frontend-filesViewer-inlineMode-index-module__container--LzxR7{position:relative}.frontend-filesViewer-inlineMode-index-module__fileDescription--55hIr{background:#f5f5f5;padding:14px 14px 7px 14px;border-top:1px solid #ddd;font-size:13px}.frontend-filesViewer-inlineMode-index-module__skipContainer--VO89A{position:relative;width:100%;height:0;z-index:1}.frontend-filesViewer-inlineMode-index-module__skipContainer--VO89A .frontend-filesViewer-inlineMode-index-module__skipButton--JbCgu:focus{position:absolute;top:7px;left:7px;right:auto}@font-face{font-family:"figIcon";src:url(data:font/woff;base64,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)format("woff")}figshare-widget{line-height:1;box-sizing:content-box;color:#444;transform:translate3d(0,0,0)}figshare-widget *{box-sizing:content-box}figshare-widget *:focus,figshare-overlay *:focus{outline:none}figshare-widget *::-moz-focus-inner,figshare-overlay *::-moz-focus-inner{border:0}figshare-widget div,figshare-widget span,figshare-widget p,figshare-widget a,figshare-widget strong,figshare-widget b,figshare-widget article,figshare-widget aside,figshare-widget footer,figshare-widget header,figshare-widget nav,figshare-widget section{margin:0;padding:0;border:0;font-size:100%;font-family:Arial,Helvetica,sans-serif;vertical-align:baseline}figshare-widget button{margin:0;font-family:Arial,Helvetica,sans-serif}figshare-widget,figshare-widget article,figshare-widget aside,figshare-widget footer,figshare-widget section{display:block}figshare-widget strong{font-weight:bold}figshare-widget button{cursor:default}figshare-widget button:focus,figshare-overlay button:focus{outline:none;box-shadow:0 0 3px 0px #ffa500 inset,0 0 3px 3px #ffa500}figshare-widget .figshare-loader .fs-figshare-loader-holder{display:inline-block;vertical-align:middle;text-align:center;position:absolute;width:100%;height:100%;top:0;bottom:0;left:0;right:0}figshare-widget .figshare-loader .fs-figshare-loader-holder:before,figshare-overlay .figshare-loader .fs-figshare-loader-holder:before{content:"";height:100%;vertical-align:middle;display:inline-block}figshare-widget .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message{padding:14px 28px;display:inline-block;vertical-align:middle;position:relative;z-index:200;border:1px solid #ddd;background:#fff}figshare-widget .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message:before,figshare-overlay .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message:before{content:"";height:100%;vertical-align:middle}figshare-widget .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .figshare-logo{width:21px;height:21px}@-webkit-keyframes opacityPulse{0%{opacity:0}10%{opacity:1}100%{opacity:0}}@keyframes opacityPulse{0%{opacity:0}10%{opacity:1}100%{opacity:0}}figshare-widget .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message g[class^="group"]{opacity:1;-webkit-animation:0.8s opacityPulse infinite linear;animation:0.8s opacityPulse infinite linear}figshare-widget .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-20{-webkit-animation-delay:0.76s!important;animation-delay:0.76s!important}figshare-widget .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-19{-webkit-animation-delay:0.72s!important;animation-delay:0.72s!important}figshare-widget .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-18{-webkit-animation-delay:0.6799999999999999s!important;animation-delay:0.6799999999999999s!important}figshare-widget .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-17{-webkit-animation-delay:0.6399999999999999s!important;animation-delay:0.6399999999999999s!important}figshare-widget .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-16{-webkit-animation-delay:0.5999999999999999s!important;animation-delay:0.5999999999999999s!important}figshare-widget .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-15{-webkit-animation-delay:0.5599999999999998s!important;animation-delay:0.5599999999999998s!important}figshare-widget .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-14{-webkit-animation-delay:0.5199999999999998s!important;animation-delay:0.5199999999999998s!important}figshare-widget .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-13{-webkit-animation-delay:0.4799999999999998s!important;animation-delay:0.4799999999999998s!important}figshare-widget .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-12{-webkit-animation-delay:0.43999999999999984s!important;animation-delay:0.43999999999999984s!important}figshare-widget .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-11{-webkit-animation-delay:0.39999999999999986s!important;animation-delay:0.39999999999999986s!important}figshare-widget .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-10{-webkit-animation-delay:0.3599999999999999s!important;animation-delay:0.3599999999999999s!important}figshare-widget .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-9{-webkit-animation-delay:0.3199999999999999s!important;animation-delay:0.3199999999999999s!important}figshare-widget .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-8{-webkit-animation-delay:0.2799999999999999s!important;animation-delay:0.2799999999999999s!important}figshare-widget .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-7{-webkit-animation-delay:0.2399999999999999s!important;animation-delay:0.2399999999999999s!important}figshare-widget .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-6{-webkit-animation-delay:0.1999999999999999s!important;animation-delay:0.1999999999999999s!important}figshare-widget .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-5{-webkit-animation-delay:0.1599999999999999s!important;animation-delay:0.1599999999999999s!important}figshare-widget .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-4{-webkit-animation-delay:0.11999999999999988s!important;animation-delay:0.11999999999999988s!important}figshare-widget .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-3{-webkit-animation-delay:0.07999999999999988s!important;animation-delay:0.07999999999999988s!important}figshare-widget .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-2{-webkit-animation-delay:0.039999999999999876s!important;animation-delay:0.039999999999999876s!important}figshare-widget .figshare-loader .fs-figshare-loader-holder .fs-figshare-loader-message .group-1{-webkit-animation-delay:-0.0000000000000001249s!important;animation-delay:-0.0000000000000001249s!important}figshare-widget .figshare-loader.fs-loading{position:relative}figshare-widget .figshare-loader.fs-loading:before,figshare-overlay .figshare-loader.fs-loading:before{content:"";opacity:0.7;background:#fff;position:absolute;width:100%;height:100%;top:0;bottom:0;left:0;right:0;z-index:100}figshare-widget .figshare-loader .fs-logo{display:inline-block;vertical-align:middle}figshare-widget .fs-figshare-viewer{text-align:left}figshare-widget .fs-figshare-viewer .fs-document-display{overflow:auto!important;position:relative}figshare-widget .fs-figshare-viewer .fs-document-display .figshare-loader{overflow:hidden!important}figshare-widget .fs-figshare-viewer{width:100%;height:100%;position:relative;z-index:0}figshare-widget .fs-figshare-viewer .figshare-loader{width:100%;height:100%}.frontend-widgets-springer_nature-theme-module__primaryButton--YVC6D{position:relative;background:#1b3051;border:1px solid #ddd;color:#fff}.frontend-widgets-springer_nature-theme-module__primaryButton--YVC6D:focus,.frontend-widgets-springer_nature-theme-module__primaryButton--YVC6D:hover{background:#4a80b5}.frontend-widgets-springer_nature-theme-module__primaryIconButton--qFTd4{padding:0}.frontend-widgets-springer_nature-theme-module__secondaryButton--k2CRj{background:#fff;border:1px solid #ddd;color:#1b3051}.frontend-widgets-springer_nature-theme-module__secondaryButton--k2CRj:focus,.frontend-widgets-springer_nature-theme-module__secondaryButton--k2CRj:hover{color:#4a80b5;border-color:#2A5886}</style><link rel=icon type=image/png sizes=32x32 href="data:image/png;base64,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"><style>.sf-hidden{display:none!important}</style><meta http-equiv=content-security-policy content="default-src 'none'; font-src 'self' data:; img-src 'self' data:; style-src 'unsafe-inline'; media-src 'self' data:; script-src 'unsafe-inline' data:;"><style>img[src="data:,"],source[src="data:,"]{display:none!important}</style></head>
 <body class="journal journal-fulltext"><div id=MathJax_Message style=display:none></div>
 
 
 
 
 <noscript class=sf-hidden>
                <iframe src="https://www.googletagmanager.com/ns.html?id=GTM-MRVXSHQ" style="display:none;visibility:hidden" width="0" height="0"></iframe>
            </noscript>
 
 
 
 <div class=u-visually-hidden aria-hidden=true>
 
 <svg xmlns=http://www.w3.org/2000/svg xmlns:xlink=http://www.w3.org/1999/xlink><defs><rect id=SVGID_1_ x=0 y=0.74 width=56.72 height=55.24></rect></defs><symbol id=icon-access viewBox="0 0 18 18"><path d="m14 8c.5522847 0 1 .44771525 1 1v7h2.5c.2761424 0 .5.2238576.5.5v1.5h-18v-1.5c0-.2761424.22385763-.5.5-.5h2.5v-7c0-.55228475.44771525-1 1-1s1 .44771525 1 1v6.9996556h8v-6.9996556c0-.55228475.4477153-1 1-1zm-8 0 2 1v5l-2 1zm6 0v7l-2-1v-5zm-2.42653766-7.59857636 7.03554716 4.92488299c.4162533.29137735.5174853.86502537.226108 1.28127873-.1721584.24594054-.4534847.39241464-.7536934.39241464h-14.16284822c-.50810197 0-.92-.41189803-.92-.92 0-.30020869.1464741-.58153499.39241464-.75369337l7.03554714-4.92488299c.34432015-.2410241.80260453-.2410241 1.14692468 0zm-.57346234 2.03988748-3.65526982 2.55868888h7.31053962z" fill-rule=evenodd></path></symbol><symbol id=icon-account viewBox="0 0 18 18"><path d="m10.2379028 16.9048051c1.3083556-.2032362 2.5118471-.7235183 3.5294683-1.4798399-.8731327-2.5141501-2.0638925-3.935978-3.7673711-4.3188248v-1.27684611c1.1651924-.41183641 2-1.52307546 2-2.82929429 0-1.65685425-1.3431458-3-3-3-1.65685425 0-3 1.34314575-3 3 0 1.30621883.83480763 2.41745788 2 2.82929429v1.27684611c-1.70347856.3828468-2.89423845 1.8046747-3.76737114 4.3188248 1.01762123.7563216 2.22111275 1.2766037 3.52946833 1.4798399.40563808.0629726.81921174.0951949 1.23790281.0951949s.83226473-.0322223 1.2379028-.0951949zm4.3421782-2.1721994c1.4927655-1.4532925 2.419919-3.484675 2.419919-5.7326057 0-4.418278-3.581722-8-8-8s-8 3.581722-8 8c0 2.2479307.92715352 4.2793132 2.41991895 5.7326057.75688473-2.0164459 1.83949951-3.6071894 3.48926591-4.3218837-1.14534283-.70360829-1.90918486-1.96796271-1.90918486-3.410722 0-2.209139 1.790861-4 4-4s4 1.790861 4 4c0 1.44275929-.763842 2.70711371-1.9091849 3.410722 1.6497664.7146943 2.7323812 2.3054378 3.4892659 4.3218837zm-5.580081 3.2673943c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z" fill-rule=evenodd></path></symbol><symbol id=icon-alert viewBox="0 0 18 18"><path d="m4 10h2.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-3.08578644l-1.12132034 1.1213203c-.18753638.1875364-.29289322.4418903-.29289322.7071068v.1715729h14v-.1715729c0-.2652165-.1053568-.5195704-.2928932-.7071068l-1.7071068-1.7071067v-3.4142136c0-2.76142375-2.2385763-5-5-5-2.76142375 0-5 2.23857625-5 5zm3 4c0 1.1045695.8954305 2 2 2s2-.8954305 2-2zm-5 0c-.55228475 0-1-.4477153-1-1v-.1715729c0-.530433.21071368-1.0391408.58578644-1.4142135l1.41421356-1.4142136v-3c0-3.3137085 2.6862915-6 6-6s6 2.6862915 6 6v3l1.4142136 1.4142136c.3750727.3750727.5857864.8837805.5857864 1.4142135v.1715729c0 .5522847-.4477153 1-1 1h-4c0 1.6568542-1.3431458 3-3 3-1.65685425 0-3-1.3431458-3-3z" fill-rule=evenodd></path></symbol><symbol id=icon-arrow-broad viewBox="0 0 16 16"><path d="m6.10307866 2.97190702v7.69043288l2.44965196-2.44676915c.38776071-.38730439 1.0088052-.39493524 1.38498697-.01919617.38609051.38563612.38643641 1.01053024-.00013864 1.39665039l-4.12239817 4.11754683c-.38616704.3857126-1.01187344.3861062-1.39846576-.0000311l-4.12258206-4.11773056c-.38618426-.38572979-.39254614-1.00476697-.01636437-1.38050605.38609047-.38563611 1.01018509-.38751562 1.4012233.00306241l2.44985644 2.4469734v-8.67638639c0-.54139983.43698413-.98042709.98493125-.98159081l7.89910522-.0043627c.5451687 0 .9871152.44142642.9871152.98595351s-.4419465.98595351-.9871152.98595351z" fill-rule=evenodd transform="matrix(-1 0 0 -1 14 15)"></path></symbol><symbol id=icon-arrow-down viewBox="0 0 16 16"><path d="m3.28337502 11.5302405 4.03074001 4.176208c.37758093.3912076.98937525.3916069 1.367372-.0000316l4.03091977-4.1763942c.3775978-.3912252.3838182-1.0190815.0160006-1.4001736-.3775061-.39113013-.9877245-.39303641-1.3700683.003106l-2.39538585 2.4818345v-11.6147896l-.00649339-.11662112c-.055753-.49733869-.46370161-.88337888-.95867408-.88337888-.49497246 0-.90292107.38604019-.95867408.88337888l-.00649338.11662112v11.6147896l-2.39518594-2.4816273c-.37913917-.39282218-.98637524-.40056175-1.35419292-.0194697-.37750607.3911302-.37784433 1.0249269.00013556 1.4165479z" fill-rule=evenodd></path></symbol><symbol id=icon-arrow-left viewBox="0 0 16 16"><path d="m4.46975946 3.28337502-4.17620792 4.03074001c-.39120768.37758093-.39160691.98937525.0000316 1.367372l4.1763942 4.03091977c.39122514.3775978 1.01908149.3838182 1.40017357.0160006.39113012-.3775061.3930364-.9877245-.00310603-1.3700683l-2.48183446-2.39538585h11.61478958l.1166211-.00649339c.4973387-.055753.8833789-.46370161.8833789-.95867408 0-.49497246-.3860402-.90292107-.8833789-.95867408l-.1166211-.00649338h-11.61478958l2.4816273-2.39518594c.39282216-.37913917.40056173-.98637524.01946965-1.35419292-.39113012-.37750607-1.02492687-.37784433-1.41654791.00013556z" fill-rule=evenodd></path></symbol><symbol id=icon-arrow-right viewBox="0 0 16 16"><path d="m11.5302405 12.716625 4.176208-4.03074003c.3912076-.37758093.3916069-.98937525-.0000316-1.367372l-4.1763942-4.03091981c-.3912252-.37759778-1.0190815-.38381821-1.4001736-.01600053-.39113013.37750607-.39303641.98772445.003106 1.37006824l2.4818345 2.39538588h-11.6147896l-.11662112.00649339c-.49733869.055753-.88337888.46370161-.88337888.95867408 0 .49497246.38604019.90292107.88337888.95867408l.11662112.00649338h11.6147896l-2.4816273 2.39518592c-.39282218.3791392-.40056175.9863753-.0194697 1.3541929.3911302.3775061 1.0249269.3778444 1.4165479-.0001355z" fill-rule=evenodd></path></symbol><symbol id=icon-arrow-sub viewBox="0 0 16 16"><path d="m7.89692134 4.97190702v7.69043288l-2.44965196-2.4467692c-.38776071-.38730434-1.0088052-.39493519-1.38498697-.0191961-.38609047.3856361-.38643643 1.0105302.00013864 1.3966504l4.12239817 4.1175468c.38616704.3857126 1.01187344.3861062 1.39846576-.0000311l4.12258202-4.1177306c.3861843-.3857298.3925462-1.0047669.0163644-1.380506-.3860905-.38563612-1.0101851-.38751563-1.4012233.0030624l-2.44985643 2.4469734v-8.67638639c0-.54139983-.43698413-.98042709-.98493125-.98159081l-7.89910525-.0043627c-.54516866 0-.98711517.44142642-.98711517.98595351s.44194651.98595351.98711517.98595351z" fill-rule=evenodd></path></symbol><symbol id=icon-arrow-up viewBox="0 0 16 16"><path d="m12.716625 4.46975946-4.03074003-4.17620792c-.37758093-.39120768-.98937525-.39160691-1.367372.0000316l-4.03091981 4.1763942c-.37759778.39122514-.38381821 1.01908149-.01600053 1.40017357.37750607.39113012.98772445.3930364 1.37006824-.00310603l2.39538588-2.48183446v11.61478958l.00649339.1166211c.055753.4973387.46370161.8833789.95867408.8833789.49497246 0 .90292107-.3860402.95867408-.8833789l.00649338-.1166211v-11.61478958l2.39518592 2.4816273c.3791392.39282216.9863753.40056173 1.3541929.01946965.3775061-.39113012.3778444-1.02492687-.0001355-1.41654791z" fill-rule=evenodd></path></symbol><symbol id=icon-article viewBox="0 0 18 18"><path d="m13 15v-12.9906311c0-.0073595-.0019884-.0093689.0014977-.0093689l-11.00158888.00087166v13.00506804c0 .5482678.44615281.9940603.99415146.9940603h10.27350412c-.1701701-.2941734-.2675644-.6357129-.2675644-1zm-12 .0059397v-13.00506804c0-.5562408.44704472-1.00087166.99850233-1.00087166h11.00299537c.5510129 0 .9985023.45190985.9985023 1.0093689v2.9906311h3v9.9914698c0 1.1065798-.8927712 2.0085302-1.9940603 2.0085302h-12.01187942c-1.09954652 0-1.99406028-.8927712-1.99406028-1.9940603zm13-9.0059397v9c0 .5522847.4477153 1 1 1s1-.4477153 1-1v-9zm-10-2h7v4h-7zm1 1v2h5v-2zm-1 4h7v1h-7zm0 2h7v1h-7zm0 2h7v1h-7z" fill-rule=evenodd></path></symbol><symbol id=icon-audio viewBox="0 0 18 18"><path d="m13.0957477 13.5588459c-.195279.1937043-.5119137.193729-.7072234.0000551-.1953098-.193674-.1953346-.5077061-.0000556-.7014104 1.0251004-1.0168342 1.6108711-2.3905226 1.6108711-3.85745208 0-1.46604976-.5850634-2.83898246-1.6090736-3.85566829-.1951894-.19379323-.1950192-.50782531.0003802-.70141028.1953993-.19358497.512034-.19341614.7072234.00037709 1.2094886 1.20083761 1.901635 2.8250555 1.901635 4.55670148 0 1.73268608-.6929822 3.35779608-1.9037571 4.55880738zm2.1233994 2.1025159c-.195234.193749-.5118687.1938462-.7072235.0002171-.1953548-.1936292-.1954528-.5076613-.0002189-.7014104 1.5832215-1.5711805 2.4881302-3.6939808 2.4881302-5.96012998 0-2.26581266-.9046382-4.3883241-2.487443-5.95944795-.1952117-.19377107-.1950777-.50780316.0002993-.70141031s.5120117-.19347426.7072234.00029682c1.7683321 1.75528196 2.7800854 4.12911258 2.7800854 6.66056144 0 2.53182498-1.0120556 4.90597838-2.7808529 6.66132328zm-14.21898205-3.6854911c-.5523759 0-1.00016505-.4441085-1.00016505-.991944v-3.96777631c0-.54783558.44778915-.99194407 1.00016505-.99194407h2.0003301l5.41965617-3.8393633c.44948677-.31842296 1.07413994-.21516983 1.39520191.23062232.12116339.16823446.18629727.36981184.18629727.57655577v12.01603479c0 .5478356-.44778914.9919441-1.00016505.9919441-.20845738 0-.41170538-.0645985-.58133413-.184766l-5.41965617-3.8393633zm0-.991944h2.32084805l5.68047235 4.0241292v-12.01603479l-5.68047235 4.02412928h-2.32084805z" fill-rule=evenodd></path></symbol><symbol id=icon-block viewBox="0 0 24 24"><path d="m0 0h24v24h-24z" fill-rule=evenodd></path></symbol><symbol id=icon-book viewBox="0 0 18 18"><path d="m4 13v-11h1v11h11v-11h-13c-.55228475 0-1 .44771525-1 1v10.2675644c.29417337-.1701701.63571286-.2675644 1-.2675644zm12 1h-13c-.55228475 0-1 .4477153-1 1s.44771525 1 1 1h13zm0 3h-13c-1.1045695 0-2-.8954305-2-2v-12c0-1.1045695.8954305-2 2-2h13c.5522847 0 1 .44771525 1 1v14c0 .5522847-.4477153 1-1 1zm-8.5-13h6c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-6c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm1 2h4c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-4c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z" fill-rule=evenodd></path></symbol><symbol id=icon-broad viewBox="0 0 24 24"><path d="m9.18274226 7.81v7.7999954l2.48162734-2.4816273c.3928221-.3928221 1.0219731-.4005617 1.4030652-.0194696.3911301.3911301.3914806 1.0249268-.0001404 1.4165479l-4.17620796 4.1762079c-.39120769.3912077-1.02508144.3916069-1.41671995-.0000316l-4.1763942-4.1763942c-.39122514-.3912251-.39767006-1.0190815-.01657798-1.4001736.39113012-.3911301 1.02337106-.3930364 1.41951349.0031061l2.48183446 2.4818344v-8.7999954c0-.54911294.4426881-.99439484.99778758-.99557515l8.00221246-.00442485c.5522847 0 1 .44771525 1 1s-.4477153 1-1 1z" fill-rule=evenodd transform="matrix(-1 0 0 -1 20.182742 24.805206)"></path></symbol><symbol id=icon-calendar viewBox="0 0 18 18"><path d="m12.5 0c.2761424 0 .5.21505737.5.49047852v.50952148h2c1.1072288 0 2 .89451376 2 2v12c0 1.1072288-.8945138 2-2 2h-12c-1.1072288 0-2-.8945138-2-2v-12c0-1.1072288.89451376-2 2-2h1v1h-1c-.55393837 0-1 .44579254-1 1v3h14v-3c0-.55393837-.4457925-1-1-1h-2v1.50952148c0 .27088381-.2319336.49047852-.5.49047852-.2761424 0-.5-.21505737-.5-.49047852v-3.01904296c0-.27088381.2319336-.49047852.5-.49047852zm3.5 7h-14v8c0 .5539384.44579254 1 1 1h12c.5539384 0 1-.4457925 1-1zm-11 6v1h-1v-1zm3 0v1h-1v-1zm3 0v1h-1v-1zm-6-2v1h-1v-1zm3 0v1h-1v-1zm6 0v1h-1v-1zm-3 0v1h-1v-1zm-3-2v1h-1v-1zm6 0v1h-1v-1zm-3 0v1h-1v-1zm-5.5-9c.27614237 0 .5.21505737.5.49047852v.50952148h5v1h-5v1.50952148c0 .27088381-.23193359.49047852-.5.49047852-.27614237 0-.5-.21505737-.5-.49047852v-3.01904296c0-.27088381.23193359-.49047852.5-.49047852z" fill-rule=evenodd></path></symbol><symbol id=icon-cart viewBox="0 0 18 18"><path d="m5 14c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm10 0c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm-10 1c-.55228475 0-1 .4477153-1 1s.44771525 1 1 1 1-.4477153 1-1-.44771525-1-1-1zm10 0c-.5522847 0-1 .4477153-1 1s.4477153 1 1 1 1-.4477153 1-1-.4477153-1-1-1zm-12.82032249-15c.47691417 0 .88746157.33678127.98070211.80449199l.23823144 1.19501025 13.36277974.00045554c.5522847.00001882.9999659.44774934.9999659 1.00004222 0 .07084994-.0075361.14150708-.022474.2107727l-1.2908094 5.98534344c-.1007861.46742419-.5432548.80388386-1.0571651.80388386h-10.24805106c-.59173366 0-1.07142857.4477153-1.07142857 1 0 .5128358.41361449.9355072.94647737.9932723l.1249512.0067277h10.35933776c.2749512 0 .4979349.2228539.4979349.4978051 0 .2749417-.2227336.4978951-.4976753.4980063l-10.35959736.0041886c-1.18346732 0-2.14285714-.8954305-2.14285714-2 0-.6625717.34520317-1.24989198.87690425-1.61383592l-1.63768102-8.19004794c-.01312273-.06561364-.01950005-.131011-.0196107-.19547395l-1.71961253-.00064219c-.27614237 0-.5-.22385762-.5-.5 0-.27614237.22385763-.5.5-.5zm14.53193359 2.99950224h-13.11300004l1.20580469 6.02530174c.11024034-.0163252.22327998-.02480398.33844139-.02480398h10.27064786z"></path></symbol><symbol id=icon-chevron-less viewBox="0 0 10 10"><path d="m5.58578644 4-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" fill-rule=evenodd transform="matrix(0 -1 -1 0 9 9)"></path></symbol><symbol id=icon-chevron-more viewBox="0 0 10 10"><path d="m5.58578644 6-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4.00000002c-.39052429.3905243-1.02368927.3905243-1.41421356 0s-.39052429-1.02368929 0-1.41421358z" fill-rule=evenodd transform="matrix(0 1 -1 0 11 1)"></path></symbol><symbol id=icon-chevron-right viewBox="0 0 10 10"><path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill-rule=evenodd transform="matrix(0 -1 1 0 0 10)"></path></symbol><symbol id=icon-circle-fill viewBox="0 0 16 16"><path d="m8 14c-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6 6 2.6862915 6 6-2.6862915 6-6 6z" fill-rule=evenodd></path></symbol><symbol id=icon-circle viewBox="0 0 16 16"><path d="m8 12c2.209139 0 4-1.790861 4-4s-1.790861-4-4-4-4 1.790861-4 4 1.790861 4 4 4zm0 2c-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6 6 2.6862915 6 6-2.6862915 6-6 6z" fill-rule=evenodd></path></symbol><symbol id=icon-citation viewBox="0 0 18 18"><path d="m8.63593473 5.99995183c2.20913897 0 3.99999997 1.79084375 3.99999997 3.99996146 0 1.40730761-.7267788 2.64486871-1.8254829 3.35783281 1.6240224.6764218 2.8754442 2.0093871 3.4610603 3.6412466l-1.0763845.000006c-.5310008-1.2078237-1.5108121-2.1940153-2.7691712-2.7181346l-.79002167-.329052v-1.023992l.63016577-.4089232c.8482885-.5504661 1.3698342-1.4895187 1.3698342-2.51898361 0-1.65683828-1.3431457-2.99996146-2.99999997-2.99996146-1.65685425 0-3 1.34312318-3 2.99996146 0 1.02946491.52154569 1.96851751 1.36983419 2.51898361l.63016581.4089232v1.023992l-.79002171.329052c-1.25835905.5241193-2.23817037 1.5103109-2.76917113 2.7181346l-1.07638453-.000006c.58561612-1.6318595 1.8370379-2.9648248 3.46106024-3.6412466-1.09870405-.7129641-1.82548287-1.9505252-1.82548287-3.35783281 0-2.20911771 1.790861-3.99996146 4-3.99996146zm7.36897597-4.99995183c1.1018574 0 1.9950893.89353404 1.9950893 2.00274083v5.994422c0 1.10608317-.8926228 2.00274087-1.9950893 2.00274087l-3.0049107-.0009037v-1l3.0049107.00091329c.5490631 0 .9950893-.44783123.9950893-1.00275046v-5.994422c0-.55646537-.4450595-1.00275046-.9950893-1.00275046h-14.00982141c-.54906309 0-.99508929.44783123-.99508929 1.00275046v5.9971821c0 .66666024.33333333.99999036 1 .99999036l2-.00091329v1l-2 .0009037c-1 0-2-.99999041-2-1.99998077v-5.9971821c0-1.10608322.8926228-2.00274083 1.99508929-2.00274083zm-8.5049107 2.9999711c.27614237 0 .5.22385547.5.5 0 .2761349-.22385763.5-.5.5h-4c-.27614237 0-.5-.2238651-.5-.5 0-.27614453.22385763-.5.5-.5zm3 0c.2761424 0 .5.22385547.5.5 0 .2761349-.2238576.5-.5.5h-1c-.27614237 0-.5-.2238651-.5-.5 0-.27614453.22385763-.5.5-.5zm4 0c.2761424 0 .5.22385547.5.5 0 .2761349-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238651-.5-.5 0-.27614453.2238576-.5.5-.5z" fill-rule=evenodd></path></symbol><symbol id=icon-close viewBox="0 0 16 16"><path d="m2.29679575 12.2772478c-.39658757.3965876-.39438847 1.0328109-.00062148 1.4265779.39651227.3965123 1.03246768.3934888 1.42657791-.0006214l4.27724782-4.27724787 4.2772478 4.27724787c.3965876.3965875 1.0328109.3943884 1.4265779.0006214.3965123-.3965122.3934888-1.0324677-.0006214-1.4265779l-4.27724787-4.2772478 4.27724787-4.27724782c.3965875-.39658757.3943884-1.03281091.0006214-1.42657791-.3965122-.39651226-1.0324677-.39348875-1.4265779.00062148l-4.2772478 4.27724782-4.27724782-4.27724782c-.39658757-.39658757-1.03281091-.39438847-1.42657791-.00062148-.39651226.39651227-.39348875 1.03246768.00062148 1.42657791l4.27724782 4.27724782z" fill-rule=evenodd></path></symbol><symbol id=icon-collections viewBox="0 0 18 18"><path d="m15 4c1.1045695 0 2 .8954305 2 2v9c0 1.1045695-.8954305 2-2 2h-8c-1.1045695 0-2-.8954305-2-2h1c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h8c.5128358 0 .9355072-.3860402.9932723-.8833789l.0067277-.1166211v-9c0-.51283584-.3860402-.93550716-.8833789-.99327227l-.1166211-.00672773h-1v-1zm-4-3c1.1045695 0 2 .8954305 2 2v9c0 1.1045695-.8954305 2-2 2h-8c-1.1045695 0-2-.8954305-2-2v-9c0-1.1045695.8954305-2 2-2zm0 1h-8c-.51283584 0-.93550716.38604019-.99327227.88337887l-.00672773.11662113v9c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h8c.5128358 0 .9355072-.3860402.9932723-.8833789l.0067277-.1166211v-9c0-.51283584-.3860402-.93550716-.8833789-.99327227zm-1.5 7c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm0-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm0-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z" fill-rule=evenodd></path></symbol><symbol id=icon-compare viewBox="0 0 18 18"><path d="m12 3c3.3137085 0 6 2.6862915 6 6s-2.6862915 6-6 6c-1.0928452 0-2.11744941-.2921742-2.99996061-.8026704-.88181407.5102749-1.90678042.8026704-3.00003939.8026704-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6c1.09325897 0 2.11822532.29239547 3.00096303.80325037.88158756-.51107621 1.90619177-.80325037 2.99903697-.80325037zm-6 1c-2.76142375 0-5 2.23857625-5 5 0 2.7614237 2.23857625 5 5 5 .74397391 0 1.44999672-.162488 2.08451611-.4539116-1.27652344-1.1000812-2.08451611-2.7287264-2.08451611-4.5460884s.80799267-3.44600721 2.08434391-4.5463015c-.63434719-.29121054-1.34037-.4536985-2.08434391-.4536985zm6 0c-.7439739 0-1.4499967.16248796-2.08451611.45391156 1.27652341 1.10008123 2.08451611 2.72872644 2.08451611 4.54608844s-.8079927 3.4460072-2.08434391 4.5463015c.63434721.2912105 1.34037001.4536985 2.08434391.4536985 2.7614237 0 5-2.2385763 5-5 0-2.76142375-2.2385763-5-5-5zm-1.4162763 7.0005324h-3.16744736c.15614659.3572676.35283837.6927622.58425872 1.0006671h1.99892988c.23142036-.3079049.42811216-.6433995.58425876-1.0006671zm.4162763-2.0005324h-4c0 .34288501.0345146.67770871.10025909 1.0011864h3.79948181c.0657445-.32347769.1002591-.65830139.1002591-1.0011864zm-.4158423-1.99953894h-3.16831543c-.13859957.31730812-.24521946.651783-.31578599.99935097h3.79988742c-.0705665-.34756797-.1771864-.68204285-.315786-.99935097zm-1.58295822-1.999926-.08316107.06199199c-.34550042.27081213-.65446126.58611297-.91825862.93727862h2.00044041c-.28418626-.37830727-.6207872-.71499149-.99902072-.99927061z" fill-rule=evenodd></path></symbol><symbol id=icon-download-file viewBox="0 0 18 18"><path d="m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm0 1h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v14.00982141c0 .5500396.44491393.9950893.99406028.9950893h12.01187942c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717zm-1.5046024 4c.27614237 0 .5.21637201.5.49209595v6.14827645l1.7462789-1.77990922c.1933927-.1971171.5125222-.19455839.7001689-.0069117.1932998.19329992.1910058.50899492-.0027774.70277812l-2.59089271 2.5908927c-.19483374.1948337-.51177825.1937771-.70556873-.0000133l-2.59099079-2.5909908c-.19484111-.1948411-.19043735-.5151448-.00279066-.70279146.19329987-.19329987.50465175-.19237083.70018565.00692852l1.74638684 1.78001764v-6.14827695c0-.27177709.23193359-.49209595.5-.49209595z" fill-rule=evenodd></path></symbol><symbol id=icon-download viewBox="0 0 16 16"><path d="m12.9975267 12.999368c.5467123 0 1.0024733.4478567 1.0024733 1.000316 0 .5563109-.4488226 1.000316-1.0024733 1.000316h-9.99505341c-.54671233 0-1.00247329-.4478567-1.00247329-1.000316 0-.5563109.44882258-1.000316 1.00247329-1.000316zm-4.9975267-11.999368c.55228475 0 1 .44497754 1 .99589209v6.80214418l2.4816273-2.48241149c.3928222-.39294628 1.0219732-.4006883 1.4030652-.01947579.3911302.39125371.3914806 1.02525073-.0001404 1.41699553l-4.17620792 4.17752758c-.39120769.3913313-1.02508144.3917306-1.41671995-.0000316l-4.17639421-4.17771394c-.39122513-.39134876-.39767006-1.01940351-.01657797-1.40061601.39113012-.39125372 1.02337105-.3931606 1.41951349.00310701l2.48183446 2.48261871v-6.80214418c0-.55001601.44386482-.99589209 1-.99589209z" fill-rule=evenodd></path></symbol><symbol id=icon-editors viewBox="0 0 18 18"><path d="m8.72592184 2.54588137c-.48811714-.34391207-1.08343326-.54588137-1.72592184-.54588137-1.65685425 0-3 1.34314575-3 3 0 1.02947485.5215457 1.96853646 1.3698342 2.51900785l.6301658.40892721v1.02400182l-.79002171.32905522c-1.93395773.8055207-3.20997829 2.7024791-3.20997829 4.8180274v.9009805h-1v-.9009805c0-2.5479714 1.54557359-4.79153984 3.82548288-5.7411543-1.09870406-.71297106-1.82548288-1.95054399-1.82548288-3.3578652 0-2.209139 1.790861-4 4-4 1.09079823 0 2.07961816.43662103 2.80122451 1.1446278-.37707584.09278571-.7373238.22835063-1.07530267.40125357zm-2.72592184 14.45411863h-1v-.9009805c0-2.5479714 1.54557359-4.7915398 3.82548288-5.7411543-1.09870406-.71297106-1.82548288-1.95054399-1.82548288-3.3578652 0-2.209139 1.790861-4 4-4s4 1.790861 4 4c0 1.40732121-.7267788 2.64489414-1.8254829 3.3578652 2.2799093.9496145 3.8254829 3.1931829 3.8254829 5.7411543v.9009805h-1v-.9009805c0-2.1155483-1.2760206-4.0125067-3.2099783-4.8180274l-.7900217-.3290552v-1.02400184l.6301658-.40892721c.8482885-.55047139 1.3698342-1.489533 1.3698342-2.51900785 0-1.65685425-1.3431458-3-3-3-1.65685425 0-3 1.34314575-3 3 0 1.02947485.5215457 1.96853646 1.3698342 2.51900785l.6301658.40892721v1.02400184l-.79002171.3290552c-1.93395773.8055207-3.20997829 2.7024791-3.20997829 4.8180274z" fill-rule=evenodd></path></symbol><symbol id=icon-email viewBox="0 0 18 18"><path d="m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587h-14.00982141c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm0 1h-14.00982141c-.54871518 0-.99508929.44887827-.99508929 1.00585866v9.98828264c0 .5572961.44630695 1.0058587.99508929 1.0058587h14.00982141c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-.0049107 2.55749512v1.44250488l-7 4-7-4v-1.44250488l7 4z" fill-rule=evenodd></path></symbol><symbol id=icon-error viewBox="0 0 18 18"><path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm2.8630343 4.71100931-2.8630343 2.86303426-2.86303426-2.86303426c-.39658757-.39658757-1.03281091-.39438847-1.4265779-.00062147-.39651227.39651226-.39348876 1.03246767.00062147 1.4265779l2.86303426 2.86303426-2.86303426 2.8630343c-.39658757.3965875-.39438847 1.0328109-.00062147 1.4265779.39651226.3965122 1.03246767.3934887 1.4265779-.0006215l2.86303426-2.8630343 2.8630343 2.8630343c.3965875.3965876 1.0328109.3943885 1.4265779.0006215.3965122-.3965123.3934887-1.0324677-.0006215-1.4265779l-2.8630343-2.8630343 2.8630343-2.86303426c.3965876-.39658757.3943885-1.03281091.0006215-1.4265779-.3965123-.39651227-1.0324677-.39348876-1.4265779.00062147z" fill-rule=evenodd></path></symbol><symbol id=icon-ethics viewBox="0 0 18 18"><path d="m6.76384967 1.41421356.83301651-.8330165c.77492941-.77492941 2.03133823-.77492941 2.80626762 0l.8330165.8330165c.3750728.37507276.8837806.58578644 1.4142136.58578644h1.3496361c1.1045695 0 2 .8954305 2 2v1.34963611c0 .53043298.2107137 1.03914081.5857864 1.41421356l.8330165.83301651c.7749295.77492941.7749295 2.03133823 0 2.80626762l-.8330165.8330165c-.3750727.3750728-.5857864.8837806-.5857864 1.4142136v1.3496361c0 1.1045695-.8954305 2-2 2h-1.3496361c-.530433 0-1.0391408.2107137-1.4142136.5857864l-.8330165.8330165c-.77492939.7749295-2.03133821.7749295-2.80626762 0l-.83301651-.8330165c-.37507275-.3750727-.88378058-.5857864-1.41421356-.5857864h-1.34963611c-1.1045695 0-2-.8954305-2-2v-1.3496361c0-.530433-.21071368-1.0391408-.58578644-1.4142136l-.8330165-.8330165c-.77492941-.77492939-.77492941-2.03133821 0-2.80626762l.8330165-.83301651c.37507276-.37507275.58578644-.88378058.58578644-1.41421356v-1.34963611c0-1.1045695.8954305-2 2-2h1.34963611c.53043298 0 1.03914081-.21071368 1.41421356-.58578644zm-1.41421356 1.58578644h-1.34963611c-.55228475 0-1 .44771525-1 1v1.34963611c0 .79564947-.31607052 1.55871121-.87867966 2.12132034l-.8330165.83301651c-.38440512.38440512-.38440512 1.00764896 0 1.39205408l.8330165.83301646c.56260914.5626092.87867966 1.3256709.87867966 2.1213204v1.3496361c0 .5522847.44771525 1 1 1h1.34963611c.79564947 0 1.55871121.3160705 2.12132034.8786797l.83301651.8330165c.38440512.3844051 1.00764896.3844051 1.39205408 0l.83301646-.8330165c.5626092-.5626092 1.3256709-.8786797 2.1213204-.8786797h1.3496361c.5522847 0 1-.4477153 1-1v-1.3496361c0-.7956495.3160705-1.5587112.8786797-2.1213204l.8330165-.83301646c.3844051-.38440512.3844051-1.00764896 0-1.39205408l-.8330165-.83301651c-.5626092-.56260913-.8786797-1.32567087-.8786797-2.12132034v-1.34963611c0-.55228475-.4477153-1-1-1h-1.3496361c-.7956495 0-1.5587112-.31607052-2.1213204-.87867966l-.83301646-.8330165c-.38440512-.38440512-1.00764896-.38440512-1.39205408 0l-.83301651.8330165c-.56260913.56260914-1.32567087.87867966-2.12132034.87867966zm3.58698944 11.4960218c-.02081224.002155-.04199226.0030286-.06345763.002542-.98766446-.0223875-1.93408568-.3063547-2.75885125-.8155622-.23496767-.1450683-.30784554-.4531483-.16277726-.688116.14506827-.2349677.45314827-.3078455.68811595-.1627773.67447084.4164161 1.44758575.6483839 2.25617384.6667123.01759529.0003988.03495764.0017019.05204365.0038639.01713363-.0017748.03452416-.0026845.05212715-.0026845 2.4852814 0 4.5-2.0147186 4.5-4.5 0-1.04888973-.3593547-2.04134635-1.0074477-2.83787157-.1742817-.21419731-.1419238-.5291218.0722736-.70340353.2141973-.17428173.5291218-.14192375.7034035.07227357.7919032.97327203 1.2317706 2.18808682 1.2317706 3.46900153 0 3.0375661-2.4624339 5.5-5.5 5.5-.02146768 0-.04261937-.0013529-.06337445-.0039782zm1.57975095-10.78419583c.2654788.07599731.419084.35281842.3430867.61829728-.0759973.26547885-.3528185.419084-.6182973.3430867-.37560116-.10752146-.76586237-.16587951-1.15568824-.17249193-2.5587807-.00064534-4.58547766 2.00216524-4.58547766 4.49928198 0 .62691557.12797645 1.23496.37274865 1.7964426.11035133.2531347-.0053975.5477984-.25853224.6581497-.25313473.1103514-.54779841-.0053975-.65814974-.2585322-.29947131-.6869568-.45606667-1.43097603-.45606667-2.1960601 0-3.05211432 2.47714695-5.50006595 5.59399617-5.49921198.48576182.00815502.96289603.0795037 1.42238033.21103795zm-1.9766658 6.41091303 2.69835-2.94655317c.1788432-.21040373.4943901-.23598862.7047939-.05714545.2104037.17884318.2359886.49439014.0571454.70479387l-3.01637681 3.34277395c-.18039088.1999106-.48669547.2210637-.69285412.0478478l-1.93095347-1.62240047c-.21213845-.17678204-.24080048-.49206439-.06401844-.70420284.17678204-.21213844.49206439-.24080048.70420284-.06401844z" fill-rule=evenodd></path></symbol><symbol id=icon-expand><path d="M7.498 11.918a.997.997 0 0 0-.003-1.411.995.995 0 0 0-1.412-.003l-4.102 4.102v-3.51A1 1 0 0 0 .98 10.09.992.992 0 0 0 0 11.092V17c0 .554.448 1.002 1.002 1.002h5.907c.554 0 1.002-.45 1.002-1.003 0-.539-.45-.978-1.006-.978h-3.51zm3.005-5.835a.997.997 0 0 0 .003 1.412.995.995 0 0 0 1.411.003l4.103-4.103v3.51a1 1 0 0 0 1.001 1.006A.992.992 0 0 0 18 6.91V1.002A1 1 0 0 0 17 0h-5.907a1.003 1.003 0 0 0-1.002 1.003c0 .539.45.978 1.006.978h3.51z" fill-rule=evenodd></path></symbol><symbol id=icon-explore viewBox="0 0 18 18"><path d="m9 17c4.418278 0 8-3.581722 8-8s-3.581722-8-8-8-8 3.581722-8 8 3.581722 8 8 8zm0 1c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9zm0-2.5c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5c2.969509 0 5.400504-2.3575119 5.497023-5.31714844.0090007-.27599565.2400359-.49243782.5160315-.48343711.2759957.0090007.4924378.2400359.4834371.51603155-.114093 3.4985237-2.9869632 6.284554-6.4964916 6.284554zm-.29090657-12.99359748c.27587424-.01216621.50937715.20161139.52154336.47748563.01216621.27587423-.20161139.50937715-.47748563.52154336-2.93195733.12930094-5.25315116 2.54886451-5.25315116 5.49456849 0 .27614237-.22385763.5-.5.5s-.5-.22385763-.5-.5c0-3.48142406 2.74307146-6.34074398 6.20909343-6.49359748zm1.13784138 8.04763908-1.2004882-1.20048821c-.19526215-.19526215-.19526215-.51184463 0-.70710678s.51184463-.19526215.70710678 0l1.20048821 1.2004882 1.6006509-4.00162734-4.50670359 1.80268144-1.80268144 4.50670359zm4.10281269-6.50378907-2.6692597 6.67314927c-.1016411.2541026-.3029834.4554449-.557086.557086l-6.67314927 2.6692597 2.66925969-6.67314926c.10164107-.25410266.30298336-.45544495.55708602-.55708602z" fill-rule=evenodd></path></symbol><symbol id=icon-filter viewBox="0 0 16 16"><path d="m14.9738641 0c.5667192 0 1.0261359.4477136 1.0261359 1 0 .24221858-.0902161.47620768-.2538899.65849851l-5.6938314 6.34147206v5.49997973c0 .3147562-.1520673.6111434-.4104543.7999971l-2.05227171 1.4999945c-.45337535.3313696-1.09655869.2418269-1.4365902-.1999993-.13321514-.1730955-.20522717-.3836284-.20522717-.5999978v-6.99997423l-5.69383133-6.34147206c-.3731872-.41563511-.32996891-1.0473954.09653074-1.41107611.18705584-.15950448.42716133-.2474224.67571519-.2474224zm-5.9218641 8.5h-2.105v6.491l.01238459.0070843.02053271.0015705.01955278-.0070558 2.0532976-1.4990996zm-8.02585008-7.5-.01564945.00240169 5.83249953 6.49759831h2.313l5.836-6.499z"></path></symbol><symbol id=icon-home viewBox="0 0 18 18"><path d="m9 5-6 6v5h4v-4h4v4h4v-5zm7 6.5857864v4.4142136c0 .5522847-.4477153 1-1 1h-5v-4h-2v4h-5c-.55228475 0-1-.4477153-1-1v-4.4142136c-.25592232 0-.51184464-.097631-.70710678-.2928932l-.58578644-.5857864c-.39052429-.3905243-.39052429-1.02368929 0-1.41421358l8.29289322-8.29289322 8.2928932 8.29289322c.3905243.39052429.3905243 1.02368928 0 1.41421358l-.5857864.5857864c-.1952622.1952622-.4511845.2928932-.7071068.2928932zm-7-9.17157284-7.58578644 7.58578644.58578644.5857864 7-6.99999996 7 6.99999996.5857864-.5857864z" fill-rule=evenodd></path></symbol><symbol id=icon-image viewBox="0 0 18 18"><path d="m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm-3.49645283 10.1752453-3.89407257 6.7495552c.11705545.048464.24538859.0751995.37998328.0751995h10.60290092l-2.4329715-4.2154691-1.57494129 2.7288098zm8.49779013 6.8247547c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v13.98991071l4.50814957-7.81026689 3.08089884 5.33809539 1.57494129-2.7288097 3.5875735 6.2159812zm-3.0059397-11c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm0 1c-.5522847 0-1 .44771525-1 1s.4477153 1 1 1 1-.44771525 1-1-.4477153-1-1-1z" fill-rule=evenodd></path></symbol><symbol id=icon-info viewBox="0 0 18 18"><path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm0 7h-1.5l-.11662113.00672773c-.49733868.05776511-.88337887.48043643-.88337887.99327227 0 .47338693.32893365.86994729.77070917.97358929l.1126697.01968298.11662113.00672773h.5v3h-.5l-.11662113.0067277c-.42082504.0488782-.76196299.3590206-.85696816.7639815l-.01968298.1126697-.00672773.1166211.00672773.1166211c.04887817.4208251.35902055.761963.76398144.8569682l.1126697.019683.11662113.0067277h3l.1166211-.0067277c.4973387-.0577651.8833789-.4804365.8833789-.9932723 0-.4733869-.3289337-.8699473-.7707092-.9735893l-.1126697-.019683-.1166211-.0067277h-.5v-4l-.00672773-.11662113c-.04887817-.42082504-.35902055-.76196299-.76398144-.85696816l-.1126697-.01968298zm0-3.25c-.69035594 0-1.25.55964406-1.25 1.25s.55964406 1.25 1.25 1.25 1.25-.55964406 1.25-1.25-.55964406-1.25-1.25-1.25z" fill-rule=evenodd></path></symbol><symbol id=icon-institution viewBox="0 0 18 18"><path d="m7 16.9998189v-2.0003623h4v2.0003623h2v-3.0005434h-8v3.0005434zm-3-10.00181122h-1.52632364c-.27614237 0-.5-.22389817-.5-.50009056 0-.13995446.05863589-.27350497.16166338-.36820841l1.23156713-1.13206327h-2.36690687v12.00217346h3v-2.0003623h-3v-1.0001811h3v-1.0001811h1v-4.00072448h-1zm10 0v2.00036224h-1v4.00072448h1v1.0001811h3v1.0001811h-3v2.0003623h3v-12.00217346h-2.3695309l1.2315671 1.13206327c.2033191.186892.2166633.50325042.0298051.70660631-.0946863.10304615-.2282126.16169266-.3681417.16169266zm3-3.00054336c.5522847 0 1 .44779634 1 1.00018112v13.00235456h-18v-13.00235456c0-.55238478.44771525-1.00018112 1-1.00018112h3.45499992l4.20535144-3.86558216c.19129876-.17584288.48537447-.17584288.67667324 0l4.2053514 3.86558216zm-4 3.00054336h-8v1.00018112h8zm-2 6.00108672h1v-4.00072448h-1zm-1 0v-4.00072448h-2v4.00072448zm-3 0v-4.00072448h-1v4.00072448zm8-4.00072448c.5522847 0 1 .44779634 1 1.00018112v2.00036226h-2v-2.00036226c0-.55238478.4477153-1.00018112 1-1.00018112zm-12 0c.55228475 0 1 .44779634 1 1.00018112v2.00036226h-2v-2.00036226c0-.55238478.44771525-1.00018112 1-1.00018112zm5.99868798-7.81907007-5.24205601 4.81852671h10.48411203zm.00131202 3.81834559c-.55228475 0-1-.44779634-1-1.00018112s.44771525-1.00018112 1-1.00018112 1 .44779634 1 1.00018112-.44771525 1.00018112-1 1.00018112zm-1 11.00199236v1.0001811h2v-1.0001811z" fill-rule=evenodd></path></symbol><symbol id=icon-location viewBox="0 0 18 18"><path d="m9.39521328 16.2688008c.79596342-.7770119 1.59208152-1.6299956 2.33285652-2.5295081 1.4020032-1.7024324 2.4323601-3.3624519 2.9354918-4.871847.2228715-.66861448.3364384-1.29323246.3364384-1.8674457 0-3.3137085-2.6862915-6-6-6-3.36356866 0-6 2.60156856-6 6 0 .57421324.11356691 1.19883122.3364384 1.8674457.50313169 1.5093951 1.53348863 3.1694146 2.93549184 4.871847.74077492.8995125 1.53689309 1.7524962 2.33285648 2.5295081.13694479.1336842.26895677.2602648.39521328.3793207.12625651-.1190559.25826849-.2456365.39521328-.3793207zm-.39521328 1.7311992s-7-6-7-11c0-4 3.13400675-7 7-7 3.8659932 0 7 3.13400675 7 7 0 5-7 11-7 11zm0-8c-1.65685425 0-3-1.34314575-3-3s1.34314575-3 3-3c1.6568542 0 3 1.34314575 3 3s-1.3431458 3-3 3zm0-1c1.1045695 0 2-.8954305 2-2s-.8954305-2-2-2-2 .8954305-2 2 .8954305 2 2 2z" fill-rule=evenodd></path></symbol><symbol id=icon-minus viewBox="0 0 16 16"><path d="m2.00087166 7h11.99825664c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-11.99825664c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule=evenodd></path></symbol><symbol id=icon-newsletter viewBox="0 0 18 18"><path d="m9 11.8482489 2-1.1428571v-1.7053918h-4v1.7053918zm-3-1.7142857v-2.1339632h6v2.1339632l3-1.71428574v-6.41967746h-12v6.41967746zm10-5.3839632 1.5299989.95624934c.2923814.18273835.4700011.50320827.4700011.8479983v8.44575236c0 1.1045695-.8954305 2-2 2h-14c-1.1045695 0-2-.8954305-2-2v-8.44575236c0-.34479003.1776197-.66525995.47000106-.8479983l1.52999894-.95624934v-2.75c0-.55228475.44771525-1 1-1h12c.5522847 0 1 .44771525 1 1zm0 1.17924764v3.07075236l-7 4-7-4v-3.07075236l-1 .625v8.44575236c0 .5522847.44771525 1 1 1h14c.5522847 0 1-.4477153 1-1v-8.44575236zm-10-1.92924764h6v1h-6zm-1 2h8v1h-8z" fill-rule=evenodd></path></symbol><symbol id=icon-orcid viewBox="0 0 18 18"><path d="m9 1c4.418278 0 8 3.581722 8 8s-3.581722 8-8 8-8-3.581722-8-8 3.581722-8 8-8zm-2.90107518 5.2732337h-1.41865256v7.1712107h1.41865256zm4.55867178.02508949h-2.99247027v7.14612121h2.91062487c.7673039 0 1.4476365-.1483432 2.0410182-.445034s1.0511995-.7152915 1.3734671-1.2558144c.3222677-.540523.4833991-1.1603247.4833991-1.85942385 0-.68545815-.1602789-1.30270225-.4808414-1.85175082-.3205625-.54904856-.7707074-.97532211-1.3504481-1.27883343-.5797408-.30351132-1.2413173-.45526471-1.9847495-.45526471zm-.1892674 1.07933542c.7877654 0 1.4143875.22336734 1.8798852.67010873.4654977.44674138.698243 1.05546001.698243 1.82617415 0 .74343221-.2310402 1.34447791-.6931277 1.80315511-.4620874.4586773-1.0750688.6880124-1.8389625.6880124h-1.46810075v-4.98745039zm-5.08652545-3.71099194c-.21825533 0-.410525.08444276-.57681478.25333081-.16628977.16888806-.24943341.36245684-.24943341.58071218 0 .22345188.08314364.41961891.24943341.58850696.16628978.16888806.35855945.25333082.57681478.25333082.233845 0 .43390938-.08314364.60019916-.24943342.16628978-.16628977.24943342-.36375592.24943342-.59240436 0-.233845-.08314364-.43131115-.24943342-.59240437s-.36635416-.24163862-.60019916-.24163862z" fill-rule=evenodd></path></symbol><symbol id=icon-plus viewBox="0 0 16 16"><path d="m2.00087166 7h4.99912834v-4.99912834c0-.55276616.44386482-1.00087166 1-1.00087166.55228475 0 1 .44463086 1 1.00087166v4.99912834h4.9991283c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-4.9991283v4.9991283c0 .5527662-.44386482 1.0008717-1 1.0008717-.55228475 0-1-.4446309-1-1.0008717v-4.9991283h-4.99912834c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule=evenodd></path></symbol><symbol id=icon-print viewBox="0 0 18 18"><path d="m16.0049107 5h-14.00982141c-.54941618 0-.99508929.4467783-.99508929.99961498v6.00077002c0 .5570958.44271433.999615.99508929.999615h1.00491071v-3h12v3h1.0049107c.5494162 0 .9950893-.4467783.9950893-.999615v-6.00077002c0-.55709576-.4427143-.99961498-.9950893-.99961498zm-2.0049107-1v-2.00208688c0-.54777062-.4519464-.99791312-1.0085302-.99791312h-7.9829396c-.55661731 0-1.0085302.44910695-1.0085302.99791312v2.00208688zm1 10v2.0018986c0 1.103521-.9019504 1.9981014-2.0085302 1.9981014h-7.9829396c-1.1092806 0-2.0085302-.8867064-2.0085302-1.9981014v-2.0018986h-1.00491071c-1.10185739 0-1.99508929-.8874333-1.99508929-1.999615v-6.00077002c0-1.10435686.8926228-1.99961498 1.99508929-1.99961498h1.00491071v-2.00208688c0-1.10341695.90195036-1.99791312 2.0085302-1.99791312h7.9829396c1.1092806 0 2.0085302.89826062 2.0085302 1.99791312v2.00208688h1.0049107c1.1018574 0 1.9950893.88743329 1.9950893 1.99961498v6.00077002c0 1.1043569-.8926228 1.999615-1.9950893 1.999615zm-1-3h-10v5.0018986c0 .5546075.44702548.9981014 1.0085302.9981014h7.9829396c.5565964 0 1.0085302-.4491701 1.0085302-.9981014zm-9 1h8v1h-8zm0 2h5v1h-5zm9-5c-.5522847 0-1-.44771525-1-1s.4477153-1 1-1 1 .44771525 1 1-.4477153 1-1 1z" fill-rule=evenodd></path></symbol><symbol id=icon-search viewBox="0 0 22 22"><path d="M21.697 20.261a1.028 1.028 0 01.01 1.448 1.034 1.034 0 01-1.448-.01l-4.267-4.267A9.812 9.811 0 010 9.812a9.812 9.811 0 1117.43 6.182zM9.812 18.222A8.41 8.41 0 109.81 1.403a8.41 8.41 0 000 16.82z" fill-rule=evenodd></path></symbol><symbol id=icon-social-facebook viewBox="0 0 24 24"><path d="m6.00368507 20c-1.10660471 0-2.00368507-.8945138-2.00368507-1.9940603v-12.01187942c0-1.10128908.89451376-1.99406028 1.99406028-1.99406028h12.01187942c1.1012891 0 1.9940603.89451376 1.9940603 1.99406028v12.01187942c0 1.1012891-.88679 1.9940603-2.0032184 1.9940603h-2.9570132v-6.1960818h2.0797387l.3114113-2.414723h-2.39115v-1.54164807c0-.69911803.1941355-1.1755439 1.1966615-1.1755439l1.2786739-.00055875v-2.15974763l-.2339477-.02492088c-.3441234-.03134957-.9500153-.07025255-1.6293054-.07025255-1.8435726 0-3.1057323 1.12531866-3.1057323 3.19187953v1.78079225h-2.0850778v2.414723h2.0850778v6.1960818z" fill-rule=evenodd></path></symbol><symbol id=icon-social-twitter viewBox="0 0 24 24"><path d="m18.8767135 6.87445248c.7638174-.46908424 1.351611-1.21167363 1.6250764-2.09636345-.7135248.43394112-1.50406.74870123-2.3464594.91677702-.6695189-.73342162-1.6297913-1.19486605-2.6922204-1.19486605-2.0399895 0-3.6933555 1.69603749-3.6933555 3.78628909 0 .29642457.0314329.58673729.0942985.8617704-3.06469922-.15890802-5.78835241-1.66547825-7.60988389-3.9574208-.3174714.56076194-.49978171 1.21167363-.49978171 1.90536824 0 1.31404706.65223085 2.47224203 1.64236444 3.15218497-.60350999-.0198635-1.17401554-.1925232-1.67222562-.47366811v.04583885c0 1.83355406 1.27302891 3.36609966 2.96411421 3.71294696-.31118484.0886217-.63651445.1329326-.97441718.1329326-.2357461 0-.47149219-.0229194-.69466516-.0672303.47149219 1.5065703 1.83253297 2.6036468 3.44975116 2.632678-1.2651707 1.0160946-2.85724264 1.6196394-4.5891906 1.6196394-.29861172 0-.59093688-.0152796-.88011875-.0504227 1.63450624 1.0726291 3.57548241 1.6990934 5.66104951 1.6990934 6.79263079 0 10.50641749-5.7711113 10.50641749-10.7751859l-.0094298-.48894775c.7229547-.53478659 1.3516109-1.20250585 1.8419628-1.96190282-.6632323.30100846-1.3751855.50422736-2.1217148.59590507z" fill-rule=evenodd></path></symbol><symbol id=icon-social-youtube viewBox="0 0 24 24"><path d="m10.1415 14.3973208-.0005625-5.19318431 4.863375 2.60554491zm9.963-7.92753362c-.6845625-.73643756-1.4518125-.73990314-1.803375-.7826454-2.518875-.18714178-6.2971875-.18714178-6.2971875-.18714178-.007875 0-3.7861875 0-6.3050625.18714178-.352125.04274226-1.1188125.04620784-1.8039375.7826454-.5394375.56084773-.7149375 1.8344515-.7149375 1.8344515s-.18 1.49597903-.18 2.99138042v1.4024082c0 1.495979.18 2.9913804.18 2.9913804s.1755 1.2736038.7149375 1.8344515c.685125.7364376 1.5845625.7133337 1.9850625.7901542 1.44.1420891 6.12.1859866 6.12.1859866s3.78225-.005776 6.301125-.1929178c.3515625-.0433198 1.1188125-.0467854 1.803375-.783223.5394375-.5608477.7155-1.8344515.7155-1.8344515s.18-1.4954014.18-2.9913804v-1.4024082c0-1.49540139-.18-2.99138042-.18-2.99138042s-.1760625-1.27360377-.7155-1.8344515z" fill-rule=evenodd></path></symbol><symbol id=icon-subject-medicine viewBox="0 0 18 18"><path d="m12.5 8h-6.5c-1.65685425 0-3 1.34314575-3 3v1c0 1.6568542 1.34314575 3 3 3h1v-2h-.5c-.82842712 0-1.5-.6715729-1.5-1.5s.67157288-1.5 1.5-1.5h1.5 2 1 2c1.6568542 0 3-1.34314575 3-3v-1c0-1.65685425-1.3431458-3-3-3h-2v2h1.5c.8284271 0 1.5.67157288 1.5 1.5s-.6715729 1.5-1.5 1.5zm-5.5-1v-1h-3.5c-1.38071187 0-2.5-1.11928813-2.5-2.5s1.11928813-2.5 2.5-2.5h1.02786405c.46573528 0 .92507448.10843528 1.34164078.31671843l1.13382424.56691212c.06026365-1.05041141.93116291-1.88363055 1.99667093-1.88363055 1.1045695 0 2 .8954305 2 2h2c2.209139 0 4 1.790861 4 4v1c0 2.209139-1.790861 4-4 4h-2v1h2c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2h-2c0 1.1045695-.8954305 2-2 2s-2-.8954305-2-2h-1c-2.209139 0-4-1.790861-4-4v-1c0-2.209139 1.790861-4 4-4zm0-2v-2.05652691c-.14564246-.03538148-.28733393-.08714006-.42229124-.15461871l-1.15541752-.57770876c-.27771087-.13885544-.583937-.21114562-.89442719-.21114562h-1.02786405c-.82842712 0-1.5.67157288-1.5 1.5s.67157288 1.5 1.5 1.5zm4 1v1h1.5c.2761424 0 .5-.22385763.5-.5s-.2238576-.5-.5-.5zm-1 1v-5c0-.55228475-.44771525-1-1-1s-1 .44771525-1 1v5zm-2 4v5c0 .5522847.44771525 1 1 1s1-.4477153 1-1v-5zm3 2v2h2c.5522847 0 1-.4477153 1-1s-.4477153-1-1-1zm-4-1v-1h-.5c-.27614237 0-.5.2238576-.5.5s.22385763.5.5.5zm-3.5-9h1c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z" fill-rule=evenodd></path></symbol><symbol id=icon-success viewBox="0 0 18 18"><path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm3.4860198 4.98163161-4.71802968 5.50657859-2.62834168-2.02300024c-.42862421-.36730544-1.06564993-.30775346-1.42283677.13301307-.35718685.44076653-.29927542 1.0958383.12934879 1.46314377l3.40735508 2.7323063c.42215801.3385221 1.03700951.2798252 1.38749189-.1324571l5.38450527-6.33394549c.3613513-.43716226.3096573-1.09278382-.115462-1.46437175-.4251192-.37158792-1.0626796-.31842941-1.4240309.11873285z" fill-rule=evenodd></path></symbol><symbol id=icon-table viewBox="0 0 18 18"><path d="m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587l-4.0059107-.001.001.001h-1l-.001-.001h-5l.001.001h-1l-.001-.001-3.00391071.001c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm-11.0059107 5h-3.999v6.9941413c0 .5572961.44630695 1.0058587.99508929 1.0058587h3.00391071zm6 0h-5v8h5zm5.0059107-4h-4.0059107v3h5.001v1h-5.001v7.999l4.0059107.001c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-12.5049107 9c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.2238576.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238576-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm-6-2c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.2238576.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238576-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm-6-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.22385763-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm1.499-5h-5v3h5zm-6 0h-3.00391071c-.54871518 0-.99508929.44887827-.99508929 1.00585866v1.99414134h3.999z" fill-rule=evenodd></path></symbol><symbol id=icon-tick-circle viewBox="0 0 24 24"><path d="m12 2c5.5228475 0 10 4.4771525 10 10s-4.4771525 10-10 10-10-4.4771525-10-10 4.4771525-10 10-10zm0 1c-4.97056275 0-9 4.02943725-9 9 0 4.9705627 4.02943725 9 9 9 4.9705627 0 9-4.0294373 9-9 0-4.97056275-4.0294373-9-9-9zm4.2199868 5.36606669c.3613514-.43716226.9989118-.49032077 1.424031-.11873285s.4768133 1.02720949.115462 1.46437175l-6.093335 6.94397871c-.3622945.4128716-.9897871.4562317-1.4054264.0971157l-3.89719065-3.3672071c-.42862421-.3673054-.48653564-1.0223772-.1293488-1.4631437s.99421256-.5003185 1.42283677-.1330131l3.11097438 2.6987741z" fill-rule=evenodd></path></symbol><symbol id=icon-tick viewBox="0 0 16 16"><path d="m6.76799012 9.21106946-3.1109744-2.58349728c-.42862421-.35161617-1.06564993-.29460792-1.42283677.12733148s-.29927541 1.04903009.1293488 1.40064626l3.91576307 3.23873978c.41034319.3393961 1.01467563.2976897 1.37450571-.0948578l6.10568327-6.660841c.3613513-.41848908.3096572-1.04610608-.115462-1.4018218-.4251192-.35571573-1.0626796-.30482786-1.424031.11366122z" fill-rule=evenodd></path></symbol><symbol id=icon-update viewBox="0 0 18 18"><path d="m1 13v1c0 .5522847.44771525 1 1 1h14c.5522847 0 1-.4477153 1-1v-1h-1v-10h-14v10zm16-1h1v2c0 1.1045695-.8954305 2-2 2h-14c-1.1045695 0-2-.8954305-2-2v-2h1v-9c0-.55228475.44771525-1 1-1h14c.5522847 0 1 .44771525 1 1zm-1 0v1h-4.5857864l-1 1h-2.82842716l-1-1h-4.58578644v-1h5l1 1h2l1-1zm-13-8h12v7h-12zm1 1v5h10v-5zm1 1h4v1h-4zm0 2h4v1h-4z" fill-rule=evenodd></path></symbol><symbol id=icon-upload viewBox="0 0 18 18"><path d="m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm0 1h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v14.00982141c0 .5500396.44491393.9950893.99406028.9950893h12.01187942c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717zm-1.85576936 4.14572769c.19483374-.19483375.51177826-.19377714.70556874.00001334l2.59099082 2.59099079c.1948411.19484112.1904373.51514474.0027906.70279143-.1932998.19329987-.5046517.19237083-.7001856-.00692852l-1.74638687-1.7800176v6.14827687c0 .2717771-.23193359.492096-.5.492096-.27614237 0-.5-.216372-.5-.492096v-6.14827641l-1.74627892 1.77990922c-.1933927.1971171-.51252214.19455839-.70016883.0069117-.19329987-.19329988-.19100584-.50899493.00277731-.70277808z" fill-rule=evenodd></path></symbol><symbol id=icon-video viewBox="0 0 18 18"><path d="m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587h-14.00982141c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm0 1h-14.00982141c-.54871518 0-.99508929.44887827-.99508929 1.00585866v9.98828264c0 .5572961.44630695 1.0058587.99508929 1.0058587h14.00982141c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-8.30912922 2.24944486 4.60460462 2.73982242c.9365543.55726659.9290753 1.46522435 0 2.01804082l-4.60460462 2.7398224c-.93655425.5572666-1.69578148.1645632-1.69578148-.8937585v-5.71016863c0-1.05087579.76670616-1.446575 1.69578148-.89375851zm-.67492769.96085624v5.5750128c0 .2995102-.10753745.2442517.16578928.0847713l4.58452283-2.67497259c.3050619-.17799716.3051624-.21655446 0-.39461026l-4.58452283-2.67497264c-.26630747-.15538481-.16578928-.20699944-.16578928.08477139z" fill-rule=evenodd></path></symbol><symbol id=icon-warning viewBox="0 0 18 18"><path d="m9 11.75c.69035594 0 1.25.5596441 1.25 1.25s-.55964406 1.25-1.25 1.25-1.25-.5596441-1.25-1.25.55964406-1.25 1.25-1.25zm.41320045-7.75c.55228475 0 1.00000005.44771525 1.00000005 1l-.0034543.08304548-.3333333 4c-.043191.51829212-.47645714.91695452-.99654578.91695452h-.15973424c-.52008864 0-.95335475-.3986624-.99654576-.91695452l-.33333333-4c-.04586475-.55037702.36312325-1.03372649.91350028-1.07959124l.04148683-.00259031zm-.41320045 14c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z" fill-rule=evenodd></path></symbol><symbol id=icon-facebook-bordered viewBox="463.812 263.868 32 32"><path d="M479.812,263.868c-8.837,0-16,7.163-16,16s7.163,16,16,16s16-7.163,16-16S488.649,263.868,479.812,263.868z
	 M479.812,293.868c-7.732,0-14-6.269-14-14s6.268-14,14-14s14,6.269,14,14S487.545,293.868,479.812,293.868z"></path><path d="M483.025,280.48l0.32-2.477h-2.453v-1.582c0-0.715,0.199-1.207,1.227-1.207h1.311v-2.213
	c-0.227-0.029-1.003-0.098-1.907-0.098c-1.894,0-3.186,1.154-3.186,3.271v1.826h-2.142v2.477h2.142v6.354h2.557v-6.354
	L483.025,280.48L483.025,280.48z"></path></symbol><symbol id=icon-twitter-bordered viewBox="463.812 263.868 32 32"><g><path d="M486.416,276.191c-0.483,0.215-1.007,0.357-1.554,0.429c0.558-0.338,0.991-0.868,1.19-1.502
		c-0.521,0.308-1.104,0.536-1.72,0.657c-0.494-0.526-1.2-0.854-1.979-0.854c-1.496,0-2.711,1.213-2.711,2.71
		c0,0.212,0.023,0.419,0.069,0.616c-2.252-0.111-4.25-1.19-5.586-2.831c-0.231,0.398-0.365,0.866-0.365,1.361
		c0,0.94,0.479,1.772,1.204,2.257c-0.441-0.015-0.861-0.138-1.227-0.339v0.031c0,1.314,0.937,2.41,2.174,2.656
		c-0.227,0.062-0.47,0.098-0.718,0.098c-0.171,0-0.343-0.018-0.511-0.049c0.35,1.074,1.347,1.859,2.531,1.883
		c-0.928,0.726-2.095,1.16-3.366,1.16c-0.22,0-0.433-0.014-0.644-0.037c1.2,0.768,2.621,1.215,4.155,1.215
		c4.983,0,7.71-4.129,7.71-7.711c0-0.115-0.004-0.232-0.006-0.351C485.592,277.212,486.054,276.734,486.416,276.191z"></path></g><path d="M479.812,263.868c-8.837,0-16,7.163-16,16s7.163,16,16,16s16-7.163,16-16S488.649,263.868,479.812,263.868z
	 M479.812,293.868c-7.732,0-14-6.269-14-14s6.268-14,14-14s14,6.269,14,14S487.545,293.868,479.812,293.868z"></path></symbol><symbol id=icon-weibo-bordered viewBox="463.812 263.868 32 32"><path d="M479.812,263.868c-8.838,0-16,7.163-16,16s7.162,16,16,16c8.837,0,16-7.163,16-16S488.649,263.868,479.812,263.868z
	 M479.812,293.868c-7.732,0-14-6.269-14-14s6.268-14,14-14c7.731,0,14,6.269,14,14S487.545,293.868,479.812,293.868z"></path><g><path d="M478.552,285.348c-2.616,0.261-4.876-0.926-5.044-2.649c-0.167-1.722,1.814-3.33,4.433-3.588
		c2.609-0.263,4.871,0.926,5.041,2.647C483.147,283.479,481.164,285.089,478.552,285.348 M483.782,279.63
		c-0.226-0.065-0.374-0.109-0.259-0.403c0.25-0.639,0.276-1.188,0.005-1.581c-0.515-0.734-1.915-0.693-3.521-0.021
		c0,0-0.508,0.224-0.378-0.181c0.247-0.798,0.209-1.468-0.178-1.852c-0.87-0.878-3.194,0.032-5.183,2.027
		c-1.489,1.494-2.357,3.082-2.357,4.453c0,2.619,3.354,4.213,6.631,4.213c4.297,0,7.154-2.504,7.154-4.493
		C485.697,280.594,484.689,279.911,483.782,279.63"></path><path d="M486.637,274.833c-1.039-1.154-2.57-1.592-3.982-1.291l0,0c-0.325,0.068-0.532,0.391-0.465,0.72
		c0.068,0.328,0.391,0.537,0.72,0.466c1.005-0.215,2.092,0.104,2.827,0.92c0.736,0.818,0.938,1.939,0.625,2.918l0,0
		c-0.102,0.318,0.068,0.661,0.39,0.762c0.32,0.104,0.658-0.069,0.763-0.391v-0.001C487.953,277.558,487.674,275.985,486.637,274.833
		"></path><path d="M485.041,276.276c-0.504-0.562-1.25-0.774-1.938-0.63c-0.279,0.06-0.461,0.339-0.396,0.621
		c0.062,0.281,0.335,0.461,0.617,0.398l0,0c0.336-0.071,0.702,0.03,0.947,0.307s0.312,0.649,0.207,0.979l0,0
		c-0.089,0.271,0.062,0.565,0.336,0.654c0.274,0.09,0.564-0.062,0.657-0.336C485.686,277.604,485.549,276.837,485.041,276.276"></path><path d="M478.694,282.227c-0.09,0.156-0.293,0.233-0.451,0.166c-0.151-0.062-0.204-0.235-0.115-0.389
		c0.093-0.155,0.284-0.229,0.44-0.168C478.725,281.892,478.782,282.071,478.694,282.227 M477.862,283.301
		c-0.253,0.405-0.795,0.58-1.202,0.396c-0.403-0.186-0.521-0.655-0.27-1.051c0.248-0.39,0.771-0.566,1.176-0.393
		C477.979,282.423,478.109,282.889,477.862,283.301 M478.812,280.437c-1.244-0.326-2.65,0.294-3.19,1.396
		c-0.553,1.119-0.021,2.369,1.236,2.775c1.303,0.42,2.84-0.225,3.374-1.436C480.758,281.989,480.1,280.77,478.812,280.437"></path></g></symbol><symbol id=icon-arrow-left-bullet viewBox="0 0 8 16"><path d="M3 8l5 5v3L0 8l8-8v3L3 8z"></path></symbol><symbol id=icon-chevron-down viewBox="0 0 16 16"><path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" fill-rule=evenodd transform="matrix(0 1 -1 0 11 3)"></path></symbol><symbol id=icon-download-rounded><path d="M0 13c0-.556.449-1 1.002-1h9.996a.999.999 0 110 2H1.002A1.006 1.006 0 010 13zM7 1v6.8l2.482-2.482c.392-.392 1.022-.4 1.403-.02a1.001 1.001 0 010 1.417l-4.177 4.177a1.001 1.001 0 01-1.416 0L1.115 6.715a.991.991 0 01-.016-1.4 1 1 0 011.42.003L5 7.8V1c0-.55.444-.996 1-.996.552 0 1 .445 1 .996z"></path></symbol><symbol id=icon-ext-link viewBox="0 0 16 16"><path d="M12.9 16H3.1C1.4 16 0 14.6 0 12.9V3.2C0 1.4 1.4 0 3.1 0h3.7v1H3.1C2 1 1 2 1 3.2v9.7C1 14 2 15 3.1 15h9.7c1.2 0 2.1-1 2.1-2.1V8.7h1v4.2c.1 1.7-1.3 3.1-3 3.1z"></path><path d="M12.8 2.5l.7.7-9 8.9-.7-.7 9-8.9z"></path><path d="M9.7 0L16 6.2V0z"></path></symbol><symbol id=icon-remove viewBox="-296 388 18 18"><path d="M-291.7 396.1h9v2h-9z"></path><path d="M-287 405.5c-4.7 0-8.5-3.8-8.5-8.5s3.8-8.5 8.5-8.5 8.5 3.8 8.5 8.5-3.8 8.5-8.5 8.5zm0-16c-4.1 0-7.5 3.4-7.5 7.5s3.4 7.5 7.5 7.5 7.5-3.4 7.5-7.5-3.4-7.5-7.5-7.5z"></path></symbol><symbol id=icon-rss viewBox="0 0 18 18"><path d="m.97480857 6.01583891.11675372.00378391c5.75903295.51984988 10.34261021 5.10537458 10.85988231 10.86480098.0494035.5500707-.3564674 1.0360406-.906538 1.0854441-.5500707.0494036-1.0360406-.3564673-1.08544412-.906538-.43079083-4.7965248-4.25151132-8.61886853-9.04770289-9.05180573-.55004837-.04965115-.95570047-.53580366-.90604933-1.08585203.04610464-.5107592.46858035-.89701345.96909831-.90983323zm1.52519143 6.95474179c1.38071187 0 2.5 1.1192881 2.5 2.5s-1.11928813 2.5-2.5 2.5-2.5-1.1192881-2.5-2.5 1.11928813-2.5 2.5-2.5zm-1.43253846-12.96884168c9.09581416.53242539 16.37540296 7.8163886 16.90205336 16.91294558.0319214.5513615-.389168 1.0242056-.9405294 1.056127-.5513615.0319214-1.0242057-.389168-1.0561271-.9405294-.4679958-8.08344784-6.93949306-14.55883389-15.02226722-15.03196077-.55134101-.03227286-.97212889-.50538538-.93985602-1.05672639.03227286-.551341.50538538-.97212888 1.05672638-.93985602z" fill-rule=evenodd></path></symbol><symbol id=icon-springer-arrow-left><path d="M15 7a1 1 0 000-2H3.385l2.482-2.482a.994.994 0 00.02-1.403 1.001 1.001 0 00-1.417 0L.294 5.292a1.001 1.001 0 000 1.416l4.176 4.177a.991.991 0 001.4.016 1 1 0 00-.003-1.42L3.385 7H15z"></path></symbol><symbol id=icon-springer-arrow-right><path d="M1 7a1 1 0 010-2h11.615l-2.482-2.482a.994.994 0 01-.02-1.403 1.001 1.001 0 011.417 0l4.176 4.177a1.001 1.001 0 010 1.416l-4.176 4.177a.991.991 0 01-1.4.016 1 1 0 01.003-1.42L12.615 7H1z"></path></symbol><symbol id=icon-springer-collections viewBox="3 3 32 32"><path fill-rule=evenodd d="M25.583333,30.1249997 L25.583333,7.1207574 C25.583333,7.10772495 25.579812,7.10416665 25.5859851,7.10416665 L6.10400517,7.10571021 L6.10400517,30.1355179 C6.10400517,31.1064087 6.89406744,31.8958329 7.86448169,31.8958329 L26.057145,31.8958329 C25.7558021,31.374901 25.583333,30.7700915 25.583333,30.1249997 Z M4.33333333,30.1355179 L4.33333333,7.10571021 C4.33333333,6.12070047 5.12497502,5.33333333 6.10151452,5.33333333 L25.5859851,5.33333333 C26.5617372,5.33333333 27.3541664,6.13359035 27.3541664,7.1207574 L27.3541664,12.4166666 L32.6666663,12.4166666 L32.6666663,30.1098941 C32.6666663,32.0694626 31.0857174,33.6666663 29.1355179,33.6666663 L7.86448169,33.6666663 C5.91736809,33.6666663 4.33333333,32.0857174 4.33333333,30.1355179 Z M27.3541664,14.1874999 L27.3541664,30.1249997 C27.3541664,31.1030039 28.1469954,31.8958329 29.1249997,31.8958329 C30.1030039,31.8958329 30.8958329,31.1030039 30.8958329,30.1249997 L30.8958329,14.1874999 L27.3541664,14.1874999 Z M9.64583326,10.6458333 L22.0416665,10.6458333 L22.0416665,17.7291665 L9.64583326,17.7291665 L9.64583326,10.6458333 Z M11.4166666,12.4166666 L11.4166666,15.9583331 L20.2708331,15.9583331 L20.2708331,12.4166666 L11.4166666,12.4166666 Z M9.64583326,19.4999998 L22.0416665,19.4999998 L22.0416665,21.2708331 L9.64583326,21.2708331 L9.64583326,19.4999998 Z M9.64583326,23.0416665 L22.0416665,23.0416665 L22.0416665,24.8124997 L9.64583326,24.8124997 L9.64583326,23.0416665 Z M9.64583326,26.583333 L22.0416665,26.583333 L22.0416665,28.3541664 L9.64583326,28.3541664 L9.64583326,26.583333 Z"></path></symbol><symbol id=icon-springer-download viewBox="-301 390 9 14"><path d="M-301 395.6l4.5 5.1 4.5-5.1h-3V390h-3v5.6h-3zm0 6.5h9v1.9h-9z"></path></symbol><symbol id=icon-springer-info viewBox="0 0 24 24"><g id=V&amp;I stroke=none stroke-width=1 fill-rule=evenodd><g id=info fill-rule=nonzero><path d="M12,0 C18.627417,0 24,5.372583 24,12 C24,18.627417 18.627417,24 12,24 C5.372583,24 0,18.627417 0,12 C0,5.372583 5.372583,0 12,0 Z M12.5540543,9.1 L11.5540543,9.1 C11.0017696,9.1 10.5540543,9.54771525 10.5540543,10.1 L10.5540543,10.1 L10.5540543,18.1 C10.5540543,18.6522847 11.0017696,19.1 11.5540543,19.1 L11.5540543,19.1 L12.5540543,19.1 C13.1063391,19.1 13.5540543,18.6522847 13.5540543,18.1 L13.5540543,18.1 L13.5540543,10.1 C13.5540543,9.54771525 13.1063391,9.1 12.5540543,9.1 L12.5540543,9.1 Z M12,5 C11.5356863,5 11.1529412,5.14640523 10.8517647,5.43921569 C10.5505882,5.73202614 10.4,6.11546841 10.4,6.58954248 C10.4,7.06361656 10.5505882,7.45054466 10.8517647,7.7503268 C11.1529412,8.05010893 11.5356863,8.2 12,8.2 C12.4768627,8.2 12.8627451,8.05010893 13.1576471,7.7503268 C13.452549,7.45054466 13.6,7.06361656 13.6,6.58954248 C13.6,6.11546841 13.452549,5.73202614 13.1576471,5.43921569 C12.8627451,5.14640523 12.4768627,5 12,5 Z" id=Combined-Shape></path></g></g></symbol><symbol id=icon-springer-tick-circle viewBox="0 0 24 24"><g id=Page-1 stroke=none stroke-width=1 fill-rule=evenodd><g id=springer-tick-circle fill-rule=nonzero><path d="M12,24 C5.372583,24 0,18.627417 0,12 C0,5.372583 5.372583,0 12,0 C18.627417,0 24,5.372583 24,12 C24,18.627417 18.627417,24 12,24 Z M7.657,10.79 C7.45285634,10.6137568 7.18569967,10.5283283 6.91717333,10.5534259 C6.648647,10.5785236 6.40194824,10.7119794 6.234,10.923 C5.87705269,11.3666969 5.93445559,12.0131419 6.364,12.387 L10.261,15.754 C10.6765468,16.112859 11.3037113,16.0695601 11.666,15.657 L17.759,8.713 C18.120307,8.27302248 18.0695334,7.62621189 17.644,7.248 C17.4414817,7.06995024 17.1751516,6.9821166 16.9064461,7.00476032 C16.6377406,7.02740404 16.3898655,7.15856958 16.22,7.368 L10.768,13.489 L7.657,10.79 Z" id=path-1></path></g></g></symbol><symbol id=icon-updates viewBox="0 0 18 18"><g fill-rule=nonzero><path d="M16.98 3.484h-.48c-2.52-.058-5.04 1.161-7.44 2.903-2.46-1.8-4.74-2.903-8.04-2.903-.3 0-.54.29-.54.58v9.813c0 .29.24.523.54.581 2.76.348 4.86 1.045 7.62 2.903.24.116.54.116.72 0 2.76-1.858 4.86-2.555 7.62-2.903.3-.058.54-.29.54-.58V4.064c0-.29-.24-.523-.54-.581zm-15.3 1.22c2.34 0 4.86 1.509 6.72 2.786v8.478c-2.34-1.394-4.38-2.09-6.72-2.439V4.703zm14.58 8.767c-2.34.348-4.38 1.045-6.72 2.439V7.374C12 5.632 14.1 4.645 16.26 4.645v8.826z"></path><path d="M9 .058c-1.56 0-2.76 1.22-2.76 2.671C6.24 4.181 7.5 5.4 9 5.4c1.5 0 2.76-1.22 2.76-2.671 0-1.452-1.2-2.67-2.76-2.67zm0 4.413c-.96 0-1.8-.755-1.8-1.742C7.2 1.8 7.98.987 9 .987s1.8.755 1.8 1.742c0 .93-.84 1.742-1.8 1.742z"></path></g></symbol><symbol id=icon-checklist-banner viewBox="0 0 56.69 56.69"><rect id=transparent_background class=st0 width=56.69 height=56.69></rect><g><clippath id=SVGID_2_><use xlink:href=#SVGID_1_ style=overflow:visible></use></clippath><path class=st1 d="M21.14,34.46c0-6.77,5.48-12.26,12.24-12.26c6.76,0,12.24,5.49,12.24,12.26c0,6.77-5.48,12.26-12.24,12.26
		C26.62,46.71,21.14,41.23,21.14,34.46z M40.47,45.12l10.23,9.22c0,0,1.21,1.09,2.3-0.12l2.09-2.32c0,0,1.09-1.21-0.12-2.3
		l-10.23-9.22 M25.45,34.46c0-4.38,3.55-7.94,7.93-7.94c4.38,0,7.93,3.55,7.93,7.94c0,4.38-3.55,7.94-7.93,7.94
		C29,42.39,25.45,38.84,25.45,34.46z M43.03,47.45l4.14-4.81"></path><path class=st2 d="M8.26,9.75H28.6 M8.26,15.98H28.6 M8.26,22.18h12.5 M35.18,16.98V4.86c0,0,0-2.93-2.93-2.93H4.13
		c0,0-2.93,0-2.93,2.93v37.57c0,0,0,2.93,2.93,2.93h15.01 M8.26,9.75H28.6 M8.26,15.98H28.6 M8.26,22.18h12.5"></path></g><g></g><g></g><g></g><g></g><g></g><g></g></symbol><symbol id=icon-submit-closed viewBox="0 0 18 18"><path d="m15 0c1.1045695 0 2 .8954305 2 2v4.5c0 .27614237-.2238576.5-.5.5s-.5-.22385763-.5-.5v-4.5c0-.51283584-.3860402-.93550716-.8833789-.99327227l-.1166211-.00672773h-9v3c0 1.1045695-.8954305 2-2 2h-3v10c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h4.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-4.5c-1.1045695 0-2-.8954305-2-2v-10.17157288c0-.53043297.21071368-1.0391408.58578644-1.41421356l3.82842712-3.82842712c.37507276-.37507276.88378059-.58578644 1.41421356-.58578644zm-2.5 7c3.0375661 0 5.5 2.46243388 5.5 5.5 0 3.0375661-2.4624339 5.5-5.5 5.5-3.03756612 0-5.5-2.4624339-5.5-5.5 0-3.03756612 2.46243388-5.5 5.5-5.5zm0 1c-2.4852814 0-4.5 2.0147186-4.5 4.5s2.0147186 4.5 4.5 4.5 4.5-2.0147186 4.5-4.5-2.0147186-4.5-4.5-4.5zm2.3087379 2.1912621c.2550161.2550162.2550161.668479 0 .9234952l-1.3859024 1.3845831 1.3859024 1.3859023c.2550161.2550162.2550161.668479 0 .9234952-.2550162.2550161-.668479.2550161-.9234952 0l-1.3859023-1.3859024-1.3845831 1.3859024c-.2550162.2550161-.668479.2550161-.9234952 0-.25501614-.2550162-.25501614-.668479 0-.9234952l1.3845831-1.3859023-1.3845831-1.3845831c-.25501614-.2550162-.25501614-.668479 0-.9234952.2550162-.25501614.668479-.25501614.9234952 0l1.3845831 1.3845831 1.3859023-1.3845831c.2550162-.25501614.668479-.25501614.9234952 0zm-9.8087379-8.7782621-3.587 3.587h2.587c.55228475 0 1-.44771525 1-1z"></path></symbol><symbol id=icon-submit-open viewBox="0 0 18 18"><path d="m15 0c1.1045695 0 2 .8954305 2 2v5.5c0 .27614237-.2238576.5-.5.5s-.5-.22385763-.5-.5v-5.5c0-.51283584-.3860402-.93550716-.8833789-.99327227l-.1166211-.00672773h-9v3c0 1.1045695-.8954305 2-2 2h-3v10c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h7.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-7.5c-1.1045695 0-2-.8954305-2-2v-10.17157288c0-.53043297.21071368-1.0391408.58578644-1.41421356l3.82842712-3.82842712c.37507276-.37507276.88378059-.58578644 1.41421356-.58578644zm-.5442863 8.18867991 3.3545404 3.35454039c.2508994.2508994.2538696.6596433.0035959.909917-.2429543.2429542-.6561449.2462671-.9065387-.0089489l-2.2609825-2.3045251.0010427 7.2231989c0 .3569916-.2898381.6371378-.6473715.6371378-.3470771 0-.6473715-.2852563-.6473715-.6371378l-.0010428-7.2231995-2.2611222 2.3046654c-.2531661.2580415-.6562868.2592444-.9065605.0089707-.24295423-.2429542-.24865597-.6576651.0036132-.9099343l3.3546673-3.35466731c.2509089-.25090888.6612706-.25227691.9135302-.00001728zm-.9557137-3.18867991c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-6c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm-8.5-3.587-3.587 3.587h2.587c.55228475 0 1-.44771525 1-1zm8.5 1.587c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-6c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z"></path></symbol><symbol id=icon-submit-upcoming viewBox="0 0 18 18"><path d="m15 0c1.1045695 0 2 .8954305 2 2v4.5c0 .27614237-.2238576.5-.5.5s-.5-.22385763-.5-.5v-4.5c0-.51283584-.3860402-.93550716-.8833789-.99327227l-.1166211-.00672773h-9v3c0 1.1045695-.8954305 2-2 2h-3v10c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h4.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-4.5c-1.1045695 0-2-.8954305-2-2v-10.17157288c0-.53043297.21071368-1.0391408.58578644-1.41421356l3.82842712-3.82842712c.37507276-.37507276.88378059-.58578644 1.41421356-.58578644zm-2.5 7c3.0375661 0 5.5 2.46243388 5.5 5.5 0 3.0375661-2.4624339 5.5-5.5 5.5-3.03756612 0-5.5-2.4624339-5.5-5.5 0-1.6607442.73606908-3.14957021 1.89976608-4.15803695l-1.51549374.02214397c-.27613212.00263356-.49998143-.22483432-.49998143-.49020681 0-.24299316.17766103-.44509007.40961587-.48700057l.08928713-.00797472h2.66407569c.2449213 0 .4486219.17766776.490865.40963137l.008038.08929051v2.6642143c0 .275547-.2296028.4989219-.4949753.4989219-.24299317 0-.44342617-.1744719-.4830969-.4093269l-.00710993-.0906783.01983146-1.46576707c-.96740882.82538117-1.58082193 2.05345007-1.58082193 3.42478927 0 2.4852814 2.0147186 4.5 4.5 4.5s4.5-2.0147186 4.5-4.5-2.0147186-4.5-4.5-4.5c-.7684937 0-.7684937-1 0-1zm0 2.85c.3263501 0 .5965265.2405082.6429523.5539478l.0070477.0960522v1.731l.8096194.8093806c.2284567.2284567.2513024.5846637.068537.8386705l-.068537.0805683c-.2284567.2284567-.5846637.2513024-.8386705.068537l-.0805683-.068537-.9707107-.9707107c-.1125218-.1125218-.1855975-.257116-.2103268-.412296l-.0093431-.1180341v-1.9585786c0-.3589851.2910149-.65.65-.65zm-7.5-8.437-3.587 3.587h2.587c.55228475 0 1-.44771525 1-1z"></path></symbol></svg>
</div>
 
 
 <div class=u-vh-full>
 <a class=c-skip-link href=#main-content>Skip to main content</a>
 
 
 
 <div class="u-hide u-show-following-ad sf-hidden"></div>
 
 <aside class="adsbox c-ad c-ad--728x90" data-component-mpu>
 <div class=c-ad__inner>
 <p class=c-ad__label>Advertisement</p>
 <div id=div-gpt-ad-LB1 data-ad-type=LB1 data-test=LB1-ad data-pa11y-ignore data-gpt data-gpt-unitpath=/270604982/bmc/cardiab/articles data-gpt-sizes=728x90,970x90 data-gpt-targeting="pos=LB1;doi=10.1186/s12933-018-0746-4;type=article;kwrd=Type 2 diabetes,DPP-4 inhibitors,GLP-1 agonists,Safety,Heart failure;pmc=H33045,H33010,H33037;" data-google-query-id=CKXTn-3MzfsCFYVcwQodSm0G8w>
 
 <div id=google_ads_iframe_/270604982/bmc/cardiab/articles_0__container__ style="border:0pt none"></div></div>
 </div>
 </aside>
 
 
 
 
 <div id=membership-message-loader-desktop class=placeholder data-placeholder=/placeholder/v1/membership/message><div class=c-banner data-test=member-banner>
 <div class=u-container>
 <div class="u-display-flex u-justify-content-space-between">
 <p>University of Florida is a member of BioMed Central.
 <a href=https://www.biomedcentral.com/about/membership/members/1600041195>Find out about member benefits and discounts.</a>
 </p>
 </div>
 </div>
</div>
</div>
 
 
 <div id=top class=u-position-relative>
 <header class=c-header data-test=publisher-header>
 <div class=c-header__container>
 <div class="c-header__brand u-mr-48" itemscope itemtype=http://schema.org/Organization data-test=navbar-logo-header>
 <div class=c-logo>
 <a href=https://www.biomedcentral.com/ itemprop=url>
 <img alt=BMC itemprop=logo role=img src=data:image/svg+xml;base64,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 width=76 height=18>
 <div class=c-logo__strapline>
 <img alt="Part of Springer Nature" role=img src=data:image/svg+xml;base64,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 width=173 height=16>
 </div>
 </a>
</div>
 </div>
 <div class=c-header__navigation>
 <button type=button class="c-header__link u-button-reset u-mr-24" data-expander data-expander-target=#publisher-header-search data-expander-autofocus=firstTabbable data-test=header-search-button aria-controls=publisher-header-search aria-expanded=false aria-haspopup=true>
 <span class="u-display-flex u-align-items-center">
 <span>Search</span>
 <svg class="u-icon u-flex-static u-ml-8" aria-hidden=true focusable=false>
 <use xlink:href=#global-icon-search></use>
 </svg>
 </span>
 </button>
 <nav>
 <ul class="c-header__menu u-hide-at-lt-lg" data-enhanced-menu data-test=publisher-navigation>
 
 
 <li class="c-header__item u-hide-at-lt-lg">
 <a class=c-header__link href=https://www.biomedcentral.com/journals>
 Explore journals
 </a>
 </li>
 
 <li class="c-header__item u-hide-at-lt-lg">
 <a class=c-header__link href=https://www.biomedcentral.com/getpublished>
 Get published
 </a>
 </li>
 
 <li class="c-header__item u-hide-at-lt-lg">
 <a class=c-header__link href=https://www.biomedcentral.com/about>
 About BMC
 </a>
 </li>
 
 
 <li class=c-header__item>
 <a href=https://cardiab.biomedcentral.com/login class=c-header__link>Login</a>
 </li>
 </ul><div class="c-dropdown u-hide-at-lg sf-hidden"></div>
 </nav>
 </div>
 </div>
 </header>
 <div class="c-popup-search u-js-hide sf-hidden" id=publisher-header-search hidden>
 
 </div>
</div>
 
 
 <header class="c-journal-header c-journal-header--cardiovascular-diabetology ctx-journal-header">
 <div class=u-container>
 <div class=c-journal-header__inner>
 
 <div class=c-journal-title id=journalTitle>
 <a href=https://cardiab.biomedcentral.com/>
 
 
 <img class=c-journal-title__logo src=data:image/svg+xml;base64,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 alt="Cardiovascular Diabetology logo">
 
 
 <span class=c-journal-title__text>Cardiovascular Diabetology</span>
 
</a>
 </div>
 
 </div>
 </div>
 <div class=c-navbar>
 <div class=c-navbar__container>
 
 <div class=c-navbar__content>
 <nav class=c-navbar__nav>
 <ul class="c-navbar__nav c-navbar__nav--journal" role=menu data-test=site-navigation>
 
 <li class=c-navbar__item role=menuitem>
 <a class=c-navbar__link data-track=click data-track-category=Home data-track-action="Clicked journal navigation link" href=https://cardiab.biomedcentral.com/>Home</a>
 </li>
 
 <li class=c-navbar__item role=menuitem>
 <a class=c-navbar__link data-track=click data-track-category=About data-track-action="Clicked journal navigation link" href=https://cardiab.biomedcentral.com/about>About</a>
 </li>
 
 <li class=c-navbar__item role=menuitem>
 <a class="c-navbar__link c-navbar__link--is-shown" data-track=click data-track-category=Articles data-track-action="Clicked journal navigation link" href=https://cardiab.biomedcentral.com/articles>Articles</a>
 </li>
 
 <li class=c-navbar__item role=menuitem>
 <a class=c-navbar__link data-track=click data-track-category="Submission Guidelines" data-track-action="Clicked journal navigation link" href=https://cardiab.biomedcentral.com/submission-guidelines>Submission Guidelines</a>
 </li>
 
 </ul>
 </nav>
 </div>
 
 </div>
 </div>
 <div class="c-journal-header__identity c-journal-header__identity--wine-red">
 
 </div>
 </header>
 
 
 <div class="u-container u-mt-32 u-mb-32 u-clearfix" id=main-content data-component=article-container>
 <main class="c-article-main-column u-float-left js-main-column" data-track-component="article body">
 <div class="c-context-bar u-hide sf-hidden" data-test=context-bar data-context-bar aria-hidden=true>
 
 </div>
 <div class="c-pdf-button__container u-hide-at-lg js-context-bar-sticky-point-mobile sf-hidden">
 
 </div>
 <article lang=en>
 <div class=c-article-header>
 
 
 <ul class=c-article-identifiers data-test=article-identifier>
 
 
 <li class=c-article-identifiers__item data-test=article-category>Original investigation</li>
 
 
 <li class=c-article-identifiers__item>
 <span class=c-article-identifiers__open data-test=open-access>Open Access</span>
 </li>
 
 
 <li class=c-article-identifiers__item><a href=#article-info data-track=click data-track-action="publication date" data-track-label=link>Published: <time datetime=2018-07-17>17 July 2018</time></a></li>
 </ul>
 <h1 class=c-article-title data-test=article-title data-article-title>Risk of heart failure hospitalization among users of dipeptidyl peptidase-4 inhibitors compared to glucagon-like peptide-1 receptor agonists</h1>
 <ul class="c-article-author-list c-article-author-list--short js-no-scroll" data-test=authors-list data-component-authors-activator=authors-list><li class=c-article-author-list__item><a data-test=author-name data-track=click data-track-action="open author" data-track-label=link href=#auth-Ghadeer_K_-Dawwas data-author-popup=auth-Ghadeer_K_-Dawwas>Ghadeer K. Dawwas</a><sup class="u-js-hide sf-hidden"></sup>, <li class=c-article-author-list__item><a data-test=author-name data-track=click data-track-action="open author" data-track-label=link href=#auth-Steven_M_-Smith data-author-popup=auth-Steven_M_-Smith>Steven M. Smith</a><sup class="u-js-hide sf-hidden">,</sup> &amp; <li class=c-article-author-list__item><a data-test=author-name data-track=click data-track-action="open author" data-track-label=link href=#auth-Haesuk-Park data-author-popup=auth-Haesuk-Park data-corresp-id=c1>Haesuk Park<svg width=16 height=16 focusable=false role=img aria-hidden=true class=u-icon><use xmlns:xlink=http://www.w3.org/1999/xlink xlink:href=#global-icon-email></use></svg></a><span class="u-js-hide sf-hidden">&nbsp;
 </span><sup class="u-js-hide sf-hidden"></sup>&nbsp;</ul>
 <p class=c-article-info-details data-container-section=info>
 
 <a data-test=journal-link href=https://cardiab.biomedcentral.com/><i data-test=journal-title>Cardiovascular Diabetology</i></a>
 <b data-test=journal-volume><span class=u-visually-hidden>volume</span>&nbsp;17</b>, Article&nbsp;number:&nbsp;<span data-test=article-number>102</span> (<span data-test=article-publication-year>2018</span>)
 <a href=#citeas class="c-article-info-details__cite-as u-hide-print" data-track=click data-track-action="cite this article" data-track-label=link>Cite this article</a>
 </p>
 
 <div class="c-article-metrics-bar__wrapper u-clear-both">
 <ul class="c-article-metrics-bar u-list-reset">
 
 <li class=c-article-metrics-bar__item>
 <p class=c-article-metrics-bar__count>3359 <span class=c-article-metrics-bar__label>Accesses</span></p>
 </li>
 
 
 <li class=c-article-metrics-bar__item>
 <p class=c-article-metrics-bar__count>16 <span class=c-article-metrics-bar__label>Citations</span></p>
 </li>
 
 
 
 
 <li class=c-article-metrics-bar__item>
 <p class=c-article-metrics-bar__details><a href=https://cardiab.biomedcentral.com/articles/10.1186/s12933-018-0746-4/metrics data-track=click data-track-action="view metrics" data-track-label=link rel=nofollow>Metrics <span class=u-visually-hidden>details</span></a></p>
 </li>
 </ul>
 </div>
 
 
 
 
 
 </div>
 <section aria-labelledby=Abs1 data-title=Abstract lang=en><div class=c-article-section id=Abs1-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Abs1>Abstract</h2><div class=c-article-section__content id=Abs1-content><h3 class=c-article__sub-heading data-test=abstract-sub-heading>Background</h3><p>Incretin-based therapies including dipeptidyl peptidase-4 (DPP-4) inhibitors and glucagon like peptide-1 (GLP-1) receptor agonists are novel medications for type 2 diabetes management. Several studies have&nbsp;found cardioprotective effects of incretin-based therapies; however, it remains unclear whether there is any difference in heart failure (HF) risk between the two incretin-based therapies (DPP-4 inhibitors and GLP-1 receptor agonists). We aimed&nbsp;to assess the risk of hospitalization due to HF with the use of DPP-4 inhibitors compared to GLP-1 receptor agonists.<h3 class=c-article__sub-heading data-test=abstract-sub-heading>Methods</h3><p>Using Truven Health Marketscan data, we conducted a retrospective cohort study of patients with type 2 diabetes, who were newly initiated on DPP-4 inhibitors or GLP-1 agonists. Follow-up continued from drug initiation until the first occurrence of: HF hospitalization (primary outcome),&nbsp;discontinuation of therapy (i.e. no fill for 7 days), switch to the comparator, end of enrollment, or end of study (December 2013). Cox proportional hazards models with propensity-score-matching were used to compare the risk of HF hospitalization between DPP-4 inhibitors and GLP-1 agonists.<h3 class=c-article__sub-heading data-test=abstract-sub-heading>Results</h3><p>A total of 321,606 propensity score-matched patients were included in the analysis (n = 160,803 for DPP-4 inhibitors; n = 160,803 for GLP-1 agonists). After adjusting for baseline characteristics and disease risk factors, the use of DPP-4 inhibitors was associated with a 14% decreased risk of HF hospitalization compared to GLP-1 agonists use [hazard ratio (HR), 0.86; 95% confidence interval (CI) 0.83, 0.90]. The results were consistent in patients without baseline HF (HR, 0.85; 95% CI 0.82, 0.89), but the association was not statistically significant for patients with baseline HF (HR, 0.90; 95% CI 0.74, 1.07).<h3 class=c-article__sub-heading data-test=abstract-sub-heading>Conclusion</h3><p>In this retrospective matched cohort of patients with type 2 diabetes, the use of DPP-4 inhibitors was associated with a reduced risk of HF hospitalization compared to GLP-1 agonists. However, the association was not statistically significant in patients who had HF prior to the use of DPP-4 inhibitors.</p></div></div></section>
 
 
 <section data-title=Background><div class=c-article-section id=Sec1-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Sec1>Background</h2><div class=c-article-section__content id=Sec1-content><p>Dipeptidyl peptidase-4 (DPP-4) inhibitors, a relatively new class of diabetes medications, have been used widely since their approval in the United States in 2006 [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 1" title="Filion KB, Suissa S. DPP-4 inhibitors and heart failure: some reassurance, some uncertainty. Diabetes Care. 2016;39(5):735–7. 
                    https://doi.org/10.2337/dci15-0036
                    
                  ." href=#ref-CR1 id=ref-link-section-d117163409e581>1</a>]. The class exerts antihyperglycemic effects by inhibiting the enzyme responsible for the degradation of glucagon-like peptide-1 (GLP-1) resulting in a reduction in both fasting and postprandial glucose concentration [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 2" title="Toh S, Hampp C, Reichman ME, et al. Risk for hospitalized heart failure among new users of saxagliptin, sitagliptin, and other antihyperglycemic drugs: a retrospective cohort study. Ann Intern Med. 2016;164(11):705–14. 
                    https://doi.org/10.7326/m15-2568
                    
                  ." href=#ref-CR2 id=ref-link-section-d117163409e584>2</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 3" title="Vella A. Mechanism of action of DPP-4 inhibitors–new insights. J Clin Endocrinol Metab. 2012;97(8):2626–8. 
                    https://doi.org/10.1210/jc.2012-2396
                    
                  ." href=#ref-CR3 id=ref-link-section-d117163409e587>3</a>]. Prior randomized clinical trials have proven these agents effective in reducing glycated hemoglobin (HbA1c), with a low risk of hypoglycemia and no clinically significant effect on weight [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 1" title="Filion KB, Suissa S. DPP-4 inhibitors and heart failure: some reassurance, some uncertainty. Diabetes Care. 2016;39(5):735–7. 
                    https://doi.org/10.2337/dci15-0036
                    
                  ." href=#ref-CR1 id=ref-link-section-d117163409e590>1</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 4" title="Li L, Li S, Deng K, et al. Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: Systematic review and meta-analysis of randomised and observational studies. BMJ. 2016;352:i610. 
                    https://doi.org/10.1136/bmj.i610
                    
                  ." href=#ref-CR4 id=ref-link-section-d117163409e593>4</a>]. Despite the reported cardioprotective effect of DPP-4 inhibitors from pre-clinical trials, concerns emerged regarding their potential association with heart failure (HF) [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 1" title="Filion KB, Suissa S. DPP-4 inhibitors and heart failure: some reassurance, some uncertainty. Diabetes Care. 2016;39(5):735–7. 
                    https://doi.org/10.2337/dci15-0036
                    
                  ." href=#ref-CR1 id=ref-link-section-d117163409e597>1</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 5" title="Karagiannis T, Boura P, Tsapas A. Safety of dipeptidyl peptidase 4 inhibitors: a perspective review. Ther Adv Drug Saf. 2014;5(3):138–46. 
                    https://doi.org/10.1177/2042098614523031
                    
                  ." href=#ref-CR5 id=ref-link-section-d117163409e600>5</a>]. For instance, a post hoc analysis from the Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus–Thrombolysis in Myocardial Infarction 53 trial (SAVOR-TIMI 53) found a 27% increase in the risk of hospitalization due to HF with saxagliptin compared to placebo [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 6" title="Scirica BM, Bhatt DL, Braunwald E, et al. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. N Engl J Med. 2013;369(14):1317–26. 
                    https://doi.org/10.1056/nejmoa1307684
                    
                  ." href=#ref-CR6 id=ref-link-section-d117163409e603>6</a>]. However, two other trials, the Examination of Cardiovascular Outcomes with Alogliptin Versus Standard of Care (EXAMINE) and Trial to Evaluate Cardiovascular Outcomes after Treatment with Sitagliptin (TECOS), reported no increased risk of hospitalization due to HF with alogliptin (EXAMINE) or sitagliptin (TECOS) compared to placebo [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 4" title="Li L, Li S, Deng K, et al. Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: Systematic review and meta-analysis of randomised and observational studies. BMJ. 2016;352:i610. 
                    https://doi.org/10.1136/bmj.i610
                    
                  ." href=#ref-CR4 id=ref-link-section-d117163409e606>4</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 7" title="Zannad F, Stough WG, Lipicky RJ, et al. Assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversion. Eur Heart J Cardiovasc Pharmacother. 2016;2(3):200–5. 
                    https://doi.org/10.1093/ehjcvp/pvw007
                    
                  ." href=#ref-CR7 id=ref-link-section-d117163409e609>7</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 8" title="Green JB, Bethel MA, Armstrong PW, et al. Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2015;373(3):232–42. 
                    https://doi.org/10.1056/nejmoa1501352
                    
                  ." href=#ref-CR8 id=ref-link-section-d117163409e612>8</a>]. Despite the uncertainty, the Food and Drug Administration (FDA) issued a warning of the increased risk of HF with two DPP-4 inhibitors: saxagliptin and alogliptin [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 9" title="Food and Drug Administration. FDA drug safety communication: FDA adds warnings about heart failure risk to labels of type 2 diabetes medicines containing saxagliptin and alogliptin. US Food and Drug Administration Web site. 
                    https://www.fda.gov/Drugs/DrugSafety/ucm486096.htm
                    
                  . Updated 2016. Accessed 04 Apr 2018." href=#ref-CR9 id=ref-link-section-d117163409e616>9</a>].<p>Subsequently, these trials were followed by several observational studies with conflicting results [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 1" title="Filion KB, Suissa S. DPP-4 inhibitors and heart failure: some reassurance, some uncertainty. Diabetes Care. 2016;39(5):735–7. 
                    https://doi.org/10.2337/dci15-0036
                    
                  ." href=#ref-CR1 id=ref-link-section-d117163409e622>1</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 2" title="Toh S, Hampp C, Reichman ME, et al. Risk for hospitalized heart failure among new users of saxagliptin, sitagliptin, and other antihyperglycemic drugs: a retrospective cohort study. Ann Intern Med. 2016;164(11):705–14. 
                    https://doi.org/10.7326/m15-2568
                    
                  ." href=#ref-CR2 id=ref-link-section-d117163409e625>2</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 4" title="Li L, Li S, Deng K, et al. Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: Systematic review and meta-analysis of randomised and observational studies. BMJ. 2016;352:i610. 
                    https://doi.org/10.1136/bmj.i610
                    
                  ." href=#ref-CR4 id=ref-link-section-d117163409e628>4</a>]. Fu et al. [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 10" title="Fu AZ, Johnston SS, Ghannam A, et al. Association between hospitalization for heart failure and dipeptidyl peptidase 4 inhibitors in patients with type 2 diabetes: an observational study. Diabetes Care. 2016;39(5):726–34. 
                    https://doi.org/10.2337/dc15-0764
                    
                  ." href=#ref-CR10 id=ref-link-section-d117163409e631>10</a>] found no significant difference in the risk of hospitalization due to HF between DPP-4 inhibitors and sulfonylureas in patients with baseline cardiovascular disease (CVD) (hazard ratio [HR], 0.95; 95% confidence interval (CI) 0.78, 1.15). Additionally, a more recent analysis found a protective effect for saxagliptin versus sulfonylureas (HR, 0.69; 95% CI 0.54, 0.87) and for sitagliptin versus sulfonylureas (HR, 0.61; 95% CI 0.50, 0.73) [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 2" title="Toh S, Hampp C, Reichman ME, et al. Risk for hospitalized heart failure among new users of saxagliptin, sitagliptin, and other antihyperglycemic drugs: a retrospective cohort study. Ann Intern Med. 2016;164(11):705–14. 
                    https://doi.org/10.7326/m15-2568
                    
                  ." href=#ref-CR2 id=ref-link-section-d117163409e634>2</a>]. Given these equivocal findings and the limitations of prior studies such as the short follow-up time, there still a need for a better understanding of the risk of HF with DPP-4 inhibitors to guide prescribing decisions, especially in patients at elevated cardiovascular risk [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 2" title="Toh S, Hampp C, Reichman ME, et al. Risk for hospitalized heart failure among new users of saxagliptin, sitagliptin, and other antihyperglycemic drugs: a retrospective cohort study. Ann Intern Med. 2016;164(11):705–14. 
                    https://doi.org/10.7326/m15-2568
                    
                  ." href=#ref-CR2 id=ref-link-section-d117163409e638>2</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 10" title="Fu AZ, Johnston SS, Ghannam A, et al. Association between hospitalization for heart failure and dipeptidyl peptidase 4 inhibitors in patients with type 2 diabetes: an observational study. Diabetes Care. 2016;39(5):726–34. 
                    https://doi.org/10.2337/dc15-0764
                    
                  ." href=#ref-CR10 id=ref-link-section-d117163409e641>10</a>]. Furthermore, given that sulfonylureas are not the only other second-line agent, important clinical questions remain, including whether differential risk of HF hospitalization exists between DPP-4 inhibitors and other preferred second line agents such as GLP-1 agonists. The latter have been recommended after metformin (± insulin in select patients) in recent guidelines, in part owing to an apparent all-cause mortality benefit observed in randomized trials [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 11" title="American Diabetes Association. 8. pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S73–85. 
                    https://doi.org/10.2337/dc18-s008
                    
                  ." href=#ref-CR11 id=ref-link-section-d117163409e644>11</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 12" title="Brunton S. GLP-1 receptor agonists vs. DPP-4 inhibitors for type 2 diabetes: Is one approach more successful or preferable than the other? Int J Clin Pract. 2014;68(5):557–67. 
                    https://doi.org/10.1111/ijcp.12361
                    
                  ." href=#ref-CR12 id=ref-link-section-d117163409e647>12</a>]. A recent meta-analysis of randomized clinical trials compared these two agents; however, the results were limited by the small number of events (9 total HF hospitalization events from 5 trials) [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 13" title="Zheng SL, Roddick AJ, Aghar-Jaffar R, et al. Association between use of sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide 1 agonists, and dipeptidyl peptidase 4 inhibitors with all-cause mortality in patients with type 2 diabetes: a systematic review and meta-analysis. JAMA. 2018;319(15):1580–91. 
                    https://doi.org/10.1001/jama.2018.3024
                    
                  ." href=#ref-CR13 id=ref-link-section-d117163409e650>13</a>]. Therefore, we sought to compare the risk of hospitalization due to HF of DPP-4 inhibitors compared with GLP-1 agonists in a large commercially-insured US population.</p></div></div></section><section data-title=Methods><div class=c-article-section id=Sec2-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Sec2>Methods</h2><div class=c-article-section__content id=Sec2-content><h3 class=c-article__sub-heading id=Sec3>Data source</h3><p>This was a retrospective cohort analysis using Truven Health Analytic&nbsp;MarketScan<sup>®</sup> commercial and Medicare supplemental databases between January 2006 and December 2013. The databases include information on inpatient and outpatient medical claims, health expenditures, enrollment, and outpatient prescription claims of more than 150 million individuals. The commercial data includes privately insured employees and their dependents who are covered under plans including preferred provider organizations, health maintenance organizations, point-of-service plans, and indemnity plans. This study was approved by the University of Florida Institutional Review Board.<h3 class=c-article__sub-heading id=Sec4>Study population and exposure determination</h3><p>New-users of DPP-4 inhibitors (sitagliptin, saxagliptin, alogliptin, or linagliptin) or GLP-1 agonists (exenatide, liraglutide, albiglutide, and dulaglutide) were identified based on the absence of any prior use during the baseline period (12&nbsp;months lookback period). The start date of the first eligible prescription was used as the index date. To be included in the cohort, patients were required to have a diagnosis of type 2 diabetes mellitus [International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM): 250.x0 or 250.x2] based on one inpatient or two outpatient encounters at two different service dates within 1&nbsp;year prior to the index date, have 12&nbsp;months of continuous enrollment in medical and pharmacy benefits prior to the index date, and be aged ≥ 18&nbsp;years on cohort entry. Patients were excluded if they had a diagnosis of type 1 diabetes (ICD-9-CM: 250.x1 or 250.x3), end-stage renal disease (ESRD) (ICD-9-CM: 585.6), a prescription for DPP-4 inhibitors or GLP-1 agonists&nbsp;during the baseline period, or if they initiated both drugs on the same date. Further, to make our results comparable with those from the SAVOR-TIMI and other observational analyses, we excluded patients who had a hospitalization due to HF (ICD-9-CM: 402.×1, 404.×1, 404.×3, and 428.×) during the 60&nbsp;days prior to the index date because a recent hospitalization due to HF is known to be highly predictive of subsequent HF exacerbations [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 2" title="Toh S, Hampp C, Reichman ME, et al. Risk for hospitalized heart failure among new users of saxagliptin, sitagliptin, and other antihyperglycemic drugs: a retrospective cohort study. Ann Intern Med. 2016;164(11):705–14. 
                    https://doi.org/10.7326/m15-2568
                    
                  ." href=#ref-CR2 id=ref-link-section-d117163409e675>2</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 10" title="Fu AZ, Johnston SS, Ghannam A, et al. Association between hospitalization for heart failure and dipeptidyl peptidase 4 inhibitors in patients with type 2 diabetes: an observational study. Diabetes Care. 2016;39(5):726–34. 
                    https://doi.org/10.2337/dc15-0764
                    
                  ." href=#ref-CR10 id=ref-link-section-d117163409e678>10</a>].<p>Patients were considered exposed as long as they continued to refill their medication, allowing a gap no longer than 7&nbsp;days between refills. Follow-up started from the index date until the first occurrence of one of the following censoring criteria: occurrence of the primary outcome (hospitalization due to HF), initiation of the study comparator (e.g. new users of DPP-4 inhibitors start or switch to GLP-1&nbsp;agonists), discontinuation of therapy (i.e. no fill for 7&nbsp;days), inpatient death (death was recorded if occurring during inpatient stay only), end of enrollment, or end of study period.<h3 class=c-article__sub-heading id=Sec5>Study outcome</h3><p>The study outcome was the first hospitalization due to HF defined as an inpatient hospital claim with a primary or secondary diagnosis of HF (ICD-9-CM: 402.×1, 404.×1, 404.×3, and 428.××). This definition has been validated previously with a positive predictive value [PPV] &gt; 90% [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 14" title="Saczynski JS, Andrade SE, Harrold LR, et al. A systematic review of validated methods for identifying heart failure using administrative data. Pharmacoepidemiol Drug Saf. 2012;21(Suppl 1):129–40. 
                    https://doi.org/10.1002/pds.2313
                    
                  ." href=#ref-CR14 id=ref-link-section-d117163409e692>14</a>].<p>We performed three secondary analyses, first, stratifying by the presence of prior diagnosis of HF defined as the occurrence of HF between 1&nbsp;year and 60&nbsp;days prior to the index date. Secondly, we stratified by the presence of prior CVD [cerebrovascular diseases, myocardial infarction (MI), stroke, coronary atherosclerosis, ischemic heart diseases, angina pectoris]. Thirdly, we assessed HF hospitalization risk of individual DPP-4 inhibitors, saxagliptin and sitagliptin, compared to GLP-1 agonists.<h3 class=c-article__sub-heading id=Sec6>Confounders adjustment</h3><p>To adjust for confounders and disease risk factors, propensity score (1:1) matching to the nearest neighbor was used. To estimate the propensity score, we used a logistic regression model to obtain the predicted probability of receiving DPP-4 inhibitors versus GLP-1 agonists as a function of pre-specified baseline covariates. Included covariates were demographics (age, sex), presence of comorbidities (asthma, chronic obstructive pulmonary disease [COPD], chronic kidney disease [CKD], ischemic heart disease, depression, stroke, hypoglycemia, hyperlipidemia, cancer, hypertension, MI, HF), use of other diabetes medications (insulin, metformin, thiazolidinediones [TZDs], α-Glucosidase inhibitors, sodium glucose co-transporter-2 [SGLT2] inhibitors, meglitinides, sulfonylureas), use of other medications (angiotensin-converting enzyme [ACE] inhibitors, aldosterone receptor blockers, β-blockers, calcium channel blockers, loop diuretics, potassium sparing diuretics, thiazide diuretics, and direct vasodilators), and measures of healthcare utilizations (total number of inpatient visits, total number of outpatient visits). The presence of baseline comorbidities were defined based on the presence of ICD-9 codes in either inpatient or outpatient claims. These variables were drawn from a prior protocol that was developed by the Mini-Sentinel for the assessment of cardiovascular outcomes among patients with type 2 diabetes [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 15" title="Fireman B, Toh S, Butler MG, et al. A protocol for active surveillance of acute myocardial infarction in association with the use of a new antidiabetic pharmaceutical agent. Pharmacoepidemiol Drug Saf. 2012;21(Suppl 1):282–90. 
                    https://doi.org/10.1002/pds.2337
                    
                  ." href=#ref-CR15 id=ref-link-section-d117163409e706>15</a>].<h3 class=c-article__sub-heading id=Sec7>Statistical analysis</h3><p>Descriptive statistics were summarized using mean for continuous variables and proportion for categorical variables. Demographics and disease risk factors were compared between users of DPP-4 inhibitors and those of GLP-1 agonists using a Chi square test for categorical variables and independent <i>t</i> test for continuous variables. After propensity score matching, standardized differences were used to examine the balance in patient characteristics, where imbalance was defined as an absolute value higher than 0.2 [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 16" title="Yang D, Dalton J. A unified approach to measuring the effect size between two groups using SAS®. SAS Global Forum. 2012;35:1–6." href=#ref-CR16 id=ref-link-section-d117163409e721>16</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 17" title="D’Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17(19):2265–81. 
                    https://doi.org/10.1002/(sici)1097-0258(19981015)17:193.0.co;2-b
                    
                  ." href=#ref-CR17 id=ref-link-section-d117163409e724>17</a>]. Proportional hazard models were used to obtain the HR and associated 95% CI after propensity score matching in the primary and secondary analyses. In secondary analyses, we examined the heterogeneity of treatment effect in patients with and without prior HF, with and without baseline CVD, and comparing saxagliptin and sitagliptin to GLP-1 agonists.<p>Sensitivity analyses were conducted to examine the robustness of the primary study results by changing the outcome definition to primary diagnosis only and, separately, extending the follow-up time to 45&nbsp;days post-treatment discontinuation. Propensity score matching was performed for each of the secondary and sensitivity analyses. All analyses were performed using SAS 9.4 (SAS Institute Inc., Cary, NC).</p></div></div></section><section data-title=Results><div class=c-article-section id=Sec8-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Sec8>Results</h2><div class=c-article-section__content id=Sec8-content><h3 class=c-article__sub-heading id=Sec9>Patient characteristics prior matching</h3><p>A flow diagram of the study population is included in the Additional file <a data-track=click data-track-label=link data-track-action="supplementary material anchor" href=#MOESM1>1</a>: Figure S1. Prior to matching, a total of 358,632 new-users of DPP-4 inhibitors, and 174,711 new-users of GLP-1 agonists were identified. Table&nbsp;<a data-track=click data-track-label=link data-track-action="table anchor" href=#Tab1>1</a> summarizes baseline characteristics comparing the new-users of DPP-4 inhibitors to GLP-1 agonists users. Prior to matching, there were significant differences in patient demographics and clinical characteristics.<div class=c-article-table data-test=inline-table data-container-section=table id=table-1><figure><figcaption class=c-article-table__figcaption><b id=Tab1 data-test=table-caption>Table&nbsp;1 Demographics and clinical characteristics of new-users of DPP-4 inhibitors and GLP-1 agonists prior to propensity score matching</b></figcaption><div class="u-text-right u-hide-print"><a class=c-article__pill-button data-test=table-link data-track=click data-track-action="view table" data-track-label=button rel=nofollow href=https://cardiab.biomedcentral.com/articles/10.1186/s12933-018-0746-4/tables/1 aria-label="Full size table 1"><span>Full size table</span><svg width=16 height=16 focusable=false role=img aria-hidden=true class=u-icon><use xmlns:xlink=http://www.w3.org/1999/xlink xlink:href=#global-icon-chevron-right></use></svg></a></div></figure></div>
<h3 class=c-article__sub-heading id=Sec10>Patient characteristics after matching</h3><p>After propensity score matching, a total of 321,606 patients were included in the analysis (n = 160,803 each for DPP-4 inhibitors and GLP-1 agonists users). Table&nbsp;<a data-track=click data-track-label=link data-track-action="table anchor" href=#Tab2>2</a> summarizes patient demographics and disease characteristics post-matching. In the propensity score matched cohort, patient demographics, including age (mean, 52.7&nbsp;years vs. 53.0&nbsp;years), proportion of men (44.7% vs. 44.1%), presence of comorbidities such as asthma (6.4% vs. 6.4%), hyperlipidemia (57.4% vs. 56.8%), and hypertension (59.6% vs. 59.5%), and prior use of medications including metformin (62.2% vs. 62.0%), TZDs (24.4% vs. 24.5%), and β-blockers (22.5% vs. 23.0%) were comparable between groups.<div class=c-article-table data-test=inline-table data-container-section=table id=table-2><figure><figcaption class=c-article-table__figcaption><b id=Tab2 data-test=table-caption>Table&nbsp;2 Demographics and clinical characteristics in propensity-score matched cohorts of new-users of DPP-4 inhibitors and GLP-1 agonists</b></figcaption><div class="u-text-right u-hide-print"><a class=c-article__pill-button data-test=table-link data-track=click data-track-action="view table" data-track-label=button rel=nofollow href=https://cardiab.biomedcentral.com/articles/10.1186/s12933-018-0746-4/tables/2 aria-label="Full size table 2"><span>Full size table</span><svg width=16 height=16 focusable=false role=img aria-hidden=true class=u-icon><use xmlns:xlink=http://www.w3.org/1999/xlink xlink:href=#global-icon-chevron-right></use></svg></a></div></figure></div><h3 class=c-article__sub-heading id=Sec11>Incident heart failure hospitalization</h3><p>The mean length of follow-up was 170 (± 290) days in the DPP-4 inhibitors group and 159 (± 285) days in the GLP-1 agonists group. Table&nbsp;<a data-track=click data-track-label=link data-track-action="table anchor" href=#Tab3>3</a> shows the unadjusted risk of hospitalization due to HF with DPP-4 inhibitors versus GLP-1 agonists&nbsp;users in the propensity score matched cohort. We identified 5714 of cases of HF hospitalization among DPP-4 inhibitors users (n = 160,803) and 6098 among GLP-1 agonists users (n = 160,803). The crude HF hospitalization incidence was 74 per 1000 person-years with DPP-4 inhibitors and 87 per 1000 person-years with GLP-1 agonists. In the proportional hazards model, use of DPP-4 inhibitors was associated with a 14% decreased risk of HF hospitalization compared to GLP-1 agonists use (HR, 0.86; 95% CI 0.83, 0.90), after adjusting for differences in baseline characteristics and disease risk factors (Fig.&nbsp;<a data-track=click data-track-label=link data-track-action="figure anchor" href=#Fig1>1</a>). Secondary analyses revealed similar results in patients without baseline HF (n = 158,543 for DPP-4 inhibitors; n = 158,543 for GLP-1 agonists; HR, 0.85; 95% CI 0.82, 0.89). However, among the comparatively small matched cohort of individuals with baseline HF (n = 1937 for DPP-4 inhibitors; n = 1937 for GLP-1 agonists), we observed no evidence of differential HF hospitalization risk (HR, 0.90; 95% CI 0.74, 1.07).<div class=c-article-table data-test=inline-table data-container-section=table id=table-3><figure><figcaption class=c-article-table__figcaption><b id=Tab3 data-test=table-caption>Table&nbsp;3 Unadjusted risk of hospitalization due to heart failure with DPP-4 inhibitors versus GLP-1 agonists in propensity score matched analyses</b></figcaption><div class="u-text-right u-hide-print"><a class=c-article__pill-button data-test=table-link data-track=click data-track-action="view table" data-track-label=button rel=nofollow href=https://cardiab.biomedcentral.com/articles/10.1186/s12933-018-0746-4/tables/3 aria-label="Full size table 3"><span>Full size table</span><svg width=16 height=16 focusable=false role=img aria-hidden=true class=u-icon><use xmlns:xlink=http://www.w3.org/1999/xlink xlink:href=#global-icon-chevron-right></use></svg></a></div></figure></div> <div class="c-article-section__figure js-c-reading-companion-figures-item" data-test=figure data-container-section=figure id=figure-1 data-title=Fig.&nbsp;1><figure><figcaption><b id=Fig1 class=c-article-section__figure-caption data-test=figure-caption-text>Fig.&nbsp;1</b></figcaption><div class=c-article-section__figure-content><div class=c-article-section__figure-item><a class=c-article-section__figure-link data-test=img-link data-track=click data-track-label=image data-track-action="view figure" href=https://cardiab.biomedcentral.com/articles/10.1186/s12933-018-0746-4/figures/1 rel=nofollow><picture><img aria-describedby=Fig1 src="data:image/webp;base64,UklGRsqCAABXRUJQVlA4IL6CAADQmQGdASqtAk8CPjEYikOiIaERmf1YIAMEtLd+PkzV9ahlfpj/S/xt/pf+38d/6T+Mf9v/3fq7+H/Iv0H+0/37+0/1v/hf6b4hf4D8oPOd6D+8f3z/Jfst+9fyT/Evqn9J/rf+I/tn9k/9P+m+8H7F/d/7p+1X9x9H/hp/D/3v9pP79+5X2C/if8b/p39t/YH+wf+T/S/X59l/wu261H/Of6T/I/tT8AXp38r/uv9w/yP+3/tX7k+wV+4f4/9pf6j/3PlX8z/sf9m/LX+v////s/oD/Ev5V/Zf7d+zv9r//n+4+4v89/sfz/9IT71/mP9j/k/yA+wH+X/0//Z/3T/M/s99J/8L/xP8h/pP+7/of///1/jF+a/3n/f/5H/Q/+L/Jf///rfoN/J/6N/nf7t/l/+P/g//9/1fvO////o+Cn7jf///s/DJ+2X///6///B7Pevfeo4zMzge/wGNV0zxn2nD/mR70cyBH4Py41iXhO6uj5zGTRMLJomFk0TCyaJhZM7qNZKmUn/+E4JVZpejFIPUqy7VADQ4Xq4AYaSBwE9DwciXXiZXt3I2EWI4EdQKoPV2O7tH+FPZUlL7zs58oz/e3/7zLP6LvGnJR1WDmVWoMVBVdQJlEg6Qj2F2EQdIR7C7CIOkI9hdhEBXsGpWhvtCKlZDPMevT+OFdgXBxNCUygUrKfU/qGR6k1N3DNudOlgBV5qt+gX71S9hdhEHSEewuwiDpCN2t4M23hFP8okHSEewuXyDVwfJYJAx3tuFw0N9CNMSyrmRlbk2MwobRNUTJ+XH4Mv/Gnhu3siOZBCmBdZLPbGWBQ61vM7BSmSdWyX47esXKMVuA+AgtQokl2/MIKHWD9BcJU/WVIojNyhfDt+0QlysYPKA7Hd5Gdy49qF2365ByuVftpkSNlLH26r5mV8TKTSGlhENLszcgBqKkA54XSE+uP4v6QnolZCAe2+9aixDgPhIvQhfj3pJpjXFsfz0SKlKfbW1xeub6csEkkTRUOs7OV4Au8xz2K5Wv4Jnaza63iWp4DYiQ7rf+MlfVuvJNN4FPSbJaPzf2Cu6HEg4vvR8q4uM7AAbQaZZfx4H+2KLodCW+UtAdfjpGymJZVLroKzAPSsSXC0BKerJofyFY0Juiy/5bDwFalAyX+MpufC/B/7V9A2zWn1ghNz3TK0S2HrZUsjZUeDafp7pEwsmjnJGUT3d+bxXQ3dGGP6/6OHRQ0cHuitMebeu2qAqFj4psqRI2VIgqlwWTRMLJomFk0Q4kcqT+7zT27R6DwwldNZtIEUNDsuVlwJ6bnipEX8DZ4F/4Ot3tb6lpdzQCsuqRI2VIkbKjwbT9PdImFk0TCyaITqfi+LAwLk/OJFb/Qne9ixs1FD+imypEhAyqFCJLj8to/I2VIfEuMAgdpeSb53OsC8zNgMMONyjd+be/3zh43o5zuL+noeI4mVPrsKQldyHNGRzes27CHKWQy06O6wk0naD7kiGQd87HReMazw1+3kYjG98CmOkbKYPgsLJl6WItUMTsrd9PdHTRyoIoSH14uapTTi/QfFxhM+HRFqtlvU9ePw3tYW+Uf3rC7xi10oXEutwwL9p+ikzdWA9WENeysVo6o+eX/tkW6f8TOiR0nRily7mypEjZS6hranxxlxSpI5l6CezjAxTCyT01sb38B0SRp3bOP6mxOIMD0tpdPyTkRD0rUsOrNEMFsoLWXjzicvVo0n7QI8x/cQcrf0HgDDRNohsU2TO9jMCD98pg6Xx8IwOQWbpYPgUx0jY6MEEw5grrNNQDihFgeZdJCrBhCOOZQpjpCLfotbCVpG9ENNUUBo1BMkrMbgbBxS3a0+sddelvz69mPXYuS/RqTMN0TMX3iivvzmiXCyaJhZNEwsmiYWJOmRI2VIkbYyJGymVx8MmhQSLszllAC8iI96e6RMLJnl5OBTHSNlSJGypDzSsMPb/liaVQvyRX66NLMMSxrVfvtOkK8GJM/rQl7GS/PKkSp1MWzRvL4ViSk/xxwk7ijMzYChdp++a4ydyCuaRsqRI2U1pW76e6RMLJomFkqb/5sdTzc2awbMghKRz/7Pl0kfKnwKXJbro5VBzxopsqN+3NiORMJnJrVqdYhwxxzMIOa2gPZC6yuIUliV34PXcyYcCx77F1LKEWfPtKgKW9x3JFYloawMb7IS8D31yvObjFWlqfApjpGjqsZcV66hw2yTklyBttdKZ3SJhYbK0NIBvzPfqnKenDihhJT2aDGig0lU/fQC1NPfhR/u0nMsGy8/So+I7VIhOtXK4AGZAYh44ToXyyzA0bThL5HmtmDrtP9kbSqmdy1EXePGOkbKWMlINp3xpKOCyaJctIrpQxzQo22hISth2dZVCb2TJmW5lK5H3nlEpfCYatpZBMs6GsYac0IRcpdXEVbi5gHVa2OL14wt2fWKS1ophG0EhwfJivEvKH9FNlR1tP6s9qIMfdrJ4Qna7nbDQonQH9FNjodsB8Rt8WFhtY1G2vriq6SXx5pow5QughruuiopUrXxp/fuAywEFdDYeBXS0Gh+fcYg0dnlbMkZGfOVNdy8qp+6IjCdglKnwKY6RsqRI2VIgqlwWTRMLJPB6y0dFPW5BcMCmOkbKkSNlSJGx+j+kTCyaJhZNEwsLigHv7IZ6vfFR1EUGR98IaEboRE+v1ABytDW56AynnUUlvqcKMDdSAxvutoL9vVYE50mt2y6tT4FMdIbOyk/opsqRI2VIkKh7ozqA2a0W12U+Tf8fcHYXBSW/EKLA/rivRtTDuCl/wRc8PECsu93FxdQtVcU6aacGFMdI2U1pW76e6OMvEyXWwCKuIfJ/lLesB9UBZnpRtWCzvENSuRnX8yWnLxBPx6SdiWXlNG7eIuxoXM9vp3jw/1z80uAwo4FodayF4AWP6GBNcLtBcSD+UKonyBLC2225t9iKK0FMdI0fEK9v1dW9BZWVTbzNCZtccigACCJqII96u97byXNlJV4pDo0m+2rDbWfOzHZvAZz0cOsBK+Sai2E9ueGJIgVXp0q7By4nmuIyCoAYenrK2wYtugz0PqJqDF4SINg5+a6S+KzDh43jxjoCBAOjC7AKKmKYUKbKkPaTo31bhNKOEveu0lmcCZ/DhNKdLOZmEk4SIEI50LWJ0gzOc7la8XfOLCMpFHsVFsbUr9g8QA5iEEToi5YdApEkryE9PZo3hiKbKkSNBVpTfRDfZSnLBDdVeKHpwKY6QqFILu9VZiFhTEEtpShTo4cXwUfOmlxe+/Pekw2H1OZXqKOgkdIyev713UznrCJ1AvNaIwaaHyQiYMns+HHmceBTOwv3qtkYQJy+fSYbGAQSBHUznCZtP7XeuEddFOplanwKY6RsbRRGOD3wVhD+imypD4SXy6SJGk07GPgEJc90NIH2aBLClYi1MuzHqfYEefWYcGzDg2YcGyhW2YhWnkjcC7CIOeMA2/Newuumrqej1Yn9FNlSJGymJB9QKGYAuBmej5ofHKYIrfAGhpednDfHPwBg6e4b5fsAsoizaoFY6MWLGxYMSS6eMc+BWO9FXWtZ6rKY2hcbNHR8iXJV6Rt53hpP6KbKkSNI+/SvAQeSFUY/U2WuhI0gZye6PJjcqzAMLMAKD/R+BIzs51ybKYTDjldZgUKyIGWeUVjA/hS0MRTZUiRsqRIP1meNHRkSNlSJGypEjbwQ+ealWVOVIkbKkSNlSH+9pnrJZod4iGGlFZodllhr3w8V2Q8VkOzO9Ej6EP8VY+TDsZ9WqM8IPNnYxkRMPRxYhsJ3asPHhDfLdygXnWkOFQwiJiQCCIF5VKRHaD7xTqr4b3iilC6NlSJGypEjZUcugNs3X2K14JDdGwei9jZyfnpd4v1LlDjmBL5HwDsa7tNCG6oFi305/hxQuEjN4Tl6wmIsOseT49TJ2X02ScEQv2OjPMDm8iny9ZF93QxSDd+FWM7sewTtJDniC+TotFh/YGrnb788dB318B7cOxuIMYMXn9EeG1w68DIACi1f5el7qEaBQr8cSTwhDQCIp/xtdz//SjkM4mKpCxZZSh1GhKap8DJomFk0TCyaJhZNEwsm3sLJnOkm0oyYn9FNlSJGypEjZUiRsqRI2VIkbKkSNlSJGypEjZUiRsqRI2VIfh8JJoWhI3RnlY9v6tYj+QuDk2SR8hTeb8jdawNGj+KlvCJ2x64BbZ6WygUMm/yXgaxKfcfKErDe53I6aNpKQGMLRTHcJQHDFA+5Br0eUP6KbKkSNlSJGypEjR/8ypyOQb8DSjjihavtP1QttTiuSGbAtZlPfkFP8Kdh8fG0F3j/poLdoyo7VYgP8kFPq6IjfMPMtn1CypJWvFLz1wluAGkNdeWJhCVIo8QmIwHohFsBX3auNlSJGyo2AAD+td13vXfCwDZHhUIf7uwPuYtw8fbXMBH5fQHTtJBd5a27WL1nAUBL87JX+l1o0eQ6ZRGe8Ibnavgh0eUWrr5HQ8Nk1dhvZHIhlf3cinuIB8VWh1W5B6BxgolIqv6P+P/HFnJ627tW+AJlgIvMvTUVW7LjgnGmUheKs0mr4NPcDHHGpEuEwn+H3ooVL0za3h5B0JsOG/+wOg3bw/ZQ2Y/JmF0HPxlAowKxa6kEYBXN7X84vLSblt0uyZZa1WvfXUpWQaw2bLa3y6yO0N29/zHooblcjrEz55O3/eSvm87zG8dlUgs4qQJekPtelZbJ7GRiFGp0VcPQEKn/oWovQsMSszrYNsNjUBNO1q5iqVh2mrqAv/mikZANGGCSKr6uDxaXUMrIJCYq+SOJwLD0ZIqZswAV0fCTHAQh6GA7ftN6lGGsceqrwxfSHxf0QvwZdvP8qoJewK+2Oyw9Vlk16xYe+m7x+uaUFcHGbZqwellKPYTW7qOOrz36ILdfgXpIUd2bmW2vCvb1ZDeX6KRp3eyPmXM5l1Tc+hy40t3BZwBsadkiXjrzC5qeO7p7QndPKhpD33MoZcCqvjUpNBxTBxfczKdKdieTQvKf1mzOghu/aYZYlU3mia9IuB/a55FMSTRWZ14cZ6vYS1TozwtDrZ9iQwlq6M4k1vHtO3x8tfXMViaAgoRAGr793uoWD1enktZdfZUYez+/+o5iv0J1TZKIIRgzZnQ5IP5Eu6mTqwIFHQEPXAykPsVvopi6wh4NDEbp6rbPls1IRMQ9dD430PZ+fCT4nALHtJevHFDlKCgO+FE7pOL61NGHhq8FIljZhZP5i/ODeThaBDTAfd+WlEH2NoJFk/N8inxoD5KtDyxrh6z4LVvVzIScbxGFZQDCWjPfoMCbMFAJm9OpQrMn1l1DAkVwSC4UrOqczOCZ7wQc6Qy8dpjTNYYS0H7slxI7YPM3f7qdfRmUYajKAhzUwZuDwhxOLJ77ojPDCYgBwcyFWfPFKs7uC6qVDjIE0ps4eeCA2GEzarNnjpTNLGiiNne3COb+CE5/+KGDGzrXhJr+sb9UBBdPdRe21WOltfuSjCqfVlXSnoFBYjTUUi5U0zMR4fCFhU60EOPK9IWjQMYWdGYg2zviJxdc3ikwIxoA4KhlaQkz9XoKkv8KceZr6BkgvaoR0BDKPSlrekWEwCp86ocZEwOnxYUy6Ozy3xnrVwzOomnaTrBek5UhXLZ/oOg8QUozkwbq/TtGEyiD3bQ/Knw9vO7oVWn8Erhq3Eaoey6oRwQ+J4vEIeJ2xQqoTDSHh4vrDwWDOxxezayOjQLN6xe1bCo9g9BqQUnlRV9i5d95ZE8JgbES4HzcRjm6llgHhflwlhgfliEcGpTYBOAoGGZgg9mOSTNjImj3mYD60owqj4/pnMeRfRzUL5fvexSvm2uXCPlyPsL3rSjIHkb5MbeIgA6zVbBGYqZgMrzhVlzzCxAhsNs4aMCZAo3cJFAfCORWTul6wzirPTDaHUT4ESjWTLSiaz1NsPH/b9TrWhs28trQzKmo1Xe9Tou2ComC6CMEyPw9foeRk4awT7JK+w7HukiyzUSYhQFy4vMEbc9SkzAN1VlNxqHkrnz1uSlmWIn5cjskjS58tzohmeRhTRQ2ZdzE0JMUVLgt4uFcwCat9eaG5ZQ0X7thjksNV0u/aWf5jmpYyrvwWxyE5Rk0JjcWmChbh2Z81175aszQWxzdoIHdBZcSYGLtwmjPnB0j141ElHP6x7F+MgRktJF20yr79svZM5EKUo0DG4/Elv75SEA8NdRtpueMea5/GpRsEjJ1jzRSC3L/co1pPr25qYPs010RjZq0nY4CHHXadBdULHAyF5m2R7i30ImCqwUuFnSNjPszZv94u21gr7MWwvSlyV/qyypmI5hyizRYtgtXRHuL31hkI6NhsEnJ0bmjyDgUNgCeO9WvpTcvGGYwiLrwJ/dwMiBU7aJaAZ/U2EQllk0Sx/qYo7WaoVitf/bG3hhaFGO0qzQVWQhCNWaaOXrmBPxeWK35b2j8U7Gbmom28Or4oEUi0AJyGkT06mQrEjGWNFcCgyLmlPJcUg5RLii8PXvkyVZpFLtgyDjVcoCZXztidYXWJu4JHX1rwghWG0h1C7AqTBJ77lGK+5ubrAN3A+aHDz+rTv9MZi/O5Y/f1PrLG04Wdnm1Qer5rN3hOhGb6jAA9rvv4++7WR1+wmGMOPBadW5+Iy0V8BFvHLUuNi9YdshYID5+4Ei8GK8G1A6jOhiY8wqdp32SGWsviQrh2mvIhT/Hw6gaq0ycHmPiWyGcDQ/AedPKDuSsOLguD6ERS1zSrJwTkXOyzAkpHVQoVXpKr/XUCtLe+U1z0gz2Eg9XKzG4ZDF/xSEFTUU8FYvCBSiZr/ZKJd4KaYunQCM6hQqBFl1ycaRZn4HoJBObYJupkntwCNaLbd+ldx+5/R2NWlfDbch9ES19sfTUdfoVHyCgbMjXP6dADe0qBgLDPiok4MRPL2lUV1R0a5amobJH516yawZx3wNVSM+FgkVQ/HqyzHY9YaNO5aYL17nZs8OAkgxrmkbA+RaoyroPr8wG0fXOy6PuIXAl+C38m8rQQYC6hoNk9GUPMGzqqUy/SsxGM6Qlq6rXtVSSvYkA/3lUex40jj0lYz6ZamlMz5berKAWTGXMYf2MgCP1cagj4Q8upLsoxzOMjlWXYRVRCxs4n1mnyY/+BajF/7eEtBvXRjAP7MdYNn7EtbQX2c6Lb5EkJ6MUBTgVa4Z8wb3ODr6qHBK9YLOVu/M+W9Q7mKlbRQcOjJF03wtFoBmfR7dw1T+4V37r+2LfgIRnmCdsog0q98Zy/+XPMFyGAQ8omIfFE0iFWM6sSeYoMjO63mwwMKiWwCu2bKwpcCkP4OnkWoX6SJbSWSKMGi8u/SGm9/AIneE5wVzFpRJjId6wEIs2iGEE9+WLw9tjuUnuwCmU/PMhJ4vAC7cMBBryGzBQ0cqOymXdVS+9k334jYG47OHTdTxRSZPqJX4zu0cDWpf3ZXb1r8pJXfuzThY8tVMeHhH1ZBF69bKhj2PTQYCwbbyqAHPft3GeRfp9bzbKGYmh2FVUAkVlNslKyRlwts5wA85KpHPN84gZ8CiE5SenkKbxX1ByiQc2XXAnoj7CyX8HjVWbjO28iEaN8mNdMldWewl2hqX68bO8D6TfoyMW7x1gX0rNRxWaCmf7vtxE2B633QROzfmmA9pKrow4izmksuViB8X1QKJe0pAvdZ16QX/XBQwdIGolHdRI6aLrRMgygaMJk4vbBiAuu645toTI83WNoWZzBmaVQ5I/3EeixzYXr/IXujAX3+Wha3B8hrxgByMxKTI7wFn91gzXXZ8W+CA17UK1l5AL82gxRVxlz2W/3EYLGMusBJGSKy33uijGlRBvIre1kkjvrr/vOiVthMiE6sclweDDRUlYas4UiMEPp66skhSadxle+l9veDOag5Gb9Zx3uGK0Irl48uO7qaRQUq0++5Se6+aNp0YFwrXVTGqztG6YvILkR9uyqn2hWFWS7T3pNvAbiv3qj2DADpSQa1yTkbvLw4qWf38fupKEBO6RAB2yB12qWKoqHv3maGpsbc+hCSQyMUMBXzkD05PR3vDE9YjT31II0/I446gif+fn4zaiOxUqufm3FgrcXN4vpn+KkdeQAcb6YWq7IEWtrgZuklvAKF0M5/aFR7x8OjaeFcc+WaGA4LY3YIC2LbBfjJXUqNUNvu3YW6tbwakXktMd56juwt6Bm2wbsgTsUxAzLq2qY5+PM3+JzEUVg7SKEhPpuBw5EuOGxZ/Whg5P/mEGzXLZMQJXR5FjlWDV/dhzN0YUCFPhhzyO78lKL8+hrtspxwEy0sK6+/2m03+QRZVolvkJeb4mHjXSROF//HXpBifkOytXd6FgvCfsyGivqGDNZyQMbq6oAUKC75pHi4GtPkkX9E7Fg0+S7h0wDZtt+XcR9lmzuovD+iOhtbaFV3n6Lg7aC2DFGSdNUtfYPPJHjxG1+srbhdNu8vrrlWgUeYJeSuH9ZCAfaeij7T+NniqkX8QgiyMsLf0Xr78hkbQHG1fJ/XxQy2TaP8rgvs0Ag+7YO6LzJu09hpyDJB2gvyOVUF35o7fg9axK6T1LVMgSphBOhFVScGXnHdD+ucIp7Ldsn/nMXBRmNPc88ve0v1Hqj2isTTMrbIXp9lsuXW+gwlTN2vMMJpdUwKPuwm8Pui/KOihs6UQIJdtWS7i7E7AdMU45mx+W/oat/6loIs2XbP5Zehvlcr7nn31VsKExi0cyNE7duXeMMjy5grblRSw/FR5tXe1q70P1deU4uEjHS21cOXnv2B6iokZQ5Ltfzv9cmlpxcq/XeekMGh2OQDVJ9FqhBYStUNlQWmGHOSq+KK+wpPTyN2RX5Yl7ZHeQIGG7PPGjSrxnIB/DHkKk28VQlH90uGxXJgyXmrcAaiO9zvkIgOf+pCRBb22LCPt6TAF41UujOcxDaKOnUIpxWSYHrwAgCagGnH5jDqeJdwfHRehgBBveydCLJF1HDiJpsYdEme9M+q7IBjpQP6N1UZl8iHFQWtBMYXMHrfgnbmRFMxW8vWRM9QrV2ASiqhEEppEL/3MT8OLyAhQDbfvVBHq1OJmn3/UsWiyf/SPJ6kEBfROkm/z+jB/3CB+q9LGeynUO1qFKAs4ZjHHfWAUBXBwwH3b/4LKTAJzR8HWSrmufLi3sR292j17KZWFWU3I4yW3uLR8dH8rBFrMW12YmiMQuyPoyTfrxEUYYkLltqDE6bQMotBAoYwVOtyn/8gXe3Do9u/J2Pl+/7p9Z3zVL5ki898txjjN3fgrwxF2ZUlY8XPbGWdq2XIW2yCxbWLLuav7ygOLWT7CXG7/wugGmUwGuhdR+OD3ClPCJsvnpDqgVITU6MxsqqTvBA1Dp3wpbKQd36qeD2E9oMYdz4NB0hLFA7CtFN19HNvb1PJN7N8DQutCOX3ACIdplKg8Y6XO9Xyjxko+brwn0XzNrMKx6u6LDXPgHj5ChmdJlHdmIJUYyRwIpB+3m0oW1b3/FbkjmocatU1gPaOKMhTBs8Q4Am5IUy7AQAj3E3hNxBsNHPUafuEDw0jEWyJEGhSYSSiLzfUgCezWIaO01MktBN509XfPK12ai38OhRQd6o2GOEi08qHNkDafklF6smfmVtGstu9VeOFE6z/oJna7s2xUloQcz+gKabyguQVNfW5AGLI4tibkKL3T9GSOwDI15jNX6Sp0yqhJ5wux7dEYlfBqy5VEPB+hkgLPE4MIFS1x3ZMXQW2t1OmeRE4oYBrpCL/jEXnbBPMRnjg839vYdLX9yZHzD/E8BDqRyCgDrCSHKK+pIxeQ0dzuEtOFey6S2DXFZxv1lMcJ3GPVCYnCen6lbLvDauhYhU0s5BHWmQeR3hHtigkM4+faB6yxBD7VCTHx+QleOLXaR9L2h66JGhOQZ/hnQ/Kt5sYWWR0bfrV2gpI0OfyYLvpC7Teu/j9WKIHQ/kjkgiV6BwkNuEDiInLJk126mB1We7eRh5cg+sIV7UZVqahcIMV5r0VOzIznRbj/waxlyvCCgnMoFWW0bU9W/eQGWi52IaJaWhA99irF91uW5r82PRutOqjghy2i2g4cFma8N4igK4alfNdHdHiKe8FMJajvPwe80yEXZ1V+wpLNYKPDRmSN+gWKXIn2jSwc+aSpC++iRLAZ6HRvZcxY8uYE0NZJh3fkawTzXnKL34mvYSkrbWBlvwOmLgDCn42QkVVEiZpcqAX/y45i9pxzVoD+vzJmJLPZcfVzSYbUVibPqyr6dozPqMINJymQCAjhlR0n9YwCZ6Hy7fjAEhvzuf6IPkrEuQKNryuME+Rgy9ijl6VoZRkrk418LW7dIqc0RkUYtEe8rXhv0Vc1SEUD1HHTs0CeGtpJsPlk9hviKOswW9+Hy596m1H8joMNybEOYOMjJBbV6TwOv8IibsGkZJJ8fmyRX9EP6r0lYL7K4wAT2Zkx0+YFm4arLTtw1mMVJKKMhuNcBIRNkF+sGcEUZ0ti4rgtPMtPuq3qX2HiZIDnINDEHjoCJpWTKpmCc+QtKjK2SKgkNcqTQMi3OwOKsxIr15F/y2LAehElvXspymheO0RT/nljxwRcNAmuoW7c677yF7q8MD5Teyf9nVdZNeU1Cps5vv3rwlUcHWD3juvsN7dvigZFTX/7hEdquQjk7wIlX5NNrVesHWuDDOiO4HOYpm2O8X7p6nPagD5LhtPYPvX9S7HOPLhCOfBKUQMGc2bRpxkzB7xTliA+qluwebIgqIf6Oy49Dver0RpnAjQb0JsJMBrbjrU0GoOLTz1TvpwTlABzV9r0zcncUIpQ/KIFYBtovnkDwfkBzQeeCkXq9VvJBN128VZ3iV+NDzrWqXaVTlUXOAnz/uP8kFLphoRjn2PzbdvOsz+svl6Rk4qCM6NCtv2MbCxAj9fGQgEBkAC71Adn+8AbFg9uFK8ffk427/dXUFIZVOBOfcNIqy+IqYcj/yp0xfYsoc7h1QIJOn/dxflcKSvIWA/v3N98YzejKmVvDoA3pq3D7dWmVPYUmA7aIf8PjuW8XHNK5/xCUc6h0VFcobE3YlFIY0wfNQvM6FVFeLL2UdsyqQHkLTkk31SExRF9OOWymH4/0KR9xFUgm2RpJc4Ccyuv2up4aztb0PRbV07KlnAN6cFysLosjNmP2FfKfuEkM6R/YUaBh74nzqC5gTx0GAObOjBe3JfAwUjoISoud69zf/03AArMZGwjCMFwhMmhRRra6MgKc+C0rwzCbl/N04f7FUfrCvPjjKx8HxEp6m/KxwZSugi7WJJF5H7MxSWTTP8eFWmS7OyJoVvogId5hbDP6//rhk83+nFH4DBLl0XoTHJHMVy2hCPnTQSyKQ38kMDacfatlOrcHObvwiQs0tyrvK36s6niGyHhFqqa+J4Tt+RPTLT6FmXiyv7Owr98lLVPKMHEW8cGenzdXLn5OJQnnS4eXiopd+hdBu7d/udU/EXwlnZqXupbW8Rj4VQ6L3r0Vabo0ySEDwB+CKZLF0N1MPmeqJ+ADgHitgwlbROVPyczuhxB5ACk6U3yNsPK1GVoMw5BJrdZFP8jleQVcqgzCOZkE92ixxLNzsvk6WfGqZmz4y+7JxclQ/1Ky+jkhojfmKbbA0GhFNmlUEB4XUKLqh9NRynGBU63l704QK17cNvfB/IP5U6qNHNQX99J61jqd0FINeTp3kXkrghwLZNj7iPywlW2e7rW6rljqrDCbhJGs6Y0cpDTIW6MbxbM3ruB+nf1W8IjpcvVGboio9ugNOE4sOS81Lc1ZtKzIvcb5/uXT25n2aNl9nc1NSg/dafzBRENC0LJRCETlYWujY06IWbFvPNATKJ0qLZ50MgYtVMlHAegpptPDdqOly/k7TkG4kLtjXSqwdcO7U75CHrRhGpeZ3QPKL9VR64vf+uQregx8Jii76VwfRTnUlHT/G3cPnR3B9rXkyaeYBWfg1BEAmav472LjOzmNzS/P4H7QrMPHKNIo8vS33g0HWr0covL3itNaEiBUs9CMttIY5Tco1RFJ+3KxRAsZoYpNfX29KdQn8GC+qKii+IlMuU2eDJxtBZbPK4QPI/nFMwJ1VenUpietCI7iKBrN88S3bhM0/2Du6lqgzTVriTyI+fDbOmApitpqhaqytheTaY9UT62SH9mPYEmkkCWXj4Aml9El5wAQ5QtNtYURKJR+OnmOwjJOm5pq1Hpcg9eW3wU27pL4b3FLfYB2Cc/0dhf4Ha+eaiPP1sM6vnjHcIeHPQFCq/zrRSnAAGuLl9b0SObV98UfroCGWk0RW4Bhr/3fDiAO/5LfgECB2fsytl8zDpW2l8PMrXREzrGmpoKi8gw3L/lvUKiOVWKK/VyxCcm3vC8Q9lmkPhD5HzOsu5TUb6Bm32vsXk13AaXrq6k+sNLxEPuugCmvqBEyB9caMU70cToavGR9VC/XqzruYQggXtQ+SUelfVz/GE4ZKa4wHC/TXKVRw4zBIq17oR+4vh79xtJl4ytdMouzSeQ+3Zgsba1CQGvVzqjXzjMDmxHA12yMa2zcVVmRY1cmo/YVtWisxunCysxoptzP+fwGB1gCHhnmE8rV1ur1GYOfe2rOdrlGuYpR8d7t6mcB8jKhhYQ8rExCZ8CnJchGXiPJim7kcmbeg3HOqf03s8HHXxsbjHgB1gib0gPj/ICURYOilYZWg6o1zklRiUuz1+eOw8Ept9hwM+ynwfb1eOXLI8JGbKHfVBPoEmrb86C+R3TuyLZTc6XBuaFTU9P3dsjY1xDPzbngMU2EsYvTS/8BEhpwMEcMFHNsT9lIQGUs/9oy6Oi09Qp1p1/F4yROnvMh4TcSRhh4hD8xvba2P2DzUGgyFMx3/w17I8L7aFkH5+Nf74nAOaG6b7uftVwYUJXfHxPyzHWLQAX1dfIuio0v4nSt6BICJfBc0l2DZ9a0elQx+tVRMHUoifmRGu6FQurOJZowAnwPREQzjfY9pu3Y8PFQV61CZo8+MndkG1w0UF21Zl7mIiYFKWwGr1bbKHbt8tOaPaQhsDArbC6jgm4naptJ6wAQQFk3q83eWpzst0ZiBFRAiBDw0VbF6dqmr0c8EKqIhyoerDLUhLZrgaleQ2K7vHc+q3sOjSI0ETeswZqb14PPYO1SL4UcGjRMSwPoGkS0/7QGPvCQohGOXxF3fhccgrYkfI9+se7r0gRBjpEJP+kQaZkU6JKwjH+cSyxgnQHo3dFwY0Jl/M/47WIYBxd/pO0U39/ee4fibcKhUGLtQtqQiCRoYhRD9a+th6ntwSqnjo9C2SXl0hwle9G4CIVnDqs9OppCvBlyilDDLDiUEtsJECtyPh1iscg+mJKdGGBXKC1JAvxZInht+KaCE9saAmSaVrULcKrGyz+ufUUClmAKDtYA002BuimTCa+8dercDLHfzVuFhg6OsJzFeunvkx9s/LvODHW30TE9DUCLWu+teDbWnAzCGK4e2pPU3E5he6LeCDHUrF04O0igDS6Wz4RA3lCTf5wR7HsP5EZlR/9irzO1lMQu0YHB2HHLp9M/X9fTxL2nLTy6WFATrTZ9+yLScP18Dvell2H39/NEMQw4UF9HfK5E7sVOjP6dNOO+u2FGp4nsEf4btwxL960mXd07CsMUOUs7XhDa7GqYXnCjYHdC0ANQ84nNfM7ioEKnDL2PuiZtrz8FM+4wJU5kEKsT1/enoxgFaPPyLVBpXnXsJrfjBDgzhPoUELoH51YvUSuk8ixsD2t6MuBWih+PtmIz0MtnpHhk3LpjrSfVfkZJaxa7BYS5850EFg8C1wHo6yn5DjFj9KqLK3SHuQbKgFenFg8jT0lS3wDBY+M+Elm7W4wRWeSGEHiZY3JTNZ+k19t6Q4A0hcEO/nnPwjbDq9jrxq+PHwYhiWhDcNjDrfv480sgUYHrc+Cp/6ROPokKtbAN7v1Eltgfg6bZTcXmv7J2KNQZMG8e+RZwYMLnmHVytXKKU10oZdNQ8NIPBjV0q2yoDL+eSwef7oYVhIchvG8JYBduJ+GXf5GVhL973VmUNHipp2/C1MWJukBvv4Ce6gjOsyVXNu5fsN4J9AoDQgGp24KFA81QbG7YoxKTAD9d2zeZxU8SMCHq1/AWBur00MzTeurNFsmIGm+WpeLEyDwdMDGVim6qr6GmaLIDCw0Va9Hvq8yUVeGSax/hpLiFK0vCC8tUg1GDxIfwu9DNHDzVkqdkLjCeCHdh0OHAsrP0XMZ/9FRk0NoPre+9Wn8ZWShfDOixYHrT8BQxqkSPpKYf10iLvtsdmEEm6YOXO+wEUrZ8zFyI9+a0cZ3d0JMzS9STShvzsAq9v3uK1DTxZGp5hLPCV5t89FgqjdAsxVMW36u27SI3pyo2zjEzkVKmCLj4DOB8EUIdPpn0T3D4QuFe81fGEy3l+5/BbFf7tvKQtjDTtvFG5Sl10uME1rDLDVFthEZQSvGBIpQMeohsnGLG1dhVr4p/C1ODZXvajKiMN3E0mQkUdzA8S0XbRNs1c3rSzskYCCn/yPBxe2AIl2p6vOPNgcz8UKgDB0IGCinWFuhXuR/UHcYENG1Cmn4bn/NIxv+xijwIysRTyl9PuSzK+bubznsr93vIuApDnYtBZeScjbXhWli6WOCdHw1M1Mt/mVHJ0VQyU7M0SdKoS7qiY9DLj+2uEUt6j0MaUeU0UDyjXdHOw3R6xWWQFkbhqFN0JQ2nDKeaRRNzjvbk4vysTulb9OpWhi1+YZZz7VZ682i+GoFBPjzb1VJt3vItJZu9LGHQtwbXV0No1O+zrhUaQcC8rHE+2rhU9yjeeNaeTF4lVi5jvucSCK/5x8Ypm8Q99dbEXcuXJRQXegNWfrLkG8u8yaccpmPxAiRIpxDQC1oTPvwF/mTZgBxUsivs8jqsnn4fMJYJKQei6Vck3deQNQpWdvMtvGs+nh1W6PoiXU94E+ifvWXwjWsNsPy9lVegB5KDqnf6nzjQ0CCZD8/c694iSR4gnoAf4QA0Qr9kNNze+minlLz0JD0TWCT9A+FxlflxxnIK+rowLQoztPLsADsHZsavMDNly5kQAK2e5DJm8UtC6VqEAnlvrk9p8f1zOEADhdYVP54gRTUxzeWVmEL9EUhCQ2i97IWslO0Y/TNHCq+//JgmRtF4Iivf7/CC1AUQUvC3v2uYYzZEB7B/293oeZuftzCVHP9R62hn8fxswlja6LSrPGxUaiZaNdIWoQcVj1s66oJYFPhT8rs1cZGZfv4bWzfOIJPJMK+z0TkcYm43B+JdMJaOAx7ieWD8jf01zqtXO1Ra9R1zY9bT5tev8N8kssctFRB+P7UWhkXkF2xbbggEXK/OLPjATQYsqM5ftjLnxlCEx9EzRseBYO91SLr+v6fTKFry0tLje66lJ7K9B3qXR1vvhyOEBZrzE+lv/w7A7JKmyqOpFB3XXFWqQAg5YKk9pltJXJAQrAwg4Px5FNAT1OdhybPAgvTn70LwGgw5FGzR8DsmteSG+aaytTJ7I+1VmGVole15Ef9xSqokUBgfg0218TUAlU75qGuMBbElMQKk7+zPLOFAX8EJXoIMSG5cVizlcaIwUzaethZK+Q1bYCUe1ybrxTue3W3wU1OVyGxPvhb/CMHH+J2JVQHhcg3Kg+EKlTwqGzO3lNes6ba8fflRUPIXm95PEYR2vUa9CH4LnhdNbMNMTbCRKt1DRFE1CWMM5ViCL4LMhzb9PrytbGOgdUxRfreHHady2RkVaoU39fpZPjK40Y8OWJUO928gJwsuDztizHD888lrLBrNWSyEyZnvHeJs8pAHRBlmsDlkZLg3KR9Nl7jjRW2aM7auOucXrH6J2yMlxw1LJCbOqzgWgbaytb/HKTtyBeL/KQJmqqZWBUNiMkGVRwkEU3HLTFWlL9Yk4YPQlemB6HKLQQWQbly6nxA0gSmZ/saarPKDMiahGbAGEkIDnQM3MibLdnc65rxji2MZhElHfooZsC3FR6Gx7JY7wHhnkfAV1sRJtHCDH5dBhtQ7TNzkU3sblsZnWFUVa9l01nMyj8M/nhVklmfnSiyEnZ0WrJdIxlYrl1UrMwLmh6gpog8Fo2paAr+CxJUFwK1PxcpSua5XW0dTF/rbKBWAKslTpYBObVzUp7cVJMyNUOoXN22WrTCpJgg67e70W88VnE/blvyOEVVsGdDNcc35pwFmxDPV/t9l0/FQcxzW6fosi5Wc4/Y/Z139JHwNfPAs5BeqNJiUiaCZfE0Dsk+cw+RosPQATDCc13CyYWTaYedUhP6aMZLAeWPXRpXgDtgk1Dg8MZlU+ZCUfV1DWKHwDPMVe8wP/5mZSgm1zu5OVDr+9o7YbzYXZg7IfaQ5HHJ2Z55bHWi3RIQfGGnN5Gc9hfI3iDdPu8bYd/xyvlz4M2cCGU5GFYDC0wmfueIp64Np13pvkueX5E3FqoWFeOimITX7HbA9SOfscgOEfU76r/z+LEVdGTrFq1XkOqlO6raxZ79Rn5XYb1z9jn39xTPHqax6idJWwbv6lUmhK2DxtQxdnNiH8UuXaxc31y68fYZzG3DKEzDs9xcsyFlqw/IsqFBR5en949buIhkF/riS7Ve/jKAwspMAMX+Tzxp0K5xL3q//nAWdg0FsIT/gZ6t1mun344HzdzJ8PE4Gj5Zn9Q33t+ExqquoNFXgjz8JbK/KunWU4ss+nyEcT7RblYys6Ov7vTv41kKa47KNxP1kVyqm4Y5HVZLUTBNBqSdf5GTa08iBViIawtPdq9uIkgYIyjZlCuV8dm4k9WFJN98NvSxPiRupn1WIIDqvck05vWkOtfcqIFKCKDrlGkItyZOEM5c8RKZULoIhGbuBpn4+Uf8UH5FPT81zqc3tWx6N2ulgeXGd9eyjXW0kXZBr5w5N4r+Gj+EEXgLm+/IKPKBx96OC9n0n50mUMn30+ruG5NmMrPnylnWyfYAu3z/jgwf0lcf7uLPKNF06FP2CbqkYJkcGJTHgcWuBIG1ITBNJP6tf0rq5uxZ8gPfEcUn6d8dCUVIwwRIWqbhqlCfpTOrQZ4egXhthVKkrroelfJ3t9t4Ncm4NRQ+1BQnORdJFquTMuUgjiYSpH/vQRmX33XykjDNbus0qNdOrRdNfl62OvtSo/OnN3IS1BW2UYRLEECHZGf3p5fmJiNpmQ2Z70rvf4V3ifInE6tyWtfkNI2/w0HByxIvy0wxuIipqNuLJEq/u7IaRK5I65topsAL5G27GP2nZ5PWBOOiLNgclJyt4O3x3XGo2IQX6i+u0WFk9FSUDeNgXkACQA4ThUAnTHo/N8D1XvsXTrKZg3i1n86Halu8SLQXeMwuyH06pxknbnvqkk87x0JgejNa+8MomrI110Z0hnGqn89/D6pD9wrYoJq2wz8D1pAcZotXpxd+MMuOLi0IkQOKQScHwHLnSAQuicH3YoSHyPJtPqPKZqG/Bx9obzztvQwMD4V3Zn40gdX6AyN3MGfaQWYBpNyUT9XNLHQCjBatuDvAhCMvlisMsf/QSarQSptZeeoYRRVaOr39uMHAt5iAHGeoBkoRWzmk5t+EVq6eMQe29TGslo0JrijXnyul+hu/LXzYmAUvmgnCNbQ6JDZoiywgsNQXYv8v+tDCtKs7sSoQ/Pef9QWxZ3JkuoOD20g2cgLbsP31Zo5osuxIdw9InFEOeWXdD9/uQJkUvtg9fjJh+MhLlY3vFEWSKFlPtdgraofwh2eRJfyrB9CjGpoYspyYBMdOAqE5FYng/gjIRETCofSNiLI5ckLlcNg7td0RW+JS9f1KwtjSbRqiMne0zV5/axkVhdGUa0DiSfoZH76LZMXnXExpbtccu2H0laFKWaTTlMsh6+VnEHod1t0Q7Kpz6iBPaQ40s3WiIs/ZBZq0+4MA95hMMEXCUC8jrY5EIQM38ATzGmTojH6fOlULRQRlSDRCChEH8JySb9gbM9YRpTBMxYBWb6iJPhe3vludQZAfEVnSYulS8KljlRa3kSu42sXAQu+e3+QYIG+VEL5qkMTDs3WcnQhfJI8Ufb8j+5lFI5l2LDj5PXixBSVqrPdcHZYz/vBZwNPHUWZjjpLHV7rkQpW6BBr2a37wsMKXapug8fOFH8HrFfFseqVpJkXf/2VIVoMDqSKTrB9fCANrMEpGzT3y6t/o1iNZMHnb0uNM5W3TjxU4qGd5iYajUZflxhyfeGoZkJW8zepOq7j8vURufbRay/5FX++dCm9SbnDskQIkAXQEX3KHSA+fid/38NPbnQrcFLEwYRA9xcCB4L9JGFAH21gR1acCz5AZq0IrcLGGKH/gKzErg0fsOZkrDii5zB9Q7xbjeXoMEpUfRjc6NOYueguNz0OrKulco8PPt9UR6396FRRZXTy4+kdNBNEMJlZ0WezrpnjV+dqF7YK9BaGh2DQaB+3wme6p0/NboBCN0k2aWpkIDOqU3B4PCK+oPtGCYpOpVjrOckZU0OGuvcYgBWGnOYwiQBJROgCsND/k+LEPG5fy9kc1nWXBhid/GNr2FOf5zqnK0fVYpYNiR2fmb1Hqj1qkFFKkL6j4bBK+PVqGNW4xBlXu6ViWXASBr/lsF/fNuoJ85S4vYSqRdNeyJmXfusmDxvtp3BnR70G6JN0zpipsPxAmz7cu1B+5VlWsWgYXuKkyea/pYaaNNI5tlKf1eR0EQ4008vlZG0ZpPlazy3PSQrXUYisC8IZgE6P6D549wKJ/XIKB1Yon14sdFLVYe158r88AOaImhijqybb1MuysT72Yya7PuaPU7g0oGBg9EeSxwuzIThhq0h17vY09YPZVy8f8mw56JexpF2lE8tYP3nyqVT5o10/m+1fY7nfZk13/qFmkfLAmfwCcISa27k/ULQOwk61DrvCoJgJcJNMFEHY5K1Zg/YHeOeFaauBAipHOfeyNMzs1Kqb4t4aIJmBkeXqaoJdQ8ZXSzzApG2fxMlaY8ed02lzsJmD1ADgAgmRts8/I8s2N9CQrJtDicNwgqaQw5XU24eKPQS5cx5fWCS6/LhEpyBIOKPjmHu/kAPOSfWqIjyLkq4VViq4fJ/BluLAWYFEYy+dXqrAFmNj2KzUerFn8VsDmBjoQC5d88SvafcwF/D28Gt5r0hCRlhbihmOtZJjBa0ZNXRJZGfXLkOeQXPt5b8Z9eqRIgxuO53TQ/43YQc5puD2Lr2vxhAe+PnnWg4MPR7Kkd6q+aIm+2UAVF39VG9NrLCfBd1qNcjiHTMvhNhCkaZvexwMQ1RUxWkeZuG2k3YLy9zUQB1mq0Rt2RBs/D98xBJItzjiARKWtbibXirMtcs+LNfy5bqp/y1HjXToQuMcqqY6XUdLxnsL130YU9OT1nsq3O6eXIZspV+R2OIecERYTLwY3W8x77gZs8lf/MN7nv6HFmv0okKcc6ywycM8s+gu8iNThgdyRBgKGYSJbYmksDtWUNpNSvpbgOSOV+vFY0shR72bemcA2xDPxb6npjaFnJ3EhWfXaTk2C3Z/AxrqQNss/+5vNnzglaohZ56tJaAIlxTDJ/aGxn1ceCmY8X2wbvbYbwXIRo11yQJhxAPAazX0dUnSjqmNrhspW9+e1w9/GCEvGtIZz05Iq3h6S8kfki6KkoDwheCFCcBWoBeR0hvP+Dw6JXswMFt6iJUGyVnIFqeZFl6Z4vZ2NhG66y9ip51wL4ztGeIawZjB5ilptElCr+xsrErizaPWs2+kH6beXqSsaYc4Zyms0y1nPB0UN9GLHBCidiFUJiaGbr5J8D/Bc0Ro3oS538Mqk0/v7pA/UCmFcarTjNziP9yUZooL6o22a4SsEfmDzZ669Sr12ZUvZfZidG8vfDdUX3gz6QQIK6yJ+1g/s1DYxNRavVuwifkztz1bTk1YAxceIUP6EnqTGTLIrY3CsKFxKzdjECIqY4vwYfMdjiXpzpTKxMB+l+PHfVw9Wz03eaYRUScK9J+V0PjdjF+iPblZYtOB4OzFZfJZ+XrpoYq8wc2DxQk4ctYbu4diGfu5QKstCgGOaZWAO+prcXLwIkBGRo95Rw4ERIhnq3edzLbGqzfUP1AYWSlb4nAX0UqX2TWoKBJRY54FIRdziKoLVbGxnrt8FkfrSqTriPDRS0YPd+2usnq+zpN7YTaYmWOB7x5GEpK6VeL4/pfbQZ28bURy2hmzIg1bXFSRp1eN5ZIIPzlqWVOAWjxWsuPNFFqHfFaWOQqnuNdf7gILGESaFd/e1NUGP7tlw+LYPkaYOKg3hCNdoSzzL8uPGzahY2wClT9rWToBUPAXX8y6yzJOJZjreHUe5nWKmZNPUfApaQedl8Cg/Hzg8Umsp/o6lxoevJ0lGwN40Lz647gLNYgDG3s505UZlnWQwgy71ClHsZ88Vq+azR7fT7IY7ZBvCxsbmACFuql0POA3qiVdNDTE6vBHGWbxjJnWgw3ewudioVWVhKptD1R1XELg7QSomu4a4xIY/EKjOXqb4T3V/JC0pkeZXFqT4Bjxgm6ZEyeI/pvMuYH+JpkCH8M6FCz33sX7I0WcjksQAo+hTGVN7i+K3ZPtsldxkpYVBjgVv9JSXapfanLRfS53FRnWiNfTWEhfkQpG3/TPhm5taxd2sEXfhBoUeWNQcZOZwcw766pGMr2ucHxc6XZVi/pAaBbrhfDSHKzu0g3XmSDCnGgxertCn/TtiX1pBahFJRnH9wgPlN0dCCdPTPPkbAo/b3bqwAXBindIj3BcTb5phPCeQSQgksZ3EKC+FtFAoMv7y8lWNwj0DqsrjoP3lcsAJVopXeGGWaPq5Ns0NXl+Sobmsape3Kw65HI/PDPW3JqdoP0FG5uQSuQu5Gyt9x42Ghb1SIZsM5c8R2da3yyENRiDopuxJzOy07gDrVoCOrIUqjFHWEKBE0MZxHF2zz4/2k1WT/pPapIkaYqG3RAOmI5MVV7qxRlSY9+Ao/SOdd40SchII70n2tGQK2gaEXm1exSM7EDoM3Tze6wP+6rv29QyuhKDzH9VlwdQC05vBmx2FeDWjILWoWcpsK5pQ9ZG8+PdJ9cnI2ZU4kyZXWD69nkcW1KYEe4hgvKZpjeG5d7zSaCFHr+q4m9//KFZ1kFeuBh7HJJ65y0NCh6NFado8sSZMuGQww6jc4qlDV7cGb9Zg5idX/bagWqmqhSlYWx+ORMqsMdi1yDIegXydMJ+taTgGMGkhJ5ZK2y1X5E68Iptjgj3hV6FFYgWiOFrFqEWUNDoZCFqQpAKMBbxCy07DQhWl6qzrma8FB/F1kIXwte31g7g94k7HP5xHdLD+DDw+JuKWsCyzxuiwAnQ57H5H2IOD6s3b6Mmvclm1KPCbcvSlBthYiCgGyoucmoqFXbQdQkoUXRZF4oXE+OIym8UPkvlOSTUl6+aNC19xg3TTQzRTZ50xx3OYcv6A7Rt6P9kTafDykIRlax0rRs57fd4+JPPqbv0iFJOiobIGmIcvhbBkI0eQXOSx1gwg+IdNHiJfE+X+sib3er2TPe+e2cyTBMJnxMtYqhuEmSKjx1PVZ8h9mSOgqah55urB4GL/IBm/8AV2C2qfrTpJWCthkCiMY0uDhAO6bkGqq5jJ8nKvUd1Ro/0TZOZPZ5z0GrezOn4fcxSKFaci0cJOytIQtAFWir7PzY6EX15pgnB39FDvHao9K+HFI709MOj/39cFQQ4kWbBh3MGjE2GVVBPZizxMR1v89U01+5c7JXHbOix8OInvHTz4znY9+YS899wH78JX+7IL/nnCFK6OwjPNqJ2y3rg9hX7mWgxV1gG8Hnu95hVDW58CLCO6Buej6ubY/PoDCDAYUP1a5gmoJcqHh3x0BI7ZsysrtnWMeXIcA3prL0LOEdIPGEfFs0ro0VIh7r+jfE7ccvl/NXm9fQ9mJl5mKq6hNHSCU5QETepEjBd906g1nt0c67Wg+/0wxHBs3EmCVL0GWg5xSI6Rx+AoPFk6/FRbK6hDoq+9Xr8Riz3jI5thUFUITulTK0ACLg8lLsbrStUpAwPskwgbxd32krU/w3wTYlaM5iVwyIB2n/zvkQGBMXkoJcDRi+JrnLHqBKlOkO5d29498gBgTqum+bmkqI9qKkn41owCPiyR9Di6oxedqQDBuFXaDg2QqSeyTFd4Q4FGkCn81ieFddP/Q3VtZshY4XjhFUGPLkaeohRZWtGYXnO+ooeZ6MYGFwy0Ql7OduI7QT8n5Us+bZlkBtNOEEQfr5Sbg56AECyDpKAPOqrYf6JZfLlsiU+pg3Y6TrjE6RTtSeoM3oczZ+8aUtrmpzvKMPLsP3eZC0ta1k12OGe0rStFvHEz+FBxXxkwEz8YjC6t2bVlJn+e97RwlKGl/BW2bCXo+r8s9dn+rxH2e/9iY6cTJZtJgf1X92VWBVmiL5eFM/nQP2aI9s71MLJAAKm1FFkTRMKYcKlIdLqZ0xAFv6WyUqS+jMFsdLzy3YS1QLFnZAQEEiv2SLnJ6oR4k5vqTO4Tp/BOaSHy0FKnN71K18ABToWc8LCT0vJqSl7e98WPS7f0Cx/o8nyCuoXOu19IB9QHDnsj6DvyDk7wOWCtRCTKX0JwFFRmRaYbARSrO21IebVdLJ1MOsa4x2NV6ttBG6S5LibbWkXTGk4IZyMkE43OMhp6zSLHOxpWnwfRrVVD9yY+Tboo7QXGHxKCNPxmN4FOqoL+XiCLNocdnSEhGvOHULAsagYA4Wg2ZZb7VhyCH8aYi8+k8YA2Fnng2OWYTmK9QZJsTckwl0NPEwJCz/TLJa9mMcWwjPsYlbgtW+9UpE9f7dAchhLibRqudkxBB5j+Pu3WW+sY4NXcO6msO0s9h/+tilWVFI6XfXez6jRAlUxGoRFZXxY5elqD+1n6GN8vr/c//bp9wt5ZWfWKeajdqcnLgngX21rdQUqa3v7BFqT+C9J+vPm23oTUk240vHQS40gGiw2w7H09WzofezCB8c7mGhBP6jqQaFPlbecC7h+M8Q7irn30YlGGvqVHiYl68s0ah1B44MQWBre+1BEWjggYcpv9QF6gU5qW12okp7qqCSrjGIix8FTX+XGby6X4u3NTw1zZk0PY3ciDGvxJZLR3Rvg54H7n5yy7Uv6SGNxZx7gTvOE6/gGLDmNZP/ujGo9YjV9b2WcLoAVCf+yms25tgr+8MOxt3Sl9ne6xIdt5qVUf6H5JosJfVYP4iMdlsEfb9GADNxBop941yR/YSwUPqc48aXf8yyVIWUyGm8lS/K3eBLUHDW2dJrgM/KrdW/mqtFgOmktuGxk9tDS6uTHAC8uYuoqUhJvrgG9hMw5X1A6zEuiOwzsKrwfUfgEPRifeDDrmZrFwO+l6Jh5qO5RvrAR9idxEEBnmf05QZhN7gH2lONOuFVTHILxr/WlGzaMIEjgVLK9s16a6DgsJE0qLOy0t06E6AdXMIc5o3wUUY+UU7HBUXgg7YiDHYgtRxKXNL8+iDEXnnIX7429rwK3yU/uTW77lepUbuYq3sg6paY9xEDI5ngMoflDIMJ7HZqhTZ02BQbSqVT5TGHc7JHcI+reodnUBMoXozSp0C7VLefF2yVI2UCArWjMgBqgWXUfDqSvRcwvfYMH6KwKD3HWzc60C5596OZg8tpqTVHgVO1wVGxG1YFnBFKDLtMRhNsEImiBoqE8L1OwtK2sXiKiqKH7RyUmNiehw0BpqkCtNBPYLLHu2XHs+u450RctqP4eurDc+7IDgq53fS/du3Hjvsii4tcEja41jokxqLQcc5GU8R7h9WMc0gACdea+vQNfhjsWmDYv6DO6P/CdOdbPncedGLH1GKDoMuq51xlzCS47C1dhNwmNjJlDh36qj5V+cfGGh2mNel0AHX3RFwJfZhx4Njfl2BQsuKLycp0GEMvtPPcKU1ymyKBfDw8++6YhKuvJNl6miXmnVS6hYUTKQ2G3fv/FFhRmXW8O8IlTDG1UWdJcekUt+NjOxmgwv+py9cj4kPk2vd002zY856FmuWvd1z29crfI9envxNhwW7QY+nS5oFXVHQhTkgvy6GfnXQ+Z3nRavfGbM6XUKUJi/eYPE80oOgU1ClZX1YJbuIYaQLq9FAePPAF2Wt8wZS2L9xBppW79Oy4x7k20HZRAauN+K/aVK+12hr3MbaHjtc3wFQ+TgcplyGyiWNUb5y3IpTVSnSCtI2hekvn5NgeoLLsg/bN/v9SG+jRr9VoTyqOj9rXKW6Z+zSXORJLAZ14PMwTUs8rliSdsgeqLGqsQG4yHrpSnWJhXiWyrHSIA+K9PibEbmxO6LbKCAHZc1dRwZC7pzrMqYX9wSxxJhtdE/aQu5th8zl47wa/nHzOrEydxYdoWB0tZ3mT2fNjLopn/dJAfiCnjsl/MWg1mSzL6K0RAo0fIXDF+skGv9RymoMZQT5aKMpvEXrnHWUdahNsIzXnOFDinJcO1YfR2BgSsOpRPwLgiZeIdCX/JxiZ4z2iftipL3y7Fe8jQQa2j2oA/FaHBFHnhxiJyNH8qWsMX6u+GQm/bRXiVEa4sA1G7V2IAx/3+AHETOXuKaHIP7EMxsgWAr4xnGUAqTAiS8o5J0xp3ELR2SBY2tGj7KMGFQSUaJ1YoeRMslzVnl/WYZqBbynQmMDnFeAH92aCMwtDfcYnb5n682Sy9cr6hUBns1jF0FP4AyYqQfJjqulcsgCbz9OMcMgvJidVmuovGCVfOsmcgVabA5yUamh1mC/RrHCFcuRXMrvu/Nj8Pfp6DYJedcWaxo/S3bCGQOm2RrKzdDV+7mDCK/Bp9VO/LaaL5wPLLGphOY7w1LlfdVXYR4OGM9F7iTIQ8dDXV1uF8wNHepFV0BFriyVdUMXTwAvKZYPz5vJDA330taRCPrJ9N/NNZTUkBb1h0HeHMO4YFqZV4smVJXUunVJuL8PEOfufjH3+4iFHKXgwjZQsW5GY/3hMnm6z0k38v8tgC/klcGdOlTvhlyN68V7objpplLVqkcgWscFy2P42b1nMW/arhvLzIZxp35VY+dcw1/jHmta4vmP7dwYVPvHQa9rgxiJ/e/FcuueWz0a5j7wEt6AFe1AcjMtssPHXGbfTe0yOgpfdZ1+4KszItQzUGEMSuzY2YCR77MeeoaxXn15H9ZQTpWHO2MkEAyTKL1sShy+LgI1csIbIw7B4eMPBKUa9Z2WTgJqSLkBWGk2Je7rNFhmjZkcKexI7ThYKx8ZQRoBmoyFd8z92GlOVkW010VKkKnRMljNOKeOW9Dd74VNj+r3QvFoFottRFG+zOoOKBvz0RScPCHW7JQ1Hj+WeLW1k/cUd15OGJ3Pdm2HvYsZhlZhB9X+BmSELb04bsIXhmDjrH3chXRQj4qX5nFuMS8I4IUkSVLfeGz4bMBC9QFlSroucmiwG1XqeFqOpi2BO02DzH1Oj3qfQRrdqajhF+0owPb3M+fAwLhoo1qXR6itlZo2LHKcRbA5AQcdXjctV7yQs+zEKYR0c/Q/YWrcWdcghFlWjyRAgAEJd8ZFCyp+kDauuYkURhGLTNbh8rZ1qLo8jcMLIcrUjK1dgSnVb6xeYs0sD98PXTe7L4AnwSOXaMb5vNQzTu/Xg9/GrNoNfPsbd25twwpzbKgeW6UFZOyvb/q4tK/0rnYYkVCm5B2rmtKadH7UU62UreER6XZS84crusdbezyOYWuh1Tq8jiqx5bulgfDcn0ygQQa4sXM/Zy1fqkhwFcoCfV7uitAPBQ2x4j6286KH8YMMO6shvIlmD4pAl224CM7XUhSUHKQ2O6eCmssokEfK/wOVnWGCNVLGnX4TORL9vHozCQivCWMIiaYCukAn23vEgBXfbtJ+SCThxnOIRj3bOKpLMwGdhy6m6g1e4pl0FpYtF6XnFErupOP8GQlvA4V5nYmFkyMxvG+6fY+kPKu8U2a4CsyKQWq8i1cjnoFRLmRwGCkqTsPaAOYvabM78kdbb1BzMw4RLGJE0k/uC7ACHGPQ3ab5Y6pYOTDlboQbvzNz1lpMTcmKXWkNhL9E+1bHs02tj9lqSCAaS0gRf6bPtLZDKvj/vkGsV9Bq5nVVTZdvPm1ZYe/q9ik8dBYxJUh8kWn91D9tdxyyhjAm24JA32SNqJjU/ZyE/8EgLBg5kQ+sfr+tE3VbZRJzgHmJ6G4tHoQKbsxrpynwueAM9/Fk19fuBMF9FNzycfdLJLdHl6zppmOqejLdJRbsFOgnAToI91u7XlZQLTTfiXFuEfQnbIscTmHLJIL63MI+d0J8n/nUHbiz95lZDMUDzKukNlzaLvMYiQ3WqvP6c6gKlCdIrelXQ4IInWJiJqmxmqpfbt7y5ySCGCwJv6yNvhj4MAyjGketSkJGdfvmQn5z09eCzQi+8fKmI7s8oz04xaV9a6nwhqywRzhWdk/uj0b1SogLmlIwqh+rWfuqFf53jZREuOaF2EExOB4HabIJmPeRquwICdIapZFDylB0Kk+mZEYCZBd7GtDMYMghZYIAB67h8anNM03e4Ab8dsBGtV3fbo7q1oYXztpnqR4vIToYU5+TxBeqeYiq9BjPK7C6C2BFL+7k469S7OE0bKI6mI1o9PBtPO1zesl0unPqRXC+L4w93rje9CkwtLrFOT1cRE9WQGbBJL0WZOhUVjGTjlLWIIHPqxY+uoH69K2kxuKdO3u5Y5LrPaVVte+8zcx3jKDRZViKoWBEumvzzYNot0NjHzow6oDXBnGO+T4r87qTwEH9mGl6PYgWd8x7A/vdwwTN21CqFLu7ZLQCvqoWg60jJiuCECBvVP1/yYg7nxrpu0B/eCP2eMwcARbuFrEY3L8WHTr4Ew2ay9wJxEvFF+MDFE4NyPZ1Lem6aY2yI7B5uv/51bh9wE6XUBYsnhfvZwdMzmYcffkWrGXaqUC9VVaw6/ocj47PYeGdddouff0ajY5D85lnLWEMsym80Oewda0hMe0HC4cXRNiRqRRcrykC+CXYbT6K3Qyi2vMNderH1CBlPv5WijcNgIsjW9evFTJS9RE7Ra/TtEkVff7Us0mjNF6A4SM3Axw+a7vXvNZdwYNCTvLMx4HtguocqziOBlaJ0Byi01sfqYuVE+ME9cn6yK4sCkTM7zi8Kz/PvaxLl3gzx0BEX6nWjOM3lmeuKnYCWQGuf2UoB2RL/cma9DH35IREBQV8kCN8olm2bZsWOYLXBtUYJk1VCWq1Vam93iTpRDllYlUVXUWKmSjSMlteQvPii4k99PoQ+R54cGAo9JJmthPN8OPiOBI0P/kEs6JT7go7THIG9imzWBiY9lQnthHAp4PwkTNcSDbgXy4BLcDFBp9i8isEbsTITT5Cpl4c0fMJ8O7vcfKzVovC8zb6s3aa79CeDQvr6IzE2t3y5W6QijUyXfaWWFO56+SZ//sa2q9BkAyOtDBS0+1BWoNatGQlzs2I1OCp2QcE0LkstZdSwi6kndmNNMLY/pvSvfsp9GKaKp6ipLGbPa1vlLRMNKaKUT1exK3duE2s2qmj+YuxwW5apStvd0/R8YJegd5bxEzPftXuORcDW9AWr+5pfG0fwu4OD1eg9JzeIRBAvK5FD7FteMvZf8R59/N2nZtOiLiCFx7myfycYu4LpFL0aFxIRWh1Iqd6KPKLIKZQK54FRv6iCZn96uFcmrK4hV+1jrxXmsJ1eCidHZwnZ4oT4zQc9huaK8uBOLP0rqZR2bj7PSOTgFZxq14c04I6bkL3gMyGpfcEP7oo7uJ1QVhj6Ef1zrV3VPOgLrxTjAYlUs6hcB9lfILl85TKEmFQX1LnGwJ5A3GGZJ6yyk85ycHw5siaabR8Gz8dxp+R1L1vhXGfC9/hSQWqumVFzAlg7vz7SK88KISvOAyLgiQmbiZfWYF9Dd8R6uBcdoepbetY+fW3O+W+s/HV7zL7tkEE8QdZshunJKuwWbTh5o60Xtvmt4R4cmr2Qq6cuuweiM0Z3ixzpGSPAPO3MWhBevwtC3p+57cuoEVgO7cgJVJUXrzWjwsQdW9wpvVZDBXZ1o6vHRFmsnv623AuyaimqmcoF2shV4aJtmBecW7w7c3BfkIxMKopXdGNG8oj/gcvE5SMGyR0+0LoPcfdDhghHgaOjTY2eW1Hacug+A4mHactXMh+JJJb/xh5xdulqAmbsWcED20NbasLZcKGUC3r/zxZraAum52O7WJa35KytN9y2sIQRFK3B1SMsuUm+1hOBl7N8LHp4N9cPjKoJ/HG2bMgc91BFTesN3SX4YpmCp4kGHvS0t0FroKO2AtQAZikhcfGHYqBPoDVZd5ySVipUYYkDxNBTABJkFjPtVUDIN7qCeYynYXZqyQgjaPyKYI6ldkaAA4AomGoO12/Rj8rrf9APw8OSj2sgDs4LTufiptc1grz/HZDci8jeTydgaoy82FhPMIg9l+gVIYDErXNrZibGi8koilnMmxMPfVFpnSmuiwJQE1RgeW5HfMZhg7XusBWpZ9y40OlvpSlVp6N521+TljMGlr6b8JOW/+UKkL00gRr6+ofYbkjvBfaYCy8ryC2MEEdQso2befdvR71e5DGFO7KmdocdkhJ4ePqVE4nOccrGIk0w5IvsAqYWGbe5DWCqXNUchxRKy2OVbApKBqzoavOTPNy9+fwOnFaoNBOKsw2DiiHu3r9nf736GiyIlJJuZ+Viy3r+3zcKWgRQuHV9QiCQWYFC+sJDZaBSDgvY+JQo0ZFxhPolNOgradfmDzI8O5oCY23JhrFvz3Il1MjGVt+dpjGo5YPNNqye9+UUaY19P7lTbcIy5cTMyWjtc6GAKgj+KWUP/wrg6N+Yf8NfJ9JPfKrtEzSRN9LbbA8TXVpQiS7K2VZYBIFOWy+GIQ51JLwdTJvsNrdC7J1kfZUJtWxGf4JhpPnXip7OZK/Db/wS7Oj2BBDxlByf+4gE86Wd1t9t/n9s9Rra53TY3cLvROwt0Fdlzsylkw5TS6MY1zDW7TSFt77tFW2QQ2GPVPJLtHBNUpobFLbzCVgWLXtxMyVB71SJ22qHj3GlIheRUgvRLU3Zab9dyz89FENTwd3loQB41ootX3QvsOMfVBwkjtRSnNdFP6ALxW4heh+p4w5O0zq7QRk1F68J30x0D8jBA6LRagF9IPbWjO0I4qDVXuHCQ+PzIoxkrPg+DZRSj5/a8V6D7rOeIi2Yk/vLHb0KyMmRM99elHFNLt3K4fG6q/uZLSId2W4sfkh40xRTSXvy0ITd7CVRlx/d4TE0tFqqTr1K6fA5r8mNT9e7NpzdRQhsg+/urqGPeUAr131PtCZ3hc7kWwNGKQOLCFev6IAA3CSV+2IlqMceukqd1vVZ6FS9npnuEAwnlHyNgBpmpaGP8mDztP3djs2iZqaFE0i+naOcAtwwhOb7b+RBB03ci943+mHrjR73H4yPIe1srsPhT0F5DqcIUbM+XuhyKbmQvDXvJ77DkWY5L9K6LGZzQqYDkfIm/7E/ExubytrGeSTRGCayR9G6t+z19FDHo3rKR7qq5augIKlTmkeRBe5FtVmV7wVKva5zcsKiF4fgUAHVKRbnceurfurJ/US5UFFGgu6JSLPB9a8RHlSX0uZuKxUTpyF+3yequVP5wXOU2hBr5srggkMT3aWzf+bhjeY7tO4OxLieU2sCDFesPnOVf3X3wNee3UJoJPVDdpCMKUjfK2jauR9PxhkwF1HfqI40tPfZgS9rQ/s/qFKanHBcXUe1Qmvg6DFTGuByNNJHvvS4zqkjsJkbeHh4yxafnllp8v2FnjGfPLyLuRCNQxGJTxGq/afndF0BEfCLvyViyFFEJg41Wub57IRApExFy3rtvMSYheoP4+/CAfNAHyTCAcsgb8/2Xi4599M0eT/iG0G9t94FgTqKcPAI4WaSglNxscwY8q24MDxRRfYsHvr49DHpv/nWJGzJR5tRM5MNFQ0w4Urh0JVIT5vl/SQSqzeWBaVz6deq/Pogz0WlZRaCmcSoAt1+pYvyVrL2TG5qbZKsz8FglhZXC1kp36s36ooUcYmFtmzj0N/8qeFoAulY19SDOagNrc7BWEkKa2uqXw+V8et1MZx3tZduRo3qsDJwfPcG3eojQbwUzi/K3iQgo+e6U8VGCq1+AO8UpyDuHttdzFktOC7RZUcDPRySkqiVH0vWD3u0awKY94UyWCo5Um04njAbw8OoMnBKtdQ6D+hDOwQsODILY0aNqT7iNXVeCVkne6x+dhamqzPTkf3aq8sBrbuGk2D9qmG/ChaVf0OQ28vQgNJdFPTHsOP5dN54qcpoT3aX5tCppKBoJ+PGVTgQzwjeZpnr+ZO3jrQjNsBxBpY64PfvIEgn1gnJp7G5t333bB6ZNcKOZOFmGt/ZgI1q8camhJfnX0Dziiqv9Cm/p38ruYk17mR5PEA5Amezc3Qto3XwpPpMtALs5VODSKo+zL3cdYaKpqUfowIaxjCjimmbKkO6IZ8wo3LFJOmIV/SSt6Lv59pcQFnldwVeE+svBLimSGAA8MCohD58Fii3S4yjT4Gg5xIYD3w+FdybuQ9c5JcHJDpHsepG+5t5c76mU32gjy3/q23OjgCJpH9Qu1CIX6e5fLEEKIBGOxXuITrTEub0o7eo8RKzsN5QiFcGtQmC2dWpejKOYNvrp3/LeprxNlKsG0crMHDDXazrSPO6aEbGFbG62ufheSgd9Ln1VsFEUWGZOHjUt4aDXQuFHUn5zCPKm1BLSY8SFPqJJeaXvSba9jXs0AT9QqEY33UITtazQT6G4e8mwMrKbh5PbSTIZz7jF9J2Bkhyr6TPvAUCl5N42VS6kDa7yCEc5FbAVaQnJA1Ickbw2ULxxTq4gv/Qc5rFakOSYC9RmeKW329FFcicuL6vPbIJuPOPZyVEZQpE0dRCMaFV8wrxCJBxfKBiJKF5+fPBNCxYEKvveu+/mUHISuHVC1LVmXPAKiS/KiD6qjOy76R/A0+EN2gRN/3ZjeNMiEKyt8bTbErghlxBNoXszPeov5xEXTBF7ebESa7vXwgYJmqqxY4xqu0VBP+3NCQHQ46XM6wZB6iF8tyzo2YsNwGM737lxTn2n9nD60vv5327Ear0SO1gm58fVg/1f23HTFA4EjhHz9eNDnPpgToHv4/DdRueC0f+9AnkIFbjGudH24ZdLmp78FTzCibbJsCyD0j9kEYNqlmvBtHeJLilVGfI3xsh5PVQfaDfwuzrs7JWHt6IQGpeb7mmURLTuingNp9s05s4LefXiGV0Ben3UVsVKXioJZ+bwhfQRabnLfzwMiaI+mLhb5omTzurPzxuZ3z0d8XsDblLZcjadJBpGUHN2CyG2AUcdn5A5XZNYulJ1rURfasL4uHopi4KsKl3pKfY3LxEk5IzYCWEtleILAuWhRi4MBTm7f3zu/KNxXu5MCDI+Xa9JbZa4/yILsB+PPDuEmpenAw5HNfp8kG/7NILwXwn/npSCgo7nN8Hp6H7Zfl6T6mru7LtpWcft4NOVodtFmpdMCC/4PT1YjMpUwsj+8XqVEISfku0dn91hEMrhCMo3kadK8M7eSuFB+KBXl7K9Q1k2FIEJAvGJwX+s1yGAD+z63gZ1ew0/p/+ueAPXIRl/koE0gtXy8xRSVCjo+HzojgQjf9YG6O/z1Lm8+YVfJbwdIRjDXkw4jgRJoa5imFhTlFoCVl34NhccIR0QwYm6VaVnP5yH4J9onLdkGRWOUmEwbuZJlqBmD+gLmw4jsDzewRcIfwdBmK5uW60Qb0ePABfow15KW5Phh6qImtOaej/+jaMUGxM5NMrMFUlRri2X43GOmQa+xBFds1bk9/myasq1PF4KpSl6zuQhQfzr/cImsmmLWvMsowwpLNk3/Li2D5pjAvwGm8871AOgLTMwqVNxI8TEg2ZCuRISEdeDZI55rAWci+PV9fAyEB1tmdrFSpKhm1PVOsGiGbdC7dM2Qpql+W8cb1IbX3cFUeKiVnJgKiF/DTTZMaTH5bMMcjDhx0JGv/4bOa/s3/N06ExuI7ij/5chBn1WVE7r9MzhwhYhxpDxHG4fhQ8pUO0cLN35yLHlqEMyiShcnb+CW3wBH4l6HtghlTdq2xdV9y8xCq8CgHoLybnFH6wC/sODGWJQCet3Ocd8shDZpRbDSEiOjhcJJEO7PsMd3BW1FIAElCjIPK4e/uS6WfSR1jy/7xbMwLhCVXfucx2c0YEso7v2qN6qIqWWFUqaJMb2xdxr4N0Xel5nglRJC3yrU5w3XxXv9q7Tdk63JTZYiDszsxjZc6upqMGYw/im6L2wvk3oDZISkBvFOrh00jFWDUZWXXToWmC85zz2b/6Kg7+CXN7Cw5PjJde9rUnUustaGQJeOz60s3rvFkBurvvH3YRnmNTOWKnj0A4rM5WW3L6G55ju4mMdPwxgsxapuoleZXvyQGiuoSOiT/WlCgt6SKmXOGC8EjmX8ZjtSJpgFDnHrlZTdIFWQn6UsrMrGG0aGmUBW/SaVwto032CIBOIRJvzDER8cEiDEQ4hm5zAz5q3LzvCUpG2zReiIh19o4rzXgrdtGKc4Ty8pIhzOmRQ5NdgoJStF/A445l4XLbcBezrgCK/DdBZJHZlSVK2aPOITFwR8GL+j57xVgB1PMutNF/JAXQUtIEtolgXbqYzkOmWlkHAKaGtIcIppVyY+2b55qI4S/xfk8sNSYuGWTOonFDAS0mRbtHys3pWKjVyP8dQHrLkqnxLKUd7KBmbY+lk4BuqlifCm8mp20TAD3iwWrFKAyp9ac2KR1RpjFS4fOQHAi2/0oM4TMV5DaKlvHHqDAqL2UCp4jHuQSegJL9kWvTNLNd3UBxML6sFmw/FH7Xe0JqgdEsRGkPZtn7Q5GJdYM9BdQU68v4rL0P7/Gn4evXuvAmomseMFQk5roavpJxS8PHs3HhpcqdAXVLiSFx/eIXzCgVlOjOS4ZiljtgsSc25imf6CRn9eLW3nz/tevN0LUazY5EuDF60dAvnsglQBa/qqfUddGfkKyL3IMwOAHUGBKQIXrlsFYa11xxqmgsKpJa+FV5ZrXxPBBT5iZ7RqfZIUVuQrm8en+TR4TXmyxCkGfqKCXWf6Xyoz3Fzea8t7//arwxQd6MidlNbxOkqr6lmE2oyarFqBCgPeLrFhf46IpV29Hk7G6hJmfzUc2P9TBO/NkiYQK3OzgmKxoNtqDdh+AQ/XQabOMyG0CSfUkCERA4cIrTFOOre6sQz/tPT35wEpako8X/bYrd4GvAOjFBKRBjLpxG0H6T0LyhTXrK9DaQ+BiFjuahfydXuznphwztSsXT/Ix4Rinzi1SSDcnO3F/EptPQkfae9FkdCwgeH+19tHNxAdoagGzHIvxlQiUShStu/SxWcxf3YRhXMZwvPWrtbO0Re3+fgNnum77Sqg+WT6jbstViU0CvvM7TfLO9x/eALjHHxit4mV6i8FxdeJqz/7Fyt45fUjbXyW1xQb6PzgDFAi36ows/aw7os05ZkiJv1zATSr4HwIVLb1UL+MJuLuARg9MZpFYi/lMgWXDi6YFiCJxlhXOmqdVOs1pzWksELjOhgPvLkugQzkYC+iOBDL7hQ0qKrL5S3rc7UpuReikj+iPw+2hL9qALMz3Tyt2BLwx5ZxkTxrvoxsq3Aee+0SwGtPsMT0BXSnS4yjKx0+g57KSVtnzhisXjkjK3GBi0yC2VpfsL9103OnT7vtuShyFHA0syxgVdSC9BCTZLFCv29ZzJ/2cNB3Uq3b97jfByyBs/tUeRnuF6PqBcUybckjuXJuXQxtXJtiFIEFrlr6b7XqgR5K2ar4W/8pzYcRioJozzO/iSnzSonk3s1DqiZBgAZzWLtd3qiaqI6e0dsJJdk5jmA8aNxqmAdJMopJ4KNRs9Uj3uGgVx/vdehizMqcyjGDgx5g/yNPUPUjSEp2MZt1aaFbQOAR4djdfZs+cDWQtnOTGWCzWLHYbqzdw+xb0z2f3H8j6PRAgPD7dImNJICY8oZ0ZQdwOfoOIgutu0L5AgRLUP6+EcGoYByN5jrk9H8ubHN/qNDJicY0CP6qhH4gTqifAPEtQlRG/LRyx0BAsevzHj34j0Vg3FeDrc8kRfP32V5Py13UD/R4wxRVyLw8Y6Qxby3Zop6jSEnmr7B79DtUiiP2JFJXwqDpk83ov/ehcVWj6X7Rg658mdg3IYPThqe1CT3AKIT1mI4BBVxb9cPNWvmFeMFfbAlK2uAzZZA+aHHJklvwpop1z6YxmSaVk3PWf6nUID9XyPaofg14FfYdGHndOfpQIza/CZdk3e9W3YMK8Rpo+MsNx3MAy41wIh+lAByYUxIB2UhBROdoAGdIYZsgwrTqph+NbrPbc2c8iq5nMKopsjyTb32VkylDvyDLsXr+vV8Wuuo7XuTeVkKeneJRWo7TwcqjsIYQtcnqaYu/jTaRB2+aGTeZY+W9JLtcPBO7uwizJ+bE96Q59HZRIGXNzTyfnVRFdnW1LJhKjJ3The4r6EyvI3OfPjtggDqw88JcoY5Tq8HjzPmvIoJqW1S6vlS+rcHTmKDadbGhXvTR0DLwrxi0Fn3rxBWQm5bfXFFSPizpZuKz4PCFv/OX7LYVl0Cqi2mhOa4MQHChdt7I7zkCvNXYzmM6cylvikKfr5QT6Ee95+Vj8YBInPS9kfC0Mle+Uec3mom0HONsoY/d45A4bpHUqF7CjDhSstUzf3U1A+kqdYnxhGVuNoaA8UZ/Pm/TkEJfshw0YL1mNhoE0V4LWsI890p/09TaXPclDdDLevhkoqHQdpMIfGqb4zlRnA8dBIHXKY8g81a/R//U5qNagbi2fBnhNzKHOk/hLuswRlLRD4aQ/aw5vRxQh3XeQfgQ2yjDjYQqqgR5Btd4dUJpHon2K/F3ferEfNiviT7QbMfCGLHl4JWztx9EUu0qSvHC2HvfHVwLYDxno0iEYyTeCkXuEXtGGA2D3mD6I9UUpDLOODOZC3vg6Am0QRyWQ1lZYHtnI+ScyBH3y6p6QKN/PswYG3tQQ7XxhqUk8lfDrGWzUfCKhH/3SnxeNDeLowwWiq+m7pPnOQrdwL2FOltlLn4M9HO0MHXdJga0MdCCcVHS87gYGkM5coTzEb4JCRr5JoWwkmMEbp9YfYOgzDo0gG0sGYN+9TMKleHTrGcoSNfKY8qm0j5dBJaKlAiqAF1pjC4Pn+vSAjoAAOGoCY6SgPXh4Id3O/nKsDA5Lc3wSEjxkclbYQ5T7W5J9eNVNqx11XgBqFoEkVuVb8AXMY90zsQxfrRwTdeQEelTMRfhkqv6Ulmq64A5TAKALALIbSQ/vaIpSTiJa5F8A8HhNA/O3UxiYmQRqkR4gafM1YQ35nqFVJmMR0I9ZBTxJHIWJI7qCTMV3l/dEyyPVNd68j95qmIDtMmvLSxSnq98rsTHTkGe0JCjTV3nwuNdUepyLx3W+eG6CECzKSB5Y5tl5CI7+f2fmbuFhlSwRAu0TdVK2n7zsq6v/yLTMAzPWBs0WhvN6t9fe8HwH6j/+ngOHampYGBtXFvh8CD+0Oo/Png0RX7rHU2D4zgi62JKWTefF0kefxMsBBk4y6fvh2MN10CESsTMACST11EaZGmAbGWXPm8SekSK6INKkizNtXMimcXZndoAj7frjx1oCTAZ8kHP0sGC9PRGZO5qsoRNbmE6OFI5mVBpXZM29fPG/3BvULFJrchI5AHgmdOqvu3C+KV5Kno+JugiCJCGEJzYCciYs7xCEu9HXrgkwYgSaShcXXZP54fB1ofdRzcEfFkxOp9HAxQDTxIprDKnjMatEhSADM3hzJAP707OeGiNAEK9Va2WbMcb5Z9R1cuA44qqQ83iIBXGIJyPtrhsA1ZWcGhzKGYfTWXUfXlIu1mSWMOxiF1656ISvytfwiHkmn42AkCAISiq9VDvyQnHIyzbCJ7dsMCJCkBgm0iyI33j+QhITQ14CGUa8pe47MKW+6vtnBdteoaP1HCxZ0cjcku8jXQCc3tp39BVwao21cccKYdZpR3ehg8dZe6HhQ6TQi9e4rSIPjWmggf8nmo+s2Qa+sNF2isbpm3wxWCtX9MVtH3MkR566WjijfADYwr3TXuV/dHwxIcIerozSa1jeknbyDtPBoQTs0wAVVdz9MQgHimftnXRqzSnc4LRMJpLt1/WUV8BBKTAW64j0jqj/+Pa+XjRsXeeMcMz/mq/pCGXHz95i6T5MRqM17UE4BD2H4fUcCDT97DLNyPiQ1KkH8TNtz/1VeGm6czSzXllxmAesK2l3pOjE7xa3HQtCeb1tH/wOdcBEr/gXL/MyoT5IrVMdWyhDS1U3agVvHN2U2WcreFv1Phg3zGUULsSkVwiNPJu5C+HnayXp+fs5lm9YJ5wKjQdfko+mP2BiH5O2OEAAahyC5IcCwp/HP6ew7Qqbz23GIMFtOfJyWm879AKZEhaJ+9v/tNCxfTzDs4xfwW5NYBANG2lC3qTaAvpbh2PUC4Sybh4Gj6/95j5mpHs8pNdjRUGHjgztlmPZQa1ejsF3ddeapxUyuOZd5rN8AilL2Gf9bFIHBzEORlwbfH13OrfZBQYlTluj0N0O7zrO0U+O0r/TquDyPPEOpZbvfSIMieypA7G6cRuafff7HxdI7FcnEVmEki3lzxG+hbPLmMmetTeZ43qtdJ5rt6HKvJKpaHM37nqscM1an4GfK9/LNLxLJEgBrR/JDkTH93qls/YMgiMbem9fIa4KLSx92W7/Rz37vrhHse/u1P+l4Cfxm38FwlN9wk5PXQa9pf2DM4GOxCLVzQZdfGACbsdxzoANbS1YmYNWybEMtFoG+Yo4pEdyRJO6Imb3/wKybU6RCQ9dXv14LoMnFeS55RAr2ESswPqP7JUd3kXGz3LG9N68lz9m73r2p9h2FYSq1s98g1NCveB7dUJCg13Bc4L4nz3Vh46ldgieXtpx052dWVGmJMDKB9UvNutUu/aRWyCZkrZb+zvIMnkyMSr+bsBQOswDzGUB1Mmy7oKWtArvzaRLgQ5hZ7Dufa0t2xAUz+FUXKSMYK5SsfK7sHQhApbOk7WfvBDEzYl3Yg5alWX7S3tAuAiTneVRDslXieAXtZC52djdamhBtp9N+zAUTglvqSr4Zo9KR5pzcnbCd5XsAxpTnkHrNyqlZjyIFaIqrHqkWA1IGu34SvWVCcyNiij46CbTacqCGo2L8NL9ZfnWcAJqbltjlI3PS+lM3SI2N/+y+Q4qihfLZNHXTxyMhPqch4xEl8CriXxNc6TQGb+2Ts4ZJFBHf4/b3S10U0LoLzPESycY08eh1Ozy9HzKtoAubl3na4JKVLNPXRW+isKFBO6OKr/Zs50BfJsTL1csztdj8gwwrEDg1Li8E0gWrP24myZjYS3ABFt2+i8ahiTNfGASJREIpgMIWkCu2e2Qwg3sbQxR3MEaMJjTXyfoJB5GyLxHKUXFDvLYdaQOA7Po1P1POdwqU6XaE/GokvcLNpv5j7hZRkgZWlpDS6F2YjuHd4GETP/OVeVS7bh9eN7XKeEZAzdc3ErTet1NTP/8Iv1sScSS75irDZxSnZ/+1I2CwKM4jzedPoDjFMBaDEC637lJ7sBX/Fi/4oGMKqxeftU5sbImrRDWMenoDjFMBaDEC6h9BT//n3kekK7d/sb6G9dFwZQ+Jxb0gXV69bI40rSBwHZ9Gp+p6zhEW+UE89NUauetIHAdn0an6nqsgPWaendrW/6BxZn7wM8Cy6A7PrgLvItDtDJC0e9BSJJyPWQcPhNC0gV2z2ypyyFNTh30EMcw8RWsZGxeyIjZI399/8lVrd+QwgAMJMaSTqAkqDGzzBaRbMjKdcq/i/FRKepNnTAgJG4gjbyT76txK3LxKrjLj9cdvtc7sIWGg2TB3s3vyLiIZMnUKvyhrY3yAUOQr+9GuRGgiGFckcMYTyWQ7v3efR+em40IRN0O4vadLCN0y3Nq531kNzi25qDq70xDBRXGrY/HJbaVWkL8bZpLbSGMAIYcSWs6nc50J4WZZBcj7qZTdSbWXN6xATpJNQjRlYA+nUrdzcFSzIAGH8r457qAUl4uGE+NenFZWud8/wXV5Qe+hp1Ci0RYBmonJTDJbV7LXo9qRA6wsc9ajcEnjH1fNNyexB2+DQ/eDbbdXCdvfp2Dxpkar9YkAFmujqmlDrE0cm8fjAJ7zPNz9Ir3faSsAiYm3Z43EqnA2IAOzkj4NwfBM5L6NpoSqE2kOrdedlRb7LRdnV48QviL7wkQTzTNoxGdheSU1pkbowIey6zOF2Sx+bM9kWDOZeAEdn84JtiOOnqyYI6bFNqpkjdvDB86dt73j0l/2dGYA93bQWNFScTaBxUl4km4Efw7CFxIpGKorDaPUzy0F4liBCOeiIUbzvsK1pOYggMLe2r/zr6gEXbK9e6YjmPq+YngAXt1mijcS3Yug/5b5mcO/1BIMU3laDpke3JgTrYVJUa+p1JqfyYNv2vTbwUURdX3q2jmsqpIHgIMbg7uut1mQ+fLaUQVQT6ikkiRNV5H3iyEyYW4d0Jq/jDKSthOrQgzdUAXpR2zIQQv8UMjnlarCXJX6FSK1WbHN7Dwy7YhE2MWqZMWCUhz79KnOIDx2JsceJEZkFpQ0g5+fOXEsEYNyOXh2msrLrb96p02gSjEs6ca67ar3bAeH5F39cKavkDjzUFdEYI+egq9C2bEyjNv/jxfqXPz+qrujD8zCS0d+IXwNhnSh0ZwKBcKF1vAMyFiH+woi7XGzK1o7w6D3KpwWHFnZ7McDlsyWSylDnBQChrY9Diht4T0WJOaJGuB2qYX6I1+BnokRtv7zeHfqpQ0ytyudxI7ejYECsYpE1fZQQY5Ahi0CzKq0pPmjOLrPctoqSVppuYFJS35wkWyER+7hrEYgt3c1axVdfiaeJA6OjEtlSpbhKGQyqmbNJM3JGQch5ZTEHXOTVlDPEu5t4QRUyN3tyTQPjp6khA/LyZH2sg2Zlb+WV2vi6I6PHkwZRWdH4StBZqrvB0Ljp7wkb/KrvF+JU31TYegIsGD8BTO/RaY+vUzynhKm7WgZYOcBhC36M8123wmaDQwpIZmJfJdsXWl/6zbYFSNH/LfB9EI3JMCYmuUqUwQB2JGM6nI1TLNX/zGhUMeAtx8v5FVhoT0bZDlTPLXJaMlhhkNuKIyaunz647EYLYANV3srcVGKZRaVYDN4bB8MGlTLjTPyxOntAa7Xz+LpiRM0fWqAKJX03hUkUuTcRpE/XE2xlvwqmYKrxW7OkkHDyNVq0zb8HIEZbA0txBcERa343wU4CCCUN3Q/5bM9cU63actk93uLSmxEEd9atAD8QbxfSfTXj+WA9eB4eDxg+CRi5nZj0+tU2TtgMXGj0DEKLM9pnEE7AH6EK049r4hMoHziSIPac7rLSLtH/M7/cjluwg+AinHYLsAjKjM1/npF9S+siYYfcJCT9NhQ7FTo6EbC/s0C+EfoOpQtuSwlVeYuJlj36YfiRUaFWXgHixVspIb+RoqWLzWxkOL7WL7yCpyfU1jp3S3zUF0tc0nDnuDHtGTIOcM+UE41qx/gW6kPyh8z2zyUhle1n2tm1pBdKa3J+mjD2YYWk/CrFhQn+QNm77fwZl4r6rxQGYc5YVMMe+HqX0326/ga4MfExLAUk2XojAyHoRmdw5dr9+w+P2A7P6brddXHX5ux81tZdmGy6EguVeCqYz1mf6bUaQMAS7+vU0b6BM9kixtDLFu6wyjq4Lmk5R3cbbs/00bgYi5tZ0tOIe+acdFsNzRH0GBQh72trzkmPydrN/RJ5TeruV30CzBJ0WL10Osop+b4vn2z3PF4VD9r1NhctAaimgm/sJ0jg95ffiUcWTtMZsO9G7TbECor/z6D96yF763Yv21ZS1aCmm9+2YOYm3CM0zMecXlRNyTQon5puyPByxS5es4s1wc/hmyR13FK4dSLbkLnJxjQ/baZ/bMXxyqR/ObldFQd9PO8ejU9n/HYp0amVAs/7EE1/3hhx3M8HnctfLJIANJMXTQM7V2CXlEyBYggdPXH0LZ+5walh3lZzWG6MioU8Ua6ZYfloGJPruBjKEv7MZRe8komoEPLcGKMZC8qHxt4/LpGK0oIND6YSO9KxMLPSpOHrx/YaCKDHeQ5b3J8nu/tqzAvECmTHLs2zKW9wqlY00mMHs5HqI9ZcyFrHNY/CbAJeEcBt3xzK/I8hXxsp9k6x6m13noeZoYXa0urC5nU3Rxd9aygTnBZLZBmUG4NcuNL/o/kCeJyYU36vxK50JSroF0ZcElapWz8wseMPDnTNOkJtFWpLxKOS7AETDFNUAd9+ZI9unvT0gyF36YxydkIFiYEy6yUIx8NZcVtsXz4g2gLBpSgwAkKpeke/ILmVSe9OL0MqDy/fDeys4/1/2aTVfAqUwsrdGCsBq0g4c9Af0gVlhHg+FoeRQLWt9Ku3HYw4khTGtykguw3k915O9L61saf86aaJWMWSltnkSNQEUoIDsDyMJliGxqbJvfk/EGS7kAcU1mt6uHM7ldKUAw0TmVJFDDHLDxL6Wvg0iLWlKEOVDW+76+/oQLPtT/2hLIhxsvyYRPvDXJG+BDQdrY65OYwmPmK+aFefvr1Lq8jj8P1yxqc/pzoELGM0nS98O8EXSWhw/cCNLYwFrNxcncmHBfkH+HmdyWjWb1/v/mtoVyAnagTT7Z9i5e998PXn1vBZga9i7767+kOi9ZVk/1hpIt1OasrGxBhtwDwesEMh3C9R049zavr+wXF9Rc0ZgT+pgp8u6Fdrt1FA6PGNZcigt8ozhmYCwWeKz0lK8FO/ciwe4EuPuqIbC7q2d3cvE7BBODhmRg+SkSqLjlcg1pddDTFeFywsCDVcN9DoH+W0hKdf1z7zMgCCXeoXUb58dS+dfvqp9B6I8Zxphsb3vmw15MDeUcUL7mmdPtjjNmZnD4FU7gWxbXRotQq9OCfTP8fvhp5RVgJUR8MM5wvLVIF8r1JD5vvsQlL8pntYn1Wnpvid+j2xWMvRPTH7ui7rDTrcZnVVe2SKV+hN0MFjfe7AkvGA2e6q4UkfR4cMRi+k9QSfTYljrEx53ae2wJ3Buz1Ch7grAh+AsRPjl4D31cDRBow0sWXkAwVV96N1Api/p56QCyqGzhd2/jnZNGlNGnOg7s5+Af07YAIyKIuw7RrCJJYatKCZRO6llGbp2MihSSy267MlX5VB1cvproR6Iy3zpLIjzDAjQu6LqQFM/KrZU/lJiH+6ypklVg76KEv4EShyJgI5hJCgynzh8djYn84B19YYVXmotELMVUwvCHE+/iZcB8bLrFs5+2NRe4YjZMwHkkoudOr9lSBoHXuU4FHFlZwrz6w3VMbVPrxUiqdAhK9UGEL1+41/QUdFWDf4rPkltZvCzVGl1dD6VNVq84UowBwUNhnGbnUb64hGCDWBYX0AaRRAgCkrTnMOfgjLojxPiqkpjVgK2LMFm/3WmrF+YcZ5lgN7y3bjz0N4crDSoZn9v1PRQnvcBdS10owCEi82RrgW4PNLRvRrg01nXGMsj2et6TkaQ21u2DjqAnuSeTmPQNPchiNEwp9UGELSfKQ23AQWEXyYu1UHL4YtbT7kWLDj8IUF2hhMGOFb1mfXChe83A721TJeeAVlRSPtym+YAqt1uukTekGVKTJpeSILC9GlAuoNSuVMXoYvDaYCoBkrUTL3sBckTQmibsDSaFisUhTk5DSJycgjK4w/VyIWFdasxwPLk7PRDy598nZs1e4EZZ5P09SUufLDYOMaWw5AAAfgj3vjiuvdS32R+1HoQyw+dAAAFDn1T/PdJal/H9PkOn2Mc3qRdUDbEVee2hIKk6GLaA550/W5r6YFwABoRGf3IMW0GwYfj4PsTVrTbZ+tBciSEFHrL5bu1npkpc/xl1+2aXBC30CyRaTeRnJRszOnFisBxu6rV57vfVhBxDB786U8J8Ihx89xm0Jk0w6jNRoxn8PeWFXHOQDwdKgXEUZS6ryseRL/BWN4jTv7FDyba9DAvGysHmHF2+43giGmMgnag0JnCDw6QbXYqwMwESeZOiYSkHusCUAdeqwoaUJzTx7+GeAujggu3KNmIQb0nbLlMy3GvblQieQJ7JQ1PGQkzjo/E1mfRVdOFBYrRRcLaBnNruIGXqZ3OyRLQqeKKY/fq5KWt23+SwGxIlq8+5FnngLg+r/LQii4imO5DuHXN9IqqtIu4hC6k8BxEqZnekMZV+65FRAk5OGmRMRG3CAujs81YpHGfv97RONcUtQbSGBMiSjUKUgL4TKfeEvSPG+g9sRiILKyUglaAvHzPqAHtXCtkV92KEHQgXSQcn6/07EELRjjNlYZ6/4v5QsHWORllwgOYLgTf94mObFexw+Eel02f3+r0Zbpb/rQ8T8PCcoU1AK62xnn0vMdo55if26cl45Eg/iM5WMqmgNmqfmGjflC0V9i3QOu5f1uHiqizD6jGzxVRuL0KQPaeGjxChWSYAdim7wVV4gBtm/3Bm1j9OqN89CUcFhXca0EJZ98FPE8iW/nX2haJTLNi+wCmNxhLVtdLwxDU7vV9tkwiduJzweyhcbIMxH0l7r3eammpFGo1mpv851hKvq9KklSGpO2hDiPDWNl8w93A6KEqPkX/vhRP7BSl317QrCM1WxMTA74D5ZjkSvuduuiHz6p3mOyXaxyffykuwas7w0Gwq8SGxiA1k43eu9dP/bHXLegSOUNctnh4FSV+yyDpz3p+pFtDLyRu1wOH0pQWZkrjZr76VyZUI+YK0jpUfpsLK0YvEhzdCfW/S4sjl2vW3rJozz1u1PwpjiUg5HKoHerMZhIlcoPyFsKgtULVCMeB5weZTo4hfDXufv0liXp+EQCtuZLoGuqZEkmVPrlpmR6S8UQkVK2ANaY20LTLqlY12KcGR2+H9nIuRvC1jXDF4tlqt0VQd/Sc5WPzCvwJW8ZnnIW52OV+ZnnO4NGudLvVs45rfmQ/XuuKr96c22ENYKk78CKlC91SXQAOzTa1AcHeISIw13qLs2yw8+ZE4qvzCaa1sIebfi7DKn14vhfHNPlmiEyqLHZ8E2wkmJhmW8HC+7/QF0CvnQQcnspFnbHIGRj77TWPJEbeuzFeYp0fCI0EfSER/WKl4zFuMaUBNTrFLQolagbIReIIsFVuhcOpkAif0PdFom7aCLlz85E7PvUPN2G89t2jc3FI1qTP1+onWpBTb+w4oTkfMnQ/SAbMSc5BKOHOiArewNaWRDa8eF+33wKtCAFZpNFSjLkuvEtIoM88raU8QjgPdIHQhJ0m+y+i2ppJgJhZGWNCP3vpqdmVED/D30GONoimoGsBkMhwKkIm/FcLsEGYQU+emqUQm/PtZgsgBuT56MxrcT5qfLsZLMRQMPHPoPJdGsOo+/whm37QjZbp/SqEoW99X7NHMGzlG06UqoA3jqCq5+boyrGbthdBE9RVNM5obzB4Rq4jotn2lAOHgpYZPLv1rEBiZw9UPgScMVp1XDKPL5S9xtQtqLcJbhphv4IrtXgjBLl5H6zhyJPLdE55aK2uueX+qAUPzug0LKTUeA9xyQXGbzJ5iaYWICXXL3hZAXifK9WvcpvOpmts1QkZMdER26t+in6QcjLYG6HccA3Hch8fVxpuTfEQLMmLx4Js2C3E/vsVpk85tKg7hmo9mCXT2YcJSejt/S6o48/vWQblzi3l9QARpenYTSc9duYQZeIpKn0E43RUsKxz6LK7m26heRszGG+PlhPYQBsTdSH1Zdx7beAMaboUkfYfX6FE+vpMXc7Q/NXA36D/WrdRmDRBDaVOvIHQxFhLMDlnkRV7SESH9/2iMgOUCphmN12eBnAJ97gCYPYv7AEDAJccxEfCKHeDbA9+1IEzGsjRSXdz+O5OuiyDpZ7E2mAbPpshvFd1XR5nepqVaSBAkdX8U7If38f0fgVVIYM290dpiyst00HUkFKMkrsKZwRrv21KqTqqYuv9jn4wMaBHUBSseKh86HZqOjFCdQQFMECrKE7WrJX1FJb8Aq7V2/HPGYtgXSZGzVvOBd2NY9c9qS5kF21aqOTZnOh0l9pQaB3ifjCGSJMyiz4S7hA+OXzKBINKivVJ5FIf2hE3OIRclyDcHGwrKh+dhu/y/euM/rwd5BrmW5j1LJFU18JhsK4APSz6QROuwyjECg3RAPoAVWfrQ4aQLJu7oQ9TKswkR6UAyk7vFmDr1lWOvmID8a/2PVRYEl5vZ271dNomQssnvKRXLYcRdquR6M9RPHiuSRAP18dQ0rqoovFIq1IU0mhD77mR8I86Rz5rnKL0l8TJyN0LD0+drkho26GeFWbOTYvwu0cWjvHszgLNfe+92qhG198q8gRYaXxDIM8KycBBJFn8+yErCQ9dU6HcfRfatPf45l418xwiwh3r1hakSpNMowQFMfnqyWK43n60F1XrDlLqN0Nho3HZBbgOxYMMND/t5VvsRbKoD7XgdUSwVZzU9QttCICifYYLAfTWYuenS4z2B4DgFjra8D+i1qvrpEZwf4yM1vLGmM8ENANPqWavcMrII8AUrTHy+AGqK/tbUUkCfM997RTDy+fbuyX8djNjWAk7hgfUgx3904EjI2e46cogJc8DVeMEeRsT6PLvJNck4w5x2vK9h79Lt2IGw75n1LDY69zsVPS0bFShi6RCReUnbGSjDg1xb8i6IX4Ot+ttUZWpGVI0msEfAqyAQ1aTUi9D/7GIG40UlMovXzQ0nEsfAnnhSzDC2TfRlxCIAfAyNjFOWEilKVm+0bT6zBIkntkae3vz5pC4CSzmpeY8Hrckx1C8gTd73Ll6GJWGQ8T8yQihb5R+gswMEsncnz5dDNrMcr/CRYq2oxMqbk4j8PcFU1b8D59kzdmjBCwAAAA==" alt="figure 1" loading=lazy srcset sizes width=685 height=592></picture></a></div><div class=c-article-section__figure-description data-test=bottom-caption id=figure-1-desc><p>Risk of hospitalization due to heart failure with DPP-4 inhibitors versus GLP-1 agonists in propensity score matched analyses</p></div></div><div class="u-text-right u-hide-print"><a class=c-article__pill-button data-test=article-link data-track=click data-track-label=button data-track-action="view figure" href=https://cardiab.biomedcentral.com/articles/10.1186/s12933-018-0746-4/figures/1 data-track-dest="link:Figure1 Full size image" aria-label="Full size image figure 1" rel=nofollow><span>Full size image</span><svg width=16 height=16 focusable=false role=img aria-hidden=true class=u-icon><use xmlns:xlink=http://www.w3.org/1999/xlink xlink:href=#global-icon-chevron-right></use></svg></a></div></figure></div><h3 class=c-article__sub-heading id=Sec12>Sensitivity and subgroup analyses</h3><p>Results of the unadjusted and adjusted secondary analyses are summarized in Table&nbsp;<a data-track=click data-track-label=link data-track-action="table anchor" href=#Tab3>3</a> and Fig.&nbsp;<a data-track=click data-track-label=link data-track-action="figure anchor" href=#Fig1>1</a>. We observed a&nbsp;18% reduction in the risk of hospitalization due to HF among patients with baseline CVD (n = 28,085 in each exposure group) comparing DPP-4 inhibitors to GLP-1 agonists users (HR, 0.82; 95% CI 0.77, 0.86). Similar results were observed in those without baseline CVD (n = 132,047 in each exposure group).<p>We identified a total of 1335 cases of HF hospitalization among users of saxagliptin (n = 49,214) compared to 2058 cases among matched GLP-1 agonists users (n = 49,214); and 6108 cases among sitagliptin users (n = 160,609) compared to 6239 among GLP-1 agonists matched users (n = 160,609). The crude incidences of HF hospitalization were 69 per 1000 person-years in saxagliptin users and 99 per 1000 person-years in matched GLP-1 agonists users. For sitagliptin users, the crude incidences were 75 per 1000 person-years compared to 89 per 1000 person-years in the matched GLP-1 agonists users. In the proportional hazards models, we observed differential within-class effect comparing individual DPP-4 inhibitors to GLP-1 agonists. Saxagliptin, compared with GLP-1 agonists, reduced HF hospitalization by 26% (HR, 0.74; 95% CI 0.69, 0.84), whereas sitagliptin reduced HF hospitalization by 8% (HR, 0.92; 95% CI 0.89, 0.95) compared to GLP-1 agonists. Study results remained consistent in the sensitivity analyses (Table&nbsp;<a data-track=click data-track-label=link data-track-action="table anchor" href=#Tab4>4</a>).<div class=c-article-table data-test=inline-table data-container-section=table id=table-4><figure><figcaption class=c-article-table__figcaption><b id=Tab4 data-test=table-caption>Table&nbsp;4 Risk of heart failure with DPP-4 inhibitors versus GLP-1 agonists in propensity score matched sensitivity analyses</b></figcaption><div class="u-text-right u-hide-print"><a class=c-article__pill-button data-test=table-link data-track=click data-track-action="view table" data-track-label=button rel=nofollow href=https://cardiab.biomedcentral.com/articles/10.1186/s12933-018-0746-4/tables/4 aria-label="Full size table 4"><span>Full size table</span><svg width=16 height=16 focusable=false role=img aria-hidden=true class=u-icon><use xmlns:xlink=http://www.w3.org/1999/xlink xlink:href=#global-icon-chevron-right></use></svg></a></div></figure></div></div></div></section><section data-title=Discussion><div class=c-article-section id=Sec13-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Sec13>Discussion</h2><div class=c-article-section__content id=Sec13-content><p>The evidence from observational data regarding the risk of hospitalization due to HF with DPP-4 inhibitors has been conflicting. For example, Fu et al. found no significant increase in the risk of hospitalization due to HF comparing DPP-4 inhibitors to sulfonylureas [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 1" title="Filion KB, Suissa S. DPP-4 inhibitors and heart failure: some reassurance, some uncertainty. Diabetes Care. 2016;39(5):735–7. 
                    https://doi.org/10.2337/dci15-0036
                    
                  ." href=#ref-CR1 id=ref-link-section-d117163409e4145>1</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 10" title="Fu AZ, Johnston SS, Ghannam A, et al. Association between hospitalization for heart failure and dipeptidyl peptidase 4 inhibitors in patients with type 2 diabetes: an observational study. Diabetes Care. 2016;39(5):726–34. 
                    https://doi.org/10.2337/dc15-0764
                    
                  ." href=#ref-CR10 id=ref-link-section-d117163409e4148>10</a>], whereas other observational studies have reported lower risk with DPP-4 inhibitors compared to other antihyperglycemic drugs, including sulfonylureas and TZDs [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 2" title="Toh S, Hampp C, Reichman ME, et al. Risk for hospitalized heart failure among new users of saxagliptin, sitagliptin, and other antihyperglycemic drugs: a retrospective cohort study. Ann Intern Med. 2016;164(11):705–14. 
                    https://doi.org/10.7326/m15-2568
                    
                  ." href=#ref-CR2 id=ref-link-section-d117163409e4151>2</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 18" title="Kim YG, Yoon D, Park S, et al. Dipeptidyl peptidase-4 inhibitors and risk of heart failure in patients with type 2 diabetes mellitus: a population-based cohort study. Circ Heart Fail. 2017;10(9):e003957. 
                    https://doi.org/10.1161/circheartfailure.117.003957
                    
                  ." href=#ref-CR18 id=ref-link-section-d117163409e4154>18</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 19" title="Nesto RW, Bell D, Bonow RO, et al. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American heart association and American diabetes association. Diabetes Care. 2004;27(1):256–63." href=#ref-CR19 id=ref-link-section-d117163409e4157>19</a>]. Our study builds on these prior observational studies and, to the best of our knowledge, is the first cohort study to compare the risk between the incretin mimetics. In this population-based matched cohort of patients with type 2 diabetes, we observed a 14% reduced risk of hospitalization due to HF among new-users of DPP-4 inhibitors, compared to new-users of GLP-1 agonists. The results were consistent in patients without baseline HF, but we were unable to confirm such an association in patients with baseline HF, in part because of a small sample size of patients with baseline HF (n = 3874).<p>A recent network meta-analysis compared the risk of HF hospitalization between DPP-4 inhibitors and GLP-1 agonists. Zheng et al. [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 13" title="Zheng SL, Roddick AJ, Aghar-Jaffar R, et al. Association between use of sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide 1 agonists, and dipeptidyl peptidase 4 inhibitors with all-cause mortality in patients with type 2 diabetes: a systematic review and meta-analysis. JAMA. 2018;319(15):1580–91. 
                    https://doi.org/10.1001/jama.2018.3024
                    
                  ." href=#ref-CR13 id=ref-link-section-d117163409e4163>13</a>] assessed direct (pairwise comparisons) and indirect evidence (from DPP-4 inhibitors and GLP-1 agonists placebo-controlled trials). The authors reported that neither DPP-4 inhibitors, nor GLP-1 agonists, were associated with HF hospitalization when compared to placebo. However, they reported a reduced risk of HF hospitalization comparing GLP-1 agonists to DPP-4 inhibitors (HR, 0.82; 95% CI 0.70, 0.95) [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 13" title="Zheng SL, Roddick AJ, Aghar-Jaffar R, et al. Association between use of sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide 1 agonists, and dipeptidyl peptidase 4 inhibitors with all-cause mortality in patients with type 2 diabetes: a systematic review and meta-analysis. JAMA. 2018;319(15):1580–91. 
                    https://doi.org/10.1001/jama.2018.3024
                    
                  ." href=#ref-CR13 id=ref-link-section-d117163409e4166>13</a>]. These results would appear to be directly contrary to our findings in the present study. But, further inspection of their results reveals interesting findings. First, their conclusion that GLP-1 agonists were associated with lower risks of HF hospitalization appear to have been driven largely by direct evidence which included only 9 total HF hospitalization events from 5 trials, resulting in a HR of 3.23 (comparing DPP-4 inhibitors to GLP-1 agonists) with very wide confidence intervals (0.70, 24.70). Conversely, indirect evidence from the placebo-controlled trials suggested the reverse: a protective effect of DPP-4 inhibitors compared to GLP-1 agonists. Furthermore, the authors reported significant inconsistency between the frequentist approach (results described above) and the Bayesian fixed-effect model, in which the latter revealed no difference in the risk of HF comparing DPP-4 inhibitors to GLP-1 agonists (HR, 1.21; 95% CI 0.91, 1.58).<h3 class=c-article__sub-heading id=Sec14>Possible mechanisms</h3><p>The precise mechanism by which DPP-4 inhibitors may reduce HF exacerbation is not known. A recent single blinded randomized clinical trial&nbsp;found that DPP-4 inhibitors have no clinically meaningful effects on the B-type natriuretic peptide (BNP), a biomarker of HF. The study suggested that any changes in the level of HF-biomarkers over time is more likely to be due to the natural history of HF and not to be attributed to the effect of DPP-4 inhibitors [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 20" title="Fadini GP, Bonora BM, Albiero M, Zaninotto M, Plebani M, Avogaro A. DPP-4 inhibition has no acute effect on BNP and its N-terminal pro-hormone measured by commercial immune-assays. A randomized cross-over trial in patients with type 2 diabetes. Cardiovasc Diabetol. 2017;16(1):22. 
                    https://doi.org/10.1186/s12933-017-0507-9
                    
                  ." href=#ref-CR20 id=ref-link-section-d117163409e4176>20</a>]. However, there are several other possible mechanisms underlying the effect of DPP-4 inhibitors on HF. DPP-4 inhibitors are responsible for the degradation of several peptides that directly affect the heart and blood vessels [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 21" title="Ussher JR, Drucker DJ. Cardiovascular biology of the incretin system. Endocr Rev. 2012;33(2):187–215. 
                    https://doi.org/10.1210/er.2011-1052
                    
                  ." href=#ref-CR21 id=ref-link-section-d117163409e4179>21</a>]. One potential effect was observed in animal models where the continuous infusion of GIP led to the inhibition of the atherosclerotic lesion and the prevention of the penetration of macrophage in the aortic wall [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 21" title="Ussher JR, Drucker DJ. Cardiovascular biology of the incretin system. Endocr Rev. 2012;33(2):187–215. 
                    https://doi.org/10.1210/er.2011-1052
                    
                  ." href=#ref-CR21 id=ref-link-section-d117163409e4182>21</a>, <a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 22" title="Miyoshi T, Nakamura K, Yoshida M, et al. Effect of vildagliptin, a dipeptidyl peptidase 4 inhibitor, on cardiac hypertrophy induced by chronic beta-adrenergic stimulation in rats. Cardiovasc Diabetol. 2014;13:43. 
                    https://doi.org/10.1186/1475-2840-13-43
                    
                  ." href=#ref-CR22 id=ref-link-section-d117163409e4185>22</a>]. The class also mediates control of the ratio of different receptor subtypes of neuropeptide Y (NPY) resulting in a regulation of blood pressure, blood flow, and inflammation [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 21" title="Ussher JR, Drucker DJ. Cardiovascular biology of the incretin system. Endocr Rev. 2012;33(2):187–215. 
                    https://doi.org/10.1210/er.2011-1052
                    
                  ." href=#ref-CR21 id=ref-link-section-d117163409e4188>21</a>]. Other studies suggest that DPP-4 inhibitors are associated with an improvement in left ventricular and endothelial functions leading to a delay in the development of HF, or worsening of HF, through its effect on blood pressure control, blood vessels, and cardiomyocytes [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Miyoshi T, Nakamura K, Yoshida M, et al. Effect of vildagliptin, a dipeptidyl peptidase 4 inhibitor, on cardiac hypertrophy induced by chronic beta-adrenergic stimulation in rats. Cardiovasc Diabetol. 2014;13:43. 
                    https://doi.org/10.1186/1475-2840-13-43
                    
                  ." href=#ref-CR22 id=ref-link-section-d117163409e4192>22</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Chin HJ, Nam JH, Lee EK, Shin JY. Comparative safety for cardiovascular outcomes of DPP-4 inhibitors versus glimepiride in patients with type 2 diabetes: a retrospective cohort study. Medicine (Baltimore). 2017;96(25):e7213. 
                    https://doi.org/10.1097/md.0000000000007213
                    
                  ." href=#ref-CR23 id=ref-link-section-d117163409e4192_1>23</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 24" title="Hashikata T, Yamaoka-Tojo M, Kakizaki R, et al. Teneligliptin improves left ventricular diastolic function and endothelial function in patients with diabetes. Heart Vessels. 2016;31(8):1303–10. 
                    https://doi.org/10.1007/s00380-015-0724-7
                    
                  ." href=#ref-CR24 id=ref-link-section-d117163409e4195>24</a>].<h3 class=c-article__sub-heading id=Sec15>Clinical implications</h3><p>Patients with type 2 diabetes are at higher risk of developing HF and the concomitant presence of both diseases can further complicate diabetes treatment. Thus, understanding the safety profile of diabetes medications—specifically the ones that were proven to be effective in reducing HbA1C level while maintaining body weight—is of particular interest to clinical practice. Our study found that despite documented safety warnings regarding the use of DPP-4 inhibitors in patients with HF, the class was not associated with an increased risk of HF compared with GLP-1 agonists. The findings complement the most recent findings from observational research and need to be considered within the context of other available alternative of diabetes therapy which have shown a lower risk of HF&nbsp;compared to DPP-4 inhibitors (i.e. SGLT2 inhibitors) [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 25" title="Gautam S, Agiro A, Barron J, Power T, Weisman H, White J. Heart failure hospitalization risk associated with use of two classes of oral antidiabetic medications: an observational, real-world analysis. Cardiovasc Diabetol. 2017;16(1):93. 
                    https://doi.org/10.1186/s12933-017-0575-x
                    
                  ." href=#ref-CR25 id=ref-link-section-d117163409e4206>25</a>]. Some may suggest that the observed protective effect of DPP-4 inhibitors on HF can be related to the higher risk of HF with the use of GLP-1 agonists. However, recent studies found no difference in the risk of HF when comparing GLP-1 agonists to placebo ruling out this alternative explanation [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Li L, Li S, Liu J, et al. Glucagon-like peptide-1 receptor agonists and heart failure in type 2 diabetes: systematic review and meta-analysis of randomized and observational studies. BMC Cardiovasc Disord. 2016;16:91. 
                    https://doi.org/10.1186/s12872-016-0260-0
                    
                  ." href=#ref-CR26 id=ref-link-section-d117163409e4209>26</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref title="Gargiulo P, Savarese G, D’Amore C, et al. Efficacy and safety of glucagon-like peptide-1 agonists on macrovascular and microvascular events in type 2 diabetes mellitus: A meta-analysis. Nutr Metab Cardiovasc Dis. 2017;27(12):1081–8." href=#ref-CR27 id=ref-link-section-d117163409e4209_1>27</a>,<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 28" title="Scheen AJ. GLP-1 receptor agonists and heart failure in diabetes. Diabetes Metab. 2017;43(Suppl 1):2S13–9." href=#ref-CR28 id=ref-link-section-d117163409e4212>28</a>].<h3 class=c-article__sub-heading id=Sec16>Strengths and limitations</h3><p>The current study has several strengths. We used GLP-1 agonists as the comparator, and these agents represent reasonable second-line therapy for most patients according to existing guidelines. Secondly, we had a large sample size that allowed for the assessment of the heterogeneity of the treatment effect in selected subgroups of diabetes patients. Third, we performed several subgroup and sensitivity analyses providing confidence in the robustness of our primary findings. Nevertheless, the current study needs to be viewed in light of several limitations. First, the current study was conducted using observational data and, because of different route of administration (DPP-4 inhibitors are administered orally whereas GLP-1 agonists are injectable) as well as slightly different A1c lowering ability and adverse drug effects (e.g. weight loss) between DPP-4 inhibitors and GLP-1 agonists, the potential of selection bias may exist. However, we used a propensity score matching approach to minimize differences in baseline characteristics and disease risk factors between the two treatment groups. Second, deaths occurring outside of hospitals were not available in our data. Recent data suggest that GLP-1 agonists may have a mortality benefit compared with DPP-4 inhibitors, although the results of the analysis were limited by the small number of events (n = 20 in 7 trials) [<a data-track=click data-track-action="reference anchor" data-track-label=link data-test=citation-ref aria-label="Reference 13" title="Zheng SL, Roddick AJ, Aghar-Jaffar R, et al. Association between use of sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide 1 agonists, and dipeptidyl peptidase 4 inhibitors with all-cause mortality in patients with type 2 diabetes: a systematic review and meta-analysis. JAMA. 2018;319(15):1580–91. 
                    https://doi.org/10.1001/jama.2018.3024
                    
                  ." href=#ref-CR13 id=ref-link-section-d117163409e4224>13</a>]. This, if true, could have led to survivor bias in our analysis, whereby GLP-1 agonists users may be less likely to die prior to a HF hospitalization, leading to more cases in this group. Nevertheless, we suspect any such bias to be negligible because the censoring rate due to end of enrollment (which include patients who died) was similar between the two groups (4% for DPP-4 inhibitors vs. 4% for GLP-1 agonists).<p>Third, the claims data used in this study were collected primarily for billing purposes and do not include clinical biomarkers, such as HbA1c. Thus, residual confounding resulting from missing data on important confounders such as demographics (e.g. race), or lab values (e.g. HbA1c) is still possible. Fourth, because outcome definition and the identification of confounders relies on ICD-9 codes only, there is the potential for bias resulting from errors in coding. However, the validity of ICD-9 codes used for the identification of the study outcome or the confounders has been assessed previously. Fifth, although informative censoring resulting from treatment discontinuation can impact the study results, our sensitivity analyses following the patients for a fixed period of time (45&nbsp;days) provides some degree of confidence that this was not a major issue in our primary findings. Results from the current study are generalizable to patients with type 2 diabetes who are covered by commercial or Medicare supplemental insurance, limiting the generalizability to the broader Medicare population.</p></div></div></section><section data-title=Conclusion><div class=c-article-section id=Sec17-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Sec17>Conclusion</h2><div class=c-article-section__content id=Sec17-content><p>In this retrospective matched cohort of patients with type 2 diabetes, the use of DPP-4 inhibitors was associated with a reduced risk of HF hospitalization compared to GLP-1 agonists, although the association was not statistically significant in patients with baseline HF. Furthermore, we found consistent beneficial effects comparing individual DPP-4 inhibitors including saxagliptin and sitagliptin to GLP-1 agonists.</p></div></div></section>
 <section data-title=Abbreviations><div class=c-article-section id=abbreviations-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=abbreviations>Abbreviations</h2><div class=c-article-section__content id=abbreviations-content><dl class=c-abbreviation_list><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>CVD:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>cardiovascular diseases</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>CI:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>confidence interval</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>DPP-4:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>dipeptidyl peptidase-4</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>ESRD:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>end-stage renal disease</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>FDA:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>Food and Drug Administration</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>GLP-1:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>glucagon-like peptide-1</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>HR:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>hazard ratio</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>HF:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>heart failure</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>ICD-9-CM:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>International Classification of Diseases, Ninth Revision, Clinical Modification</p>
 <dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>TZA:</dfn><dd class="c-abbreviation_list__description u-mb-24">
 <p>thiazolidinediones</p>
 </dl></div></div></section><div id=MagazineFulltextArticleBodySuffix><section aria-labelledby=Bib1 data-title=References><div class=c-article-section id=Bib1-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Bib1>References</h2><div class=c-article-section__content id=Bib1-content><div data-container-section=references><ol class=c-article-references data-track-component="outbound reference"><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=1.><p class=c-article-references__text id=ref-CR1>Filion KB, Suissa S. DPP-4 inhibitors and heart failure: some reassurance, some uncertainty. Diabetes Care. 2016;39(5):735–7. <a href=https://doi.org/10.2337/dci15-0036>https://doi.org/10.2337/dci15-0036</a>.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.2337/dci15-0036 data-track-action="article reference" href=https://doi.org/10.2337%2Fdci15-0036 aria-label="Article reference 1" data-doi=10.2337/dci15-0036>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27208376" aria-label="PubMed reference 1">PubMed</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="cas reference" href=https://cardiab.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC2sXivV2qt78%3D aria-label="CAS reference 1">CAS</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 1" href="http://scholar.google.com/scholar_lookup?&amp;title=DPP-4%20inhibitors%20and%20heart%20failure%3A%20some%20reassurance%2C%20some%20uncertainty&amp;journal=Diabetes%20Care&amp;doi=10.2337%2Fdci15-0036&amp;volume=39&amp;issue=5&amp;pages=735-737&amp;publication_year=2016&amp;author=Filion%2CKB&amp;author=Suissa%2CS">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=2.><p class=c-article-references__text id=ref-CR2>Toh S, Hampp C, Reichman ME, et al. Risk for hospitalized heart failure among new users of saxagliptin, sitagliptin, and other antihyperglycemic drugs: a retrospective cohort study. Ann Intern Med. 2016;164(11):705–14. <a href=https://doi.org/10.7326/m15-2568>https://doi.org/10.7326/m15-2568</a>.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.7326/M15-2568 data-track-action="article reference" href=https://doi.org/10.7326%2FM15-2568 aria-label="Article reference 2" data-doi=10.7326/M15-2568>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27110660" aria-label="PubMed reference 2">PubMed</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed central reference" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5178978 aria-label="PubMed Central reference 2">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 2" href="http://scholar.google.com/scholar_lookup?&amp;title=Risk%20for%20hospitalized%20heart%20failure%20among%20new%20users%20of%20saxagliptin%2C%20sitagliptin%2C%20and%20other%20antihyperglycemic%20drugs%3A%20a%20retrospective%20cohort%20study&amp;journal=Ann%20Intern%20Med&amp;doi=10.7326%2Fm15-2568&amp;volume=164&amp;issue=11&amp;pages=705-714&amp;publication_year=2016&amp;author=Toh%2CS&amp;author=Hampp%2CC&amp;author=Reichman%2CME">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=3.><p class=c-article-references__text id=ref-CR3>Vella A. Mechanism of action of DPP-4 inhibitors–new insights. J Clin Endocrinol Metab. 2012;97(8):2626–8. <a href=https://doi.org/10.1210/jc.2012-2396>https://doi.org/10.1210/jc.2012-2396</a>.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1210/jc.2012-2396 data-track-action="article reference" href=https://doi.org/10.1210%2Fjc.2012-2396 aria-label="Article reference 3" data-doi=10.1210/jc.2012-2396>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22869847" aria-label="PubMed reference 3">PubMed</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed central reference" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3410278 aria-label="PubMed Central reference 3">PubMed Central</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="cas reference" href=https://cardiab.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC38XhtlGnt7bM aria-label="CAS reference 3">CAS</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 3" href="http://scholar.google.com/scholar_lookup?&amp;title=Mechanism%20of%20action%20of%20DPP-4%20inhibitors%E2%80%93new%20insights&amp;journal=J%20Clin%20Endocrinol%20Metab&amp;doi=10.1210%2Fjc.2012-2396&amp;volume=97&amp;issue=8&amp;pages=2626-2628&amp;publication_year=2012&amp;author=Vella%2CA">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=4.><p class=c-article-references__text id=ref-CR4>Li L, Li S, Deng K, et al. Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: Systematic review and meta-analysis of randomised and observational studies. BMJ. 2016;352:i610. <a href=https://doi.org/10.1136/bmj.i610>https://doi.org/10.1136/bmj.i610</a>.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1136/bmj.i610 data-track-action="article reference" href=https://doi.org/10.1136%2Fbmj.i610 aria-label="Article reference 4" data-doi=10.1136/bmj.i610>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26888822" aria-label="PubMed reference 4">PubMed</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed central reference" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772781 aria-label="PubMed Central reference 4">PubMed Central</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="cas reference" href=https://cardiab.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC28XitV2qsrjP aria-label="CAS reference 4">CAS</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 4" href="http://scholar.google.com/scholar_lookup?&amp;title=Dipeptidyl%20peptidase-4%20inhibitors%20and%20risk%20of%20heart%20failure%20in%20type%202%20diabetes%3A%20Systematic%20review%20and%20meta-analysis%20of%20randomised%20and%20observational%20studies&amp;journal=BMJ&amp;doi=10.1136%2Fbmj.i610&amp;volume=352&amp;publication_year=2016&amp;author=Li%2CL&amp;author=Li%2CS&amp;author=Deng%2CK">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=5.><p class=c-article-references__text id=ref-CR5>Karagiannis T, Boura P, Tsapas A. Safety of dipeptidyl peptidase 4 inhibitors: a perspective review. Ther Adv Drug Saf. 2014;5(3):138–46. <a href=https://doi.org/10.1177/2042098614523031>https://doi.org/10.1177/2042098614523031</a>.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1177/2042098614523031 data-track-action="article reference" href=https://doi.org/10.1177%2F2042098614523031 aria-label="Article reference 5" data-doi=10.1177/2042098614523031>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25083269" aria-label="PubMed reference 5">PubMed</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed central reference" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4110853 aria-label="PubMed Central reference 5">PubMed Central</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="cas reference" href=https://cardiab.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC2cXhslens7jN aria-label="CAS reference 5">CAS</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 5" href="http://scholar.google.com/scholar_lookup?&amp;title=Safety%20of%20dipeptidyl%20peptidase%204%20inhibitors%3A%20a%20perspective%20review&amp;journal=Ther%20Adv%20Drug%20Saf&amp;doi=10.1177%2F2042098614523031&amp;volume=5&amp;issue=3&amp;pages=138-146&amp;publication_year=2014&amp;author=Karagiannis%2CT&amp;author=Boura%2CP&amp;author=Tsapas%2CA">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=6.><p class=c-article-references__text id=ref-CR6>Scirica BM, Bhatt DL, Braunwald E, et al. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. N Engl J Med. 2013;369(14):1317–26. <a href=https://doi.org/10.1056/nejmoa1307684>https://doi.org/10.1056/nejmoa1307684</a>.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1056/NEJMoa1307684 data-track-action="article reference" href=https://doi.org/10.1056%2FNEJMoa1307684 aria-label="Article reference 6" data-doi=10.1056/NEJMoa1307684>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=23992601" aria-label="PubMed reference 6">PubMed</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="cas reference" href=https://cardiab.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC3sXhsF2ksbzN aria-label="CAS reference 6">CAS</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 6" href="http://scholar.google.com/scholar_lookup?&amp;title=Saxagliptin%20and%20cardiovascular%20outcomes%20in%20patients%20with%20type%202%20diabetes%20mellitus&amp;journal=N%20Engl%20J%20Med&amp;doi=10.1056%2Fnejmoa1307684&amp;volume=369&amp;issue=14&amp;pages=1317-1326&amp;publication_year=2013&amp;author=Scirica%2CBM&amp;author=Bhatt%2CDL&amp;author=Braunwald%2CE">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=7.><p class=c-article-references__text id=ref-CR7>Zannad F, Stough WG, Lipicky RJ, et al. Assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversion. Eur Heart J Cardiovasc Pharmacother. 2016;2(3):200–5. <a href=https://doi.org/10.1093/ehjcvp/pvw007>https://doi.org/10.1093/ehjcvp/pvw007</a>.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1093/ehjcvp/pvw007 data-track-action="article reference" href=https://doi.org/10.1093%2Fehjcvp%2Fpvw007 aria-label="Article reference 7" data-doi=10.1093/ehjcvp/pvw007>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27418973" aria-label="PubMed reference 7">PubMed</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed central reference" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907355 aria-label="PubMed Central reference 7">PubMed Central</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="cas reference" href=https://cardiab.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC1cXnslWmsLc%3D aria-label="CAS reference 7">CAS</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 7" href="http://scholar.google.com/scholar_lookup?&amp;title=Assessment%20of%20cardiovascular%20risk%20of%20new%20drugs%20for%20the%20treatment%20of%20diabetes%20mellitus%3A%20risk%20assessment%20vs.%20risk%20aversion&amp;journal=Eur%20Heart%20J%20Cardiovasc%20Pharmacother&amp;doi=10.1093%2Fehjcvp%2Fpvw007&amp;volume=2&amp;issue=3&amp;pages=200-205&amp;publication_year=2016&amp;author=Zannad%2CF&amp;author=Stough%2CWG&amp;author=Lipicky%2CRJ">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=8.><p class=c-article-references__text id=ref-CR8>Green JB, Bethel MA, Armstrong PW, et al. Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2015;373(3):232–42. <a href=https://doi.org/10.1056/nejmoa1501352>https://doi.org/10.1056/nejmoa1501352</a>.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1056/NEJMoa1501352 data-track-action="article reference" href=https://doi.org/10.1056%2FNEJMoa1501352 aria-label="Article reference 8" data-doi=10.1056/NEJMoa1501352>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26052984" aria-label="PubMed reference 8">PubMed</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="cas reference" href=https://cardiab.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC2MXhtlKrtbnN aria-label="CAS reference 8">CAS</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 8" href="http://scholar.google.com/scholar_lookup?&amp;title=Effect%20of%20sitagliptin%20on%20cardiovascular%20outcomes%20in%20type%202%20diabetes&amp;journal=N%20Engl%20J%20Med&amp;doi=10.1056%2Fnejmoa1501352&amp;volume=373&amp;issue=3&amp;pages=232-242&amp;publication_year=2015&amp;author=Green%2CJB&amp;author=Bethel%2CMA&amp;author=Armstrong%2CPW">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=9.><p class=c-article-references__text id=ref-CR9>Food and Drug Administration. FDA drug safety communication: FDA adds warnings about heart failure risk to labels of type 2 diabetes medicines containing saxagliptin and alogliptin. US Food and Drug Administration Web site. <a href=https://www.fda.gov/Drugs/DrugSafety/ucm486096.htm>https://www.fda.gov/Drugs/DrugSafety/ucm486096.htm</a>. Updated 2016. Accessed 04 Apr 2018.</p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=10.><p class=c-article-references__text id=ref-CR10>Fu AZ, Johnston SS, Ghannam A, et al. Association between hospitalization for heart failure and dipeptidyl peptidase 4 inhibitors in patients with type 2 diabetes: an observational study. Diabetes Care. 2016;39(5):726–34. <a href=https://doi.org/10.2337/dc15-0764>https://doi.org/10.2337/dc15-0764</a>.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.2337/dc15-0764 data-track-action="article reference" href=https://doi.org/10.2337%2Fdc15-0764 aria-label="Article reference 10" data-doi=10.2337/dc15-0764>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26740636" aria-label="PubMed reference 10">PubMed</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="cas reference" href=https://cardiab.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC2sXivV2qsbk%3D aria-label="CAS reference 10">CAS</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 10" href="http://scholar.google.com/scholar_lookup?&amp;title=Association%20between%20hospitalization%20for%20heart%20failure%20and%20dipeptidyl%20peptidase%204%20inhibitors%20in%20patients%20with%20type%202%20diabetes%3A%20an%20observational%20study&amp;journal=Diabetes%20Care&amp;doi=10.2337%2Fdc15-0764&amp;volume=39&amp;issue=5&amp;pages=726-734&amp;publication_year=2016&amp;author=Fu%2CAZ&amp;author=Johnston%2CSS&amp;author=Ghannam%2CA">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=11.><p class=c-article-references__text id=ref-CR11>American Diabetes Association. 8. pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S73–85. <a href=https://doi.org/10.2337/dc18-s008>https://doi.org/10.2337/dc18-s008</a>.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.2337/dc18-S008 data-track-action="article reference" href=https://doi.org/10.2337%2Fdc18-S008 aria-label="Article reference 11" data-doi=10.2337/dc18-S008>Article</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 11" href="http://scholar.google.com/scholar_lookup?&amp;title=8.%20pharmacologic%20approaches%20to%20glycemic%20treatment%3A%20standards%20of%20medical%20care%20in%20diabetes-2018&amp;journal=Diabetes%20Care&amp;doi=10.2337%2Fdc18-s008&amp;volume=41&amp;issue=Suppl%201&amp;pages=S73-S85&amp;publication_year=2018">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=12.><p class=c-article-references__text id=ref-CR12>Brunton S. GLP-1 receptor agonists vs. DPP-4 inhibitors for type 2 diabetes: Is one approach more successful or preferable than the other? Int J Clin Pract. 2014;68(5):557–67. <a href=https://doi.org/10.1111/ijcp.12361>https://doi.org/10.1111/ijcp.12361</a>.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1111/ijcp.12361 data-track-action="article reference" href=https://doi.org/10.1111%2Fijcp.12361 aria-label="Article reference 12" data-doi=10.1111/ijcp.12361>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24499291" aria-label="PubMed reference 12">PubMed</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed central reference" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4238422 aria-label="PubMed Central reference 12">PubMed Central</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="cas reference" href=https://cardiab.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC2cXmslyjt74%3D aria-label="CAS reference 12">CAS</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 12" href="http://scholar.google.com/scholar_lookup?&amp;title=GLP-1%20receptor%20agonists%20vs.%20DPP-4%20inhibitors%20for%20type%202%20diabetes%3A%20Is%20one%20approach%20more%20successful%20or%20preferable%20than%20the%20other%3F&amp;journal=Int%20J%20Clin%20Pract&amp;doi=10.1111%2Fijcp.12361&amp;volume=68&amp;issue=5&amp;pages=557-567&amp;publication_year=2014&amp;author=Brunton%2CS">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=13.><p class=c-article-references__text id=ref-CR13>Zheng SL, Roddick AJ, Aghar-Jaffar R, et al. Association between use of sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide 1 agonists, and dipeptidyl peptidase 4 inhibitors with all-cause mortality in patients with type 2 diabetes: a systematic review and meta-analysis. JAMA. 2018;319(15):1580–91. <a href=https://doi.org/10.1001/jama.2018.3024>https://doi.org/10.1001/jama.2018.3024</a>.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1001/jama.2018.3024 data-track-action="article reference" href=https://doi.org/10.1001%2Fjama.2018.3024 aria-label="Article reference 13" data-doi=10.1001/jama.2018.3024>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=29677303" aria-label="PubMed reference 13">PubMed</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="cas reference" href=https://cardiab.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC1cXotVCmsLY%3D aria-label="CAS reference 13">CAS</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed central reference" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933330 aria-label="PubMed Central reference 13">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 13" href="http://scholar.google.com/scholar_lookup?&amp;title=Association%20between%20use%20of%20sodium-glucose%20cotransporter%202%20inhibitors%2C%20glucagon-like%20peptide%201%20agonists%2C%20and%20dipeptidyl%20peptidase%204%20inhibitors%20with%20all-cause%20mortality%20in%20patients%20with%20type%202%20diabetes%3A%20a%20systematic%20review%20and%20meta-analysis&amp;journal=JAMA&amp;doi=10.1001%2Fjama.2018.3024&amp;volume=319&amp;issue=15&amp;pages=1580-1591&amp;publication_year=2018&amp;author=Zheng%2CSL&amp;author=Roddick%2CAJ&amp;author=Aghar-Jaffar%2CR">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=14.><p class=c-article-references__text id=ref-CR14>Saczynski JS, Andrade SE, Harrold LR, et al. A systematic review of validated methods for identifying heart failure using administrative data. Pharmacoepidemiol Drug Saf. 2012;21(Suppl 1):129–40. <a href=https://doi.org/10.1002/pds.2313>https://doi.org/10.1002/pds.2313</a>.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1002/pds.2313 data-track-action="article reference" href=https://doi.org/10.1002%2Fpds.2313 aria-label="Article reference 14" data-doi=10.1002/pds.2313>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22262599" aria-label="PubMed reference 14">PubMed</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 14" href="http://scholar.google.com/scholar_lookup?&amp;title=A%20systematic%20review%20of%20validated%20methods%20for%20identifying%20heart%20failure%20using%20administrative%20data&amp;journal=Pharmacoepidemiol%20Drug%20Saf&amp;doi=10.1002%2Fpds.2313&amp;volume=21&amp;issue=Suppl%201&amp;pages=129-140&amp;publication_year=2012&amp;author=Saczynski%2CJS&amp;author=Andrade%2CSE&amp;author=Harrold%2CLR">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=15.><p class=c-article-references__text id=ref-CR15>Fireman B, Toh S, Butler MG, et al. A protocol for active surveillance of acute myocardial infarction in association with the use of a new antidiabetic pharmaceutical agent. Pharmacoepidemiol Drug Saf. 2012;21(Suppl 1):282–90. <a href=https://doi.org/10.1002/pds.2337>https://doi.org/10.1002/pds.2337</a>.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1002/pds.2337 data-track-action="article reference" href=https://doi.org/10.1002%2Fpds.2337 aria-label="Article reference 15" data-doi=10.1002/pds.2337>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22262618" aria-label="PubMed reference 15">PubMed</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 15" href="http://scholar.google.com/scholar_lookup?&amp;title=A%20protocol%20for%20active%20surveillance%20of%20acute%20myocardial%20infarction%20in%20association%20with%20the%20use%20of%20a%20new%20antidiabetic%20pharmaceutical%20agent&amp;journal=Pharmacoepidemiol%20Drug%20Saf&amp;doi=10.1002%2Fpds.2337&amp;volume=21&amp;issue=Suppl%201&amp;pages=282-290&amp;publication_year=2012&amp;author=Fireman%2CB&amp;author=Toh%2CS&amp;author=Butler%2CMG">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=16.><p class=c-article-references__text id=ref-CR16>Yang D, Dalton J. A unified approach to measuring the effect size between two groups using SAS<sup>®</sup>. SAS Global Forum. 2012;35:1–6.<p class="c-article-references__links u-hide-print"><a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 16" href="http://scholar.google.com/scholar_lookup?&amp;title=A%20unified%20approach%20to%20measuring%20the%20effect%20size%20between%20two%20groups%20using%20SAS%C2%AE&amp;journal=SAS%20Global%20Forum&amp;volume=35&amp;pages=1-6&amp;publication_year=2012&amp;author=Yang%2CD&amp;author=Dalton%2CJ">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=17.><p class=c-article-references__text id=ref-CR17>D’Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17(19):2265–81. <a href=https://doi.org/10.1002/(sici)1097-0258(19981015)17:193.0.co;2-b>https://doi.org/10.1002/(sici)1097-0258(19981015)17:193.0.co;2-b</a>.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label="10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B" data-track-action="article reference" href=https://doi.org/10.1002%2F%28SICI%291097-0258%2819981015%2917%3A19%3C2265%3A%3AAID-SIM918%3E3.0.CO%3B2-B aria-label="Article reference 17" data-doi="10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B">Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=9802183" aria-label="PubMed reference 17">PubMed</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 17" href="http://scholar.google.com/scholar_lookup?&amp;title=Propensity%20score%20methods%20for%20bias%20reduction%20in%20the%20comparison%20of%20a%20treatment%20to%20a%20non-randomized%20control%20group&amp;journal=Stat%20Med&amp;doi=10.1002%2F%28sici%291097-0258%2819981015%2917%3A193.0.co%3B2-b&amp;volume=17&amp;issue=19&amp;pages=2265-2281&amp;publication_year=1998&amp;author=D%E2%80%99Agostino%2CRB">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=18.><p class=c-article-references__text id=ref-CR18>Kim YG, Yoon D, Park S, et al. Dipeptidyl peptidase-4 inhibitors and risk of heart failure in patients with type 2 diabetes mellitus: a population-based cohort study. Circ Heart Fail. 2017;10(9):e003957. <a href=https://doi.org/10.1161/circheartfailure.117.003957>https://doi.org/10.1161/circheartfailure.117.003957</a>.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1161/CIRCHEARTFAILURE.117.003957 data-track-action="article reference" href=https://doi.org/10.1161%2FCIRCHEARTFAILURE.117.003957 aria-label="Article reference 18" data-doi=10.1161/CIRCHEARTFAILURE.117.003957>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=28899989" aria-label="PubMed reference 18">PubMed</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="cas reference" href=https://cardiab.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC2sXhsFWqurzL aria-label="CAS reference 18">CAS</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 18" href="http://scholar.google.com/scholar_lookup?&amp;title=Dipeptidyl%20peptidase-4%20inhibitors%20and%20risk%20of%20heart%20failure%20in%20patients%20with%20type%202%20diabetes%20mellitus%3A%20a%20population-based%20cohort%20study&amp;journal=Circ%20Heart%20Fail&amp;doi=10.1161%2Fcircheartfailure.117.003957&amp;volume=10&amp;issue=9&amp;publication_year=2017&amp;author=Kim%2CYG&amp;author=Yoon%2CD&amp;author=Park%2CS">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=19.><p class=c-article-references__text id=ref-CR19>Nesto RW, Bell D, Bonow RO, et al. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American heart association and American diabetes association. Diabetes Care. 2004;27(1):256–63.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.2337/diacare.27.1.256 data-track-action="article reference" href=https://doi.org/10.2337%2Fdiacare.27.1.256 aria-label="Article reference 19" data-doi=10.2337/diacare.27.1.256>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=14693998" aria-label="PubMed reference 19">PubMed</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="cas reference" href=https://cardiab.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BD2cXmvV2isQ%3D%3D aria-label="CAS reference 19">CAS</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 19" href="http://scholar.google.com/scholar_lookup?&amp;title=Thiazolidinedione%20use%2C%20fluid%20retention%2C%20and%20congestive%20heart%20failure%3A%20a%20consensus%20statement%20from%20the%20American%20heart%20association%20and%20American%20diabetes%20association&amp;journal=Diabetes%20Care&amp;doi=10.2337%2Fdiacare.27.1.256&amp;volume=27&amp;issue=1&amp;pages=256-263&amp;publication_year=2004&amp;author=Nesto%2CRW&amp;author=Bell%2CD&amp;author=Bonow%2CRO">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=20.><p class=c-article-references__text id=ref-CR20>Fadini GP, Bonora BM, Albiero M, Zaninotto M, Plebani M, Avogaro A. DPP-4 inhibition has no acute effect on BNP and its N-terminal pro-hormone measured by commercial immune-assays. A randomized cross-over trial in patients with type 2 diabetes. Cardiovasc Diabetol. 2017;16(1):22. <a href=https://doi.org/10.1186/s12933-017-0507-9>https://doi.org/10.1186/s12933-017-0507-9</a>.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1186/s12933-017-0507-9 data-track-action="article reference" href=https://doi.org/10.1186%2Fs12933-017-0507-9 aria-label="Article reference 20" data-doi=10.1186/s12933-017-0507-9>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=28183314" aria-label="PubMed reference 20">PubMed</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed central reference" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5301429 aria-label="PubMed Central reference 20">PubMed Central</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="cas reference" href=https://cardiab.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC1cXkslyqu70%3D aria-label="CAS reference 20">CAS</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 20" href="http://scholar.google.com/scholar_lookup?&amp;title=DPP-4%20inhibition%20has%20no%20acute%20effect%20on%20BNP%20and%20its%20N-terminal%20pro-hormone%20measured%20by%20commercial%20immune-assays.%20A%20randomized%20cross-over%20trial%20in%20patients%20with%20type%202%20diabetes&amp;journal=Cardiovasc%20Diabetol&amp;doi=10.1186%2Fs12933-017-0507-9&amp;volume=16&amp;issue=1&amp;publication_year=2017&amp;author=Fadini%2CGP&amp;author=Bonora%2CBM&amp;author=Albiero%2CM&amp;author=Zaninotto%2CM&amp;author=Plebani%2CM&amp;author=Avogaro%2CA">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=21.><p class=c-article-references__text id=ref-CR21>Ussher JR, Drucker DJ. Cardiovascular biology of the incretin system. Endocr Rev. 2012;33(2):187–215. <a href=https://doi.org/10.1210/er.2011-1052>https://doi.org/10.1210/er.2011-1052</a>.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1210/er.2011-1052 data-track-action="article reference" href=https://doi.org/10.1210%2Fer.2011-1052 aria-label="Article reference 21" data-doi=10.1210/er.2011-1052>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22323472" aria-label="PubMed reference 21">PubMed</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed central reference" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528785 aria-label="PubMed Central reference 21">PubMed Central</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="cas reference" href=https://cardiab.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC38XnsVOrsLc%3D aria-label="CAS reference 21">CAS</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 21" href="http://scholar.google.com/scholar_lookup?&amp;title=Cardiovascular%20biology%20of%20the%20incretin%20system&amp;journal=Endocr%20Rev&amp;doi=10.1210%2Fer.2011-1052&amp;volume=33&amp;issue=2&amp;pages=187-215&amp;publication_year=2012&amp;author=Ussher%2CJR&amp;author=Drucker%2CDJ">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=22.><p class=c-article-references__text id=ref-CR22>Miyoshi T, Nakamura K, Yoshida M, et al. Effect of vildagliptin, a dipeptidyl peptidase 4 inhibitor, on cardiac hypertrophy induced by chronic beta-adrenergic stimulation in rats. Cardiovasc Diabetol. 2014;13:43. <a href=https://doi.org/10.1186/1475-2840-13-43>https://doi.org/10.1186/1475-2840-13-43</a>.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1186/1475-2840-13-43 data-track-action="article reference" href=https://doi.org/10.1186%2F1475-2840-13-43 aria-label="Article reference 22" data-doi=10.1186/1475-2840-13-43>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24521405" aria-label="PubMed reference 22">PubMed</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed central reference" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3926272 aria-label="PubMed Central reference 22">PubMed Central</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="cas reference" href=https://cardiab.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC2MXivV2qt7c%3D aria-label="CAS reference 22">CAS</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 22" href="http://scholar.google.com/scholar_lookup?&amp;title=Effect%20of%20vildagliptin%2C%20a%20dipeptidyl%20peptidase%204%20inhibitor%2C%20on%20cardiac%20hypertrophy%20induced%20by%20chronic%20beta-adrenergic%20stimulation%20in%20rats&amp;journal=Cardiovasc%20Diabetol&amp;doi=10.1186%2F1475-2840-13-43&amp;volume=13&amp;publication_year=2014&amp;author=Miyoshi%2CT&amp;author=Nakamura%2CK&amp;author=Yoshida%2CM">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=23.><p class=c-article-references__text id=ref-CR23>Chin HJ, Nam JH, Lee EK, Shin JY. Comparative safety for cardiovascular outcomes of DPP-4 inhibitors versus glimepiride in patients with type 2 diabetes: a retrospective cohort study. Medicine (Baltimore). 2017;96(25):e7213. <a href=https://doi.org/10.1097/md.0000000000007213>https://doi.org/10.1097/md.0000000000007213</a>.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1097/MD.0000000000007213 data-track-action="article reference" href=https://doi.org/10.1097%2FMD.0000000000007213 aria-label="Article reference 23" data-doi=10.1097/MD.0000000000007213>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="cas reference" href=https://cardiab.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC2sXhtVektLnF aria-label="CAS reference 23">CAS</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 23" href="http://scholar.google.com/scholar_lookup?&amp;title=Comparative%20safety%20for%20cardiovascular%20outcomes%20of%20DPP-4%20inhibitors%20versus%20glimepiride%20in%20patients%20with%20type%202%20diabetes%3A%20a%20retrospective%20cohort%20study&amp;journal=Medicine%20%28Baltimore%29&amp;doi=10.1097%2Fmd.0000000000007213&amp;volume=96&amp;issue=25&amp;publication_year=2017&amp;author=Chin%2CHJ&amp;author=Nam%2CJH&amp;author=Lee%2CEK&amp;author=Shin%2CJY">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=24.><p class=c-article-references__text id=ref-CR24>Hashikata T, Yamaoka-Tojo M, Kakizaki R, et al. Teneligliptin improves left ventricular diastolic function and endothelial function in patients with diabetes. Heart Vessels. 2016;31(8):1303–10. <a href=https://doi.org/10.1007/s00380-015-0724-7>https://doi.org/10.1007/s00380-015-0724-7</a>.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1007/s00380-015-0724-7 data-track-action="article reference" href=https://doi.org/10.1007%2Fs00380-015-0724-7 aria-label="Article reference 24" data-doi=10.1007/s00380-015-0724-7>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26266630" aria-label="PubMed reference 24">PubMed</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 24" href="http://scholar.google.com/scholar_lookup?&amp;title=Teneligliptin%20improves%20left%20ventricular%20diastolic%20function%20and%20endothelial%20function%20in%20patients%20with%20diabetes&amp;journal=Heart%20Vessels&amp;doi=10.1007%2Fs00380-015-0724-7&amp;volume=31&amp;issue=8&amp;pages=1303-1310&amp;publication_year=2016&amp;author=Hashikata%2CT&amp;author=Yamaoka-Tojo%2CM&amp;author=Kakizaki%2CR">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=25.><p class=c-article-references__text id=ref-CR25>Gautam S, Agiro A, Barron J, Power T, Weisman H, White J. Heart failure hospitalization risk associated with use of two classes of oral antidiabetic medications: an observational, real-world analysis. Cardiovasc Diabetol. 2017;16(1):93. <a href=https://doi.org/10.1186/s12933-017-0575-x>https://doi.org/10.1186/s12933-017-0575-x</a>.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1186/s12933-017-0575-x data-track-action="article reference" href=https://doi.org/10.1186%2Fs12933-017-0575-x aria-label="Article reference 25" data-doi=10.1186/s12933-017-0575-x>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=28756774" aria-label="PubMed reference 25">PubMed</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed central reference" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5535291 aria-label="PubMed Central reference 25">PubMed Central</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 25" href="http://scholar.google.com/scholar_lookup?&amp;title=Heart%20failure%20hospitalization%20risk%20associated%20with%20use%20of%20two%20classes%20of%20oral%20antidiabetic%20medications%3A%20an%20observational%2C%20real-world%20analysis&amp;journal=Cardiovasc%20Diabetol&amp;doi=10.1186%2Fs12933-017-0575-x&amp;volume=16&amp;issue=1&amp;publication_year=2017&amp;author=Gautam%2CS&amp;author=Agiro%2CA&amp;author=Barron%2CJ&amp;author=Power%2CT&amp;author=Weisman%2CH&amp;author=White%2CJ">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=26.><p class=c-article-references__text id=ref-CR26>Li L, Li S, Liu J, et al. Glucagon-like peptide-1 receptor agonists and heart failure in type 2 diabetes: systematic review and meta-analysis of randomized and observational studies. BMC Cardiovasc Disord. 2016;16:91. <a href=https://doi.org/10.1186/s12872-016-0260-0>https://doi.org/10.1186/s12872-016-0260-0</a>.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1186/s12872-016-0260-0 data-track-action="article reference" href=https://doi.org/10.1186%2Fs12872-016-0260-0 aria-label="Article reference 26" data-doi=10.1186/s12872-016-0260-0>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27169565" aria-label="PubMed reference 26">PubMed</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed central reference" href=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863354 aria-label="PubMed Central reference 26">PubMed Central</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="cas reference" href=https://cardiab.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC2sXnvVSmtb4%3D aria-label="CAS reference 26">CAS</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 26" href="http://scholar.google.com/scholar_lookup?&amp;title=Glucagon-like%20peptide-1%20receptor%20agonists%20and%20heart%20failure%20in%20type%202%20diabetes%3A%20systematic%20review%20and%20meta-analysis%20of%20randomized%20and%20observational%20studies&amp;journal=BMC%20Cardiovasc%20Disord&amp;doi=10.1186%2Fs12872-016-0260-0&amp;volume=16&amp;publication_year=2016&amp;author=Li%2CL&amp;author=Li%2CS&amp;author=Liu%2CJ">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=27.><p class=c-article-references__text id=ref-CR27>Gargiulo P, Savarese G, D’Amore C, et al. Efficacy and safety of glucagon-like peptide-1 agonists on macrovascular and microvascular events in type 2 diabetes mellitus: A meta-analysis. Nutr Metab Cardiovasc Dis. 2017;27(12):1081–8.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1016/j.numecd.2017.09.006 data-track-action="article reference" href=https://doi.org/10.1016%2Fj.numecd.2017.09.006 aria-label="Article reference 27" data-doi=10.1016/j.numecd.2017.09.006>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=29113708" aria-label="PubMed reference 27">PubMed</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="cas reference" href=https://cardiab.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC2sXhs1Sqtb3L aria-label="CAS reference 27">CAS</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 27" href="http://scholar.google.com/scholar_lookup?&amp;title=Efficacy%20and%20safety%20of%20glucagon-like%20peptide-1%20agonists%20on%20macrovascular%20and%20microvascular%20events%20in%20type%202%20diabetes%20mellitus%3A%20A%20meta-analysis&amp;journal=Nutr%20Metab%20Cardiovasc%20Dis&amp;doi=10.1016%2Fj.numecd.2017.09.006&amp;volume=27&amp;issue=12&amp;pages=1081-1088&amp;publication_year=2017&amp;author=Gargiulo%2CP&amp;author=Savarese%2CG&amp;author=D%E2%80%99Amore%2CC">
 Google Scholar</a>&nbsp;
 </p><li class="c-article-references__item js-c-reading-companion-references-item" data-counter=28.><p class=c-article-references__text id=ref-CR28>Scheen AJ. GLP-1 receptor agonists and heart failure in diabetes. Diabetes Metab. 2017;43(Suppl 1):2S13–9.<p class="c-article-references__links u-hide-print"><a data-track=click rel="nofollow noopener" data-track-label=10.1016/S1262-3636(17)30068-X data-track-action="article reference" href=https://doi.org/10.1016%2FS1262-3636%2817%2930068-X aria-label="Article reference 28" data-doi=10.1016/S1262-3636(17)30068-X>Article</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=28431666" aria-label="PubMed reference 28">PubMed</a>&nbsp;
 <a data-track=click rel="nofollow noopener" data-track-label=link data-track-action="cas reference" href=https://cardiab.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BC2sXmt1Kgur4%3D aria-label="CAS reference 28">CAS</a>&nbsp;
 <a data-track=click data-track-action="google scholar reference" data-track-label=link rel="nofollow noopener" aria-label="Google Scholar reference 28" href="http://scholar.google.com/scholar_lookup?&amp;title=GLP-1%20receptor%20agonists%20and%20heart%20failure%20in%20diabetes&amp;journal=Diabetes%20Metab&amp;doi=10.1016%2FS1262-3636%2817%2930068-X&amp;volume=43&amp;issue=Suppl%201&amp;pages=2S13-2S19&amp;publication_year=2017&amp;author=Scheen%2CAJ">
 Google Scholar</a>&nbsp;
 </p></ol><p class="c-article-references__download u-hide-print"><a data-track=click data-track-action="download citation references" data-track-label=link href="https://citation-needed.springer.com/v2/references/10.1186/s12933-018-0746-4?format=refman&amp;flavour=references">Download references<svg width=16 height=16 focusable=false role=img aria-hidden=true class=u-icon><use xmlns:xlink=http://www.w3.org/1999/xlink xlink:href=#global-icon-download></use></svg></a></p></div></div></div></section></div><section data-title="Authors’ contributions"><div class=c-article-section id=Ack1-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Ack1>Authors’ contributions</h2><div class=c-article-section__content id=Ack1-content><p>GD and HP created study concept and design. GD analyzed data. Data interpretation was performed by GD and HP, with assistance from SS. The manuscript was written primarily by GD, assisted and revised by HP and SS. All authors read and approved the final manuscript.</p>
 <h3 class=c-article__sub-heading id=FPar1>Acknowledgements</h3>
 <p>Not applicable.</p>
 
 <h3 class=c-article__sub-heading id=FPar2>Competing interests</h3>
 <p>The authors declare that they have no competing interests.</p>
 
 <h3 class=c-article__sub-heading id=FPar3>Availability of data and materials</h3>
 <p>The data used for this study is not publicly available.</p>
 
 <h3 class=c-article__sub-heading id=FPar4>Consent for publication</h3>
 <p>Each author has read and approved the manuscript and assumes responsibility of the content of the manuscript. The authors of the manuscript do not have any closely related papers or manuscripts that have been submitted or published elsewhere and declare that they do not have any competing interests.</p>
 
 <h3 class=c-article__sub-heading id=FPar5>Ethics approval and consent to participate</h3>
 <p>The study was approved by the institutional review board of the University of Florida Health Science Centers.</p>
 
 <h3 class=c-article__sub-heading id=FPar6>Funding</h3>
 <p>This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit-sector. Ghadeer Dawwas is a recipient of the American Association of Graduate Women (AAUW) fellowship for the 2017–2018&nbsp;year.</p>
 
 <h3 class=c-article__sub-heading id=FPar7>Publisher’s Note</h3>
 <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
 </div></div></section><section aria-labelledby=author-information data-title="Author information"><div class=c-article-section id=author-information-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=author-information>Author information</h2><div class=c-article-section__content id=author-information-content><h3 class=c-article__sub-heading id=affiliations>Authors and Affiliations</h3><ol class=c-article-author-affiliation__list><li id=Aff1><p class=c-article-author-affiliation__address>Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, PO Box 100495, Gainesville, FL, 32610, USA<p class=c-article-author-affiliation__authors-list>Ghadeer K. Dawwas&nbsp;&amp;&nbsp;Haesuk Park</p><li id=Aff2><p class=c-article-author-affiliation__address>Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, PO Box 100486, Gainesville, FL, 32610, USA<p class=c-article-author-affiliation__authors-list>Steven M. Smith</p><li id=Aff3><p class=c-article-author-affiliation__address>Department of Community Health and Family Medicine, College of Medicine, University of Florida, PO Box 100237, Gainesville, FL, 32610, USA<p class=c-article-author-affiliation__authors-list>Steven M. Smith</p></ol><div class="u-js-hide u-hide-print sf-hidden" data-test=author-info></div><h3 class=c-article__sub-heading id=corresponding-author>Corresponding author</h3><p id=corresponding-author-list>Correspondence to
 <a id=corresp-c1 href=mailto:hpark@cop.ufl.edu>Haesuk Park</a>.</p></div></div></section><section data-title="Additional file"><div class=c-article-section id=Sec18-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=Sec18>Additional file</h2><div class=c-article-section__content id=Sec18-content><div data-test=supplementary-info><div id=figshareContainer class=c-article-figshare-container data-test=figshare-container data-gtm-vis-recent-on-screen-50443292_310=44279 data-gtm-vis-first-on-screen-50443292_310=44279 data-gtm-vis-total-visible-time-50443292_310=100 data-gtm-vis-has-fired-50443292_310=1><div style="display:inline-block;position:relative;width:100%;height:100%;border:0px none transparent;margin:0px;padding:0px"><figshare-widget style=width:650px><article class=frontend-filesViewer-inlineMode-index-module__container--LzxR7><header class=frontend-filesViewer-inlineMode-header-module__header--L5zPq><div class=frontend-filesViewer-inlineMode-header-module__titleSection--cXZcY><p class=frontend-filesViewer-inlineMode-header-module__title--WcAab>MOESM1 of Risk of heart failure hospitalization among users of dipeptidyl peptidase-4 inhibitors compared to glucagon-like peptide-1 receptor agonists</p></div></header><div class=frontend-filesViewer-inlineMode-index-module__skipContainer--VO89A><button class="frontend-filesViewer-components-skipButton-index-module__button--wpP+- frontend-filesViewer-components-skipButton-index-module__hidden--TAOdS frontend-filesViewer-inlineMode-index-module__skipButton--JbCgu frontend-widgets-springer_nature-theme-module__skipButton--lH6gj frontend-widgets-springer_nature-theme-module__secondaryButton--k2CRj" type=button>Skip to fig<b>share</b> navigation</button></div><section class=frontend-filesViewer-inlineMode-mainSection-module__mainSection--xdIHv><div class=frontend-filesViewer-inlineMode-mainSection-module__viewerContainer--HLGmA style=width:650px;height:450px><div class=click-outside-wrapper><div class=fs-figshare-viewer><div class="fs-display fs-document-display" style=width:650px;height:450px><div class="figshare-loader fs-loading"><div class=fs-figshare-loader-holder><div class=fs-figshare-loader-message><div aria-hidden=true class=fs-logo><svg aria-hidden=true class=figshare-logo focusable=false height=36px role=img viewBox="0 0 14 14" width=36px><g class=group-1><path class=style3 d="M5.578 0.72C5.679 1 5.5 1.4 5.2 1.461C4.892 1.6 4.6 1.4 4.5 1.1 c-0.102-0.309 0.068-0.641 0.377-0.74C5.146 0.2 5.5 0.4 5.6 0.7"></path><path class=style3 d="M4.987 1.953C5.11 2.2 5 2.5 4.8 2.621C4.525 2.7 4.2 2.6 4.1 2.4 C3.978 2.2 4.1 1.9 4.3 1.737C4.562 1.6 4.9 1.7 5 2"></path><path class=style3 d="M4.686 3.109c0.134 0.2 0.1 0.443-0.092 0.577C4.408 3.8 4.2 3.8 4 3.6 C3.882 3.4 3.9 3.2 4.1 3.018C4.292 2.9 4.6 2.9 4.7 3.1"></path><path class=style3 d="M4.588 4.099c0.135 0.1 0.1 0.4 0 0.487c-0.135 0.136-0.354 0.136-0.488 0 C3.966 4.5 4 4.2 4.1 4.1S4.453 4 4.6 4.1"></path><path class=style3 d="M4.655 4.943c0.127 0.1 0.2 0.3 0.1 0.398C4.625 5.5 4.4 5.5 4.3 5.4 S4.165 5.1 4.3 5.007C4.35 4.9 4.5 4.9 4.7 4.9"></path><path class=style3 d="M4.83 5.631C4.945 5.7 5 5.8 4.9 5.946C4.874 6.1 4.7 6.1 4.6 6 c-0.115-0.059-0.161-0.2-0.103-0.315C4.574 5.6 4.7 5.6 4.8 5.6"></path></g><g class=group-2><path class=style0 d="M3.708 1.467c0.19 0.3 0.1 0.631-0.131 0.821c-0.263 0.191-0.631 0.133-0.822-0.13 c-0.19-0.264-0.132-0.631 0.131-0.822C3.148 1.1 3.5 1.2 3.7 1.5"></path><path class=style0 d="M3.526 2.823c0.193 0.2 0.2 0.5 0 0.702c-0.195 0.193-0.509 0.193-0.703 0 C2.63 3.3 2.6 3 2.8 2.823C3.018 2.6 3.3 2.6 3.5 2.8"></path><path class=style0 d="M3.596 4.015c0.186 0.1 0.2 0.4 0.1 0.578S3.295 4.8 3.1 4.7 C2.926 4.5 2.9 4.3 3 4.107C3.152 3.9 3.4 3.9 3.6 4"></path><path class=style0 d="M3.81 4.986C3.979 5.1 4 5.3 4 5.451C3.873 5.6 3.7 5.7 3.5 5.6 C3.327 5.5 3.3 5.3 3.3 5.138C3.432 5 3.6 4.9 3.8 5"></path><path class=style0 d="M4.135 5.769c0.149 0 0.2 0.2 0.2 0.359C4.27 6.3 4.1 6.4 4 6.3 c-0.15-0.049-0.231-0.21-0.184-0.359C3.824 5.8 4 5.7 4.1 5.8"></path><path class=style0 d="M4.513 6.367c0.13 0 0.2 0.1 0.2 0.271c-0.021 0.126-0.14 0.213-0.267 0.2 c-0.129-0.021-0.217-0.14-0.196-0.269C4.267 6.4 4.4 6.3 4.5 6.4"></path></g><g class=group-3><path class=style2 d="M2.158 2.755c0.264 0.2 0.3 0.6 0.1 0.821C2.098 3.8 1.7 3.9 1.5 3.7 c-0.262-0.19-0.321-0.559-0.131-0.82C1.527 2.6 1.9 2.6 2.2 2.8"></path><path class=style2 d="M2.405 4.101c0.244 0.1 0.3 0.4 0.2 0.668C2.498 5 2.2 5.1 2 5 C1.71 4.9 1.6 4.6 1.7 4.318C1.862 4.1 2.2 4 2.4 4.1"></path><path class=style2 d="M2.84 5.214c0.219 0.1 0.3 0.3 0.3 0.521S2.802 6.1 2.6 6 c-0.217-0.07-0.336-0.304-0.265-0.521C2.39 5.3 2.6 5.1 2.8 5.2"></path><path class=style2 d="M3.343 6.071C3.531 6.1 3.7 6.3 3.6 6.466S3.424 6.8 3.2 6.8 C3.048 6.7 2.9 6.5 2.9 6.357C2.979 6.2 3.2 6 3.3 6.1"></path><path class=style2 d="M3.895 6.714c0.157 0 0.3 0.1 0.3 0.285c0 0.157-0.128 0.285-0.285 0.3 C3.737 7.3 3.6 7.2 3.6 6.999C3.609 6.8 3.7 6.7 3.9 6.7"></path><path class=style2 d="M4.44 7.168c0.128-0.021 0.2 0.1 0.3 0.194C4.729 7.5 4.6 7.6 4.5 7.6 C4.386 7.7 4.3 7.6 4.2 7.436S4.312 7.2 4.4 7.2"></path></g><g class=group-4><path class=style1 d="M1.084 4.458C1.393 4.6 1.6 4.9 1.5 5.2C1.361 5.5 1 5.7 0.7 5.6 c-0.31-0.1-0.479-0.432-0.378-0.741C0.443 4.5 0.8 4.4 1.1 4.5"></path><path class=style1 d="M1.735 5.662C2.006 5.7 2.2 6 2.1 6.231C2.104 6.5 1.9 6.7 1.6 6.6 S1.124 6.3 1.2 6.075C1.21 5.8 1.5 5.6 1.7 5.7"></path><path class=style1 d="M2.492 6.586c0.229 0 0.4 0.2 0.4 0.413c0 0.229-0.186 0.414-0.414 0.414S2.079 7.2 2.1 7 C2.078 6.8 2.3 6.6 2.5 6.6"></path><path class=style1 d="M3.234 7.247c0.189-0.03 0.4 0.1 0.4 0.286c0.03 0.188-0.099 0.364-0.287 0.4 C3.155 8 3 7.8 2.9 7.641C2.92 7.5 3 7.3 3.2 7.2"></path><path class=style1 d="M3.959 7.688C4.108 7.6 4.3 7.7 4.3 7.871C4.366 8 4.3 8.2 4.1 8.2 c-0.15 0.049-0.311-0.032-0.359-0.182C3.728 7.9 3.8 7.7 4 7.7"></path><path class=style1 d="M4.619 7.95c0.114-0.059 0.255-0.013 0.3 0.103S4.945 8.3 4.8 8.4 C4.715 8.4 4.6 8.4 4.5 8.266C4.456 8.1 4.5 8 4.6 8"></path></g><g class=group-5><path class=style3 d="M0.588 6.411c0.325 0 0.6 0.3 0.6 0.588c0 0.325-0.264 0.589-0.589 0.589S0 7.3 0 7 C0 6.7 0.3 6.4 0.6 6.4"></path><path class=style3 d="M1.579 7.355C1.85 7.3 2.1 7.5 2.1 7.768C2.19 8 2 8.3 1.7 8.3 C1.464 8.4 1.2 8.2 1.2 7.924C1.124 7.7 1.3 7.4 1.6 7.4"></path><path class=style3 d="M2.584 7.999c0.218-0.071 0.5 0 0.5 0.266C3.176 8.5 3.1 8.7 2.8 8.8 C2.623 8.9 2.4 8.7 2.3 8.521C2.248 8.3 2.4 8.1 2.6 8"></path><path class=style3 d="M3.496 8.397c0.17-0.087 0.378-0.019 0.5 0.151c0.087 0.2 0 0.377-0.151 0.5 C3.64 9.1 3.4 9 3.3 8.861C3.259 8.7 3.3 8.5 3.5 8.4"></path><path class=style3 d="M4.32 8.594C4.447 8.5 4.6 8.5 4.7 8.657c0.092 0.1 0.1 0.306-0.063 0.4 C4.527 9.1 4.3 9.1 4.3 8.992C4.165 8.9 4.2 8.7 4.3 8.6"></path><path class=style3 d="M5.028 8.64c0.091-0.092 0.239-0.091 0.3 0c0.092 0.1 0.1 0.2 0 0.3 c-0.092 0.091-0.239 0.092-0.331 0S4.937 8.7 5 8.6"></path></g><g class=group-6><path class=style0 d="M0.721 8.422C1.029 8.3 1.4 8.5 1.5 8.799c0.1 0.31-0.069 0.641-0.378 0.741S0.443 9.5 0.3 9.2 C0.242 8.9 0.4 8.5 0.7 8.4"></path><path class=style0 d="M1.954 9.013C2.198 8.9 2.5 9 2.6 9.23c0.124 0.2 0 0.543-0.218 0.7 c-0.244 0.125-0.544 0.027-0.668-0.217S1.71 9.1 2 9"></path><path class=style0 d="M3.109 9.313C3.295 9.2 3.6 9.2 3.7 9.406C3.822 9.6 3.8 9.8 3.6 10 c-0.184 0.135-0.443 0.095-0.577-0.091C2.884 9.7 2.9 9.4 3.1 9.3"></path><path class=style0 d="M4.1 9.412c0.135-0.135 0.354-0.135 0.5 0s0.135 0.4 0 0.487s-0.354 0.135-0.488 0 C3.966 9.8 4 9.5 4.1 9.4"></path><path class=style0 d="M5.405 9.679C5.313 9.8 5.1 9.8 5 9.742C4.88 9.7 4.9 9.5 4.9 9.3 c0.093-0.128 0.271-0.156 0.398-0.063C5.469 9.4 5.5 9.6 5.4 9.7"></path><path class=style0 d="M6.05 9.382c-0.059 0.115-0.2 0.161-0.315 0.103C5.618 9.4 5.6 9.3 5.6 9.2 C5.69 9.1 5.8 9 5.9 9.066C6.062 9.1 6.1 9.3 6 9.4"></path></g><g class=group-7><path class=style2 d="M1.467 10.292c0.264-0.19 0.631-0.133 0.8 0.13s0.133 0.631-0.131 0.8 c-0.263 0.191-0.63 0.132-0.82-0.13C1.146 10.9 1.2 10.5 1.5 10.3"></path><path class=style2 d="M2.824 10.474c0.193-0.194 0.507-0.194 0.7 0c0.193 0.2 0.2 0.5 0 0.7 c-0.195 0.193-0.509 0.193-0.702 0C2.63 11 2.6 10.7 2.8 10.5"></path><path class=style2 d="M4.686 10.89c-0.135 0.185-0.394 0.226-0.579 0.092c-0.184-0.135-0.225-0.394-0.091-0.578 c0.135-0.185 0.393-0.227 0.578-0.092C4.778 10.4 4.8 10.7 4.7 10.9"></path><path class=style2 d="M5.603 10.502c-0.088 0.171-0.295 0.238-0.465 0.151c-0.169-0.087-0.236-0.293-0.15-0.464 c0.086-0.169 0.294-0.236 0.464-0.15C5.62 10.1 5.7 10.3 5.6 10.5"></path><path class=style2 d="M6.312 10.041c-0.049 0.149-0.209 0.231-0.359 0.184c-0.15-0.049-0.231-0.21-0.183-0.36 c0.049-0.149 0.21-0.23 0.358-0.183C6.278 9.7 6.4 9.9 6.3 10"></path><path class=style2 d="M6.833 9.559C6.812 9.7 6.7 9.8 6.6 9.754C6.436 9.7 6.3 9.6 6.4 9.5 c0.021-0.129 0.141-0.216 0.27-0.195C6.765 9.3 6.9 9.4 6.8 9.6"></path></g><g class=group-8><path class=style1 d="M3.708 12.532c-0.192 0.263-0.56 0.32-0.822 0.13s-0.321-0.559-0.131-0.821 c0.191-0.264 0.56-0.321 0.822-0.131C3.84 11.9 3.9 12.3 3.7 12.5"></path><path class=style1 d="M4.102 11.594c0.125-0.243 0.424-0.341 0.668-0.217c0.245 0.1 0.3 0.4 0.2 0.7 s-0.423 0.341-0.668 0.217C4.074 12.1 4 11.8 4.1 11.6"></path><path class=style1 d="M6.001 11.415c-0.071 0.217-0.304 0.336-0.521 0.266c-0.218-0.071-0.336-0.305-0.266-0.522 c0.07-0.217 0.304-0.335 0.521-0.265S6.071 11.2 6 11.4"></path><path class=style1 d="M6.753 10.764c-0.03 0.188-0.207 0.316-0.395 0.286c-0.188-0.029-0.316-0.206-0.286-0.394 c0.029-0.188 0.206-0.316 0.395-0.287C6.654 10.4 6.8 10.6 6.8 10.8"></path><path class=style1 d="M7.285 10.105c0 0.157-0.127 0.284-0.285 0.284c-0.157 0-0.285-0.127-0.285-0.284 C6.715 9.9 6.8 9.8 7 9.82C7.158 9.8 7.3 9.9 7.3 10.1"></path><path class=style1 d="M7.631 9.486c0.021 0.127-0.065 0.247-0.194 0.268C7.309 9.8 7.2 9.7 7.2 9.6 c-0.02-0.128 0.066-0.248 0.194-0.269C7.491 9.3 7.6 9.4 7.6 9.5"></path></g><g class=group-9><path class=style3 d="M5.578 13.278c-0.1 0.31-0.433 0.479-0.741 0.378c-0.31-0.101-0.479-0.432-0.377-0.741 c0.1-0.309 0.432-0.478 0.74-0.377C5.51 12.6 5.7 13 5.6 13.3"></path><path class=style3 d="M5.664 12.266c0.043-0.271 0.298-0.457 0.568-0.414c0.27 0 0.5 0.3 0.4 0.6 c-0.042 0.271-0.297 0.456-0.567 0.412C5.806 12.8 5.6 12.5 5.7 12.3"></path><path class=style3 d="M7.413 11.508c0 0.228-0.185 0.414-0.413 0.414s-0.413-0.187-0.413-0.414c0-0.229 0.185-0.414 0.413-0.414 S7.413 11.3 7.4 11.5"></path><path class=style3 d="M7.928 10.656c0.03 0.188-0.099 0.364-0.286 0.395c-0.188 0.03-0.364-0.1-0.394-0.287 c-0.03-0.188 0.099-0.364 0.285-0.394C7.722 10.3 7.9 10.5 7.9 10.7"></path><path class=style3 d="M8.231 9.864c0.048 0.15-0.034 0.312-0.184 0.36c-0.149 0.048-0.311-0.034-0.358-0.184 C7.64 9.9 7.7 9.7 7.9 9.682C8.021 9.6 8.2 9.7 8.2 9.9"></path><path class=style3 d="M8.369 9.169c0.059 0.1 0 0.257-0.104 0.315C8.151 9.5 8 9.5 8 9.4 S7.938 9.1 8.1 9.066C8.169 9 8.3 9.1 8.4 9.2"></path></g><g class=group-10><path class=style0 d="M7.589 13.411C7.589 13.7 7.3 14 7 14s-0.588-0.264-0.588-0.589c0-0.324 0.263-0.589 0.588-0.589 S7.589 13.1 7.6 13.4"></path><path class=style0 d="M7.356 12.42c-0.043-0.271 0.142-0.524 0.413-0.568c0.27-0.043 0.5 0.1 0.6 0.4 c0.043 0.271-0.141 0.524-0.412 0.566C7.653 12.9 7.4 12.7 7.4 12.4"></path><path class=style0 d="M8.787 11.158c0.07 0.218-0.049 0.451-0.267 0.522C8.304 11.8 8.1 11.6 8 11.4 c-0.07-0.218 0.048-0.451 0.265-0.521C8.482 10.8 8.7 10.9 8.8 11.2"></path><path class=style0 d="M9.012 10.189c0.088 0.2 0 0.377-0.149 0.464c-0.17 0.087-0.377 0.02-0.465-0.15 c-0.085-0.17-0.019-0.377 0.151-0.463C8.719 10 8.9 10 9 10.2"></path><path class=style0 d="M9.056 9.345C9.149 9.5 9.1 9.7 9 9.742C8.866 9.8 8.7 9.8 8.6 9.7 C8.503 9.6 8.5 9.4 8.7 9.281C8.785 9.2 9 9.2 9.1 9.3"></path><path class=style0 d="M8.972 8.64c0.092 0.1 0.1 0.2 0 0.332c-0.091 0.092-0.239 0.092-0.331 0 c-0.092-0.091-0.092-0.24 0-0.332S8.88 8.5 9 8.6"></path></g><g class=group-11><path class=style2 d="M9.542 12.915c0.1 0.31-0.07 0.641-0.379 0.741s-0.642-0.068-0.741-0.378 c-0.101-0.309 0.069-0.64 0.378-0.74C9.109 12.4 9.4 12.6 9.5 12.9"></path><path class=style2 d="M9.897 11.594c0.125 0.2 0 0.544-0.216 0.668c-0.244 0.124-0.544 0.027-0.668-0.217 C8.889 11.8 9 11.5 9.2 11.377C9.475 11.3 9.8 11.4 9.9 11.6"></path><path class=style2 d="M9.984 10.403c0.135 0.2 0.1 0.443-0.091 0.578c-0.186 0.134-0.444 0.093-0.578-0.092 c-0.135-0.185-0.093-0.444 0.091-0.578C9.591 10.2 9.9 10.2 10 10.4"></path><path class=style2 d="M9.9 9.412c0.134 0.1 0.1 0.4 0 0.487c-0.135 0.135-0.354 0.135-0.487 0 c-0.136-0.135-0.136-0.353 0-0.487C9.547 9.3 9.8 9.3 9.9 9.4"></path><path class=style2 d="M9.68 8.594c0.128 0.1 0.2 0.3 0.1 0.398C9.651 9.1 9.5 9.1 9.3 9.1 C9.218 9 9.2 8.8 9.3 8.657S9.553 8.5 9.7 8.6"></path><path class=style2 d="M9.383 7.95c0.115 0.1 0.2 0.2 0.1 0.314c-0.059 0.116-0.2 0.162-0.315 0.1 c-0.115-0.06-0.161-0.201-0.103-0.315C9.126 7.9 9.3 7.9 9.4 8"></path></g><g class=group-12><path class=style1 d="M11.245 11.841c0.19 0.3 0.1 0.631-0.13 0.821c-0.264 0.191-0.631 0.133-0.822-0.13 s-0.134-0.631 0.13-0.822C10.686 11.5 11.1 11.6 11.2 11.8"></path><path class=style1 d="M11.177 10.474c0.194 0.2 0.2 0.5 0 0.702c-0.195 0.193-0.508 0.193-0.702 0 c-0.194-0.194-0.194-0.508 0-0.702C10.669 10.3 11 10.3 11.2 10.5"></path><path class=style1 d="M10.89 9.313c0.186 0.1 0.2 0.4 0.1 0.579c-0.134 0.186-0.392 0.226-0.577 0.1 c-0.186-0.134-0.227-0.393-0.092-0.577S10.706 9.2 10.9 9.3"></path><path class=style1 d="M10.504 8.397c0.17 0.1 0.2 0.3 0.1 0.464c-0.086 0.17-0.294 0.237-0.463 0.2 c-0.17-0.087-0.238-0.295-0.151-0.465C10.127 8.4 10.3 8.3 10.5 8.4"></path><path class=style1 d="M10.042 7.688c0.149 0 0.2 0.2 0.2 0.359c-0.047 0.149-0.208 0.23-0.358 0.2 C9.717 8.2 9.6 8 9.7 7.871C9.731 7.7 9.9 7.6 10 7.7"></path><path class=style1 d="M9.56 7.168c0.129 0 0.2 0.1 0.2 0.268C9.733 7.6 9.6 7.7 9.5 7.6 C9.358 7.6 9.3 7.5 9.3 7.362S9.433 7.1 9.6 7.2"></path></g><g class=group-13><path class=style3 d="M12.533 10.292c0.263 0.2 0.3 0.6 0.1 0.822c-0.19 0.262-0.558 0.321-0.821 0.1 c-0.264-0.19-0.322-0.56-0.131-0.822C11.902 10.2 12.3 10.1 12.5 10.3"></path><path class=style3 d="M12.046 9.013c0.244 0.1 0.3 0.4 0.2 0.668c-0.125 0.244-0.424 0.342-0.668 0.2 c-0.244-0.124-0.342-0.423-0.217-0.667S11.802 8.9 12 9"></path><path class=style3 d="M11.416 7.999c0.216 0.1 0.3 0.3 0.3 0.521c-0.07 0.217-0.304 0.336-0.521 0.3 c-0.218-0.069-0.336-0.304-0.267-0.521C10.965 8 11.2 7.9 11.4 8"></path><path class=style3 d="M10.765 7.247c0.188 0 0.3 0.2 0.3 0.394c-0.029 0.188-0.206 0.316-0.395 0.3 c-0.188-0.03-0.315-0.206-0.286-0.394C10.399 7.3 10.6 7.2 10.8 7.2"></path><path class=style3 d="M10.105 6.714c0.158 0 0.3 0.1 0.3 0.285c0 0.157-0.127 0.285-0.285 0.3 C9.948 7.3 9.8 7.2 9.8 6.999C9.821 6.8 9.9 6.7 10.1 6.7"></path><path class=style3 d="M9.486 6.368c0.128-0.02 0.2 0.1 0.3 0.195c0.02 0.128-0.067 0.247-0.195 0.3 c-0.127 0.02-0.248-0.066-0.268-0.194C9.271 6.5 9.4 6.4 9.5 6.4"></path></g><g class=group-14><path class=style0 d="M13.279 8.422c0.31 0.1 0.5 0.4 0.4 0.741c-0.101 0.309-0.432 0.478-0.741 0.4 c-0.309-0.101-0.478-0.432-0.378-0.741C12.64 8.5 13 8.3 13.3 8.4"></path><path class=style0 d="M12.422 7.355c0.271 0 0.5 0.3 0.4 0.568c-0.043 0.271-0.297 0.455-0.567 0.4 c-0.271-0.043-0.456-0.298-0.414-0.568C11.896 7.5 12.2 7.3 12.4 7.4"></path><path class=style0 d="M11.508 6.586c0.229 0 0.4 0.2 0.4 0.413c0 0.229-0.185 0.414-0.414 0.4 c-0.228 0-0.413-0.185-0.413-0.414C11.095 6.8 11.3 6.6 11.5 6.6"></path><path class=style0 d="M10.657 6.071c0.188-0.03 0.4 0.1 0.4 0.286c0.03 0.188-0.099 0.365-0.286 0.4 c-0.188 0.03-0.365-0.099-0.395-0.286S10.469 6.1 10.7 6.1"></path><path class=style0 d="M9.865 5.769c0.15-0.049 0.3 0 0.4 0.183c0.049 0.149-0.032 0.311-0.182 0.4 S9.731 6.3 9.7 6.128S9.717 5.8 9.9 5.8"></path><path class=style0 d="M9.17 5.631c0.115-0.059 0.256-0.013 0.3 0.102C9.545 5.8 9.5 6 9.4 6 C9.269 6.1 9.1 6.1 9.1 5.946C9.009 5.8 9.1 5.7 9.2 5.6"></path></g><g class=group-15><path class=style2 d="M13.412 6.411C13.736 6.4 14 6.7 14 6.999c0 0.325-0.264 0.589-0.588 0.6 c-0.325 0-0.589-0.264-0.589-0.588C12.823 6.7 13.1 6.4 13.4 6.4"></path><path class=style2 d="M12.267 5.662c0.271-0.042 0.5 0.1 0.6 0.413c0.043 0.271-0.142 0.525-0.413 0.6 c-0.271 0.043-0.524-0.142-0.567-0.412C11.811 6 12 5.7 12.3 5.7"></path><path class=style2 d="M11.16 5.214c0.217-0.071 0.5 0 0.5 0.265c0.07 0.217-0.05 0.45-0.266 0.5 c-0.218 0.071-0.451-0.048-0.521-0.265S10.942 5.3 11.2 5.2"></path><path class=style2 d="M10.191 4.986c0.169-0.086 0.377-0.019 0.5 0.151c0.087 0.2 0 0.377-0.15 0.5 c-0.17 0.086-0.377 0.019-0.463-0.15C9.955 5.3 10 5.1 10.2 5"></path><path class=style2 d="M9.346 4.943c0.127-0.092 0.306-0.064 0.4 0.063C9.836 5.1 9.8 5.3 9.7 5.4 C9.553 5.5 9.4 5.5 9.3 5.342C9.189 5.2 9.2 5 9.3 4.9"></path><path class=style2 d="M8.641 5.027c0.092-0.092 0.24-0.092 0.3 0c0.092 0.1 0.1 0.239-0.001 0.3 c-0.091 0.092-0.239 0.091-0.33 0C8.549 5.3 8.5 5.1 8.6 5"></path></g><g class=group-16><path class=style1 d="M12.916 4.458c0.309-0.1 0.6 0.1 0.7 0.378c0.101 0.31-0.068 0.642-0.378 0.7 c-0.309 0.102-0.64-0.068-0.741-0.377C12.438 4.9 12.6 4.6 12.9 4.5"></path><path class=style1 d="M11.595 4.101c0.244-0.124 0.543-0.026 0.7 0.218c0.124 0.2 0 0.542-0.218 0.7 c-0.243 0.125-0.543 0.027-0.667-0.217S11.351 4.2 11.6 4.1"></path><path class=style1 d="M10.404 4.015c0.186-0.134 0.443-0.094 0.6 0.093c0.135 0.2 0.1 0.442-0.092 0.6 c-0.184 0.134-0.442 0.093-0.577-0.092S10.219 4.1 10.4 4"></path><path class=style1 d="M9.413 4.1c0.134-0.135 0.353-0.136 0.5 0c0.134 0.1 0.1 0.4 0 0.5 c-0.135 0.135-0.353 0.135-0.487 0C9.277 4.5 9.3 4.2 9.4 4.1"></path><path class=style1 d="M9.056 4.654C8.964 4.8 8.8 4.8 8.7 4.718C8.53 4.6 8.5 4.4 8.6 4.3 c0.091-0.128 0.271-0.155 0.397-0.063C9.12 4.3 9.1 4.5 9.1 4.7"></path><path class=style1 d="M8.369 4.829c-0.06 0.115-0.2 0.162-0.315 0.103C7.938 4.9 7.9 4.7 8 4.6 c0.059-0.115 0.2-0.161 0.314-0.103C8.382 4.6 8.4 4.7 8.4 4.8"></path></g><g class=group-17><path class=style3 d="M11.842 2.755c0.263-0.191 0.631-0.133 0.8 0.13c0.191 0.3 0.1 0.631-0.13 0.8 c-0.263 0.19-0.631 0.133-0.822-0.131C11.521 3.3 11.6 2.9 11.8 2.8"></path><path class=style3 d="M10.475 2.823c0.194-0.194 0.508-0.194 0.7 0s0.194 0.5 0 0.702c-0.194 0.193-0.508 0.193-0.702 0 C10.28 3.3 10.3 3 10.5 2.8"></path><path class=style3 d="M9.984 3.596C9.851 3.8 9.6 3.8 9.4 3.687C9.223 3.6 9.2 3.3 9.3 3.1 c0.134-0.186 0.393-0.227 0.578-0.092C10.078 3.2 10.1 3.4 10 3.6"></path><path class=style3 d="M9.013 3.809c-0.086 0.17-0.294 0.237-0.464 0.15C8.38 3.9 8.3 3.7 8.4 3.5 c0.086-0.17 0.293-0.236 0.462-0.15C9.031 3.4 9.1 3.6 9 3.8"></path><path class=style3 d="M8.231 4.134c-0.049 0.149-0.21 0.231-0.36 0.183C7.723 4.3 7.6 4.1 7.7 4 c0.048-0.149 0.209-0.231 0.358-0.182C8.197 3.8 8.3 4 8.2 4.1"></path><path class=style3 d="M7.632 4.512c-0.021 0.13-0.141 0.216-0.27 0.196C7.235 4.7 7.1 4.6 7.2 4.4 c0.021-0.129 0.141-0.217 0.269-0.196C7.563 4.3 7.7 4.4 7.6 4.5"></path></g><g class=group-18><path class=style0 d="M11.245 2.158c-0.191 0.263-0.56 0.32-0.822 0.13c-0.264-0.19-0.321-0.559-0.13-0.821 c0.19-0.264 0.559-0.321 0.822-0.131C11.377 1.5 11.4 1.9 11.2 2.2"></path><path class=style0 d="M9.014 1.953c0.124-0.244 0.424-0.341 0.668-0.216c0.244 0.1 0.3 0.4 0.2 0.7 C9.774 2.6 9.5 2.7 9.2 2.621C8.986 2.5 8.9 2.2 9 2"></path><path class=style0 d="M8.787 2.84c-0.07 0.217-0.305 0.336-0.522 0.266C8.048 3 7.9 2.8 8 2.584s0.304-0.336 0.521-0.266 C8.738 2.4 8.9 2.6 8.8 2.8"></path><path class=style0 d="M7.928 3.343C7.898 3.5 7.7 3.7 7.5 3.629C7.347 3.6 7.2 3.4 7.2 3.2 c0.029-0.188 0.205-0.317 0.394-0.287C7.829 3 8 3.2 7.9 3.3"></path><path class=style0 d="M7.285 3.894c0 0.157-0.127 0.285-0.285 0.285c-0.157 0-0.285-0.128-0.285-0.285S6.843 3.6 7 3.6 C7.158 3.6 7.3 3.7 7.3 3.9"></path><path class=style0 d="M6.832 4.439c0.02 0.128-0.066 0.248-0.195 0.269c-0.129 0.02-0.248-0.066-0.268-0.194 C6.349 4.4 6.4 4.3 6.6 4.245C6.692 4.2 6.8 4.3 6.8 4.4"></path></g><g class=group-19><path class=style2 d="M9.542 1.083C9.44 1.4 9.1 1.6 8.8 1.461S8.321 1 8.4 0.72c0.1-0.31 0.432-0.479 0.741-0.378 C9.472 0.4 9.6 0.8 9.5 1.1"></path><path class=style2 d="M7.356 1.578c0.043-0.271 0.297-0.455 0.567-0.412c0.271 0 0.5 0.3 0.4 0.6 C8.293 2 8 2.2 7.8 2.146S7.312 1.9 7.4 1.6"></path><path class=style2 d="M7.413 2.491C7.413 2.7 7.2 2.9 7 2.905S6.587 2.7 6.6 2.491S6.771 2.1 7 2.1 S7.413 2.3 7.4 2.5"></path><path class=style2 d="M6.753 3.235C6.782 3.4 6.7 3.6 6.5 3.629C6.278 3.7 6.1 3.5 6.1 3.3 c-0.03-0.188 0.099-0.364 0.286-0.395S6.723 3 6.8 3.2"></path><path class=style2 d="M6.312 3.957c0.049 0.15-0.033 0.312-0.184 0.359C5.979 4.4 5.8 4.3 5.8 4.1 s0.033-0.311 0.183-0.359C6.103 3.7 6.3 3.8 6.3 4"></path><path class=style2 d="M6.05 4.617c0.059 0.1 0 0.256-0.104 0.314C5.831 5 5.7 4.9 5.6 4.8 C5.572 4.7 5.6 4.6 5.7 4.515C5.85 4.5 6 4.5 6 4.6"></path></g><g class=group-20><path class=style1 d="M7.589 0.588c0 0.325-0.264 0.588-0.589 0.588S6.412 0.9 6.4 0.588S6.675 0 7 0 S7.589 0.3 7.6 0.6"></path><path class=style1 d="M5.664 1.733C5.62 1.5 5.8 1.2 6.1 1.166s0.524 0.1 0.6 0.4 c0.042 0.271-0.143 0.525-0.413 0.568C5.96 2.2 5.7 2 5.7 1.7"></path><path class=style1 d="M6.001 2.584c0.07 0.217-0.05 0.45-0.267 0.521c-0.217 0.07-0.45-0.049-0.521-0.266 c-0.07-0.218 0.048-0.451 0.266-0.521C5.696 2.2 5.9 2.4 6 2.6"></path><path class=style1 d="M5.603 3.495C5.688 3.7 5.6 3.9 5.5 3.96c-0.17 0.085-0.378 0.019-0.464-0.152 c-0.086-0.169-0.019-0.376 0.15-0.462C5.308 3.3 5.5 3.3 5.6 3.5"></path><path class=style1 d="M5.405 4.319c0.092 0.1 0.1 0.306-0.062 0.398C5.215 4.8 5 4.8 4.9 4.7 S4.88 4.3 5 4.256C5.134 4.2 5.3 4.2 5.4 4.3"></path><path class=style1 d="M5.359 5.027c0.092 0.1 0.1 0.2 0 0.332s-0.24 0.091-0.331 0c-0.092-0.093-0.092-0.24-0.001-0.332 C5.119 4.9 5.3 4.9 5.4 5"></path></g></svg></div></div></div></div></div></div></div></div><div></div></section><footer class=frontend-filesViewer-inlineMode-footer-index-module__footer--9uUmL><nav aria-label=Figshare class=frontend-filesViewer-inlineMode-footer-index-module__navigation--+GhAf><div class="frontend-filesViewer-inlineMode-footer-genericControls-module__container--Ok8Uj frontend-filesViewer-inlineMode-footer-index-module__genericControls--q+AJj"><button aria-expanded=false aria-haspopup=dialog aria-label=Expand class="frontend-filesViewer-inlineMode-footer-genericControls-module__enlargeButton--qJnBC frontend-widgets-springer_nature-theme-module__inlineMode_enlargeButton--2anyr frontend-widgets-springer_nature-theme-module__primaryIconButton--qFTd4 frontend-widgets-springer_nature-theme-module__primaryButton--YVC6D" type=button></button><button aria-expanded=false aria-haspopup=dialog aria-label=Share class="frontend-filesViewer-inlineMode-footer-genericControls-module__shareButton--RoEPD frontend-filesViewer-inlineMode-footer-genericControls-module__hide--xlLS- frontend-widgets-springer_nature-theme-module__inlineMode_shareButton--EvgBm frontend-widgets-springer_nature-theme-module__secondaryButton--k2CRj sf-hidden" disabled type=button></button><a aria-label=Download class="frontend-filesViewer-inlineMode-downloadMenu-trigger-module__downloadButton--UsBvq frontend-widgets-springer_nature-theme-module__inlineMode_downloadButton--i6grg frontend-widgets-springer_nature-theme-module__primaryButton--YVC6D" href=https://ndownloader.figstatic.com/files/12430637><span aria-hidden=true class=frontend-filesViewer-inlineMode-downloadMenu-trigger-module__buttonText--GEnvG>Download</span></a></div><a aria-label="Open in figshare" class="frontend-filesViewer-inlineMode-footer-figshareButton-module__figshareButton--jh7bg frontend-filesViewer-inlineMode-footer-index-module__figshareButton--nJvGg" href=https://figshare.com/articles/journal_contribution/MOESM1_of_Risk_of_heart_failure_hospitalization_among_users_of_dipeptidyl_peptidase-4_inhibitors_compared_to_glucagon-like_peptide-1_receptor_agonists/6831239 rel="noopener noreferrer" target=_blank><div aria-hidden=true class=fs-logo><svg aria-hidden=true class=figshare-logo focusable=false height=36px role=img viewBox="0 0 14 14" width=36px><style>.style0{fill:#566471}.style1{fill:#A2CD3C}.style2{fill:#C54C59}.style3{fill:#5BC4BD}</style><g class=group-1><path class=style3 d="M5.578 0.72C5.679 1 5.5 1.4 5.2 1.461C4.892 1.6 4.6 1.4 4.5 1.1 c-0.102-0.309 0.068-0.641 0.377-0.74C5.146 0.2 5.5 0.4 5.6 0.7"></path><path class=style3 d="M4.987 1.953C5.11 2.2 5 2.5 4.8 2.621C4.525 2.7 4.2 2.6 4.1 2.4 C3.978 2.2 4.1 1.9 4.3 1.737C4.562 1.6 4.9 1.7 5 2"></path><path class=style3 d="M4.686 3.109c0.134 0.2 0.1 0.443-0.092 0.577C4.408 3.8 4.2 3.8 4 3.6 C3.882 3.4 3.9 3.2 4.1 3.018C4.292 2.9 4.6 2.9 4.7 3.1"></path><path class=style3 d="M4.588 4.099c0.135 0.1 0.1 0.4 0 0.487c-0.135 0.136-0.354 0.136-0.488 0 C3.966 4.5 4 4.2 4.1 4.1S4.453 4 4.6 4.1"></path><path class=style3 d="M4.655 4.943c0.127 0.1 0.2 0.3 0.1 0.398C4.625 5.5 4.4 5.5 4.3 5.4 S4.165 5.1 4.3 5.007C4.35 4.9 4.5 4.9 4.7 4.9"></path><path class=style3 d="M4.83 5.631C4.945 5.7 5 5.8 4.9 5.946C4.874 6.1 4.7 6.1 4.6 6 c-0.115-0.059-0.161-0.2-0.103-0.315C4.574 5.6 4.7 5.6 4.8 5.6"></path></g><g class=group-2><path class=style0 d="M3.708 1.467c0.19 0.3 0.1 0.631-0.131 0.821c-0.263 0.191-0.631 0.133-0.822-0.13 c-0.19-0.264-0.132-0.631 0.131-0.822C3.148 1.1 3.5 1.2 3.7 1.5"></path><path class=style0 d="M3.526 2.823c0.193 0.2 0.2 0.5 0 0.702c-0.195 0.193-0.509 0.193-0.703 0 C2.63 3.3 2.6 3 2.8 2.823C3.018 2.6 3.3 2.6 3.5 2.8"></path><path class=style0 d="M3.596 4.015c0.186 0.1 0.2 0.4 0.1 0.578S3.295 4.8 3.1 4.7 C2.926 4.5 2.9 4.3 3 4.107C3.152 3.9 3.4 3.9 3.6 4"></path><path class=style0 d="M3.81 4.986C3.979 5.1 4 5.3 4 5.451C3.873 5.6 3.7 5.7 3.5 5.6 C3.327 5.5 3.3 5.3 3.3 5.138C3.432 5 3.6 4.9 3.8 5"></path><path class=style0 d="M4.135 5.769c0.149 0 0.2 0.2 0.2 0.359C4.27 6.3 4.1 6.4 4 6.3 c-0.15-0.049-0.231-0.21-0.184-0.359C3.824 5.8 4 5.7 4.1 5.8"></path><path class=style0 d="M4.513 6.367c0.13 0 0.2 0.1 0.2 0.271c-0.021 0.126-0.14 0.213-0.267 0.2 c-0.129-0.021-0.217-0.14-0.196-0.269C4.267 6.4 4.4 6.3 4.5 6.4"></path></g><g class=group-3><path class=style2 d="M2.158 2.755c0.264 0.2 0.3 0.6 0.1 0.821C2.098 3.8 1.7 3.9 1.5 3.7 c-0.262-0.19-0.321-0.559-0.131-0.82C1.527 2.6 1.9 2.6 2.2 2.8"></path><path class=style2 d="M2.405 4.101c0.244 0.1 0.3 0.4 0.2 0.668C2.498 5 2.2 5.1 2 5 C1.71 4.9 1.6 4.6 1.7 4.318C1.862 4.1 2.2 4 2.4 4.1"></path><path class=style2 d="M2.84 5.214c0.219 0.1 0.3 0.3 0.3 0.521S2.802 6.1 2.6 6 c-0.217-0.07-0.336-0.304-0.265-0.521C2.39 5.3 2.6 5.1 2.8 5.2"></path><path class=style2 d="M3.343 6.071C3.531 6.1 3.7 6.3 3.6 6.466S3.424 6.8 3.2 6.8 C3.048 6.7 2.9 6.5 2.9 6.357C2.979 6.2 3.2 6 3.3 6.1"></path><path class=style2 d="M3.895 6.714c0.157 0 0.3 0.1 0.3 0.285c0 0.157-0.128 0.285-0.285 0.3 C3.737 7.3 3.6 7.2 3.6 6.999C3.609 6.8 3.7 6.7 3.9 6.7"></path><path class=style2 d="M4.44 7.168c0.128-0.021 0.2 0.1 0.3 0.194C4.729 7.5 4.6 7.6 4.5 7.6 C4.386 7.7 4.3 7.6 4.2 7.436S4.312 7.2 4.4 7.2"></path></g><g class=group-4><path class=style1 d="M1.084 4.458C1.393 4.6 1.6 4.9 1.5 5.2C1.361 5.5 1 5.7 0.7 5.6 c-0.31-0.1-0.479-0.432-0.378-0.741C0.443 4.5 0.8 4.4 1.1 4.5"></path><path class=style1 d="M1.735 5.662C2.006 5.7 2.2 6 2.1 6.231C2.104 6.5 1.9 6.7 1.6 6.6 S1.124 6.3 1.2 6.075C1.21 5.8 1.5 5.6 1.7 5.7"></path><path class=style1 d="M2.492 6.586c0.229 0 0.4 0.2 0.4 0.413c0 0.229-0.186 0.414-0.414 0.414S2.079 7.2 2.1 7 C2.078 6.8 2.3 6.6 2.5 6.6"></path><path class=style1 d="M3.234 7.247c0.189-0.03 0.4 0.1 0.4 0.286c0.03 0.188-0.099 0.364-0.287 0.4 C3.155 8 3 7.8 2.9 7.641C2.92 7.5 3 7.3 3.2 7.2"></path><path class=style1 d="M3.959 7.688C4.108 7.6 4.3 7.7 4.3 7.871C4.366 8 4.3 8.2 4.1 8.2 c-0.15 0.049-0.311-0.032-0.359-0.182C3.728 7.9 3.8 7.7 4 7.7"></path><path class=style1 d="M4.619 7.95c0.114-0.059 0.255-0.013 0.3 0.103S4.945 8.3 4.8 8.4 C4.715 8.4 4.6 8.4 4.5 8.266C4.456 8.1 4.5 8 4.6 8"></path></g><g class=group-5><path class=style3 d="M0.588 6.411c0.325 0 0.6 0.3 0.6 0.588c0 0.325-0.264 0.589-0.589 0.589S0 7.3 0 7 C0 6.7 0.3 6.4 0.6 6.4"></path><path class=style3 d="M1.579 7.355C1.85 7.3 2.1 7.5 2.1 7.768C2.19 8 2 8.3 1.7 8.3 C1.464 8.4 1.2 8.2 1.2 7.924C1.124 7.7 1.3 7.4 1.6 7.4"></path><path class=style3 d="M2.584 7.999c0.218-0.071 0.5 0 0.5 0.266C3.176 8.5 3.1 8.7 2.8 8.8 C2.623 8.9 2.4 8.7 2.3 8.521C2.248 8.3 2.4 8.1 2.6 8"></path><path class=style3 d="M3.496 8.397c0.17-0.087 0.378-0.019 0.5 0.151c0.087 0.2 0 0.377-0.151 0.5 C3.64 9.1 3.4 9 3.3 8.861C3.259 8.7 3.3 8.5 3.5 8.4"></path><path class=style3 d="M4.32 8.594C4.447 8.5 4.6 8.5 4.7 8.657c0.092 0.1 0.1 0.306-0.063 0.4 C4.527 9.1 4.3 9.1 4.3 8.992C4.165 8.9 4.2 8.7 4.3 8.6"></path><path class=style3 d="M5.028 8.64c0.091-0.092 0.239-0.091 0.3 0c0.092 0.1 0.1 0.2 0 0.3 c-0.092 0.091-0.239 0.092-0.331 0S4.937 8.7 5 8.6"></path></g><g class=group-6><path class=style0 d="M0.721 8.422C1.029 8.3 1.4 8.5 1.5 8.799c0.1 0.31-0.069 0.641-0.378 0.741S0.443 9.5 0.3 9.2 C0.242 8.9 0.4 8.5 0.7 8.4"></path><path class=style0 d="M1.954 9.013C2.198 8.9 2.5 9 2.6 9.23c0.124 0.2 0 0.543-0.218 0.7 c-0.244 0.125-0.544 0.027-0.668-0.217S1.71 9.1 2 9"></path><path class=style0 d="M3.109 9.313C3.295 9.2 3.6 9.2 3.7 9.406C3.822 9.6 3.8 9.8 3.6 10 c-0.184 0.135-0.443 0.095-0.577-0.091C2.884 9.7 2.9 9.4 3.1 9.3"></path><path class=style0 d="M4.1 9.412c0.135-0.135 0.354-0.135 0.5 0s0.135 0.4 0 0.487s-0.354 0.135-0.488 0 C3.966 9.8 4 9.5 4.1 9.4"></path><path class=style0 d="M5.405 9.679C5.313 9.8 5.1 9.8 5 9.742C4.88 9.7 4.9 9.5 4.9 9.3 c0.093-0.128 0.271-0.156 0.398-0.063C5.469 9.4 5.5 9.6 5.4 9.7"></path><path class=style0 d="M6.05 9.382c-0.059 0.115-0.2 0.161-0.315 0.103C5.618 9.4 5.6 9.3 5.6 9.2 C5.69 9.1 5.8 9 5.9 9.066C6.062 9.1 6.1 9.3 6 9.4"></path></g><g class=group-7><path class=style2 d="M1.467 10.292c0.264-0.19 0.631-0.133 0.8 0.13s0.133 0.631-0.131 0.8 c-0.263 0.191-0.63 0.132-0.82-0.13C1.146 10.9 1.2 10.5 1.5 10.3"></path><path class=style2 d="M2.824 10.474c0.193-0.194 0.507-0.194 0.7 0c0.193 0.2 0.2 0.5 0 0.7 c-0.195 0.193-0.509 0.193-0.702 0C2.63 11 2.6 10.7 2.8 10.5"></path><path class=style2 d="M4.686 10.89c-0.135 0.185-0.394 0.226-0.579 0.092c-0.184-0.135-0.225-0.394-0.091-0.578 c0.135-0.185 0.393-0.227 0.578-0.092C4.778 10.4 4.8 10.7 4.7 10.9"></path><path class=style2 d="M5.603 10.502c-0.088 0.171-0.295 0.238-0.465 0.151c-0.169-0.087-0.236-0.293-0.15-0.464 c0.086-0.169 0.294-0.236 0.464-0.15C5.62 10.1 5.7 10.3 5.6 10.5"></path><path class=style2 d="M6.312 10.041c-0.049 0.149-0.209 0.231-0.359 0.184c-0.15-0.049-0.231-0.21-0.183-0.36 c0.049-0.149 0.21-0.23 0.358-0.183C6.278 9.7 6.4 9.9 6.3 10"></path><path class=style2 d="M6.833 9.559C6.812 9.7 6.7 9.8 6.6 9.754C6.436 9.7 6.3 9.6 6.4 9.5 c0.021-0.129 0.141-0.216 0.27-0.195C6.765 9.3 6.9 9.4 6.8 9.6"></path></g><g class=group-8><path class=style1 d="M3.708 12.532c-0.192 0.263-0.56 0.32-0.822 0.13s-0.321-0.559-0.131-0.821 c0.191-0.264 0.56-0.321 0.822-0.131C3.84 11.9 3.9 12.3 3.7 12.5"></path><path class=style1 d="M4.102 11.594c0.125-0.243 0.424-0.341 0.668-0.217c0.245 0.1 0.3 0.4 0.2 0.7 s-0.423 0.341-0.668 0.217C4.074 12.1 4 11.8 4.1 11.6"></path><path class=style1 d="M6.001 11.415c-0.071 0.217-0.304 0.336-0.521 0.266c-0.218-0.071-0.336-0.305-0.266-0.522 c0.07-0.217 0.304-0.335 0.521-0.265S6.071 11.2 6 11.4"></path><path class=style1 d="M6.753 10.764c-0.03 0.188-0.207 0.316-0.395 0.286c-0.188-0.029-0.316-0.206-0.286-0.394 c0.029-0.188 0.206-0.316 0.395-0.287C6.654 10.4 6.8 10.6 6.8 10.8"></path><path class=style1 d="M7.285 10.105c0 0.157-0.127 0.284-0.285 0.284c-0.157 0-0.285-0.127-0.285-0.284 C6.715 9.9 6.8 9.8 7 9.82C7.158 9.8 7.3 9.9 7.3 10.1"></path><path class=style1 d="M7.631 9.486c0.021 0.127-0.065 0.247-0.194 0.268C7.309 9.8 7.2 9.7 7.2 9.6 c-0.02-0.128 0.066-0.248 0.194-0.269C7.491 9.3 7.6 9.4 7.6 9.5"></path></g><g class=group-9><path class=style3 d="M5.578 13.278c-0.1 0.31-0.433 0.479-0.741 0.378c-0.31-0.101-0.479-0.432-0.377-0.741 c0.1-0.309 0.432-0.478 0.74-0.377C5.51 12.6 5.7 13 5.6 13.3"></path><path class=style3 d="M5.664 12.266c0.043-0.271 0.298-0.457 0.568-0.414c0.27 0 0.5 0.3 0.4 0.6 c-0.042 0.271-0.297 0.456-0.567 0.412C5.806 12.8 5.6 12.5 5.7 12.3"></path><path class=style3 d="M7.413 11.508c0 0.228-0.185 0.414-0.413 0.414s-0.413-0.187-0.413-0.414c0-0.229 0.185-0.414 0.413-0.414 S7.413 11.3 7.4 11.5"></path><path class=style3 d="M7.928 10.656c0.03 0.188-0.099 0.364-0.286 0.395c-0.188 0.03-0.364-0.1-0.394-0.287 c-0.03-0.188 0.099-0.364 0.285-0.394C7.722 10.3 7.9 10.5 7.9 10.7"></path><path class=style3 d="M8.231 9.864c0.048 0.15-0.034 0.312-0.184 0.36c-0.149 0.048-0.311-0.034-0.358-0.184 C7.64 9.9 7.7 9.7 7.9 9.682C8.021 9.6 8.2 9.7 8.2 9.9"></path><path class=style3 d="M8.369 9.169c0.059 0.1 0 0.257-0.104 0.315C8.151 9.5 8 9.5 8 9.4 S7.938 9.1 8.1 9.066C8.169 9 8.3 9.1 8.4 9.2"></path></g><g class=group-10><path class=style0 d="M7.589 13.411C7.589 13.7 7.3 14 7 14s-0.588-0.264-0.588-0.589c0-0.324 0.263-0.589 0.588-0.589 S7.589 13.1 7.6 13.4"></path><path class=style0 d="M7.356 12.42c-0.043-0.271 0.142-0.524 0.413-0.568c0.27-0.043 0.5 0.1 0.6 0.4 c0.043 0.271-0.141 0.524-0.412 0.566C7.653 12.9 7.4 12.7 7.4 12.4"></path><path class=style0 d="M8.787 11.158c0.07 0.218-0.049 0.451-0.267 0.522C8.304 11.8 8.1 11.6 8 11.4 c-0.07-0.218 0.048-0.451 0.265-0.521C8.482 10.8 8.7 10.9 8.8 11.2"></path><path class=style0 d="M9.012 10.189c0.088 0.2 0 0.377-0.149 0.464c-0.17 0.087-0.377 0.02-0.465-0.15 c-0.085-0.17-0.019-0.377 0.151-0.463C8.719 10 8.9 10 9 10.2"></path><path class=style0 d="M9.056 9.345C9.149 9.5 9.1 9.7 9 9.742C8.866 9.8 8.7 9.8 8.6 9.7 C8.503 9.6 8.5 9.4 8.7 9.281C8.785 9.2 9 9.2 9.1 9.3"></path><path class=style0 d="M8.972 8.64c0.092 0.1 0.1 0.2 0 0.332c-0.091 0.092-0.239 0.092-0.331 0 c-0.092-0.091-0.092-0.24 0-0.332S8.88 8.5 9 8.6"></path></g><g class=group-11><path class=style2 d="M9.542 12.915c0.1 0.31-0.07 0.641-0.379 0.741s-0.642-0.068-0.741-0.378 c-0.101-0.309 0.069-0.64 0.378-0.74C9.109 12.4 9.4 12.6 9.5 12.9"></path><path class=style2 d="M9.897 11.594c0.125 0.2 0 0.544-0.216 0.668c-0.244 0.124-0.544 0.027-0.668-0.217 C8.889 11.8 9 11.5 9.2 11.377C9.475 11.3 9.8 11.4 9.9 11.6"></path><path class=style2 d="M9.984 10.403c0.135 0.2 0.1 0.443-0.091 0.578c-0.186 0.134-0.444 0.093-0.578-0.092 c-0.135-0.185-0.093-0.444 0.091-0.578C9.591 10.2 9.9 10.2 10 10.4"></path><path class=style2 d="M9.9 9.412c0.134 0.1 0.1 0.4 0 0.487c-0.135 0.135-0.354 0.135-0.487 0 c-0.136-0.135-0.136-0.353 0-0.487C9.547 9.3 9.8 9.3 9.9 9.4"></path><path class=style2 d="M9.68 8.594c0.128 0.1 0.2 0.3 0.1 0.398C9.651 9.1 9.5 9.1 9.3 9.1 C9.218 9 9.2 8.8 9.3 8.657S9.553 8.5 9.7 8.6"></path><path class=style2 d="M9.383 7.95c0.115 0.1 0.2 0.2 0.1 0.314c-0.059 0.116-0.2 0.162-0.315 0.1 c-0.115-0.06-0.161-0.201-0.103-0.315C9.126 7.9 9.3 7.9 9.4 8"></path></g><g class=group-12><path class=style1 d="M11.245 11.841c0.19 0.3 0.1 0.631-0.13 0.821c-0.264 0.191-0.631 0.133-0.822-0.13 s-0.134-0.631 0.13-0.822C10.686 11.5 11.1 11.6 11.2 11.8"></path><path class=style1 d="M11.177 10.474c0.194 0.2 0.2 0.5 0 0.702c-0.195 0.193-0.508 0.193-0.702 0 c-0.194-0.194-0.194-0.508 0-0.702C10.669 10.3 11 10.3 11.2 10.5"></path><path class=style1 d="M10.89 9.313c0.186 0.1 0.2 0.4 0.1 0.579c-0.134 0.186-0.392 0.226-0.577 0.1 c-0.186-0.134-0.227-0.393-0.092-0.577S10.706 9.2 10.9 9.3"></path><path class=style1 d="M10.504 8.397c0.17 0.1 0.2 0.3 0.1 0.464c-0.086 0.17-0.294 0.237-0.463 0.2 c-0.17-0.087-0.238-0.295-0.151-0.465C10.127 8.4 10.3 8.3 10.5 8.4"></path><path class=style1 d="M10.042 7.688c0.149 0 0.2 0.2 0.2 0.359c-0.047 0.149-0.208 0.23-0.358 0.2 C9.717 8.2 9.6 8 9.7 7.871C9.731 7.7 9.9 7.6 10 7.7"></path><path class=style1 d="M9.56 7.168c0.129 0 0.2 0.1 0.2 0.268C9.733 7.6 9.6 7.7 9.5 7.6 C9.358 7.6 9.3 7.5 9.3 7.362S9.433 7.1 9.6 7.2"></path></g><g class=group-13><path class=style3 d="M12.533 10.292c0.263 0.2 0.3 0.6 0.1 0.822c-0.19 0.262-0.558 0.321-0.821 0.1 c-0.264-0.19-0.322-0.56-0.131-0.822C11.902 10.2 12.3 10.1 12.5 10.3"></path><path class=style3 d="M12.046 9.013c0.244 0.1 0.3 0.4 0.2 0.668c-0.125 0.244-0.424 0.342-0.668 0.2 c-0.244-0.124-0.342-0.423-0.217-0.667S11.802 8.9 12 9"></path><path class=style3 d="M11.416 7.999c0.216 0.1 0.3 0.3 0.3 0.521c-0.07 0.217-0.304 0.336-0.521 0.3 c-0.218-0.069-0.336-0.304-0.267-0.521C10.965 8 11.2 7.9 11.4 8"></path><path class=style3 d="M10.765 7.247c0.188 0 0.3 0.2 0.3 0.394c-0.029 0.188-0.206 0.316-0.395 0.3 c-0.188-0.03-0.315-0.206-0.286-0.394C10.399 7.3 10.6 7.2 10.8 7.2"></path><path class=style3 d="M10.105 6.714c0.158 0 0.3 0.1 0.3 0.285c0 0.157-0.127 0.285-0.285 0.3 C9.948 7.3 9.8 7.2 9.8 6.999C9.821 6.8 9.9 6.7 10.1 6.7"></path><path class=style3 d="M9.486 6.368c0.128-0.02 0.2 0.1 0.3 0.195c0.02 0.128-0.067 0.247-0.195 0.3 c-0.127 0.02-0.248-0.066-0.268-0.194C9.271 6.5 9.4 6.4 9.5 6.4"></path></g><g class=group-14><path class=style0 d="M13.279 8.422c0.31 0.1 0.5 0.4 0.4 0.741c-0.101 0.309-0.432 0.478-0.741 0.4 c-0.309-0.101-0.478-0.432-0.378-0.741C12.64 8.5 13 8.3 13.3 8.4"></path><path class=style0 d="M12.422 7.355c0.271 0 0.5 0.3 0.4 0.568c-0.043 0.271-0.297 0.455-0.567 0.4 c-0.271-0.043-0.456-0.298-0.414-0.568C11.896 7.5 12.2 7.3 12.4 7.4"></path><path class=style0 d="M11.508 6.586c0.229 0 0.4 0.2 0.4 0.413c0 0.229-0.185 0.414-0.414 0.4 c-0.228 0-0.413-0.185-0.413-0.414C11.095 6.8 11.3 6.6 11.5 6.6"></path><path class=style0 d="M10.657 6.071c0.188-0.03 0.4 0.1 0.4 0.286c0.03 0.188-0.099 0.365-0.286 0.4 c-0.188 0.03-0.365-0.099-0.395-0.286S10.469 6.1 10.7 6.1"></path><path class=style0 d="M9.865 5.769c0.15-0.049 0.3 0 0.4 0.183c0.049 0.149-0.032 0.311-0.182 0.4 S9.731 6.3 9.7 6.128S9.717 5.8 9.9 5.8"></path><path class=style0 d="M9.17 5.631c0.115-0.059 0.256-0.013 0.3 0.102C9.545 5.8 9.5 6 9.4 6 C9.269 6.1 9.1 6.1 9.1 5.946C9.009 5.8 9.1 5.7 9.2 5.6"></path></g><g class=group-15><path class=style2 d="M13.412 6.411C13.736 6.4 14 6.7 14 6.999c0 0.325-0.264 0.589-0.588 0.6 c-0.325 0-0.589-0.264-0.589-0.588C12.823 6.7 13.1 6.4 13.4 6.4"></path><path class=style2 d="M12.267 5.662c0.271-0.042 0.5 0.1 0.6 0.413c0.043 0.271-0.142 0.525-0.413 0.6 c-0.271 0.043-0.524-0.142-0.567-0.412C11.811 6 12 5.7 12.3 5.7"></path><path class=style2 d="M11.16 5.214c0.217-0.071 0.5 0 0.5 0.265c0.07 0.217-0.05 0.45-0.266 0.5 c-0.218 0.071-0.451-0.048-0.521-0.265S10.942 5.3 11.2 5.2"></path><path class=style2 d="M10.191 4.986c0.169-0.086 0.377-0.019 0.5 0.151c0.087 0.2 0 0.377-0.15 0.5 c-0.17 0.086-0.377 0.019-0.463-0.15C9.955 5.3 10 5.1 10.2 5"></path><path class=style2 d="M9.346 4.943c0.127-0.092 0.306-0.064 0.4 0.063C9.836 5.1 9.8 5.3 9.7 5.4 C9.553 5.5 9.4 5.5 9.3 5.342C9.189 5.2 9.2 5 9.3 4.9"></path><path class=style2 d="M8.641 5.027c0.092-0.092 0.24-0.092 0.3 0c0.092 0.1 0.1 0.239-0.001 0.3 c-0.091 0.092-0.239 0.091-0.33 0C8.549 5.3 8.5 5.1 8.6 5"></path></g><g class=group-16><path class=style1 d="M12.916 4.458c0.309-0.1 0.6 0.1 0.7 0.378c0.101 0.31-0.068 0.642-0.378 0.7 c-0.309 0.102-0.64-0.068-0.741-0.377C12.438 4.9 12.6 4.6 12.9 4.5"></path><path class=style1 d="M11.595 4.101c0.244-0.124 0.543-0.026 0.7 0.218c0.124 0.2 0 0.542-0.218 0.7 c-0.243 0.125-0.543 0.027-0.667-0.217S11.351 4.2 11.6 4.1"></path><path class=style1 d="M10.404 4.015c0.186-0.134 0.443-0.094 0.6 0.093c0.135 0.2 0.1 0.442-0.092 0.6 c-0.184 0.134-0.442 0.093-0.577-0.092S10.219 4.1 10.4 4"></path><path class=style1 d="M9.413 4.1c0.134-0.135 0.353-0.136 0.5 0c0.134 0.1 0.1 0.4 0 0.5 c-0.135 0.135-0.353 0.135-0.487 0C9.277 4.5 9.3 4.2 9.4 4.1"></path><path class=style1 d="M9.056 4.654C8.964 4.8 8.8 4.8 8.7 4.718C8.53 4.6 8.5 4.4 8.6 4.3 c0.091-0.128 0.271-0.155 0.397-0.063C9.12 4.3 9.1 4.5 9.1 4.7"></path><path class=style1 d="M8.369 4.829c-0.06 0.115-0.2 0.162-0.315 0.103C7.938 4.9 7.9 4.7 8 4.6 c0.059-0.115 0.2-0.161 0.314-0.103C8.382 4.6 8.4 4.7 8.4 4.8"></path></g><g class=group-17><path class=style3 d="M11.842 2.755c0.263-0.191 0.631-0.133 0.8 0.13c0.191 0.3 0.1 0.631-0.13 0.8 c-0.263 0.19-0.631 0.133-0.822-0.131C11.521 3.3 11.6 2.9 11.8 2.8"></path><path class=style3 d="M10.475 2.823c0.194-0.194 0.508-0.194 0.7 0s0.194 0.5 0 0.702c-0.194 0.193-0.508 0.193-0.702 0 C10.28 3.3 10.3 3 10.5 2.8"></path><path class=style3 d="M9.984 3.596C9.851 3.8 9.6 3.8 9.4 3.687C9.223 3.6 9.2 3.3 9.3 3.1 c0.134-0.186 0.393-0.227 0.578-0.092C10.078 3.2 10.1 3.4 10 3.6"></path><path class=style3 d="M9.013 3.809c-0.086 0.17-0.294 0.237-0.464 0.15C8.38 3.9 8.3 3.7 8.4 3.5 c0.086-0.17 0.293-0.236 0.462-0.15C9.031 3.4 9.1 3.6 9 3.8"></path><path class=style3 d="M8.231 4.134c-0.049 0.149-0.21 0.231-0.36 0.183C7.723 4.3 7.6 4.1 7.7 4 c0.048-0.149 0.209-0.231 0.358-0.182C8.197 3.8 8.3 4 8.2 4.1"></path><path class=style3 d="M7.632 4.512c-0.021 0.13-0.141 0.216-0.27 0.196C7.235 4.7 7.1 4.6 7.2 4.4 c0.021-0.129 0.141-0.217 0.269-0.196C7.563 4.3 7.7 4.4 7.6 4.5"></path></g><g class=group-18><path class=style0 d="M11.245 2.158c-0.191 0.263-0.56 0.32-0.822 0.13c-0.264-0.19-0.321-0.559-0.13-0.821 c0.19-0.264 0.559-0.321 0.822-0.131C11.377 1.5 11.4 1.9 11.2 2.2"></path><path class=style0 d="M9.014 1.953c0.124-0.244 0.424-0.341 0.668-0.216c0.244 0.1 0.3 0.4 0.2 0.7 C9.774 2.6 9.5 2.7 9.2 2.621C8.986 2.5 8.9 2.2 9 2"></path><path class=style0 d="M8.787 2.84c-0.07 0.217-0.305 0.336-0.522 0.266C8.048 3 7.9 2.8 8 2.584s0.304-0.336 0.521-0.266 C8.738 2.4 8.9 2.6 8.8 2.8"></path><path class=style0 d="M7.928 3.343C7.898 3.5 7.7 3.7 7.5 3.629C7.347 3.6 7.2 3.4 7.2 3.2 c0.029-0.188 0.205-0.317 0.394-0.287C7.829 3 8 3.2 7.9 3.3"></path><path class=style0 d="M7.285 3.894c0 0.157-0.127 0.285-0.285 0.285c-0.157 0-0.285-0.128-0.285-0.285S6.843 3.6 7 3.6 C7.158 3.6 7.3 3.7 7.3 3.9"></path><path class=style0 d="M6.832 4.439c0.02 0.128-0.066 0.248-0.195 0.269c-0.129 0.02-0.248-0.066-0.268-0.194 C6.349 4.4 6.4 4.3 6.6 4.245C6.692 4.2 6.8 4.3 6.8 4.4"></path></g><g class=group-19><path class=style2 d="M9.542 1.083C9.44 1.4 9.1 1.6 8.8 1.461S8.321 1 8.4 0.72c0.1-0.31 0.432-0.479 0.741-0.378 C9.472 0.4 9.6 0.8 9.5 1.1"></path><path class=style2 d="M7.356 1.578c0.043-0.271 0.297-0.455 0.567-0.412c0.271 0 0.5 0.3 0.4 0.6 C8.293 2 8 2.2 7.8 2.146S7.312 1.9 7.4 1.6"></path><path class=style2 d="M7.413 2.491C7.413 2.7 7.2 2.9 7 2.905S6.587 2.7 6.6 2.491S6.771 2.1 7 2.1 S7.413 2.3 7.4 2.5"></path><path class=style2 d="M6.753 3.235C6.782 3.4 6.7 3.6 6.5 3.629C6.278 3.7 6.1 3.5 6.1 3.3 c-0.03-0.188 0.099-0.364 0.286-0.395S6.723 3 6.8 3.2"></path><path class=style2 d="M6.312 3.957c0.049 0.15-0.033 0.312-0.184 0.359C5.979 4.4 5.8 4.3 5.8 4.1 s0.033-0.311 0.183-0.359C6.103 3.7 6.3 3.8 6.3 4"></path><path class=style2 d="M6.05 4.617c0.059 0.1 0 0.256-0.104 0.314C5.831 5 5.7 4.9 5.6 4.8 C5.572 4.7 5.6 4.6 5.7 4.515C5.85 4.5 6 4.5 6 4.6"></path></g><g class=group-20><path class=style1 d="M7.589 0.588c0 0.325-0.264 0.588-0.589 0.588S6.412 0.9 6.4 0.588S6.675 0 7 0 S7.589 0.3 7.6 0.6"></path><path class=style1 d="M5.664 1.733C5.62 1.5 5.8 1.2 6.1 1.166s0.524 0.1 0.6 0.4 c0.042 0.271-0.143 0.525-0.413 0.568C5.96 2.2 5.7 2 5.7 1.7"></path><path class=style1 d="M6.001 2.584c0.07 0.217-0.05 0.45-0.267 0.521c-0.217 0.07-0.45-0.049-0.521-0.266 c-0.07-0.218 0.048-0.451 0.266-0.521C5.696 2.2 5.9 2.4 6 2.6"></path><path class=style1 d="M5.603 3.495C5.688 3.7 5.6 3.9 5.5 3.96c-0.17 0.085-0.378 0.019-0.464-0.152 c-0.086-0.169-0.019-0.376 0.15-0.462C5.308 3.3 5.5 3.3 5.6 3.5"></path><path class=style1 d="M5.405 4.319c0.092 0.1 0.1 0.306-0.062 0.398C5.215 4.8 5 4.8 4.9 4.7 S4.88 4.3 5 4.256C5.134 4.2 5.3 4.2 5.4 4.3"></path><path class=style1 d="M5.359 5.027c0.092 0.1 0.1 0.2 0 0.332s-0.24 0.091-0.331 0c-0.092-0.093-0.092-0.24-0.001-0.332 C5.119 4.9 5.3 4.9 5.4 5"></path></g></svg></div><div aria-hidden=true class=frontend-filesViewer-inlineMode-footer-figshareButton-module__figshareText--yx0hv>fig<strong>share</strong></div></a></nav></footer><aside class="frontend-filesViewer-components-fileDescription-module__descriptionContainer--5IiG5 frontend-filesViewer-inlineMode-index-module__fileDescription--55hIr"><div class=frontend-filesViewer-components-fileDescription-module__title--Zri4r>Additional File 1</div><div class=frontend-filesViewer-components-fileDescription-module__description--rwuvv>Additional file 1: Figure S1. Flow diagram of the study population.</div></aside></article></figshare-widget></div></div><div class=c-article-supplementary__item data-test=supp-item id=MOESM1><h3 class="c-article-supplementary__title u-h3"><a class=print-link data-track=click data-track-action="view supplementary info" data-track-label=link data-test=supp-info-link href=https://static-content.springer.com/esm/art%3A10.1186%2Fs12933-018-0746-4/MediaObjects/12933_2018_746_MOESM1_ESM.docx data-supp-info-image><b>Additional file 1: Figure S1.</b></a></h3><div class=c-article-supplementary__description data-component=thumbnail-container><p> Flow diagram of the study population.</p></div></div></div></div></div></section><section data-title="Rights and permissions"><div class=c-article-section id=rightslink-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=rightslink>Rights and permissions</h2><div class=c-article-section__content id=rightslink-content>
 <p><b>Open Access</b> This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<a href=http://creativecommons.org/licenses/by/4.0/ rel=license>http://creativecommons.org/licenses/by/4.0/</a>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<a href=http://creativecommons.org/publicdomain/zero/1.0/ rel=license>http://creativecommons.org/publicdomain/zero/1.0/</a>) applies to the data made available in this article, unless otherwise stated.</p>
 <p class=c-article-rights><a data-track=click data-track-action="view rights and permissions" data-track-label=link href="https://s100.copyright.com/AppDispatchServlet?title=Risk%20of%20heart%20failure%20hospitalization%20among%20users%20of%20dipeptidyl%20peptidase-4%20inhibitors%20compared%20to%20glucagon-like%20peptide-1%20receptor%20agonists&amp;author=Ghadeer%20K.%20Dawwas%20et%20al&amp;contentID=10.1186%2Fs12933-018-0746-4&amp;copyright=The%20Author%28s%29&amp;publication=1475-2840&amp;publicationDate=2018-07-17&amp;publisherName=SpringerNature&amp;orderBeanReset=true&amp;oa=CC%20BY%20%2B%20CC0">Reprints and Permissions</a></p></div></div></section><section aria-labelledby=article-info data-title="About this article"><div class=c-article-section id=article-info-section><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id=article-info>About this article</h2><div class=c-article-section__content id=article-info-content><div class=c-bibliographic-information><div class="u-hide-print c-bibliographic-information__column c-bibliographic-information__column--border"><a data-crossmark=10.1186/s12933-018-0746-4 target=_blank rel=noopener href="https://crossmark.crossref.org/dialog/?doi=10.1186/s12933-018-0746-4" data-track=click data-track-action="Click Crossmark" data-track-label=link data-test=crossmark><img alt="Verify currency and authenticity via CrossMark" src=data:image/svg+xml;base64,<svg height="81" width="57" xmlns="http://www.w3.org/2000/svg"><g fill="none" fill-rule="evenodd"><path d="m17.35 35.45 21.3-14.2v-17.03h-21.3" fill="#989898"/><path d="m38.65 35.45-21.3-14.2v-17.03h21.3" fill="#747474"/><path d="m28 .5c-12.98 0-23.5 10.52-23.5 23.5s10.52 23.5 23.5 23.5 23.5-10.52 23.5-23.5c0-6.23-2.48-12.21-6.88-16.62-4.41-4.4-10.39-6.88-16.62-6.88zm0 41.25c-9.8 0-17.75-7.95-17.75-17.75s7.95-17.75 17.75-17.75 17.75 7.95 17.75 17.75c0 4.71-1.87 9.22-5.2 12.55s-7.84 5.2-12.55 5.2z" fill="#535353"/><path d="m41 36c-5.81 6.23-15.23 7.45-22.43 2.9-7.21-4.55-10.16-13.57-7.03-21.5l-4.92-3.11c-4.95 10.7-1.19 23.42 8.78 29.71 9.97 6.3 23.07 4.22 30.6-4.86z" fill="#9c9c9c"/><path d="m.2 58.45c0-.75.11-1.42.33-2.01s.52-1.09.91-1.5c.38-.41.83-.73 1.34-.94.51-.22 1.06-.32 1.65-.32.56 0 1.06.11 1.51.35.44.23.81.5 1.1.81l-.91 1.01c-.24-.24-.49-.42-.75-.56-.27-.13-.58-.2-.93-.2-.39 0-.73.08-1.05.23-.31.16-.58.37-.81.66-.23.28-.41.63-.53 1.04-.13.41-.19.88-.19 1.39 0 1.04.23 1.86.68 2.46.45.59 1.06.88 1.84.88.41 0 .77-.07 1.07-.23s.59-.39.85-.68l.91 1c-.38.43-.8.76-1.28.99-.47.22-1 .34-1.58.34-.59 0-1.13-.1-1.64-.31-.5-.2-.94-.51-1.31-.91-.38-.4-.67-.9-.88-1.48-.22-.59-.33-1.26-.33-2.02zm8.4-5.33h1.61v2.54l-.05 1.33c.29-.27.61-.51.96-.72s.76-.31 1.24-.31c.73 0 1.27.23 1.61.71.33.47.5 1.14.5 2.02v4.31h-1.61v-4.1c0-.57-.08-.97-.25-1.21-.17-.23-.45-.35-.83-.35-.3 0-.56.08-.79.22-.23.15-.49.36-.78.64v4.8h-1.61zm7.37 6.45c0-.56.09-1.06.26-1.51.18-.45.42-.83.71-1.14.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.36c.07.62.29 1.1.65 1.44.36.33.82.5 1.38.5.29 0 .57-.04.83-.13s.51-.21.76-.37l.55 1.01c-.33.21-.69.39-1.09.53-.41.14-.83.21-1.26.21-.48 0-.92-.08-1.34-.25-.41-.16-.76-.4-1.07-.7-.31-.31-.55-.69-.72-1.13-.18-.44-.26-.95-.26-1.52zm4.6-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.07.45-.31.29-.5.73-.58 1.3zm2.5.62c0-.57.09-1.08.28-1.53.18-.44.43-.82.75-1.13s.69-.54 1.1-.71c.42-.16.85-.24 1.31-.24.45 0 .84.08 1.17.23s.61.34.85.57l-.77 1.02c-.19-.16-.38-.28-.56-.37-.19-.09-.39-.14-.61-.14-.56 0-1.01.21-1.35.63-.35.41-.52.97-.52 1.67 0 .69.17 1.24.51 1.66.34.41.78.62 1.32.62.28 0 .54-.06.78-.17.24-.12.45-.26.64-.42l.67 1.03c-.33.29-.69.51-1.08.65-.39.15-.78.23-1.18.23-.46 0-.9-.08-1.31-.24-.4-.16-.75-.39-1.05-.7s-.53-.69-.7-1.13c-.17-.45-.25-.96-.25-1.53zm6.91-6.45h1.58v6.17h.05l2.54-3.16h1.77l-2.35 2.8 2.59 4.07h-1.75l-1.77-2.98-1.08 1.23v1.75h-1.58zm13.69 1.27c-.25-.11-.5-.17-.75-.17-.58 0-.87.39-.87 1.16v.75h1.34v1.27h-1.34v5.6h-1.61v-5.6h-.92v-1.2l.92-.07v-.72c0-.35.04-.68.13-.98.08-.31.21-.57.4-.79s.42-.39.71-.51c.28-.12.63-.18 1.04-.18.24 0 .48.02.69.07.22.05.41.1.57.17zm.48 5.18c0-.57.09-1.08.27-1.53.17-.44.41-.82.72-1.13.3-.31.65-.54 1.04-.71.39-.16.8-.24 1.23-.24s.84.08 1.24.24c.4.17.74.4 1.04.71s.54.69.72 1.13c.19.45.28.96.28 1.53s-.09 1.08-.28 1.53c-.18.44-.42.82-.72 1.13s-.64.54-1.04.7-.81.24-1.24.24-.84-.08-1.23-.24-.74-.39-1.04-.7c-.31-.31-.55-.69-.72-1.13-.18-.45-.27-.96-.27-1.53zm1.65 0c0 .69.14 1.24.43 1.66.28.41.68.62 1.18.62.51 0 .9-.21 1.19-.62.29-.42.44-.97.44-1.66 0-.7-.15-1.26-.44-1.67-.29-.42-.68-.63-1.19-.63-.5 0-.9.21-1.18.63-.29.41-.43.97-.43 1.67zm6.48-3.44h1.33l.12 1.21h.05c.24-.44.54-.79.88-1.02.35-.24.7-.36 1.07-.36.32 0 .59.05.78.14l-.28 1.4-.33-.09c-.11-.01-.23-.02-.38-.02-.27 0-.56.1-.86.31s-.55.58-.77 1.1v4.2h-1.61zm-47.87 15h1.61v4.1c0 .57.08.97.25 1.2.17.24.44.35.81.35.3 0 .57-.07.8-.22.22-.15.47-.39.73-.73v-4.7h1.61v6.87h-1.32l-.12-1.01h-.04c-.3.36-.63.64-.98.86-.35.21-.76.32-1.24.32-.73 0-1.27-.24-1.61-.71-.33-.47-.5-1.14-.5-2.02zm9.46 7.43v2.16h-1.61v-9.59h1.33l.12.72h.05c.29-.24.61-.45.97-.63.35-.17.72-.26 1.1-.26.43 0 .81.08 1.15.24.33.17.61.4.84.71.24.31.41.68.53 1.11.13.42.19.91.19 1.44 0 .59-.09 1.11-.25 1.57-.16.47-.38.85-.65 1.16-.27.32-.58.56-.94.73-.35.16-.72.25-1.1.25-.3 0-.6-.07-.9-.2s-.59-.31-.87-.56zm0-2.3c.26.22.5.37.73.45.24.09.46.13.66.13.46 0 .84-.2 1.15-.6.31-.39.46-.98.46-1.77 0-.69-.12-1.22-.35-1.61-.23-.38-.61-.57-1.13-.57-.49 0-.99.26-1.52.77zm5.87-1.69c0-.56.08-1.06.25-1.51.16-.45.37-.83.65-1.14.27-.3.58-.54.93-.71s.71-.25 1.08-.25c.39 0 .73.07 1 .2.27.14.54.32.81.55l-.06-1.1v-2.49h1.61v9.88h-1.33l-.11-.74h-.06c-.25.25-.54.46-.88.64-.33.18-.69.27-1.06.27-.87 0-1.56-.32-2.07-.95s-.76-1.51-.76-2.65zm1.67-.01c0 .74.13 1.31.4 1.7.26.38.65.58 1.15.58.51 0 .99-.26 1.44-.77v-3.21c-.24-.21-.48-.36-.7-.45-.23-.08-.46-.12-.7-.12-.45 0-.82.19-1.13.59-.31.39-.46.95-.46 1.68zm6.35 1.59c0-.73.32-1.3.97-1.71.64-.4 1.67-.68 3.08-.84 0-.17-.02-.34-.07-.51-.05-.16-.12-.3-.22-.43s-.22-.22-.38-.3c-.15-.06-.34-.1-.58-.1-.34 0-.68.07-1 .2s-.63.29-.93.47l-.59-1.08c.39-.24.81-.45 1.28-.63.47-.17.99-.26 1.54-.26.86 0 1.51.25 1.93.76s.63 1.25.63 2.21v4.07h-1.32l-.12-.76h-.05c-.3.27-.63.48-.98.66s-.73.27-1.14.27c-.61 0-1.1-.19-1.48-.56-.38-.36-.57-.85-.57-1.46zm1.57-.12c0 .3.09.53.27.67.19.14.42.21.71.21.28 0 .54-.07.77-.2s.48-.31.73-.56v-1.54c-.47.06-.86.13-1.18.23-.31.09-.57.19-.76.31s-.33.25-.41.4c-.09.15-.13.31-.13.48zm6.29-3.63h-.98v-1.2l1.06-.07.2-1.88h1.34v1.88h1.75v1.27h-1.75v3.28c0 .8.32 1.2.97 1.2.12 0 .24-.01.37-.04.12-.03.24-.07.34-.11l.28 1.19c-.19.06-.4.12-.64.17-.23.05-.49.08-.76.08-.4 0-.74-.06-1.02-.18-.27-.13-.49-.3-.67-.52-.17-.21-.3-.48-.37-.78-.08-.3-.12-.64-.12-1.01zm4.36 2.17c0-.56.09-1.06.27-1.51s.41-.83.71-1.14c.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.37c.08.62.29 1.1.65 1.44.36.33.82.5 1.38.5.3 0 .58-.04.84-.13.25-.09.51-.21.76-.37l.54 1.01c-.32.21-.69.39-1.09.53s-.82.21-1.26.21c-.47 0-.92-.08-1.33-.25-.41-.16-.77-.4-1.08-.7-.3-.31-.54-.69-.72-1.13-.17-.44-.26-.95-.26-1.52zm4.61-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.08.45-.31.29-.5.73-.57 1.3zm3.01 2.23c.31.24.61.43.92.57.3.13.63.2.98.2.38 0 .65-.08.83-.23s.27-.35.27-.6c0-.14-.05-.26-.13-.37-.08-.1-.2-.2-.34-.28-.14-.09-.29-.16-.47-.23l-.53-.22c-.23-.09-.46-.18-.69-.3-.23-.11-.44-.24-.62-.4s-.33-.35-.45-.55c-.12-.21-.18-.46-.18-.75 0-.61.23-1.1.68-1.49.44-.38 1.06-.57 1.83-.57.48 0 .91.08 1.29.25s.71.36.99.57l-.74.98c-.24-.17-.49-.32-.73-.42-.25-.11-.51-.16-.78-.16-.35 0-.6.07-.76.21-.17.15-.25.33-.25.54 0 .14.04.26.12.36s.18.18.31.26c.14.07.29.14.46.21l.54.19c.23.09.47.18.7.29s.44.24.64.4c.19.16.34.35.46.58.11.23.17.5.17.82 0 .3-.06.58-.17.83-.12.26-.29.48-.51.68-.23.19-.51.34-.84.45-.34.11-.72.17-1.15.17-.48 0-.95-.09-1.41-.27-.46-.19-.86-.41-1.2-.68z" fill="#535353"/></g></svg> width=57 height=81></a></div><div class=c-bibliographic-information__column><h3 class=c-article__sub-heading id=citeas>Cite this article</h3><p class=c-bibliographic-information__citation>Dawwas, G.K., Smith, S.M. &amp; Park, H. Risk of heart failure hospitalization among users of dipeptidyl peptidase-4 inhibitors compared to glucagon-like peptide-1 receptor agonists.
 <i>Cardiovasc Diabetol</i> <b>17</b>, 102 (2018). https://doi.org/10.1186/s12933-018-0746-4<p class="c-bibliographic-information__download-citation u-hide-print"><a data-test=citation-link data-track=click data-track-action="download article citation" data-track-label=link data-track-external href="https://citation-needed.springer.com/v2/references/10.1186/s12933-018-0746-4?format=refman&amp;flavour=citation">Download citation<svg width=16 height=16 focusable=false role=img aria-hidden=true class=u-icon><use xmlns:xlink=http://www.w3.org/1999/xlink xlink:href=#global-icon-download></use></svg></a><ul class=c-bibliographic-information__list data-test=publication-history><li class=c-bibliographic-information__list-item><p>Received<span class="u-hide sf-hidden">: </span><span class=c-bibliographic-information__value><time datetime=2018-05-19>19 May 2018</time></span></p><li class=c-bibliographic-information__list-item><p>Accepted<span class="u-hide sf-hidden">: </span><span class=c-bibliographic-information__value><time datetime=2018-07-07>07 July 2018</time></span></p><li class=c-bibliographic-information__list-item><p>Published<span class="u-hide sf-hidden">: </span><span class=c-bibliographic-information__value><time datetime=2018-07-17>17 July 2018</time></span></p><li class="c-bibliographic-information__list-item c-bibliographic-information__list-item--doi"><p><abbr title="Digital Object Identifier">DOI</abbr><span class="u-hide sf-hidden">: </span><span class=c-bibliographic-information__value>https://doi.org/10.1186/s12933-018-0746-4</span></p></ul><div data-component=share-box><div class="c-article-share-box u-display-block"><h3 class=c-article__sub-heading>Share this article</h3><p class=c-article-share-box__description>Anyone you share the following link with will be able to read this content:</p><button class="js-get-share-url c-article-share-box__button" id=get-share-url data-track=click data-track-label=button data-track-external data-track-action="get shareable link">Get shareable link</button><div class="js-no-share-url-container u-display-none sf-hidden" hidden></div><div class="js-share-url-container u-display-none sf-hidden" hidden></div><p class="js-c-article-share-box__additional-info c-article-share-box__additional-info">
 Provided by the Springer Nature SharedIt content-sharing initiative
 </p></div></div><h3 class=c-article__sub-heading>Keywords</h3><ul class=c-article-subject-list><li class=c-article-subject-list__subject><span>Type 2 diabetes</span><li class=c-article-subject-list__subject><span>DPP-4 inhibitors</span><li class=c-article-subject-list__subject><span>GLP-1 agonists</span><li class=c-article-subject-list__subject><span>Safety</span><li class=c-article-subject-list__subject><span>Heart failure</span></ul><div data-component=article-info-list></div></div></div></div></div></section>
 
 </article>
 </main>
 <div class="c-article-extras u-text-sm u-hide-print" data-container-type=reading-companion data-track-component="reading companion">
 <aside>
 <div data-test=download-article-link-wrapper class=js-context-bar-sticky-point-desktop>
 
 <div class="c-pdf-download u-clear-both">
 <a href=https://cardiab.biomedcentral.com/counter/pdf/10.1186/s12933-018-0746-4.pdf class="u-button u-button--full-width u-button--primary u-justify-content-space-between c-pdf-download__link" data-article-pdf=true data-readcube-pdf-url=true data-test=pdf-link data-draft-ignore=true data-track=click data-track-action="download pdf" data-track-label=link data-track-external download>
 <span class=c-pdf-download__text>Download PDF</span>
 <svg aria-hidden=true focusable=false width=16 height=16 class=u-icon><use xlink:href=#global-icon-download></use></svg>
 </a>
 </div>
 
 <div class="c-pdf-download u-clear-both">
 <a id=articleEpub class="u-button u-button--full-width u-justify-content-space-between c-pdf-download__link" href=https://cardiab.biomedcentral.com/counter/epub/10.1186/s12933-018-0746-4 data-track=click data-track-category="EPUB Download" data-track-action="Click download article EPUB" data-track-label=10.1186/s12933-018-0746-4>
 <span class=c-pdf-download__text>Download ePub</span>
 <svg aria-hidden=true focusable=false width=16 height=16 class=u-icon>
 <use xlink:href=#global-icon-download></use>
 </svg>
 </a>
 </div>
 </div>
 
 
 <div class=c-reading-companion>
 <div class=c-reading-companion__sticky data-component=reading-companion-sticky data-test=reading-companion-sticky style=top:40px>
 <ul class=c-reading-companion__tabs role=tablist><li role=presentation><button data-tab-target=sections role=tab id=tab-sections aria-controls=tabpanel-sections aria-selected=true class="c-reading-companion__tab c-reading-companion__tab--active" data-track=click data-track-action="sections tab" data-track-label=tab>Sections</button><li role=presentation><button data-tab-target=figures role=tab id=tab-figures aria-controls=tabpanel-figures aria-selected=false tabindex=-1 class=c-reading-companion__tab data-track=click data-track-action="figures tab" data-track-label=tab>Figures</button><li role=presentation><button data-tab-target=references role=tab id=tab-references aria-controls=tabpanel-references aria-selected=false tabindex=-1 class=c-reading-companion__tab data-track=click data-track-action="references tab" data-track-label=tab>References</button></ul><div class="c-reading-companion__panel c-reading-companion__sections c-reading-companion__panel--active" id=tabpanel-sections aria-labelledby=tab-sections role=tabpanel><div class=c-reading-companion__scroll-pane style=max-height:none><ul class=c-reading-companion__sections-list><li id=rc-sec-Abs1 class="c-reading-companion__section-item c-reading-companion__section-item--active"><a href=#Abs1 data-track=click data-track-action="section anchor" data-track-label=link:Abstract>Abstract</a><li id=rc-sec-Sec1 class=c-reading-companion__section-item><a href=#Sec1 data-track=click data-track-action="section anchor" data-track-label=link:Background>Background</a><li id=rc-sec-Sec2 class=c-reading-companion__section-item><a href=#Sec2 data-track=click data-track-action="section anchor" data-track-label=link:Methods>Methods</a><li id=rc-sec-Sec8 class=c-reading-companion__section-item><a href=#Sec8 data-track=click data-track-action="section anchor" data-track-label=link:Results>Results</a><li id=rc-sec-Sec13 class=c-reading-companion__section-item><a href=#Sec13 data-track=click data-track-action="section anchor" data-track-label=link:Discussion>Discussion</a><li id=rc-sec-Sec17 class=c-reading-companion__section-item><a href=#Sec17 data-track=click data-track-action="section anchor" data-track-label=link:Conclusion>Conclusion</a><li id=rc-sec-abbreviations class=c-reading-companion__section-item><a href=#abbreviations data-track=click data-track-action="section anchor" data-track-label=link:Abbreviations>Abbreviations</a><li id=rc-sec-Bib1 class=c-reading-companion__section-item><a href=#Bib1 data-track=click data-track-action="section anchor" data-track-label=link:References>References</a><li id=rc-sec-Ack1 class=c-reading-companion__section-item><a href=#Ack1 data-track=click data-track-action="section anchor" data-track-label="link:Authors contributions">Authors’ contributions</a><li id=rc-sec-author-information class=c-reading-companion__section-item><a href=#author-information data-track=click data-track-action="section anchor" data-track-label="link:Author information">Author information</a><li id=rc-sec-Sec18 class=c-reading-companion__section-item><a href=#Sec18 data-track=click data-track-action="section anchor" data-track-label="link:Additional file">Additional file</a><li id=rc-sec-rightslink class=c-reading-companion__section-item><a href=#rightslink data-track=click data-track-action="section anchor" data-track-label="link:Rights and permissions">Rights and permissions</a><li id=rc-sec-article-info class=c-reading-companion__section-item><a href=#article-info data-track=click data-track-action="section anchor" data-track-label="link:About this article">About this article</a></ul></div>
 <div class="js-ad u-lazy-ad-wrapper u-mt-16 u-show" data-component-mpu>
 
 
 <aside class="adsbox c-ad c-ad--300x250 u-mt-16" data-component-mpu>
 <div class=c-ad__inner>
 <p class=c-ad__label>Advertisement</p>
 <div id=div-gpt-ad-MPU1 data-ad-type=MPU1 data-test=MPU1-ad data-pa11y-ignore data-gpt data-gpt-unitpath=/270604982/bmc/cardiab/articles data-gpt-sizes=300x250 data-gpt-targeting="pos=MPU1;doi=10.1186/s12933-018-0746-4;type=article;kwrd=Type 2 diabetes,DPP-4 inhibitors,GLP-1 agonists,Safety,Heart failure;pmc=H33045,H33010,H33037;">
 <noscript class=sf-hidden>
                    <a href="//pubads.g.doubleclick.net/gampad/jump?iu=/270604982/bmc/cardiab/articles&amp;sz=300x250&amp;pos=MPU1&amp;doi=10.1186/s12933-018-0746-4&amp;type=article&amp;kwrd=Type 2 diabetes,DPP-4 inhibitors,GLP-1 agonists,Safety,Heart failure&amp;pmc=H33045,H33010,H33037&amp;">
                        <img data-test="gpt-advert-fallback-img" src="//pubads.g.doubleclick.net/gampad/ad?iu=/270604982/bmc/cardiab/articles&amp;sz=300x250&amp;pos=MPU1&amp;doi=10.1186/s12933-018-0746-4&amp;type=article&amp;kwrd=Type 2 diabetes,DPP-4 inhibitors,GLP-1 agonists,Safety,Heart failure&amp;pmc=H33045,H33010,H33037&amp;" alt="Advertisement" width="300" height="250">
                    </a>
                </noscript>
 </div>
 </div>
 </aside>
 </div>
 </div>
 <div class="c-reading-companion__panel c-reading-companion__figures c-reading-companion__panel--full-width sf-hidden" id=tabpanel-figures aria-labelledby=tab-figures role=tabpanel><div class="c-reading-companion__scroll-pane sf-hidden"><ul class="c-reading-companion__figures-list sf-hidden"><li class="c-reading-companion__figure-item sf-hidden"><figure class=sf-hidden><picture class=sf-hidden><source type=image/webp data-srcset="https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12933-018-0746-4/MediaObjects/12933_2018_746_Fig1_HTML.png?as=webp"></picture></figure></ul></div></div>
 <div class="c-reading-companion__panel c-reading-companion__references c-reading-companion__panel--full-width sf-hidden" id=tabpanel-references aria-labelledby=tab-references role=tabpanel></div>
 </div>
 </div>
 </aside>
 </div>
 </div>
 
 <div class=c-journal-footer>
 <div class=c-journal-footer__inner>
 <div class=c-journal-footer__summary>
 <h4 class="c-journal-title c-journal-title--footer">
 <img class=c-journal-title__logo src=data:image/svg+xml;base64,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>
 <span class=c-journal-title__text>Cardiovascular Diabetology</span>
 </h4>
 <p class=c-journal-footer__issn>ISSN: 1475-2840</p>
 </div>
 
 <div class=c-journal-footer__contact>
 <h4 class="c-journal-footer__contact-title c-journal-footer__contact-title--adjust-for-logo">Contact us</h4>
 <ul class=c-journal-footer__contact-list>
 
 <li class=c-journal-footer__contact-item>Submission enquiries: <a href=mailto:sathish.venkatesan@springernature.com>sathish.venkatesan@springernature.com</a></li>
 
 
 <li class=c-journal-footer__contact-item>General enquiries: <a href=mailto:info@biomedcentral.com>info@biomedcentral.com</a></li>
 
 </ul>
 </div>
 
 </div>
 </div>
 
 
 <img rel=nofollow class=tracker style=display:none src=data:, alt>
 
 <footer>
 
 <div class=c-publisher-footer data-test=publisher-footer>
 <div class=u-container>
 <div class="u-display-flex u-flex-wrap u-justify-content-space-between" data-test=publisher-footer-menu>
 <div class=u-display-flex>
 
 
 <ul class="c-list-group c-list-group--sm u-mr-24 u-mb-16">
 
 <li class=c-list-group__item>
 <a class=u-gray-link href=http://blogs.biomedcentral.com/>Read more on our blogs</a>
 </li>
 
 <li class=c-list-group__item>
 <a class=u-gray-link href=https://www.biomedcentral.com/login>Receive BMC newsletters</a>
 </li>
 
 <li class=c-list-group__item>
 <a class=u-gray-link href=https://www.biomedcentral.com/account>Manage article alerts</a>
 </li>
 
 <li class=c-list-group__item>
 <a class=u-gray-link href="https://authorservices.springernature.com/go/sn/?utm_source=Website&amp;utm_medium=BMC&amp;utm_campaign=SNAS+Referrals+2022&amp;utm_id=ref2022">Language editing for authors</a>
 </li>
 
 <li class=c-list-group__item>
 <a class=u-gray-link href="https://authorservices.springernature.com/go/sn/?utm_source=Website&amp;utm_medium=BMC&amp;utm_campaign=SNAS+Referrals+2022&amp;utm_id=ref2022">Scientific editing for authors</a>
 </li>
 
 </ul>
 
 <ul class="c-list-group c-list-group--sm u-mr-24 u-mb-16">
 
 <li class=c-list-group__item>
 <a class=u-gray-link href=https://www.biomedcentral.com/about/policies>Policies</a>
 </li>
 
 <li class=c-list-group__item>
 <a class=u-gray-link href=https://www.biomedcentral.com/accessibility>Accessibility</a>
 </li>
 
 <li class=c-list-group__item>
 <a class=u-gray-link href=https://www.biomedcentral.com/about/press-centre>Press center</a>
 </li>
 
 </ul>
 
 <ul class="c-list-group c-list-group--sm u-mr-24 u-mb-16">
 
 <li class=c-list-group__item>
 <a class=u-gray-link href=https://support.biomedcentral.com/support/home>Support and Contact</a>
 </li>
 
 <li class=c-list-group__item>
 <a class=u-gray-link href=https://biomedcentral.typeform.com/to/VLXboo>Leave feedback</a>
 </li>
 
 <li class=c-list-group__item>
 <a class=u-gray-link href=https://www.biomedcentral.com/about/jobs>Careers</a>
 </li>
 
 </ul>
 
 
 </div>
 <div class=u-mb-24>
 <h3 id=social-menu class="u-text-sm u-reset-margin u-text-normal">Follow BMC</h3>
 <ul class="u-display-flex u-list-reset" data-test=footer-social-links>
 
 <li class="u-mt-8 u-mr-8">
 <a href=https://twitter.com/biomedcentral data-track=click data-track-category=Social data-track-action="Clicked BMC Twitter" class=u-gray-link>
 <span class=u-visually-hidden>BMC Twitter page</span>
 <svg class="u-icon u-text-lg" width=24 height=24 aria-hidden=true focusable=false>
 <use xlink:href=#icon-twitter-bordered></use>
 </svg>
 </a>
 </li>
 
 <li class="u-mt-8 u-mr-8">
 <a href=https://www.facebook.com/BioMedCentral data-track=click data-track-category=Social data-track-action="Clicked BMC Facebook" class=u-gray-link>
 <span class=u-visually-hidden>BMC Facebook page</span>
 <svg class="u-icon u-text-lg" width=24 height=24 aria-hidden=true focusable=false>
 <use xlink:href=#icon-facebook-bordered></use>
 </svg>
 </a>
 </li>
 
 <li class="u-mt-8 u-mr-8">
 <a href=http://www.weibo.com/biomedcentral data-track=click data-track-category=Social data-track-action="Clicked BMC Weibo" class=u-gray-link>
 <span class=u-visually-hidden>BMC Weibo page</span>
 <svg class="u-icon u-text-lg" width=24 height=24 aria-hidden=true focusable=false>
 <use xlink:href=#icon-weibo-bordered></use>
 </svg>
 </a>
 </li>
 
 </ul>
 </div>
 </div>
 <p class=u-reset-margin>
 By using this website, you agree to our
 <a class=u-gray-link href=https://www.biomedcentral.com/terms-and-conditions>Terms and Conditions</a>,
 <a class=u-gray-link href=https://www.springernature.com/ccpa>California Privacy Statement</a>,
 <a class=u-gray-link href=https://www.biomedcentral.com/privacy-statement>Privacy
 statement</a> and
 <a class=u-gray-link href=https://www.biomedcentral.com/cookies data-test=cookie-link>Cookies</a> policy.
 
 <a class="optanon-toggle-display u-gray-link" data-cc-action=preferences>Manage cookies/Do not sell my data</a> we use in the preference centre.
 
 </p>
 </div>
</div>
 
 <div class=c-corporate-footer>
 <div class=u-container>
 <img src=data:image/svg+xml;base64,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 class=c-corporate-footer__logo alt="Springer Nature" itemprop=logo role=img>
 <p class=c-corporate-footer__legal data-test=copyright> © 2022 BioMed Central Ltd unless otherwise stated. Part of
 <a class=c-corporate-footer__link href=https://www.springernature.com/ itemscope itemtype=http://schema.org/Organization itemid=#parentOrganization>Springer Nature</a>.
 </p>
 </div>
</div>
 </footer>
 </div>
 
 <svg class="u-hide hide">
 <symbol id=global-icon-chevron-right viewBox="0 0 10 10" xmlns=http://www.w3.org/2000/svg>
 <path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill=currentColor fill-rule=evenodd transform="matrix(0 -1 1 0 0 10)"></path>
 </symbol>
 <symbol id=global-icon-download viewBox="0 0 16 16">
 <path d="M2 14c0-.556.449-1 1.002-1h9.996a.999.999 0 110 2H3.002A1.006 1.006 0 012 14zM9 2v6.8l2.482-2.482c.392-.392 1.022-.4 1.403-.02a1.001 1.001 0 010 1.417l-4.177 4.177a1.001 1.001 0 01-1.416 0L3.115 7.715a.991.991 0 01-.016-1.4 1 1 0 011.42.003L7 8.8V2c0-.55.444-.996 1-.996.552 0 1 .445 1 .996z" fill-rule=evenodd></path>
 </symbol>
 <symbol id=global-icon-email viewBox="0 0 18 18">
 <path d="M1.995 2h14.01A2 2 0 0118 4.006v9.988A2 2 0 0116.005 16H1.995A2 2 0 010 13.994V4.006A2 2 0 011.995 2zM1 13.994A1 1 0 001.995 15h14.01A1 1 0 0017 13.994V4.006A1 1 0 0016.005 3H1.995A1 1 0 001 4.006zM9 11L2 7V5.557l7 4 7-4V7z" fill-rule=evenodd></path>
 </symbol>
 <symbol id=global-icon-institution viewBox="0 0 18 18">
 <path d="M14 8a1 1 0 011 1v6h1.5a.5.5 0 01.5.5v.5h.5a.5.5 0 01.5.5V18H0v-1.5a.5.5 0 01.5-.5H1v-.5a.5.5 0 01.5-.5H3V9a1 1 0 112 0v6h8V9a1 1 0 011-1zM6 8l2 1v4l-2 1zm6 0v6l-2-1V9zM9.573.401l7.036 4.925A.92.92 0 0116.081 7H1.92a.92.92 0 01-.528-1.674L8.427.401a1 1 0 011.146 0zM9 2.441L5.345 5h7.31z" fill-rule=evenodd></path>
 </symbol>
 <symbol id=global-icon-search viewBox="0 0 22 22">
 <path fill-rule=evenodd d="M21.697 20.261a1.028 1.028 0 01.01 1.448 1.034 1.034 0 01-1.448-.01l-4.267-4.267A9.812 9.811 0 010 9.812a9.812 9.811 0 1117.43 6.182zM9.812 18.222A8.41 8.41 0 109.81 1.403a8.41 8.41 0 000 16.82z"></path>
 </symbol>
 <symbol id=icon-info viewBox="0 0 18 18">
 <path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm0 7h-1.5l-.11662113.00672773c-.49733868.05776511-.88337887.48043643-.88337887.99327227 0 .47338693.32893365.86994729.77070917.97358929l.1126697.01968298.11662113.00672773h.5v3h-.5l-.11662113.0067277c-.42082504.0488782-.76196299.3590206-.85696816.7639815l-.01968298.1126697-.00672773.1166211.00672773.1166211c.04887817.4208251.35902055.761963.76398144.8569682l.1126697.019683.11662113.0067277h3l.1166211-.0067277c.4973387-.0577651.8833789-.4804365.8833789-.9932723 0-.4733869-.3289337-.8699473-.7707092-.9735893l-.1126697-.019683-.1166211-.0067277h-.5v-4l-.00672773-.11662113c-.04887817-.42082504-.35902055-.76196299-.76398144-.85696816l-.1126697-.01968298zm0-3.25c-.69035594 0-1.25.55964406-1.25 1.25s.55964406 1.25 1.25 1.25 1.25-.55964406 1.25-1.25-.55964406-1.25-1.25-1.25z" fill-rule=evenodd></path>
 </symbol>
 <symbol id=icon-success viewBox="0 0 18 18">
 <path d="M9 0a9 9 0 110 18A9 9 0 019 0zm3.486 4.982l-4.718 5.506L5.14 8.465a.991.991 0 00-1.423.133 1.06 1.06 0 00.13 1.463l3.407 2.733a1 1 0 001.387-.133l5.385-6.334a1.06 1.06 0 00-.116-1.464.991.991 0 00-1.424.119z" fill-rule=evenodd></path>
 </symbol>
 <symbol id=icon-chevron-down viewBox="0 0 16 16">
 <path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" fill-rule=evenodd transform="matrix(0 1 -1 0 11 1)"></path>
 </symbol>
 <symbol id=icon-warning viewBox="0 0 18 18">
 <path d="m9 11.75c.69035594 0 1.25.5596441 1.25 1.25s-.55964406 1.25-1.25 1.25-1.25-.5596441-1.25-1.25.55964406-1.25 1.25-1.25zm.41320045-7.75c.55228475 0 1.00000005.44771525 1.00000005 1l-.0034543.08304548-.3333333 4c-.043191.51829212-.47645714.91695452-.99654578.91695452h-.15973424c-.52008864 0-.95335475-.3986624-.99654576-.91695452l-.33333333-4c-.04586475-.55037702.36312325-1.03372649.91350028-1.07959124l.04148683-.00259031zm-.41320045 14c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z" fill-rule=evenodd></path>
 </symbol>
 <symbol id=icon-plus viewBox="0 0 16 16">
 <path d="m2.00087166 7h4.99912834v-4.99912834c0-.55276616.44386482-1.00087166 1-1.00087166.55228475 0 1 .44463086 1 1.00087166v4.99912834h4.9991283c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-4.9991283v4.9991283c0 .5527662-.44386482 1.0008717-1 1.0008717-.55228475 0-1-.4446309-1-1.0008717v-4.9991283h-4.99912834c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule=evenodd></path>
 </symbol>
 <symbol id=icon-minus viewBox="0 0 16 16">
 <path d="m2.00087166 7h11.99825664c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-11.99825664c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule=evenodd></path>
 </symbol>
 <symbol id=icon-error viewBox="0 0 18 18">
 <path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm2.8630343 4.71100931-2.8630343 2.86303426-2.86303426-2.86303426c-.39658757-.39658757-1.03281091-.39438847-1.4265779-.00062147-.39651227.39651226-.39348876 1.03246767.00062147 1.4265779l2.86303426 2.86303426-2.86303426 2.8630343c-.39658757.3965875-.39438847 1.0328109-.00062147 1.4265779.39651226.3965122 1.03246767.3934887 1.4265779-.0006215l2.86303426-2.8630343 2.8630343 2.8630343c.3965875.3965876 1.0328109.3943885 1.4265779.0006215.3965122-.3965123.3934887-1.0324677-.0006215-1.4265779l-2.8630343-2.8630343 2.8630343-2.86303426c.3965876-.39658757.3943885-1.03281091.0006215-1.4265779-.3965123-.39651227-1.0324677-.39348876-1.4265779.00062147z" fill=currentColor fill-rule=evenodd></path>
 </symbol>
 <symbol id=icon-springer-arrow-left>
 <path d="M15 7a1 1 0 000-2H3.385l2.482-2.482a.994.994 0 00.02-1.403 1.001 1.001 0 00-1.417 0L.294 5.292a1.001 1.001 0 000 1.416l4.176 4.177a.991.991 0 001.4.016 1 1 0 00-.003-1.42L3.385 7H15z"></path>
 </symbol>
 <symbol id=icon-springer-arrow-right>
 <path d="M1 7a1 1 0 010-2h11.615l-2.482-2.482a.994.994 0 01-.02-1.403 1.001 1.001 0 011.417 0l4.176 4.177a1.001 1.001 0 010 1.416l-4.176 4.177a.991.991 0 01-1.4.016 1 1 0 01.003-1.42L12.615 7H1z"></path>
 </symbol>
 <symbol id=icon-arrow-up viewBox="0 0 16 16">
 <path d="m12.716625 4.46975946-4.03074003-4.17620792c-.37758093-.39120768-.98937525-.39160691-1.367372.0000316l-4.03091981 4.1763942c-.37759778.39122514-.38381821 1.01908149-.01600053 1.40017357.37750607.39113012.98772445.3930364 1.37006824-.00310603l2.39538588-2.48183446v11.61478958l.00649339.1166211c.055753.4973387.46370161.8833789.95867408.8833789.49497246 0 .90292107-.3860402.95867408-.8833789l.00649338-.1166211v-11.61478958l2.39518592 2.4816273c.3791392.39282216.9863753.40056173 1.3541929.01946965.3775061-.39113012.3778444-1.02492687-.0001355-1.41654791z" fill-rule=evenodd></path>
 </symbol>
 <symbol id=icon-tick viewBox="0 0 24 24">
 <path d="M12,24 C5.372583,24 0,18.627417 0,12 C0,5.372583 5.372583,0 12,0 C18.627417,0 24,5.372583 24,12 C24,18.627417 18.627417,24 12,24 Z M7.657,10.79 C7.45285634,10.6137568 7.18569967,10.5283283 6.91717333,10.5534259 C6.648647,10.5785236 6.40194824,10.7119794 6.234,10.923 C5.87705269,11.3666969 5.93445559,12.0131419 6.364,12.387 L10.261,15.754 C10.6765468,16.112859 11.3037113,16.0695601 11.666,15.657 L17.759,8.713 C18.120307,8.27302248 18.0695334,7.62621189 17.644,7.248 C17.4414817,7.06995024 17.1751516,6.9821166 16.9064461,7.00476032 C16.6377406,7.02740404 16.3898655,7.15856958 16.22,7.368 L10.768,13.489 L7.657,10.79 Z"></path>
 </symbol>
 <symbol id=icon-expand-image viewBox="0 0 18 18">
 <path d="m7.49754099 11.9178212c.38955542-.3895554.38761957-1.0207846-.00290473-1.4113089-.39324695-.3932469-1.02238878-.3918247-1.41130883-.0029047l-4.10273549 4.1027355.00055454-3.5103985c.00008852-.5603185-.44832171-1.006032-1.00155062-1.0059446-.53903074.0000852-.97857527.4487442-.97866268 1.0021075l-.00093318 5.9072465c-.00008751.553948.44841131 1.001882 1.00174994 1.0017946l5.906983-.0009331c.5539233-.0000875 1.00197907-.4486389 1.00206646-1.0018679.00008515-.5390307-.45026621-.9784332-1.00588841-.9783454l-3.51010549.0005545zm3.00571741-5.83449376c-.3895554.38955541-.3876196 1.02078454.0029047 1.41130883.393247.39324696 1.0223888.39182478 1.4113089.00290473l4.1027355-4.10273549-.0005546 3.5103985c-.0000885.56031852.4483217 1.006032 1.0015506 1.00594461.5390308-.00008516.9785753-.44874418.9786627-1.00210749l.0009332-5.9072465c.0000875-.553948-.4484113-1.00188204-1.0017499-1.00179463l-5.906983.00093313c-.5539233.00008751-1.0019791.44863892-1.0020665 1.00186784-.0000852.53903074.4502662.97843325 1.0058884.97834547l3.5101055-.00055449z" fill=currentColor fill-rule=evenodd></path>
 </symbol>
 <symbol id=icon-close viewBox="0 0 16 16">
 <path d="m2.29679575 12.2772478c-.39658757.3965876-.39438847 1.0328109-.00062148 1.4265779.39651227.3965123 1.03246768.3934888 1.42657791-.0006214l4.27724782-4.27724787 4.2772478 4.27724787c.3965876.3965875 1.0328109.3943884 1.4265779.0006214.3965123-.3965122.3934888-1.0324677-.0006214-1.4265779l-4.27724787-4.2772478 4.27724787-4.27724782c.3965875-.39658757.3943884-1.03281091.0006214-1.42657791-.3965122-.39651226-1.0324677-.39348875-1.4265779.00062148l-4.2772478 4.27724782-4.27724782-4.27724782c-.39658757-.39658757-1.03281091-.39438847-1.42657791-.00062148-.39651226.39651227-.39348875 1.03246768.00062148 1.42657791l4.27724782 4.27724782z" fill=currentColor fill-rule=evenodd></path>
 </symbol>
 <symbol id=icon-chevron-right viewBox="0 0 7 12">
 <path d="M2.782 5 .3 2.518c-.393-.392-.4-1.022-.02-1.403a1.001 1.001 0 0 1 1.417 0l4.176 4.177a1.001 1.001 0 0 1 0 1.416l-4.176 4.177a.991.991 0 0 1-1.4.016A1 1 0 0 1 .3 9.481L2.782 7l1.013-.998L2.782 5Z" fill-rule=evenodd></path>
 </symbol>
 <symbol id=icon-checklist-banner viewBox="0 0 56.69 56.69">
 <style>.st0{fill:none}.st1{clip-path:url(#SVGID_2_);fill:none;stroke:#01324B;stroke-width:2;stroke-linecap:round}.st2{clip-path:url(#SVGID_2_);fill:none;stroke:#01324B;stroke-width:2;stroke-linecap:round;stroke-linejoin:round}</style>
 <rect id=transparent_background class=st0 width=56.69 height=56.69></rect>
 <g>
 <clippath id=SVGID_2_>
 <use xlink:href=#SVGID_1_ style=overflow:visible></use>
 </clippath>
 <path class=st1 d="M21.14,34.46c0-6.77,5.48-12.26,12.24-12.26c6.76,0,12.24,5.49,12.24,12.26c0,6.77-5.48,12.26-12.24,12.26
		C26.62,46.71,21.14,41.23,21.14,34.46z M40.47,45.12l10.23,9.22c0,0,1.21,1.09,2.3-0.12l2.09-2.32c0,0,1.09-1.21-0.12-2.3
		l-10.23-9.22 M25.45,34.46c0-4.38,3.55-7.94,7.93-7.94c4.38,0,7.93,3.55,7.93,7.94c0,4.38-3.55,7.94-7.93,7.94
		C29,42.39,25.45,38.84,25.45,34.46z M43.03,47.45l4.14-4.81"></path>
 <path class=st2 d="M8.26,9.75H28.6 M8.26,15.98H28.6 M8.26,22.18h12.5 M35.18,16.98V4.86c0,0,0-2.93-2.93-2.93H4.13
		c0,0-2.93,0-2.93,2.93v37.57c0,0,0,2.93,2.93,2.93h15.01 M8.26,9.75H28.6 M8.26,15.98H28.6 M8.26,22.18h12.5"></path>
 </g>
 <g></g>
 <g></g>
 <g></g>
 <g></g>
 <g></g>
 <g></g>
 </symbol>
 </svg>
 
 
<img src="data:image/gif;base64,R0lGODlhAQABAJAAAP8AAAAAACH5BAUQAAAALAAAAAABAAEAAAICBAEAOw=="><figshare-overlay class="fs-overlay fs-inactive sf-hidden"></figshare-overlay>